US20030236208A1 - Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides - Google Patents
Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides Download PDFInfo
- Publication number
- US20030236208A1 US20030236208A1 US10/307,005 US30700502A US2003236208A1 US 20030236208 A1 US20030236208 A1 US 20030236208A1 US 30700502 A US30700502 A US 30700502A US 2003236208 A1 US2003236208 A1 US 2003236208A1
- Authority
- US
- United States
- Prior art keywords
- oligonucleotide
- oligonucleotides
- dna
- alteration
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- SQBVRLOTCQRRRT-UHFFFAOYSA-N C=C(CC=N1)CC1=C Chemical compound C=C(CC=N1)CC1=C SQBVRLOTCQRRRT-UHFFFAOYSA-N 0.000 description 1
- UXOCACNJPHTVKE-SSZFMOIBSA-N CC/C(/C=C)=C(\CC1CC2)/C=C1C=CC2=C Chemical compound CC/C(/C=C)=C(\CC1CC2)/C=C1C=CC2=C UXOCACNJPHTVKE-SSZFMOIBSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8213—Targeted insertion of genes into the plant genome by homologous recombination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
- C12N2310/3231—Chemical structure of the sugar modified ring structure having an additional ring, e.g. LNA, ENA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the technical field of the invention is oligonucleotide-directed repair or alteration of plant genetic information using novel chemically modified oligonucleotides.
- a number of methods have been developed specifically to alter the genomic information of plants. These methods generally include the use of vectors such as, for example, T-DNA, carrying nucleic acid sequences encoding partial or complete portions of a particular protein which is expressed in a cell or tissue to effect the alteration. The expression of the particular protein then results in the desired phenotype. See, for example, U.S. Pat. No. 4,459,355 which describes a method for transforming plants with a DNA vector and U.S. Pat. No. 5,188,642 which describes cloning or expression vectors containing a transgenic DNA sequence which when expressed in plants confers resistance to the herbicide glyphosate.
- vectors such as, for example, T-DNA
- transgene-containing vectors adds one or more exogenous copies of a gene in a usually random fashion at one or more integration sites of the plant's genome at some variable frequency.
- the introduced gene may be foreign or may be derived from the host plant. Any gene which was originally present in the genome, which may be, for example, a normal allelic variant, mutated, defective, and/or functional copy of the introduced gene, is retained in the genome of the host plant.
- RNA-DNA oligonucleotides requiring contiguous RNA and DNA bases in a double-stranded molecule folded by complementarity into a double hairpin conformation, have been shown to effect single basepair or frameshift alterations, for example, for mutation or repair of plant, animal or fungal genomes. See, for example, WO 99/07865 and U.S. Pat. No. 5,565,350.
- RNA-containing strand of the chimeric RNA-DNA oligonucleotide is designed so as to direct gene alteration, a series of mutagenic reactions resulting in nonspecific base alteration can result. Such a result reduces the utility of such a molecule in methods designed for targeted gene alteration.
- oligo- or poly-nucleotides which require a triplex forming, usually polypurine or polypyrimidine, structural domain which binds to a DNA helical duplex through Hoogsteen interactions between the major groove of the DNA duplex and the oligonucleotide.
- Such oligonucleotides may have an additional DNA reactive moiety, such as psoralen, covalently linked to the oligonucleotide. These reactive moieties function as effective intercalation agents, stabilize the formation of a triplex and can be mutagenic.
- Such agents may be required in order to stabilize the triplex forming domain of the oligonucleotide with the DNA double helix if the Hoogsteen interactions from the oligonucleotide/target base composition are insufficient. See, e.g., U.S. Pat. No. 5,422,251.
- the utility of these oligonucleotides for directing targeted gene alteration is compromised by a high frequency of nonspecific base changes.
- the domain for altering a genome is linked or tethered to the triplex forming domain of the bi-functional oligonucleotide, adding an additional linking or tethering functional domain to the oligonucleotide.
- Such chimeric or triplex forming molecules have distinct structural requirements for each of the different domains of the complete poly- or oligo-nucleotide in order to effect the desired genomic alteration in either episomal or chromosomal targets.
- Oligonucleotides designed for use in the targeted alteration of genetic information are significantly different from oligonucleotides designed for antisense approaches.
- antisense oligonucleotides are perfectly complementary to and bind an mRNA strand in order to modify expression of a targeted mRNA and are used at high concentration. As a consequence, they are unable to produce a gene conversion event by either mutagenesis or repair of a defect in the chromosomal DNA of a host genome.
- antisense oligonucleotides must be complementary to the mRNA and therefore, may not be complementary to the other DNA strand or to genomic sequences that span the junction between intron sequence and exon sequence.
- Artificial chromosomes can be useful for the screening purposes identified herein. These molecules are man-made linear or circular DNA molecules constructed from essential cis-acting DNA sequence elements that are responsible for the proper replication and partitioning of natural chromosomes (Murray et al., 1983). The essential elements are: (1) Autonomous Replication Sequences (ARS), (2) Centromeres, and (3) Telomeres.
- ARS Autonomous Replication Sequences
- Centromeres Centromeres
- Telomeres Telomeres
- Yeast artificial chromosomes allow large segments of genomic DNA to be cloned and modified (Burke et al., Science 236:806; Peterson et al., Trends Genet. 13:61 (1997); Choi, et al., Nat. Genet., 4:117-223 (1993), Davies, et al., Biotechnology 11:911-914 (1993), Matsuura, et al., Hum. Mol. Genet., 5:451-459 (1996), Peterson et al., Proc. Natl. Acad. Sci., 93:6605-6609 (1996); and Schedl, et al., Cell, 86:71-82 (1996)).
- YACs Yeast artificial chromosomes
- YACs have certain advantages over these alternative large capacity cloning vectors (Burke et al., Science, 236:806-812 (1987)).
- the maximum insert size is 35-30 kb for cosmids, and 100 kb for bacteriophage P1, both of which are much smaller than the maximal insert size for a YAC.
- YACs cloning systems based on the E. coli fertility factor that have been developed to construct large genomic DNA insert libraries. They are bacterial artificial chromosomes (BACs) and P-1 derived artificial chromosomes (PACs) (Mejia et al., Genome Res. 7:179-186 (1997); Shizuya et al., Proc. Natl. Acad. Sci. 89:8794-8797 (1992); Sicilnou et al., Nat. Genet., 6:84-89 (1994); Hosoda et al., Nucleic Acids Res. 18:3863 (1990)). BACs are based on the E.
- coli fertility plasmid F factor
- PACs are based on the bacteriophage P1. These vectors propagate at a very low copy number (1-2 per cell) enabling genomic inserts up to 300 kb in size to be stably maintained in recombination deficient hosts.
- the PACs and BACs are circular DNA molecules that are readily isolated from the host genomic background by classical alkaline lysis (Birnboim et al., Nucleic Acids Res. 7:1513-1523 (1979)).
- BACs have been developed for transformation of plants with high-molecular weight DNA using the T-DNA system (Hamilton, Gene 24:107-116 (1997); Frary & Hamilton, Transgenic Res. 10: 121-132 (2001)).
- Novel, modified single-stranded nucleic acid molecules that direct gene alteration in plants are identified and the efficiency of alteration is analyzed both in vitro using a cell-free extract assay and in vivo using a yeast system and a plant system.
- the alteration in an oligonucleotide of the invention may comprise an insertion, deletion, substitution, as well as any combination of these.
- Site specific alteration of DNA is not only useful for studying function of proteins in vivo, but it is also useful for creating plants with desired phenotypes, including, for example, environmental stress tolerance, improved nutritional value, herbicide resistance, disease resistance, modified oil production, modified starch production, and altered floral morphology including selective sterility.
- oligonucleotides of the invention target directed specific gene alterations in genomic double-stranded DNA in cells.
- the target genomic DNA can be nuclear chromosomal DNA as well as plastid or mitochondrial chromosomal DNA.
- the target DNA can also be a transgene present in the plant cell, including, for example, a previously introduced T-DNA.
- the target plant DNA can also be extrachromosomal DNA present in plant or non-plant cells in various forms including, e.g., mammalian artificial chromosomes (MACs), PACs from P-1 vectors, yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs), plant artificial chromosomes (PLACs), as well as episomal DNA, including episomal DNA from an exogenous source such as a plasmid or recombinant vector.
- MACs mammalian artificial chromosomes
- PACs from P-1 vectors
- yeast artificial chromosomes YACs
- BACs bacterial artificial chromosomes
- PLACs plant artificial chromosomes
- episomal DNA including episomal DNA from an exogenous source such as a plasmid or recombinant vector.
- the target DNA may be transcriptionally silent or active.
- the target DNA to be altered is the non-transcribed strand of a genomic DNA duplex.
- the target DNA to be altered is the non-transcribed strand of a transcribed gene of a genomic DNA duplex.
- nucleic acid analogs which increase the nuclease resistance of oligonucleotides that contain them, including, e.g., “locked nucleic acids” or “LNAs”, xylo-LNAs and L-ribo-LNAs; see, for example, Wengel & Nielsen, WO 99/14226; Wengel, WO 00/56748; Wengel, WO 00/66604; and Jakobsen & Koshkin, WO 01/25478 also allow specific targeted alteration of genetic information.
- LNAs locked nucleic acids
- xylo-LNAs xylo-LNAs
- L-ribo-LNAs L-ribo-LNAs
- the assay allows for determining the optimum length of the oligonucleotide, optimum sequence of the oligonucleotide, optimum position of the mismatched base or bases, optimum chemical modification or modifications, optimum strand targeted for identifying and selecting the most efficient oligonucleotide for a particular gene alteration event by comparing to a control oligonucleotide.
- Control oligonucleotides may include a chimeric RNA-DNA double hairpin oligonucleotide directing the same gene alteration event, an oligonucleotide that matches its target completely, an oligonucleotide in which all linkages are phosphorothiolated, an oligonucleotide fully substituted with 2′-O-methyl analogs or an RNA oligonucleotide.
- Such control oligonucleotides either fail to direct a targeted alteration or do so at a lower efficiency as compared to the oligonucleotides of the invention.
- the assay further allows for determining the optimum position of a gene alteration event within an oligonucleotide, optimum concentration of the selected oligonucleotide for maximum alteration efficiency by systematically testing a range of concentrations, as well as optimization of either the source of cell extract by testing different plants or strains, or testing cells derived from different plants or strains, or plant cell lines.
- a series of single-stranded oligonucleotides comprising all RNA or DNA residues and various mixtures of the two, several new structures are identified as viable molecules in nucleotide conversion to direct or repair a genomic mutagenic event.
- the present invention provides oligonucleotides having chemically modified, nuclease resistant residues, preferably at or near the termini of the oligonucleotides, and methods for their identification and use in targeted alteration of plant genetic material, including gene mutation, targeted gene repair and gene knockout.
- the oligonucleotides are preferably used for mismatch repair or alteration by changing at least one nucleic acid base, or for frameshift repair or alteration by addition or deletion of at least one nucleic acid base.
- the oligonucleotides of the invention direct any such alteration, including gene correction, gene repair or gene mutation and can be used, for example, to introduce a polymorphism or haplotype or to eliminate (“knockout”) a particular protein activity.
- gene alterations that knockout a particular protein activity can be obtained using oligonucleotides designed to convert a codon in the coding region of the protein to a stop codon, thus prematurely terminating translation of the protein.
- Oligonucleotides that introduce stop codons in the open-reading-frame of the protein are one embodiment of the invention. Generally, oligonucleotides that introduce stop codons early in the open-reading-frame of the protein are preferred. If the open-reading-frame contains more than one methionine, oligonucleotides that introduce stop codons after the second methionine are preferred.
- oligonucleotides that introduce stop codons in exons after the alternative splice site are preferred.
- the following table provides examples of codons that can be converted to stop codons by altering a single oligonucleotide. A skilled artisan could readily identify other codons that can be converted to stop codons by altering one, two or three of the base pairs in a given codon. Similarly, a skilled artisan could readily identify codons that can be converted to stop codons by a frameshift mutations that inserts or deletes one or two base pairs in the open-reading-frame.
- stop codons can be generated in a single open-reading-frame and that these stop codons can be adjacent in the sequence or separated by intervening codons. Where more than one stop codon is introduced into a single open-reading-frame, such alterations can be generated by a single or multiple oligonucleotides and can be generated simultaneously or by sequential mutagenesis of the target nucleic acid.
- the oligonucleotides of the invention are designed as substrates for homologous pairing and repair enzymes and as such have a unique backbone composition that differs from chimeric RNA-DNA double hairpin oligonucleotides, antisense oligonucleotides, and/or other poly- or oligo-nucleotides used for altering genomic DNA, such as triplex forming oligonucleotides.
- the single-stranded oligo-nucleotides described herein are inexpensive to synthesize and easy to purify.
- an optimized single-stranded oligonucleotide comprising modified residues as described herein is significantly more efficient than a chimeric RNA-DNA double hairpin oligonucleotide in directing a base substitution or frameshift mutation in a cell-free extract assay.
- oligonucleotides having a DNA domain surrounding the targeted base with the domain preferably central to the poly- or oligo-nucleotide, and having at least one modified end, preferably at the 3′ terminal region, are able to alter a target genetic sequence and with an efficiency that is higher than chimeric RNA-DNA double hairpin oligonucleotides disclosed in U.S. Pat. No. 5,565,350.
- Preferred oligonucleotides of the invention have at least two modified bases on at least one of the termini, preferably the 3′ terminus of the oligonucleotide.
- Oligonucleotides of the invention can efficiently be used to introduce targeted alterations in a genetic sequence of DNA in the presence of human, animal, plant, fungal (including yeast) proteins and in cells of different types including, for example, plant cells, fungal cells including S. cerevisiae, Ustillago maydis, Candida albicans, and mammalian cells.
- Particularly preferred are cells and cell extracts derived from plants including, for example, experimental model plants such as Chiamydomonas reinhardtii, Physcomitrella patens, and Arabidopsis thaliana in addition to crop plants such as cauliflower ( Brassica oleracea ), artichoke ( Cynara scolymus ), fruits such as apples ( Malus, e.g.
- leek Allium, e.g. porrum
- lettuce Lactuca, e.g. sativa
- spinach Spinacia, e.g. oleraceae
- tobacco Nicotiana, e.g. tabacum
- roots such as arrowroot ( Maranta, e.g. arundinacea ), beet ( Beta, e.g. vulgaris ), carrot ( Daucus, e.g. carota ), cassava ( Manihot, e.g. esculenta ), turnip ( Brassica, e.g. rapa ), radish ( Raphanus, e.g.
- oilseeds such as beans ( Phaseolus, e.g. vulgaris ), pea ( Pisum, e.g. sativum ), soybean ( Glycine, e.g. max ), cowpea ( Vigna unguiculata ), mothbean ( Vigna aconitifolia ), wheat ( Triticum, e.g. aestivum ), sorghum ( Sorghum e.g. bicolor ), barley ( Hordeum, e.g. vulgare ), corn ( Zea, e.g.
- ssypium mays ), rice ( Oryza, e.g. sativa ), rapeseed ( Brassica napus ), millet (Panicum sp.), sunflower ( Helianthus annuus ), oats ( Avena sativa ), chickpea ( Cicer, e.g. arietinum ); tubers, such as kohlrabi ( Brassica, e.g. oleraceae ), potato ( Solanum, e.g. tuberosum ) and the like; fiber and wood plants, such as flax ( Linum e.g. usitatissimum ), cotton ( Gossypium e.g.
- hirsutum pine (Pinus sp.), oak (Quercus sp.), eucalyptus (Eucalyptus sp.), and the like and ornamental plants such as turfgrass ( Lolium, e.g. rigidum ), petunia ( Petunia, e.g. x hybrida ), hyacinth ( Hyacinthus orientalis ), carnation ( Dianthus e.g. caryophyllus ), delphinium ( Delphinium, e.g.
- the DNA domain of the oligonucleotides is preferably fully complementary to one strand of the gene target, except for the mismatch base or bases responsible for the gene alteration event(s).
- the contiguous bases may be either RNA bases or, preferably, are primarily DNA bases.
- the central DNA domain is generally at least 8 nucleotides in length.
- the base(s) targeted for alteration in the most preferred embodiments are at least about 8, 9 or 10 bases from one end of the oligonucleotide.
- one or both of the termini of the oligonucleotides of the present invention comprise phosphorothioate modifications, LNA backbone (including LNA derivatives and analogs) modifications, or 2′-O-methyl base analogs, or any combination of these modifications.
- Oligonucleotides comprising 2′-O-methyl or LNA analogs are a mixed DNA/RNA polymer.
- the oligonucleotides of the invention are, however, single-stranded and are not designed to form a stable internal duplex structure within the oligonucleotide.
- the efficiency of gene alteration is surprisingly increased with oligonucleotides having internal complementary sequence comprising phosphorothioate modified bases as compared to 2′-O-methyl modifications.
- This result indicates that specific chemical interactions are involved between the converting oligonucleotide and the proteins involved in the conversion.
- the effect of other such chemical interactions to produce nuclease resistant termini using modifications other than LNA (including LNA derivatives or analogs), phosphorothioate linkages, or 2′-O-methyl analog incorporation into an oligonucleotide can not yet be predicted because the proteins involved in the alteration process and their particular chemical interaction with the oligonucleotide substituents are not yet known and cannot be predicted.
- oligonucleotides of defined sequence are provided for alteration of genes in particular plants. Provided the teachings of the instant application, one of skill in the art could readily design oligonucleotides to introduce analogous alterations in homologous genes from any plant. Furthermore, in the tables of these examples, the oligonucleotides of the invention are not limited to the particular sequences disclosed. The oligonucleotides of the invention include extensions of the appropriate sequence of the longer 120 base oligonucleotides which can be added base by base to the smallest disclosed oligonucleotides of 17 bases.
- oligonucleotides of the invention include for each correcting change, oligonucleotides of length 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114,
- nucleic acids of up to 240 bases which comprise the sequences disclosed herein may be used.
- the oligonucleotides of the invention do not require a symmetrical extension on either side of the central DNA domain.
- the oligonucleotides of the invention as disclosed in the various tables for alteration of particular plant genes contain phosphorothioate linkages, 2′-O-methyl analog or LNA (including LNA derivatives and analogs) or any combination of these modifications just as the assay oligonucleotides do.
- oligonucleotides that contain any particular nuclease resistant modification.
- Oligonucleotides of the invention may be altered with any combination of additional LNAs (including LNA derivatives and analogs), phosphorothioate linkages or 2′-O-methyl analogs to maximize conversion efficiency.
- additional LNAs including LNA derivatives and analogs
- phosphorothioate linkages or 2′-O-methyl analogs to maximize conversion efficiency.
- internal as well as terminal region segments of the backbone may be altered.
- simple fold-back structures at each end of a oligonucleotide or appended end groups may be used in addition to a modified backbone for conferring additional nuclease resistance.
- the different oligonucleotides of the present invention preferably contain more than one of the aforementioned backbone modifications at each end.
- the backbone modifications are adjacent to one another.
- the optimal number and placement of backbone modifications for any individual oligonucleotide will vary with the length of the oligonucleotide and the particular type of backbone modification(s) that are used. If constructs of identical sequence having phosphorothioate linkages are compared, 2, 3, 4, 5, or 6 phosphorothioate linkages at each end are preferred. If constructs of identical sequence having 2′-O-methyl base analogs are compared, 1, 2, 3 or 4 analogs are preferred.
- the optimal number and type of backbone modifications for any particular oligo-nucleotide useful for altering target DNA may be determined empirically by comparing the alteration efficiency of the oligonucleotide comprising any combination of the modifications to a control molecule of comparable sequence using any of the assays described herein.
- the optimal position(s) for oligonucleotide modifications for a maximally efficient altering oligonucleotide can be determined by testing the various modifications as compared to control molecule of comparable sequence in one of the assays disclosed herein.
- a control molecule includes, e.g., a completely 2′-O-methyl substituted molecule, a completely complementary oligonucleotide, or a chimeric RNA-DNA double hairpin.
- Efficiency of conversion is defined herein as the percentage of recovered substrate molecules that have undergone a conversion event. Depending on the nature of the target genetic material, e.g. the genome of a cell, efficiency could be represented as the proportion of cells or clones containing an extrachromosomal element that exhibit a particular phenotype. Alternatively, representative samples of the target genetic material can be sequenced to determine the percentage that have acquired the desire change.
- the oligonucleotides of the invention in different embodiments can alter DNA two, three, four, five, six, seven, eight, nine, ten, twelve, fifteen, twenty, thirty, and fifty or more fold more than control oligonucleotides.
- Such control oligonucleotides are oligonucleotides with fully phosphorothiolated linkages, oligonucleotides that are fully substituted with 2′-O-methyl analogs, a perfectly matched oligonucleotide that is fully complementary to a target sequence or a chimeric DNA-RNA double hairpin oligonucleotide such as disclosed in U.S. Pat. No. 5,565,350.
- the oligonucleotides of the invention as optimized for the purpose of targeted alteration of genetic material, including gene knockout or repair, are different in structure from antisense oligo-nucleotides that may possess a similar mixed chemical composition backbone.
- the oligonucleotides of the invention differ from such antisense oligonucleotides in chemical composition, structure, sequence, and in their ability to alter genomic DNA.
- antisense oligonucleotides fail to direct targeted gene alteration.
- the oligonucleotides of the invention may target either strand of DNA and can include any component of the genome including, for example, intron and exon sequences.
- the preferred embodiment of the invention is a modified oligonucleotide that binds to the non-transcribed strand of a genomic DNA duplex.
- the preferred oligonucleotides of the invention target the sense strand of the DNA, i.e. the oligonucleotides of the invention are complementary to the non-transcribed strand of the target duplex DNA.
- the sequence of the non-transcribed strand of a DNA duplex is found in the mRNA produced from that duplex, given that mRNA uses uracil-containing nucleotides in place of thymine-containing nucleotides.
- the molecules of the invention lack any particular triplex forming domain involved in Hoogsteen interactions with the DNA double helix and required by other known oligonucleotides in other oligonucleotide-dependant gene conversion systems. Although the lack of these functional domains was expected to decrease the efficiency of an alteration in a sequence, just the opposite occurs: the efficiency of sequence alteration using the modified oligonucleotides of the invention is higher than the efficiency of sequence alteration using a chimeric RNA-DNA hairpin targeting the same sequence alteration.
- the efficiency of sequence alteration or gene conversion directed by an unmodified oligonucleotide is many times lower as compared to a control chimeric RNA-DNA molecule or the modified oligonucleotides of the invention targeting the same sequence alteration.
- molecules containing at least 3 2′-O-methyl base analogs are about four to five fold less efficient as compared to an oligonucleotide having the same number of phosphorothioate linkages.
- the oligonucleotides of the present invention for alteration of a single base are about 17 to about 121 nucleotides in length, preferably about 17 to about 74 nucleotides in length. Most preferably, however, the oligonucleotides of the present invention are at least about 25 bases in length, unless there are self-dimerization structures within the oligonucleotide. If the oligonucleotide has such an unfavorable structure, lengths longer than 35 bases are preferred. Oligonucleotides with modified ends both shorter and longer than certain of the exemplified, modified oligonucleotides herein function as gene repair or gene knockout agents and are within the scope of the present invention.
- oligomer Once an oligomer is chosen, it can be tested for its tendency to self-dimerize, since self-dimerization may result in reduced efficiency of alteration of genetic information. Checking for self-dimerization tendency can be accomplished manually or, preferably, using a software program.
- Oligo Analyzer 2.0 available through Integrated DNA Technologies (Coralville, Iowa 52241) (http://www.idtdna.com); this program is available for use on the world wide web at http://www.idtdna.com/program/oligoanalyzer/oligoanalyzer.asp.
- Oligo Analyzer 2.0 reports possible self-dimerized duplex forms, which are usually only partially duplexed, along with the free energy change associated with such self-dimerization. Delta G-values that are negative and large in magnitude, indicating strong self-dimerization potential, are automatically flagged by the software as “bad”.
- Another software program that analyzes oligomers for pair dimer formation is Primer Select from DNASTAR, Inc., 1228 S. Park St., Madison, Wis. 53715, Phone: (608) 258-7420 (http://www.dnastar.com/products/PrimerSelect.html).
- the oligonucleotides of the present invention are identical in sequence to one strand of the target DNA, which can be either strand of the target DNA, with the exception of one or more targeted bases positioned within the DNA domain of the oligonucleotide, and preferably toward the middle between the modified terminal regions.
- the difference in sequence of the oligonucleotide as compared to the targeted genomic DNA is located at about the middle of the oligo-nucleotide sequence.
- the oligonucleotides of the invention are complementary to the non-transcribed strand of a duplex.
- the preferred oligonucleotides target the sense strand of the DNA i.e. the oligonucleotides of the invention are preferably complementary to the strand of the target DNA the sequence of which is found in the mRNA.
- the oligonucleotides of the invention can include more than a single base change.
- multiple bases can be simultaneously targeted for change.
- the target bases may be up to 27 nucleotides apart and may not be changed together in all resultant plasmids in all cases. There is a frequency distribution such that the closer the target bases are to each other in the central DNA domain within the oligonucleotides of the invention, the higher the frequency of change in a given cell.
- Target bases only two nucleotides apart are changed together in every case that has been analyzed. The farther apart the two target bases are, the less frequent the simultaneous change.
- oligonucleotides of the invention may be used to repair or alter multiple bases rather than just one single base.
- a base change event up to about 27 nucleotides away can also be effected.
- the positions of the altering bases within the oligonucleotide can be optimized using any one of the assays described herein.
- the altering bases are at least about 8 nucleotides from one end of the oligonucleotide.
- the oligonucleotides of the present invention can be introduced into cells by any suitable means.
- the modified oligonucleotides may be used alone.
- Suitable means include the use of polycations, cationic lipids, liposomes, polyethylenimine (PEI), electroporation, biolistics, microinjection and other methods known in the art to facilitate cellular uptake.
- PEI polyethylenimine
- electroporation biolistics, microinjection and other methods known in the art to facilitate cellular uptake.
- biolistic or particle bombardment methods are typically used.
- isolated plant cells are treated in culture according to the methods of the invention, to mutate or repair a target gene.
- plant target DNA may be modified in vitro or in another cell type, including for example, yeast or bacterial cells and then introduced into a plant cell as, for example, a T-DNA.
- Plant cells thus modified may be used to regenerate the whole organism as, for example, in a plant having a desired targeted genomic change.
- targeted genomic alteration including repair or mutagenesis, may take place in vivo following direct administration of the modified, single-stranded oligonucleotides of the invention to a subject.
- the single-stranded, modified oligonucleotides of the present invention have numerous applications as gene repair, gene modification, or gene knockout agents. Such oligonucleotides may be advantageously used, for example, to introduce or correct multiple point mutations. Each mutation leads to the addition, deletion or substitution of at least one base pair.
- the methods of the present invention offer distinct advantages over other methods of altering the genetic makeup of an organism, in that only the individually targeted bases are altered. No additional foreign DNA sequences are added to the genetic complement of the organism.
- Such agents may, for example, be used to develop plants with improved traits by rationally changing the sequence of selected genes in isolated cells and using these modified cells to regenerate whole plants having the altered gene. See, e.g., U.S. Pat. No.
- Such plants produced using the compositions of the invention lack additional undesirable selectable markers or other foreign DNA sequences.
- Targeted base pair substitution or frameshift mutations introduced by an oligonucleotide in the presence of a cell-free extract also provides a way to modify the sequence of extrachromosomal elements, including, for example, plasmids, cosmids and artificial chromosomes.
- the oligonucleotides of the invention also simplify the production of plants having particular modified or inactivated genes. Altered plant model systems such as those produced using the methods and oligonucleotides of the invention are invaluable in determining the function of a gene and in evaluating drugs.
- the oligonucleotides and methods of the present invention may also be used to introduce molecular markers, including, for example, SNPs, RFLPs, AFLPs and CAPs.
- the purified oligonucleotide compositions may be formulated in accordance with routine procedures depending on the target.
- purified oligonucleotide can be used directly in a standard reaction mixture to introduce alterations into targeted DNA in vitro or where cells are the target as a composition adapted for bathing cells in culture or for microinjection into cells in culture.
- the purified oligonucleotide compositions may also be provided on coated microbeads for biolistic delivery into plant cells. Where necessary, the composition may also include a solubilizing agent.
- the ingredients will be supplied either separately or mixed together in single-use form, for example, as a dry, lyophilized powder or water-free concentrate.
- dosage required for efficient targeted gene alteration will range from about 0.001 to 50,000 ⁇ g/kg target tissue, preferably between 1 to 250 ⁇ g/kg, and most preferably at a concentration of between 30 and 60 micromolar.
- DOTAP Boehringer-Mannheim
- the amount of the oligonucleotide used is about 500 nanograms in 3 micrograms of DOTAP per 100,000 cells.
- microbeads are generally coated with resuspended oligonucleotides, which range of oligonucleotide to microbead concentration can be similarly adjusted to improve efficiency as determined using one of the assay methods described herein, starting with about 0.05 to 1 microgram of oligonucleotide to 25 microgram of 1.0 micrometer gold beads or similar microcarrier.
- kits comprising at least one oligonucleotide of the invention.
- the kit may comprise an additional reagent or article of manufacture.
- the additional reagent or article of manufacture may comprise a delivery mechanism, cell extract, a cell, or a plasmid, such as one of those disclosed in the Figures herein, for use in an assay of the invention.
- the invention includes a kit comprising an isogenic set of cells in which each cell in the kit comprises a different altered amino acid for a target protein encoded by a targeted altered gene within the cell produced according to the methods of the invention.
- FIG. 1 Flow diagram for the generation of modified single-stranded oligonucleotides.
- the upper strands of chimeric oligonucleotides I and II are separated into pathways resulting in the generation of single-stranded oligonucleotides that contain (A) 2′-O-methyl RNA nucleotides or (B) phosphorothioate linkages.
- Fold changes in repair activity for correction of kan s in the HUH7 cell-free extract are presented in parenthesis.
- HUH7 cells are described in Nakabayashi et al., Cancer Research 42: 3858-3863 (1982).
- Each single-stranded oligonucleotide is 25 bases in length and contains a G residue mismatched to the complementary sequence of the kan s gene.
- the numbers 3, 6, 8, 10, 12 and 12.5 respectively indicate how many phosphorothioate linkages (S) or 2′-O-methyl RNA nucleotides (R) are at each end of the molecule.
- oligo 12S/25G contains an all phosphorothioate backbone, displayed as a dotted line. Smooth lines indicate DNA residues, wavy lines indicate 2′-O-methyl RNA residues and the carat indicates the mismatched base site (G).
- FIG. 1(C) provides a schematic plasmid indicating the sequence of the kan chimeric double-stranded hairpin oligonucleotide (left; SEQ ID NO: 2673) and the sequence the tet chimeric double-stranded hairpin oligonucleotide used in other experiments (right; SEQ ID NO: 2674).
- FIG. 1(D) provides a flow chart of a kan experiment in which a chimeric double-stranded hairpin oligonucleotide (SEQ ID NO: 2673) is used.
- SEQ ID NO: 2673 a chimeric double-stranded hairpin oligonucleotide
- the Kan mutant sequence corresponds to SEQ ID NO: 2675 and SEQ ID NO: 2676; the Kan converted sequence corresponds to SEQ ID NO: 2677 and SEQ ID NO: 2678; the mutant sequence in the sequence trace corresponds to SEQ ID NO: 2679 and the converted sequences in the sequence trace correspond to SEQ ID NO: 2680.
- FIG. 2 Genetic readout system for correction of a point mutation in plasmid pK s m4021.
- a mutant kanamycin gene harbored in plasmid pK s m4021 is the target for correction by oligonucleotides.
- the mutant G is converted to a C by the action of the oligo.
- Corrected plasmids confer resistance to kanamycin in E.coli (DH10B) after electroporation leading to the genetic readout and colony counts.
- the wild type sequence corresponds to SEQ ID NO: 2681.
- FIG. 3 Target plasmid and sequence correction of a frameshift mutation by chimeric and single-stranded oligonucleotides.
- Plasmid pT s ⁇ 208 contains a single base deletion mutation at position 208 rendering it unable to confer tet resistance.
- the target sequence presented below indicates the insertion of a T directed by the oligonucleotides to re-establish the resistant phenotype.
- B DNA sequence confirming base insertion directed by Tet 3S/25G; the yellow highlight indicates the position of frameshift repair.
- the wild type sequence corresponds to SEQ ID NO: 2682
- the mutant sequence corresponds to SEQ ID NO: 2683
- the converted sequence corresponds to SEQ ID NO: 2684.
- the control sequence in the sequence trace corresponds to SEQ ID NO: 2685 and the 3S/25A sequence in the sequence trace corresponds to SEQ ID NO: 2686.
- FIG. 4 DNA sequences of representative kan r colonies. Confirmation of sequence alteration directed by the indicated molecule is presented along with a table outlining codon distribution. Note that 10S/25G and 12S/25G elicit both mixed and unfaithful gene repair. The number of clones sequenced is listed in parentheses next to the designation for the single-stranded oligonucleotide. A plus (+) symbol indicates the codon identified while a figure after the (+) symbol indicates the number of colonies with a particular sequence. TAC/TAG indicates a mixed peak. Representative DNA sequences are presented below the table with yellow highlighting altered residues.
- sequences in the sequence traces have been assigned numbers as follows: 3S/25G, 6S/25G and 8S/25G correspond to SEQ ID NO: 2687, 10S/25G corresponds to SEQ ID NO: 2688, 25S/25G on the lower left corresponds to SEQ ID NO: 2689 and 25S/25G on the lower right corresponds to SEQ ID NO: 2690.
- FIG. 5 Gene correction in HeLa cells.
- Representative oligonucleotides of the invention are co-transfected with the pCMVneo( ⁇ )FIAsH plasmid (shown in FIG. 9) into HeLa cells.
- Ligand is diffused into cells after co-transfection of plasmid and oligonucleotides.
- Green fluorescence indicates gene correction of the mutation in the antibiotic resistance gene. Correction of the mutation results in the expression of a fusion protein that carries a marker ligand binding site and when the fusion protein binds the ligand, a green fluorescence is emitted.
- the ligand is produced by Aurora Biosciences and can readily diffuse into cells enabling a measurement of corrected protein function; the protein must bind the ligand directly to induce fluorescence. Hence cells bearing the corrected plasmid gene appear green while “uncorrected” cells remain colorless.
- FIG. 6 Z-series imaging of corrected cells. Serial cross-sections of the HeLa cell represented in FIG. 5 are produced by Zeiss 510 LSM confocal microscope revealing that the fusion protein is contained within the cell.
- FIG. 7 Hygromycin-eGFP target plasmids.
- Plasmid pAURHYG(ins)GFP contains a single base insertion mutation between nucleotides 136 and 137, at codon 46, of the Hygromycin B coding sequence (cds) which is transcribed from the constitutive ADH1 promoter.
- the target sequence presented below indicates the deletion of an A and the substitution of a C for a T directed by the oligonucleotides to re-establish the resistant phenotype.
- FIG. 1 Plasmid pAURHYG(ins)GFP
- Plasmid pAURHYG(rep)GFP contains a base substitution mutation introducing a G at nucleotide 137, at codon 46, of the Hygromycin B coding sequence (cds).
- the target sequence presented below the diagram indicates the amino acid conservative replacement of G with C, restoring gene function.
- the sequence of the normal allele correspond to SEQ ID NO: 2691
- the sequence of the targe/existing mutation corresponds to SEQ ID NO: 2694
- the sequence of the desired alteration corresponds to SEQ ID NO: 2693.
- FIG. 8 Oligonucleotides for correction of hygromycin resistance gene. The sequence of the oligonucleotides used in experiments to assay correction of a hygromycin resistance gene are shown. DNA residues are shown in capital letters, RNA residues are shown in lowercase and nucleotides with a phosphorothioate backbone are capitalized and underlined. In FIG.
- the sequence of HygE3T/25 corresponds to SEQ ID NO: 2695
- the sequence of HygE3T/74 corresponds to SEQ ID NO: 2696
- the sequence of HygE3T/74a corresponds to SEQ ID NO: 2697
- the sequence of HygGG/Rev corresponds to SEQ ID NO: 2698
- the sequence of Kan70T corresponds to SEQ ID NO: 2699.
- FIG. 9 pAURNeo( ⁇ )FIAsH plasmid. This figure describes the plasmid structure, target sequence, oligonucleotides, and the basis for detection of the gene alteration event by fluorescence.
- the sequence of the Neo/kan target mutant corresponds to SEQ ID NO: 2675 and SEQ ID NO: 2676
- the converted sequence corresponds to SEQ ID NO: 2677 and SEQ ID NO: 2678
- the FIAsH peptide sequence corresponds to SEQ ID NO: 2700.
- FIG. 10 pYESHyg(x)eGFP plasmid.
- This plasmid is a construct similar to the pAURHyg(x)eGFP construct shown in FIG. 7, except the promoter is the inducible GAL1 promoter. This promoter is inducible with galactose, leaky in the presence of raffinose, and repressed in the presence of dextrose.
- FIG. 11 pBI-HygeGFP plasmid.
- This plasmid is a construct based on the plasmids pBI101, pBI 101.2, pBI101.3 or pBI 121 available from Clontech in which HygeGFP replaces the beta-glucuronidase gene of the Clontech plasmids.
- the different Clontech plasmids vary by a reading frame shift relative to the polylinker, or the presence of the Cauliflower mosaic virus promoter.
- single-stranded and double-hairpin oligonucleotides with chimeric backbones are used to correct a point mutation in the kanamycin gene of pK s m4021 (FIG. 2) or the tetracycline gene of pT s ⁇ 208 (FIG. 3).
- All kan oligonucleotides share the same 25 base sequence surrounding the target base identified for change, just as all tet oligonucleotides do. The sequence is given in FIG. 1C and FIG. 1D.
- Each plasmid contains a functional ampicillin gene.
- Kanamycin gene function is restored when a G at position 4021 is converted to a C (via a substitution mutation); tetracycline gene function is restored when a deletion at position 208 is replaced by a C (via frameshift mutation).
- a separate plasmid, pAURNeo( ⁇ )FIAsH (FIG. 9), bearing the kan s gene is used in the cell culture experiments.
- This plasmid was constructed by inserting a synthetic expression cassette containing a neomycin phosphotransferasea (kanamycin resistance) gene and an extended reading frame that encodes a receptor for the FIAsH ligand into the pAUR123 shuttle vector (Panvera Corp., Madison, Wis.). The resulting construct replicates in S.
- Neo+/FIAsH fusion product after alteration
- Neo ⁇ /FIAsH product before alteration
- Additional constructs can be made to test additional gene alteration events or for specific use in different expression systems.
- alternative comparable plant plasmids or integration vectors such as, e.g. those based on T-DNA, can be constructed for stable expression in plant cells according to the disclosures herein.
- Such constructs would use a plant specific promoter such as, e.g., cauliflower mosaic virus 35S promoter, to replace the promoters directing expression of the neo, hyg or aureobasidinA resistance gene disclosed herein, including for example, in FIGS. 7B, 9 and 10 herein.
- the green fluorescent protein (GFP) sequence used herein may be modified to increase expression in plant cells such as Arabidopsis and the other plants disclosed herein as described in Haseloff et al., Proc. Natl.Acad. Sci. 94(6): 2122-7 (1997), Rouwendal et al. Plant Mol. Biol. 33(6): 989-99 (1997) and Hu et al. FEBS Lett. 369(2-3): 331-4 (1995). Codon usage for optimal expression of GFP in plants results from increasing the frequency of codons with a C or a G in the third position from 32 to about 60%. Specific constructs are disclosed and can be used as follows with such plant specific alterations.
- pHYGeGFP plasmid Invitrogen, CA DNA as a template to introduce the mutations into the hygromycin-eGFP fusion gene by a two step site-directed mutagenesis PCR protocol.
- a 215 bp 5′ amplicon for the (rep), ( ⁇ ) or (ins) was generated by polymerization from oligonucleotide primer HygEGFPf (5′-AATACGACTCACTATAGG-3′; SEQ ID NO: 2701) to primer Hygrepr (5′GACCTATCCACGCCCTCC-3′; SEQ ID NO: 2702), Hyg ⁇ r (5′-GACTATCCACGCCCTCC-3′; SEQ ID NO: 2703), or Hyginsr (5′-GACATTATCCACGCCCTCC-3′; SEQ ID NO: 2704), respectively.
- Oligonucleotide synthesis and cells Chimeric oligonucleotides and single-stranded oligonucleotides (including those with the indicated modifications) are synthesized using available phosphoramidites on controlled pore glass supports. After deprotection and detachment from the solid support, each oligonucleotide is gel-purified using, for example, procedures such as those described in Gamper et al., Biochem. 39, 5808-5816 (2000) and the concentrations determined spectrophotometrically (33 or 40 ⁇ g/ml per A 260 unit of single-stranded or hairpin oligomer).
- HUH7 cells are grown in DMEM, 10% FBS, 2 mM glutamine, 0.5% pen/strep.
- the E.coli strain, DH10B is obtained from Life Technologies (Gaithersburg, Md.); DH10B cells contain a mutation in the RECA gene (recA).
- Cell-free extracts Although this portion of this example is directed to mammalian systems, similar extracts from plants can be prepared as disclosed elsewhere in this application and used as disclosed in this example.
- We employ this protocol with essentially any mammalian cell including, for example, H1299 cells (human epithelial carcinoma, non-small cell lung cancer), C127I (immortal murine mammary epithelial cells), MEF (mouse embryonic fibroblasts), HEC-1-A (human uterine carcinoma), HCT15 (human colon cancer), HCT116 (human colon carcinoma), LoVo (human colon adenocarcinoma), and HeLa (human cervical carcinoma).
- yeast S. cerevisiae
- Ustilago maydis Ustilago maydis
- Candida albicans cell-free extracts obtained from fungal cells, including, for example, S. cerevisiae (yeast), Ustilago maydis, and Candida albicans.
- yeast cells For example, we grow yeast cells into log phase in 2L YPD medium for 3 days at 30° C. We then centrifuge the cultures at 5000 ⁇ g, resuspend the pellets in a 10% sucrose, 50 mM Tris, 1 mM EDTA lysis solution and freeze them on dry ice. After thawing, we add KCl, spermidine and lyticase to final concentrations of 0.25 mM, 5 mM and 0.1 mg/ml, respectively.
- Reaction mixtures of 50 ⁇ l consisting of 10-30 ⁇ g protein of cell-free extract, which can be optionally substituted with purified proteins or enriched fractions, about 1.5 ⁇ g chimeric double-hairpin oligonucleotide or 0.55 ⁇ g single-stranded molecule (3S/25G or 6S/25G, see FIG. 1), and 1 ⁇ g of plasmid DNA (see FIGS. 2 and 3) in a reaction buffer of 20 mM Tris, pH 7.4, 15 mM MgCl 2 , 0.4 mM DTT, and 1.0 mM ATP. Reactions are initiated with extract and incubated at 30° C. for 45 min.
- the reaction is stopped by placing the tubes on ice and then immediately deproteinized by two phenol/chloroform (1:1) extractions. Samples are then ethanol precipitated.
- the nucleic acid is pelleted at 15,000 r.p.m. at 4° C. for 30 min., is washed with 70% ethanol, resuspended in 50 ⁇ l H 2 O, and is stored at ⁇ 20° C. 5 ⁇ l of plasmid from the resuspension ( ⁇ 100 ng) was transfected in 20 ⁇ l of DH10B cells by electroporation (400 V, 300 ⁇ F, 4 k ⁇ ) in a Cell-Porator apparatus (Life Technologies).
- FIG. 1 Chimeric single-stranded oligonucleotides.
- the upper strands of chimeric oligonucleotides I and II are separated into pathways resulting in the generation of single-stranded oligo-nucleotides that contain (FIG. 1A) 2′-O-methyl RNA nucleotides or (FIG. 1B) phosphorothioate linkages.
- Fold changes in repair activity for correction of kan s in the HUH7 cell-free extract are presented in parenthesis.
- Each single-stranded oligonucleotide is 25 bases in length and contains a G residue mismatched to the complementary sequence of the kan s gene.
- a reduction in alteration activity may be observed as the number of modified linkages in the molecule is further increased.
- a single-strand molecule containing 24 phosphorothioate linkages is minimally active suggesting that this backbone modification when used throughout the molecule supports only a low level of targeted gene repair or alteration.
- Such a non-altering, completely modified molecule can provide a baseline control for determining efficiency of correction for a specific oligonucleotide molecule of known sequence in defining the optimum oligonucleotide for a particular alteration event.
- oligo 12S/25G represents a 25-mer oligonucleotide which contains 12 phosphorothioate linkages on each side of the central G target mismatch base producing a fully phosphorothioate linked backbone, displayed as a dotted line.
- the dots are merely representative of a linkage in the figure and do not depict the actual number of linkages of the oligonucleotide.
- Smooth lines indicate DNA residues
- wavy lines indicate 2′-O-methyl RNA residues
- the carat indicates the mismatched base site (G).
- the cells are co-transfected with 10 ⁇ g of plasmid pAURNeo( ⁇ ) FIAsH and 5 ⁇ g of modified single-stranded oligonucleotide (3S/25G) that is previously complexed with 10 ⁇ g lipofectamine, according to the manufacturer's directions (Life Technologies).
- the cells are treated with the liposome-DNA-oligo mix for 6 hrs at 37° C. Treated cells are washed with PBS and fresh DMEM is added. After a 16-18 hr recovery period, the culture is assayed for gene repair.
- oligonucleotide used in the cell-free extract experiments is used to target transfected plasmid bearing the kan s gene. Correction of the point mutation in this gene eliminates a stop codon and restores full expression. This expression can be detected by adding a small non-fluorescent ligand that bound to a C-C-R-E-C-C sequence (SEQ ID NO: 2717) in the genetically modified carboxy terminus of the kan protein, to produce a highly fluorescent complex (FIAsH system, Aurora Biosciences Corporation).
- Tables 1, 2 and 3 respectively provide data on the efficiency of gene repair directed by single-stranded oligonucleotides.
- Table 1 presents data using a cell-free extract from human liver cells (HUH7) to catalyze repair of the point mutation in plasmid pkan s m4021 (see FIG. 1).
- Table 2 illustrates that the oligomers are not dependent on MSH2 or MSH3 for optimal gene repair activity.
- Table 3 illustrates data from the repair of a frameshift mutation (FIG. 3) in the tet gene contained in plasmid pTet ⁇ 208.
- Table 4 illustrates data from repair of the pkan s m4021 point mutation catalyzed by plant cell extracts prepared from canola and musa (banana). Colony numbers are presented as kan r or tet r and fold increases (single strand versus double hairpin) are presented for kan r in Table 1.
- FIG. 5A is a confocal picture of HeLa cells expressing the corrected fusion protein from an episomal target. Gene repair is accomplished by the action of a modified single-stranded oligonucleotide containing 3 phosphorothioate linkages at each end (3S/25G).
- FIG. 5B represents a “Z-series” of HeLa cells bearing the corrected fusion gene. This series sections the cells from bottom to top and illustrates that the fluorescent signal is “inside the cells”.
- This strategy centers around the use of extracts from various sources to correct a mutation in a plasmid using a modified single-stranded or a chimeric RNA-DNA double hairpin oligonucleotide.
- a mutation is placed inside the coding region of a gene conferring antibiotic resistance in bacteria, here kanamycin or tetracycline. The appearance of resistance is measured by genetic readout in E.coli grown in the presence of the specified antibiotic. The importance of this system is that both phenotypic alteration and genetic inheritance can be measured.
- Plasmid pK s m4021 contains a mutation (T ⁇ G) at residue 4021 rendering it unable to confer antibiotic resistance in E.coli.
- This point mutation is targeted for repair by oligonucleotides designed to restore kanamycin resistance.
- the directed correction is from G ⁇ C rather than G ⁇ T (wild-type).
- the plasmid is electroporated into the DH10B strain of E.coli, which contains inactive RecA protein.
- the number of kanamycin colonies is counted and normalized by ascertaining the number of ampicillin colonies, a process that controls for the influence of electroporation.
- the number of colonies generated from three to five independent reactions was averaged and is presented for each experiment. A fold increase number is recorded to aid in comparison.
- the original RNA-DNA double hairpin chimera design e.g., as disclosed in U.S. Pat. No. 5,565,350, consists of two hybridized regions of a single-stranded oligonucleotide folded into a double hairpin configuration.
- the double-stranded targeting region is made up of a 5 base pair DNA/DNA segment bracketed by 10 base pair RNA/DNA segments.
- the central base pair is mismatched to the corresponding base pair in the target gene.
- Frame shift mutations are repaired.
- plasmid pT s ⁇ 208 described in FIG. 1(C) and FIG. 3, the capacity of the modified single-stranded molecules that showed activity in correcting a point mutation, can be tested for repair of a frameshift.
- a chimeric oligonucleotide (Tet I), which is designed to insert a T residue at position 208, is used.
- a modified single-stranded oligonucleotide (Tet IX) directs the insertion of a T residue at this same site.
- FIG. 3 illustrates the plasmid and target bases designated for change in the experiments.
- Oligonucleotides can target multiple nucleotide alterations within the same template. The ability of individual single-stranded oligonucleotides to correct multiple mutations in a single target template is tested using the plasmid pK s m4021 and the following single-stranded oligonucleotides modified with 3 phosphorothioate linkages at each end (indicated as underlined nucleotides): Oligo1 is a 25-mer with the sequence TTC GATAAGCCTATGCTGACCC GTG (SEQ ID NO: 2709) corrects the original mutation present in the kanamycin resistance gene of pK s m4021 as well as directing another alteration 2 basepairs away in the target sequence (both indicated in boldface); Oligo2 is a 70-mer with the 5′-end sequence TTC GGCTACGACTGGGCACAACAGACAATTGGC (SEQ ID NO: 2710) with the remaining nucleotides being completely complementary to the plasmid
- oligonucleotides to assay the ability of individual oligonucleotides to correct multiple mutations in the pK s M4021 plasmid.
- these include, for example, a second 25-mer that alters two nucleotides that are three nucleotides apart with the sequence 5′-TTGTGCCCAGTC G TA T CCGAATAGC-3′ (SEQ ID NO: 2711); a 70-mer that alters two nucleotides that are 21 nucleotides apart with the sequence 5′-CATCAGAGCAGCC A ATTGTCTGTTGTGCCCAGTC G TAGCCGAATAGCCTCTCCACCCAAGCGGCCGGAGA-3′ (SEQ ID NO: 2712); and another 70-mer that alters two nucleotides that are 21 nucleotides apart with the sequence 5′-GCTGACAGCCGGAACACGGCGGCATCAGAGCAGCC A ATTGTCTGTTGTGCCCAGTC G TAGCCGMTAGCCT-3
- Plant extracts direct repair.
- the modified single-stranded constructs can be tested in plant cell extracts.
- We prepare the extracts by grinding plant tissue or cultured cells under liquid nitrogen with a mortar and pestle.
- Some plant cell-free extracts also include about 1% (w/v) PVP.
- Plasmid pK S m4021 (1 ⁇ g), the indicated oligonucleotide (1.5 ⁇ g chimeric oligonucleotide or 0.55 ⁇ g single-stranded oligonucleotide; molar ratio of oligo to plasmid of 360 to 1) and either 10 or 20 ⁇ g of HUH7 cell-free extract were incubated 45 min at 37° C. Isolated plasmid DNA was electroporated into E. coli (strain DH10B) and the number of kan r colonies counted.
- TABLE III Frameshift mutation repair is directed by single-stranded oligonucleotides Oligonucleotide Plasmid Extract tet r colonies Tet IX (3S/25A; 0.5 ⁇ g) pT S ⁇ 208 (1 ⁇ g) — 0 — ⁇ 20 ⁇ g 0 Tet IX (0.5 ⁇ g) ⁇ ⁇ 48 Tet IX (1.5 ⁇ g) ⁇ ⁇ 130 Tet IX (2.0 ⁇ g) ⁇ ⁇ 68 Tet I (chimera; 1.5 ⁇ g) ⁇ ⁇ 48
- Each reaction mixture contained the indicated amounts of plasmid and oligonucleotide.
- the extract used for these experiments came from HUH7 cells.
- the data represent the number of tetracycline resistant colonies per 10 6 ampicillin resistant colonies generated from the same reaction and is the average of 3 independent experiments.
- Tet I is a chimeric oligonucleotide and Tet IX is a modified single-stranded oligonucleotide that are designed to insert a T residue at position 208 of pT s ⁇ 208.
- the oligonucleotides are equivalent to structures I and IX in FIG. 2.
- Canola or Musa cell-free extracts were tested for gene repair activity on the kanamycin-sensitive gene as previously described in (18).
- Chimeric oligonucleotide II 1.5 ⁇ g
- modified single-stranded oligonucleotides IX and X (0.55 ⁇ g) were used to correct pK S m4021.
- Total number of kan r colonies are present per 10 7 ampicillin resistant colonies and represent an average of four independent experiments.
- single-stranded oligonucleotides with modified backbones and double-hairpin oligonucleotides with chimeric, RNA-DNA backbones are used to measure gene repair using two episomal targets with a fusion between a hygromycin resistance gene and eGFP as a target for gene repair.
- These plasmids are pAURHYG(rep)GFP, which contains a point mutation in the hygromycin resistance gene (FIG. 7), pAURHYG(ins)GFP, which contains a single-base insertion in the hygromycin resistance gene (FIG. 7) and pAURHYG( ⁇ )GFP which has a single base deletion.
- pAURHYG(wt)GFP a wild-type copy of the hygromycin-eGFP fusion gene
- pAURHYG(wt)GFP a wild-type copy of the hygromycin-eGFP fusion gene
- These plasmids also contain an aureobasidinA resistance gene.
- pAURHYG(rep)GFP hygromycin resistance gene function and green fluorescence from the eGFP protein are restored when a G at position 137, at codon 46 of the hygromycin B coding sequence, is converted to a C thus removing a premature stop codon in the hygromycin resistance gene coding region.
- hygromycin resistance gene function and green fluorescence from the eGFP protein are restored when an A inserted between nucleotide positions 136 and 137, at codon 46 of the hygromycin B coding sequence, is deleted and a C is substituted for the T at position 137, thus correcting a frameshift mutation and restoring the reading frame of the hygromycin-eGFP fusion gene.
- oligonucleotides shown in FIG. 8
- the oligonucleotides which direct correction of the mutation in pAURHYG(rep)GFP can also direct correction of the mutation in pAURHYG(ins)GFP.
- Three of the four oligonucleotides (HygE3T/25, HygE3T/74 and HygGG/Rev) share the same 25-base sequence surrounding the base targeted for alteration.
- HygGG/Rev is an RNA-DNA chimeric double hairpin oligonucleotide of the type described in the prior art.
- HygE3T/74 is a 74-base oligonucleotide with the 25-base sequence centrally positioned.
- the fifth oligonucleotide, designated Kan70T is a non-specific, control oligonucleotide which is not complementary to the target sequence.
- an oligonucleotide of identical sequence but lacking a mismatch to the target or a completely thioate modified oligonucleotide or a completely 2-O-methylated modified oligonucleotide may be used as a control.
- oligonucleotides containing one, two, three, four, five, six, eight, ten or more LNA modifications on at least one of the two termini (and preferrably the 3′ terminus) may be used in different embodiments.
- Oligonucleotide synthesis and cells We synthesized and purified the chimeric, double-hairpin oligonucleotides and single-stranded oligonucleotides (including those with the indicated modifications) as described in Example 1. Plasmids used for assay were maintained stably in yeast ( Saccharomyces cerevisiae ) strain LSY678 MAT ⁇ at low copy number under aureobasidin selection. Plasmids and oligonucleotides are introduced into yeast cells by electroporation as follows: to prepare electrocompetent yeast cells, we inoculate 10 ml of YPD media from a single colony and grow the cultures overnight with shaking at 300 rpm at 30° C.
- This gene correction activity is also specific as transformation of cells with the control oligonucleotide Kan70T produced no hygromycin resistant colonies above background and thus Kan70T did not support gene correction in this system.
- the 74-base oligonucleotide (HygE3T/74) corrects the mutation in pAURHYG(ins)GFP approximately five-fold more efficiently than the 25-base oligonucleotide (HygE3T/25).
- LSY678 yeast cells containing the plasmid pAURHYG(wt)GFP With this strain we observed that even without added oligonucleotides, there are too many hygromycin resistant colonies to count.
- oligonucleotides to assay the ability of individual oligonucleotides to correct multiple mutations in the pAURHYG(x)eGFP plasmid.
- these include, for example, one that alters two basepairs that are 3 nucleotides apart is a 74-mer with the sequence 5′-CTCGTGCTTTCAGCTTCGATGTAGGAGGGCGTGG G TA C GTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTAC-3′ (SEQ ID NO: 2714); a 74-mer that alters two basepairs that are 15 nucleotides apart with the sequence 5′-CTCGTGCTTTCAGCTTCGATGTAGGAGGGCGTGGATA C GTCCTGCGGGTAAA C AGCTGCGCCGATGGTTTCTAC-3′ (SEQ ID NO: 2715); and a 74-mer that alters two basepairs that are 27 nucleotides apart with the sequence 5′-CTCGTGCTTT
- Oligonucleotides targeting the sense strand direct gene correction more efficiently.
- the strand of the target sequence that is identical to the mRNA) of the target sequence facilitates gene correction approximately ten-fold more efficiently than an oligonucleotide, HygE3T/74, with sequence complementary to the non-transcribed strand which serves as the template for the synthesis of RNA.
- HygE3T/74 an oligonucleotide
- this effect was observed over a range of oligonucleotide concentrations from 0-3.6 ⁇ g, although we did observe some variability in the difference between the two oligonucleotides (indicated in Table 7 as a fold difference between HygE3T/74 ⁇ and HygE3T/74).
- microinjection procedures may also be used with cultured plant cells or protoplasts using any plant species, including those disclosed herein.
- Mononuclear cells are isolated from human umbilical cord blood of normal donors using Ficoll Hypaque (Pharmacia Biotech, Uppsala, Sweden) density centrifugation.
- CD34+ cells are immunomagnetically purified from mononuclear cells using either the progenitor or Multisort Kits (Miltenyi Biotec, Auburn, Calif.).
- Lin ⁇ CD38 ⁇ cells are purified from the mononuclear cells using negative selection with StemSep system according to the manufacturer's protocol (Stem Cell Technologies, Vancouver, Calif.). Cells used for microinjection are either freshly isolated or cryopreserved and cultured in Stem Medium (S Medium) for 2 to 5 days prior to microinjection.
- Stem Medium Stem Medium
- S Medium contains Iscoves' Modified Dulbecc's Medium without phenol red (IMDM) with 100 ⁇ g/ml glutamine/penicillin/streptomycin, 50 mg/ml bovine serum albumin, 50 ⁇ g/ml bovine pancreatic insulin, 1 mg/ml human transferrin, and IMDM; Stem Cell Technologies), 40 ⁇ g/ml low-density lipoprotein (LDL; Sigma, St. Louis, Mo.), 50 mM HEPEs buffer and 50 ⁇ M 2-mercaptoethanol, 20 ng/ml each of thrombopoietin, flt-3 ligand, stem cell factor and human IL-6 (Pepro Tech Inc., Rocky Hill, N.J.). After microinjection, cells are detached and transferred in bulk into wells of 48 well plates for culturing.
- IMDM Iscoves' Modified Dulbecc's Medium without phenol red
- Cells are visualized with a microscope equipped with a temperature controlled stage set at 37° C. and injected using an electronically interfaced Eppendorf Micromanipulator and Transjector. Successfully injected cells are intact, alive and remain attached to the plate post injection. Molecules that are flourescently labeled allow determination of the amount of oligonucleotide delivered to the cells.
- CD34+ cells can convert a normal A ( ⁇ A ) to sickle T ( ⁇ S ) mutation in the ⁇ -globin gene or can be altered using any of the oligonucleotides of the invention herein for correction or alteration of a normal gene to a mutant gene.
- stem cells can be isolated from blood of humans having genetic disease mutations and the oligonucleotides of the invention can be used to correct a defect or to modify genomes within those cells.
- non-stem cell populations of cultured cells can be manipulated using any method known to those of skill in the art including, for example, the use of polycations, cationic lipids, liposomes, polyethylenimine (PEI), electroporation, biolistics, calcium phosphate precipitation, or any other method known in the art.
- PEI polyethylenimine
- Biolistic delivery of oligonucleotide into plant cells may be accomplished according to the following method.
- One milliliter of packed cell volume of plant cell suspensions are subcultured onto plates containing solid medium [with Murashige and Skoog salts from Gibco/BRL, 500 mg/liter Mes, 1 mg/liter thiamin, 100 mg/liter myo-inositol, 180 mg/liter KH2PO4, 2.21 mg/liter 2,4-dichlorophenoxyacetic acid (2,4-D), and 30 g/liter sucrose (pH 5.7) and having 8 g/liter agar-agar from Sigma added before autoclaving].
- solid medium with Murashige and Skoog salts from Gibco/BRL, 500 mg/liter Mes, 1 mg/liter thiamin, 100 mg/liter myo-inositol, 180 mg/liter KH2PO4, 2.21 mg/liter 2,4-dichlorophenoxyacetic acid (2,4-D), and 30 g/liter sucrose
- oligonucleotides may be introduced to cells after precipitation onto 1 micrometer or comparable gold microcarriers (Bio-Rad).
- Bio-Rad a helium-driven particle gun
- 35 microliters of a particle suspension 60 mg of microcarriers per ml of 100% ethanol
- 35 microliters of a particle suspension 60 mg of microcarriers per ml of 100% ethanol
- 40 microliter of resuspended oligonucleotide 60 ng/microliter water
- 75 microliter of ice-cold 2.5 M CaCl2 is added
- 75 microliter of ice-cold 0.1 M spermidine is added.
- the tube is mixed vigorously or a vortex mixer for 10 min at room temperature.
- the particles are allowed to settle for 10 min and are centrifuged at 11,750 g for 30 sec.
- the supernatant is removed and the particles are resuspended in 50 microliter of 100% ethanol.
- An alternative method of delivery can be used as follows. Cultured cells are suspended in liquid N6 medium and then plated on a VWR Scientific glass fiber filter. About 0.4 microgram of oligonucleotide are precipitated with 15 microliter of 2.5 mM CaCl2 and 5 microliter of 0.1 M spermidine onto 25 microgram of 1.0 micrometer gold particles. Microprojectile bombardment is performed by using a Bio-Rad PDS-1000 He particle delivery system or comparable machine following manufacturers instructions. Alterations in oligonucleotide concentrations can be employed to determine the optimum concentration of oligonucleotide according to the procedures described herein for any particular oligonucleotide of the invention.
- the oligonucleotide of the invention may be delivered to a plant cell by electroporation of a protoplast derived from a plant part.
- the protoplasts may be formed by enzymatic treatment of a plant part, particularly a leaf, according to techniques such as those in Gallois et al., Methods in Molecular Biology 55: 89-107 by Humana Press.
- Such conditions for electroporation use about 3 ⁇ 10 5 protoplasts in a total volume of about 0.3 ml with a concentration of oligonucleotide of between 0.6 to 4 microgram per ml.
- the oligonucleotides of the invention can also be used to repair or direct a mutagenic event in plants and animal cells. Although little information is available on plant mutations amongst natural cultivars, the oligonucleotides of the invention can be used to produce “knock out” mutations by modification of specific amino acid codons to produce stop codons (e.g., a CAA codon specifying Gln can be modified at a specific site to TAA; a AAG codon specifying Lys can be modified to UAG at a specific site; and a CGA codon for Arg can be modified to a UGA codon at a specific site). Such base pair changes will terminate the reading frame and produce a defective truncated protein, shortened at the site of the stop codon.
- stop codons e.g., a CAA codon specifying Gln can be modified at a specific site to TAA; a AAG codon specifying Lys can be modified to UAG at a specific site
- frameshift additions or deletions can be directed into the genome at a specific sequence to interrupt the reading frame and produce a garbled downstream protein.
- stop or frameshift mutations can be introduced to determine the effect of knocking out the protein in either plant or animal cells.
- Agrobacterium tumefaciens is used for introduction of a T-DNA, including the T-DNA in the plasmid of FIG. 11, into a plant cell.
- Agrobacterium tumefaciens is used. These techniques are routine standard techniques known in the art. For example, one method follows. We transform A. tumefaciens is transformed by electroporation (using a BioRad Gene PulserTM). Competent A. tumefaciens is prepared using a method similar to that of preparing competent E. coli by suspending a freshly grown culture three times in ice-cold water and a final resuspension in 10% glycerol. Electroporation conditions are a 0.2 cm gap cuvette at a setting of 25 ⁇ F,200 ⁇ and2.5 kV.
- A. tumefaciens containing a plasmid with a T-DNA is then used to introduce the T-DNA into a plant cell using routine standard techniques known in the art. For example, we transform Arabidopsis by vacuum infiltration or by dipping flowers in an Agrobacterium solution containing a surfactant, e.g. L-77. Seeds are then collected, grown and screened for presence of the T-DNA. Alternatively, Agrobacterium can be used to transform callus tissue and the callus tissue can then be used to regenerate transformed plants.
- the left-most column identifies each alteration or mutation and the phenotype that the alteration/mutation confers.
- the mutation/alteration is identified at both the nucleic acid and protein level.
- mutations are presented according to the following standard nomenclature. The centered number identifies the position of the mutated codon in the protein sequence; to the left of the number is the wild type residue and to the right of the number is the mutant codon. Terminator codons are shown as “TERM”.
- the nucleic acid level the entire triplet of the wild type and mutated codons is shown.
- the middle column presents, for each mutation, four oligonucleotides capable of repairing the mutation site-specifically in the genome or in cloned DNA including DNA in artificial chromosomes, episomes, plasmids, or other types of vectors.
- the oligonucleotides of the invention may include any of the oligonucleotides sharing portions of the sequence of the 121 base sequence.
- oligonucleotides of the invention for each of the depicted targets may be 18, 19, 20 up to about 121 nucleotides in length. Sequence may be added non-symmetrically.
- the first of the four oligonucleotides for each mutation is a 121 nt oligonucleotide centered about the repair/altering nucleotide.
- the second oligonucleotide targets the opposite strand of the DNA duplex for repair/alteration.
- the third oligonucleotide is the minimal 17 nt domain of the first oligonucleotide, also centered about the repair/alteration nucleotide.
- the fourth oligonucleotide is the reverse complement of the third, and thus represents the minimal 17 nt domain of the second.
- the third column of each table presents the SEQ ID NO: of the respective repair oligonucleotide.
- Herbicides having broad-spectrum activity are particularly useful because they obviate the need for multiple herbicides targeting different classes of weeds.
- the problem with such herbicides is that they typically also affect crops which are exposed to the herbicide.
- One way to overcome this is to generate plants which are resistant to one or more broad-spectrum herbicides.
- Such herbicide-tolerant plants may reduce the need for tillage to control weeds, thereby effectively reducing soil erosion and can reduce the quantity and number of different herbicides applied in the field.
- Common herbicides used include those that inhibit the enzyme 5-enolpyruvyl-3-phosphoshikimic acid synthase (EPSPS), for example N-phosphonomethyl-glycine (e.g. glyphosate), those that inhibit acetolactate synthase (ALS) activity, for example the sulfonylureas and related herbicides, and those that inhibit dihydropteroate synthase, for example methyl[(4-amino-phenyl)sulfonyl]carbamate (e.g. Asulam).
- EPSPS 5-enolpyruvyl-3-phosphoshikimic acid synthase
- N-phosphonomethyl-glycine e.g. glyphosate
- ALS acetolactate synthase
- dihydropteroate synthase for example methyl[(4-amino-phenyl)sulfonyl]carbamate (e.g. Asulam).
- Herbicide-tolerant plants can be produced by several methods, including, for example, introducing into the genome of the plant the ability to degrade the herbicide, the capacity to produce a higher level of the targeted enzyme, and/or expressing an herbicide-tolerant allele of the enzyme.
- Physiological and biochemical responses to high levels of ionic or nonionic solutes and decreased water potential have been studied in a variety of plants. It is known, for example, that increasing levels of alcohol dehydrogenase can confer enhances flooding resistance in plants.
- one mechanism underlying the adaptation or tolerance of plants to osmotic stresses is the accumulation of compatible, low molecular weight osmolytes such as sugar alcohols, special amino acids, and glycinebetaine.
- Such accumulation can be engineered, for example, by removing feedback inhibition on 1-pyrroline-t-carboxylate synthetase, which results in accumulation of proline.
- recent experiments suggest that altering the expression or activity of specific sodium or potassium transporters can confer enhanced salt tolerance.
- AACACCGACGTTCTTTGATACGACGCACTATCCCCAGCTGCACAA 1158 Ser27Term ACCGATGCAGAGAGCTAAGATTCATGGCTATAAGCCGAAGATGAA TCG-TAG GGCCGGAGATGATGTAGCAGAATGCTCTGCC TGAATCTT A GCTCTCTG 1159 CAGAGAGC T AAGATTCA 1160 2,4-DB resistance TGCTACATCATCTCCGGCCTTCATCTTCGGCTTATAGCCATGAATC 1161 3-ketoacyl-CoA TTCGCTCTCTGCAT A GGTTTGTGCAGCTGGGGATAGTGCGTCGTA thiolase TCAAAGAACGTCGGTGTTTGGAGATGATGT Cucurbita sp.
- ACATCATCTCCAAACACCGACGTTCTTTGATACGACGCACTATCCC 1162 Ser31Term CAGCTGCACAAACC T ATGCAGAGAGCGAAGATTCATGGCTATAAG TCG-TAG CCGAAGATGAAGGCCGGAGATGATGTAGCA CTCTGCAT A GGTTTGTG 1163 CACAAACC T ATGCAGAG 1164 2,4-DB resistance TCATCTCCGGCCTTCATCTTCGGCTTATAGCCATGAATCTTCGCTC 1165 3-ketoacyl-CoA TCTGCATCGGTTTG A GCAGCTGGGGATAGTGCGTCGTATCAAAGA thiolase ACGTCGGTGTTTGGAGATGATGTCGTGATA Cucurbita sp.
- Plant productivity is limited by resources available and the ability of plants to harness these resources.
- the conversion of light to chemical energy which is then used to synthesize carbohydrates, fatty acids, sugars, amino acids and other compounds, requires a complex system which combines the light harvesting apparatus of pigments and proteins.
- the value of light energy to the plant can only be realized when it is efficiently converted into chemical energy by photosynthesis and fed into various biochemical processes.
- Significant effort has therefore been directed at studying photosynthetic processes in plants in order to improve productivity and/or the efficiency of photosynthesis.
- the analysis of the photosynthetic process is substantially aided by the ability to produce albino plants.
- the attached table discloses exemplary oligonucleotide base sequences which can be used to generate site-specific mutations in genes involved in starch metabolism.
- TABLE 18 Oligonucleotides to produce albino plants Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: White leaves TTCTTTCCTGTGAAATTATCTGCTCAAATCTTTGGTTCCTGACGGAG 1189 Immutans ATGGCGGCGATTT G AGGCATCTCCTCTGGTACGTTGACGATTTCA Arabidopsis thaliana CGGCCTTTGGTTACTCTTCGACGCTCTAG Ser5Term CTAGAGCGTCGAAGAGTAACCAAAGGCCGTGAAATCGTCAACGTA 1190 TCA-TGA CCAGAGGAGATGCCT C AAATCGCCGCCATCTCCGTCAGGAACCAA AGATTTGAGCAGATAATTTCACAGGAAAGAA GGCGATTT G AGGCATCT 1191 AGATGCCT C AAATCGCC 1192 White leaves G
- Another aim of biotechnology is to generate plants, especially crop plants, with added value traits.
- An example of such a trait is improved nutritional quality in food crops.
- lysine, tryptophan and threonine which are essential amino acids in the diet of humans and many animals, are limiting nutrients in most cereal crops. Consequently, grain-based diets, such as those based on corn, barley, wheat, rice, maize, millet, sorghum, and the like, must be supplemented with more expensive synthetic amino acids or amino-acid-containing oilseed protein meals. Increasing the lysine content of these grains or of any of the feed component crops would result in significant added value.
- Naturally occurring mutants of plants that have different levels of particular essential amino acids have been identified. However, these mutants are generally not the result of increased free amino acid, but are instead the result of shifts in the overall protein profile of the grain. For example, in maize, reduced levels of lysine-deficient endosperm proteins (prolamines) are complemented by elevated levels of more lysine-rich proteins (albumins, globulins and glutelins). While nutritionally superior, these mutants are associated with reduced yields and poor grain quality, limiting their agronomic usefulness.
- An alternative approach is to generate plants with mutations that render key amino acid biosynthetic enzymes insensitive to feedback inhibition. Many such mutations are known and mutation results in increased free amino acid.
- the increased production can optionally be coupled to increased expression of an abundant storage protein comprising the chosen amino acid.
- a normally abundant protein can be engineered to contain more of the target amino acid.
- the attached table discloses exemplary oligonucleotide base sequences which can be used to generate site-specific mutations that remove feedback inhibition in plant amino acid biosynthetic enzymes.
- TABLE 19 Genome-Altering Oligos Conferring Amino Acid Overproduction Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Met Overproduction TATCCTCCAGGATCTTAAGATTTCCTCCTAATTTCGTCCGTCAGCT 1289 CGS GAGCATTAAAGCCC A TAGAAACTGTAGCAACATCGGTGTTGCACA Arabidopsis thaliana GATCGTGGCGGCTAAGTGGTCCAACAACCC Arg77His GGGTTGTTGGACCACTTAGCCGCCACGATCTGTGCAACACCGAT 1290 CGT-CAT GTTGCTACAGTTTCTA T GGGCTTTAATGCTCAGCTGACGGACGAA ATTAGGAGGAAATCTTAAGATCCTGGAGGATA TAAAGCCC A TAGAAACT 12
- a principal aim of biotechnology is the improvement of crop plants for food value, agriculture, and to produce a range of plant-derived raw materials.
- polysaccharides constitute the main raw materials derived from plants, and apart from cellulose, the storage polymer starch is the most important polysaccharide raw material.
- Starch is derived from a range of plants, but maize is the most important cultivated plant for the production of starch.
- the polysaccharide starch is a polymer made up of glucose molecules.
- starch is not a homogeneous raw material and is, in fact, a highly complex mixture of various types of molecules which differ from each other, for example, in their degree of polymerization and in the degree of branching of the glucose chains.
- amylose-starch is a basically non-branched polymer made up of ⁇ -1,4-glycosidically branched glucose molecules
- amylopectin-starch is a complex mixture of variously branched glucose chains. The branching results from additional ⁇ -1,6-glycosidic linkages.
- the starch is approximately 25% amylose-starch and 75% amylopectin-starch.
- Fatty Acid Synthase Fatty Acid Synthase
- Fatty acid synthesis is the result of the three enzymatic activities: acyl-ACP elongase, acyl-ACP desaturase and acyl-ACP thioesterases specific for each of palmitoyl-, stearoyl- and oleoyl-ACP.
- a variety of enzymes have been identified that influence the relative levels of saturated vs. unsaturated fatty acids in plants.
- the enzymes stearoyl-acyl carrier protein (stearoyl-ACP) desaturase, oleoyl desaturase and linoleate desaturase produce unsaturated fatty acids from saturated precursors.
- stearoyl-ACP stearoyl-acyl carrier protein
- oleoyl desaturase oleoyl desaturase
- linoleate desaturase produce unsaturated fatty acids from saturated precursors.
- relative enzymatic activities of the various acyl-ACP thioesterases influences the relative acyl-chain composition of the resultant fatty acids. Consequently a reduction or an increase of the activity of these enzymes can alter the properties of oils produced in a plant. In fact, specific targeting of particular enzymatic activities can results in altered levels of particular fatty acids.
- oligonucleotides base sequences which can be used to generate site-specific mutations in plant genes encoding proteins involved in fatty acid biosynthesis.
- TABLE 22 Oligonucleotides to produce plants with reduced palmitate Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Reduced palmitate TTTGGTGGCAGTGTCTTTGAACGCTTCATCTCCTCGTCATGGTGGC 2065 Acyl-ACP-thioesterase CACCTCTGCTACGT A GTCATTCTTTCCTGTACCATCTTCTTCACTTG Arabidopsis thaliana ATCCTAATGGAAAAGGCAATAAGATTGG Ser8Term CCAATCTTATTGCCTTTTCCATTAGGATCAAGTGAAGAAGATGGTA 2066 TCG-TAG CAGGAAAGAATGAC T ACGTCGCAGAGGTGGCCACCATGACGAGG AGATGAAGCGTTCAAAGACACTGCCACCAAA TGCTACGT A GTCATTCT
Abstract
Presented are methods and compositions for targeted chromosomal genomic alterations with modified single-stranded oligonucleotides. The oligonucleotides of the invention have modified nuclease-resistant termini comprising LNA, phosphorothioate linkages or 2′-O-Me base analogues or combinations of such modifications.
Description
- The technical field of the invention is oligonucleotide-directed repair or alteration of plant genetic information using novel chemically modified oligonucleotides.
- A number of methods have been developed specifically to alter the genomic information of plants. These methods generally include the use of vectors such as, for example, T-DNA, carrying nucleic acid sequences encoding partial or complete portions of a particular protein which is expressed in a cell or tissue to effect the alteration. The expression of the particular protein then results in the desired phenotype. See, for example, U.S. Pat. No. 4,459,355 which describes a method for transforming plants with a DNA vector and U.S. Pat. No. 5,188,642 which describes cloning or expression vectors containing a transgenic DNA sequence which when expressed in plants confers resistance to the herbicide glyphosate. The use of such transgene-containing vectors adds one or more exogenous copies of a gene in a usually random fashion at one or more integration sites of the plant's genome at some variable frequency. The introduced gene may be foreign or may be derived from the host plant. Any gene which was originally present in the genome, which may be, for example, a normal allelic variant, mutated, defective, and/or functional copy of the introduced gene, is retained in the genome of the host plant.
- These methods of gene alteration are problematic in that complications which can compromise the vigor, productivity, yield, etc. of the plant may result. One such problem is that insertion of exogenous nucleic acid at random location(s) in the genome can have deleterious effects. The random nature of this insertion and/or the use of exogenous promoters can also cause the timing, location or strength of expression of the introduced transgene to be inappropriate or unpredictable. Another problem with such systems includes the addition of unnecessary and unwanted genetic material to the genome of the recipient, including, for example, T-DNA ends or other vector remnants, exogenous control sequences required to allow production of the transgene protein, which control sequences may be exogenous or native to the host plant and/or the transgene, and reporter genes or resistance markers. Such remnants and added sequences may have presently unrecognized consequences, for example, involving genetic rearrangements of the recipient genomes. In addition, concerns have been raised with consumption, especially by humans, of plants containing such exogenous genetic material.
- More recently, simpler systems involving poly- or oligo-nucleotides have been described for use in the alteration of genomic DNA. These chimeric RNA-DNA oligonucleotides, requiring contiguous RNA and DNA bases in a double-stranded molecule folded by complementarity into a double hairpin conformation, have been shown to effect single basepair or frameshift alterations, for example, for mutation or repair of plant, animal or fungal genomes. See, for example, WO 99/07865 and U.S. Pat. No. 5,565,350. In the chimeric RNA-DNA oligonucleotide, an uninterrupted stretch of DNA bases within the molecule is required for sequence alteration of the targeted genome while the obligate RNA residues are involved in complex stability. Due to the length, backbone composition, and structural configuration of these chimeric RNA-DNA molecules, they are expensive to synthesize and difficult to purify. Moreover, if the RNA-containing strand of the chimeric RNA-DNA oligonucleotide is designed so as to direct gene alteration, a series of mutagenic reactions resulting in nonspecific base alteration can result. Such a result reduces the utility of such a molecule in methods designed for targeted gene alteration.
- Alternatively, other oligo- or poly-nucleotides have been used which require a triplex forming, usually polypurine or polypyrimidine, structural domain which binds to a DNA helical duplex through Hoogsteen interactions between the major groove of the DNA duplex and the oligonucleotide. Such oligonucleotides may have an additional DNA reactive moiety, such as psoralen, covalently linked to the oligonucleotide. These reactive moieties function as effective intercalation agents, stabilize the formation of a triplex and can be mutagenic. Such agents may be required in order to stabilize the triplex forming domain of the oligonucleotide with the DNA double helix if the Hoogsteen interactions from the oligonucleotide/target base composition are insufficient. See, e.g., U.S. Pat. No. 5,422,251. The utility of these oligonucleotides for directing targeted gene alteration is compromised by a high frequency of nonspecific base changes.
- In more recent work, the domain for altering a genome is linked or tethered to the triplex forming domain of the bi-functional oligonucleotide, adding an additional linking or tethering functional domain to the oligonucleotide. See, e.g., Culver et al.,Nature Biotechnology 17: 989-93 (1999). Such chimeric or triplex forming molecules have distinct structural requirements for each of the different domains of the complete poly- or oligo-nucleotide in order to effect the desired genomic alteration in either episomal or chromosomal targets.
- Other genes, e.g. CFTR, have been targeted by homologous recombination using duplex fragments having several hundred basepairs. See, e.g., Kunzelmann et al.,Gene Ther. 3:859-867 (1996). Similar efforts to target genes by homologous recombination in plants using large fragments of DNA had some success. See Kempin et al., Nature 389:802-803 (1997). However, the efficiency and reproducibility of the published homologous recombination approach in plants has severely limited the widespread use of this method.
- Earlier experiments to mutagenize an antibiotic resistance indicator gene by homologous recombination used an unmodified DNA oligonucleotide rather than larger fragments of DNA, wherein the oligonucleotide had no functional domains other than a region of complementary sequence to the target. See Campbell et al.,New Biologist 1: 223-227 (1989). These experiments required large concentrations of the oligonucleotide, exhibited a very low frequency of episomal modification of a targeted exogenous plasmid gene not normally found in the cell and have not been reproduced. However, as shown in examples herein, we have observed that an unmodified DNA oligonucleotide can convert a base at low frequency which is detectable using the assay systems described herein.
- Oligonucleotides designed for use in the targeted alteration of genetic information are significantly different from oligonucleotides designed for antisense approaches. For example, antisense oligonucleotides are perfectly complementary to and bind an mRNA strand in order to modify expression of a targeted mRNA and are used at high concentration. As a consequence, they are unable to produce a gene conversion event by either mutagenesis or repair of a defect in the chromosomal DNA of a host genome. Furthermore, the backbone chemical composition used in most oligonucleotides designed for use in antisense approaches renders them inactive as substrates for homologous pairing or mismatch repair enzymes and the high concentrations of oligonucleotide required for antisense applications can be toxic with some types of nucleotide modifications. In addition, antisense oligonucleotides must be complementary to the mRNA and therefore, may not be complementary to the other DNA strand or to genomic sequences that span the junction between intron sequence and exon sequence.
- Artificial chromosomes can be useful for the screening purposes identified herein. These molecules are man-made linear or circular DNA molecules constructed from essential cis-acting DNA sequence elements that are responsible for the proper replication and partitioning of natural chromosomes (Murray et al., 1983). The essential elements are: (1) Autonomous Replication Sequences (ARS), (2) Centromeres, and (3) Telomeres.
- Yeast artificial chromosomes (YACs) allow large segments of genomic DNA to be cloned and modified (Burke et al., Science 236:806; Peterson et al., Trends Genet. 13:61 (1997); Choi, et al., Nat. Genet., 4:117-223 (1993), Davies, et al., Biotechnology 11:911-914 (1993), Matsuura, et al., Hum. Mol. Genet., 5:451-459 (1996), Peterson et al., Proc. Natl. Acad. Sci., 93:6605-6609 (1996); and Schedl, et al., Cell, 86:71-82 (1996)). Other vectors also have been developed for the cloning of large segments of genomic DNA, including cosmids, and bacteriophage P1 (Sternberg et al., Proc. Natl. Acad. Sci. U.S.A., 87:103-107 (1990)). YACs have certain advantages over these alternative large capacity cloning vectors (Burke et al., Science, 236:806-812 (1987)). The maximum insert size is 35-30 kb for cosmids, and 100 kb for bacteriophage P1, both of which are much smaller than the maximal insert size for a YAC.
- An alternative to YACs are cloning systems based on theE. coli fertility factor that have been developed to construct large genomic DNA insert libraries. They are bacterial artificial chromosomes (BACs) and P-1 derived artificial chromosomes (PACs) (Mejia et al., Genome Res. 7:179-186 (1997); Shizuya et al., Proc. Natl. Acad. Sci. 89:8794-8797 (1992); Ioannou et al., Nat. Genet., 6:84-89 (1994); Hosoda et al., Nucleic Acids Res. 18:3863 (1990)). BACs are based on the E. coli fertility plasmid (F factor); and PACs are based on the bacteriophage P1. These vectors propagate at a very low copy number (1-2 per cell) enabling genomic inserts up to 300 kb in size to be stably maintained in recombination deficient hosts. The PACs and BACs are circular DNA molecules that are readily isolated from the host genomic background by classical alkaline lysis (Birnboim et al., Nucleic Acids Res. 7:1513-1523 (1979)). In addition, BACs have been developed for transformation of plants with high-molecular weight DNA using the T-DNA system (Hamilton, Gene 24:107-116 (1997); Frary & Hamilton, Transgenic Res. 10: 121-132 (2001)).
- A need exists for simple, inexpensive oligonucleotides capable of producing targeted alteration of genetic material such as those described herein as well as methods to identify optimal oligonucleotides that accurately and efficiently alter target DNA.
- Novel, modified single-stranded nucleic acid molecules that direct gene alteration in plants are identified and the efficiency of alteration is analyzed both in vitro using a cell-free extract assay and in vivo using a yeast system and a plant system. The alteration in an oligonucleotide of the invention may comprise an insertion, deletion, substitution, as well as any combination of these. Site specific alteration of DNA is not only useful for studying function of proteins in vivo, but it is also useful for creating plants with desired phenotypes, including, for example, environmental stress tolerance, improved nutritional value, herbicide resistance, disease resistance, modified oil production, modified starch production, and altered floral morphology including selective sterility. As described herein, oligonucleotides of the invention target directed specific gene alterations in genomic double-stranded DNA in cells. The target genomic DNA can be nuclear chromosomal DNA as well as plastid or mitochondrial chromosomal DNA. The target DNA can also be a transgene present in the plant cell, including, for example, a previously introduced T-DNA. For screening purposes, the target plant DNA can also be extrachromosomal DNA present in plant or non-plant cells in various forms including, e.g., mammalian artificial chromosomes (MACs), PACs from P-1 vectors, yeast artificial chromosomes (YACs), bacterial artificial chromosomes (BACs), plant artificial chromosomes (PLACs), as well as episomal DNA, including episomal DNA from an exogenous source such as a plasmid or recombinant vector. Many of these artificial chromosome constructs containing plant DNA can be obtained from a variety of sources, including, e.g., the Arabidopsis Biological Resource Center (ABRC) at the Ohio State University, and the Rice Genome Research Program at the MAFF DNA bank in Ibaraki, Japan. The target DNA may be transcriptionally silent or active. In a preferred embodiment, the target DNA to be altered is the non-transcribed strand of a genomic DNA duplex. In a more preferred embodiment, the target DNA to be altered is the non-transcribed strand of a transcribed gene of a genomic DNA duplex.
- The low efficiency of targeted gene alteration obtained using unmodified DNA oligonucleotides is believed to be largely the result of degradation by nucleases present in the reaction mixture or the target cell. Although different modifications are known to have different effects on the nuclease resistance of oligonucleotides or stability of duplexes formed by such oligonucleotides (see, e.g., Koshkin et al.,J. Am. Chem. Soc., 120:13252-3), we have found that it is not possible to predict which of any particular known modification would be most useful for any given alteration event, including for the construction of gene alteration oligonucleotides, because of the interaction of different as yet unidentified proteins during the gene alteration event. Herein, a variety of nucleic acid analogs have been developed that increase the nuclease resistance of oligonucleotides that contain them, including, e.g., nucleotides containing phosphorothioate linkages or 2′-O-methyl analogs. We recently discovered that single-stranded DNA oligonucleotides modified to contain 2′-O-methyl RNA nucleotides or phosphorothioate linkages can enable specific alteration of genetic information at a higher level than either unmodified single-stranded DNA or a chimeric RNA/DNA molecule. See, for example, copending applications U.S. application Ser. No. 60/208,538, U.S. application Ser. No. 60/244,989, U.S. application Ser. No. 09/818,875, international application no. PCT/US01/09761 and Gamper et al., Nucleic Acids Research 28: 4332-4339 (2000), the disclosures of which are incorporated herein in their entirety by reference. We also found that additional nucleic acid analogs which increase the nuclease resistance of oligonucleotides that contain them, including, e.g., “locked nucleic acids” or “LNAs”, xylo-LNAs and L-ribo-LNAs; see, for example, Wengel & Nielsen, WO 99/14226; Wengel, WO 00/56748; Wengel, WO 00/66604; and Jakobsen & Koshkin, WO 01/25478 also allow specific targeted alteration of genetic information.
- The assay allows for determining the optimum length of the oligonucleotide, optimum sequence of the oligonucleotide, optimum position of the mismatched base or bases, optimum chemical modification or modifications, optimum strand targeted for identifying and selecting the most efficient oligonucleotide for a particular gene alteration event by comparing to a control oligonucleotide. Control oligonucleotides may include a chimeric RNA-DNA double hairpin oligonucleotide directing the same gene alteration event, an oligonucleotide that matches its target completely, an oligonucleotide in which all linkages are phosphorothiolated, an oligonucleotide fully substituted with 2′-O-methyl analogs or an RNA oligonucleotide. Such control oligonucleotides either fail to direct a targeted alteration or do so at a lower efficiency as compared to the oligonucleotides of the invention. The assay further allows for determining the optimum position of a gene alteration event within an oligonucleotide, optimum concentration of the selected oligonucleotide for maximum alteration efficiency by systematically testing a range of concentrations, as well as optimization of either the source of cell extract by testing different plants or strains, or testing cells derived from different plants or strains, or plant cell lines. Using a series of single-stranded oligonucleotides, comprising all RNA or DNA residues and various mixtures of the two, several new structures are identified as viable molecules in nucleotide conversion to direct or repair a genomic mutagenic event. When extracts from mammalian, plant and fungal cells are used and are analyzed using a genetic readout assay in bacteria, single-stranded oligonucleotides having one of several modifications are found to be more active than a control RNA-DNA double hairpin chimera structure when evaluated using an in vitro gene repair assay. Similar results are also observed in vivo using yeast, mammalian and plant cells. Molecules containing various lengths of modified bases were found to possess greater activity than unmodified single-stranded DNA molecules.
- The present invention provides oligonucleotides having chemically modified, nuclease resistant residues, preferably at or near the termini of the oligonucleotides, and methods for their identification and use in targeted alteration of plant genetic material, including gene mutation, targeted gene repair and gene knockout. The oligonucleotides are preferably used for mismatch repair or alteration by changing at least one nucleic acid base, or for frameshift repair or alteration by addition or deletion of at least one nucleic acid base. The oligonucleotides of the invention direct any such alteration, including gene correction, gene repair or gene mutation and can be used, for example, to introduce a polymorphism or haplotype or to eliminate (“knockout”) a particular protein activity. For example, gene alterations that knockout a particular protein activity can be obtained using oligonucleotides designed to convert a codon in the coding region of the protein to a stop codon, thus prematurely terminating translation of the protein. Oligonucleotides that introduce stop codons in the open-reading-frame of the protein are one embodiment of the invention. Generally, oligonucleotides that introduce stop codons early in the open-reading-frame of the protein are preferred. If the open-reading-frame contains more than one methionine, oligonucleotides that introduce stop codons after the second methionine are preferred. Additionally, if the gene exhibits alternative splice sites, oligonucleotides that introduce stop codons in exons after the alternative splice site are preferred. The following table provides examples of codons that can be converted to stop codons by altering a single oligonucleotide. A skilled artisan could readily identify other codons that can be converted to stop codons by altering one, two or three of the base pairs in a given codon. Similarly, a skilled artisan could readily identify codons that can be converted to stop codons by a frameshift mutations that inserts or deletes one or two base pairs in the open-reading-frame. It is also understood that more than one stop codon can be generated in a single open-reading-frame and that these stop codons can be adjacent in the sequence or separated by intervening codons. Where more than one stop codon is introduced into a single open-reading-frame, such alterations can be generated by a single or multiple oligonucleotides and can be generated simultaneously or by sequential mutagenesis of the target nucleic acid.
Corresponding Original codons* stop codon G GA (glycine), A GA (arginine), C GA (arginine), T T A TGA (leucine), T C A (serine), TG T (cysteine), TG G (tryptophan), TG C (cysteine) A AG (lysine), G AG (glutamate), C AG (glutamine), T T G TAG (leucine), T C G (serine), T G G (tryptophan), TA T (cysteine), TA C (tyrosine) A AA (lysine), G AA (glutamate), C AA (glutamine), T T A TAA (leucine), T C A (serine), TA T (cysteine), TA C (tyrosine) - The oligonucleotides of the invention are designed as substrates for homologous pairing and repair enzymes and as such have a unique backbone composition that differs from chimeric RNA-DNA double hairpin oligonucleotides, antisense oligonucleotides, and/or other poly- or oligo-nucleotides used for altering genomic DNA, such as triplex forming oligonucleotides. The single-stranded oligo-nucleotides described herein are inexpensive to synthesize and easy to purify. In side-by-side comparisons, an optimized single-stranded oligonucleotide comprising modified residues as described herein is significantly more efficient than a chimeric RNA-DNA double hairpin oligonucleotide in directing a base substitution or frameshift mutation in a cell-free extract assay.
- We have discovered that single-stranded oligonucleotides having a DNA domain surrounding the targeted base, with the domain preferably central to the poly- or oligo-nucleotide, and having at least one modified end, preferably at the 3′ terminal region, are able to alter a target genetic sequence and with an efficiency that is higher than chimeric RNA-DNA double hairpin oligonucleotides disclosed in U.S. Pat. No. 5,565,350. Preferred oligonucleotides of the invention have at least two modified bases on at least one of the termini, preferably the 3′ terminus of the oligonucleotide. Oligonucleotides of the invention can efficiently be used to introduce targeted alterations in a genetic sequence of DNA in the presence of human, animal, plant, fungal (including yeast) proteins and in cells of different types including, for example, plant cells, fungal cells includingS. cerevisiae, Ustillago maydis, Candida albicans, and mammalian cells. Particularly preferred are cells and cell extracts derived from plants including, for example, experimental model plants such as Chiamydomonas reinhardtii, Physcomitrella patens, and Arabidopsis thaliana in addition to crop plants such as cauliflower (Brassica oleracea), artichoke (Cynara scolymus), fruits such as apples (Malus, e.g. domesticus), mangoes (Mangifera, e.g. indica), banana (Musa, e.g. acuminata), berries (such as currant, Ribes, e.g. rubrum), kiwifruit (Actinidia, e.g. chinensis), grapes (Vitis, e.g. vinifera), bell peppers (Capsicum, e.g. annuum), cherries (such as the sweet cherry, Prunus, e.g. avium), cucumber (Cucumis, e.g. sativus), melons (Cucumis, e.g. melo), nuts (such as walnut, Juglans, e.g. regia; peanut, Arachis hypogeae), orange (Citrus, e.g. maxima), peach (Prunus, e.g. persica), pear (Pyra, e.g. communis), plum (Prunus, e.g. domestica), strawberry (Fragaria, e.g. moschata or vesca), tomato (Lycopersicon, e.g. esculentum); leaves and forage, such as alfalfa (Medicago, e.g. sativa or truncatula), cabbage (e.g. Brassica oleracea), endive (Cichoreum, e.g. endivia), leek (Allium, e.g. porrum), lettuce (Lactuca, e.g. sativa), spinach (Spinacia, e.g. oleraceae), tobacco (Nicotiana, e.g. tabacum); roots, such as arrowroot (Maranta, e.g. arundinacea), beet (Beta, e.g. vulgaris), carrot (Daucus, e.g. carota), cassava (Manihot, e.g. esculenta), turnip (Brassica, e.g. rapa), radish (Raphanus, e.g. sativus), yam (Dioscorea, e.g. esculenta), sweet potato (Ipomoea batatas); seeds, including oilseeds, such as beans (Phaseolus, e.g. vulgaris), pea (Pisum, e.g. sativum), soybean (Glycine, e.g. max), cowpea (Vigna unguiculata), mothbean (Vigna aconitifolia), wheat (Triticum, e.g. aestivum), sorghum (Sorghum e.g. bicolor), barley (Hordeum, e.g. vulgare), corn (Zea, e.g. mays), rice (Oryza, e.g. sativa), rapeseed (Brassica napus), millet (Panicum sp.), sunflower (Helianthus annuus), oats (Avena sativa), chickpea (Cicer, e.g. arietinum); tubers, such as kohlrabi (Brassica, e.g. oleraceae), potato (Solanum, e.g. tuberosum) and the like; fiber and wood plants, such as flax (Linum e.g. usitatissimum), cotton (Gossypium e.g. hirsutum), pine (Pinus sp.), oak (Quercus sp.), eucalyptus (Eucalyptus sp.), and the like and ornamental plants such as turfgrass (Lolium, e.g. rigidum), petunia (Petunia, e.g. x hybrida), hyacinth (Hyacinthus orientalis), carnation (Dianthus e.g. caryophyllus), delphinium (Delphinium, e.g. ajacis), Job's tears (Coix lacryma-jobi), snapdragon (Antirrhinum majus), poppy (Papaver, e.g. nudicaule), lilac (Syringa, e.g. vulgaris), hydrangea (Hydrangea e.g. macrophylla), roses (including Gallicas, Albas, Damasks, Damask Perpetuals, Centifolias, Chinas, Teas and Hybrid Teas) and ornamental goldenrods (e.g. Solidago spp.). Such plant cells can then be used to regenerate whole plants according to methods described herein or any method known in the art. The DNA domain of the oligonucleotides is preferably fully complementary to one strand of the gene target, except for the mismatch base or bases responsible for the gene alteration event(s). On either side of the preferably central DNA domain, the contiguous bases may be either RNA bases or, preferably, are primarily DNA bases. The central DNA domain is generally at least 8 nucleotides in length. The base(s) targeted for alteration in the most preferred embodiments are at least about 8, 9 or 10 bases from one end of the oligonucleotide.
- According to certain embodiments, one or both of the termini of the oligonucleotides of the present invention comprise phosphorothioate modifications, LNA backbone (including LNA derivatives and analogs) modifications, or 2′-O-methyl base analogs, or any combination of these modifications. Oligonucleotides comprising 2′-O-methyl or LNA analogs are a mixed DNA/RNA polymer. The oligonucleotides of the invention are, however, single-stranded and are not designed to form a stable internal duplex structure within the oligonucleotide. The efficiency of gene alteration is surprisingly increased with oligonucleotides having internal complementary sequence comprising phosphorothioate modified bases as compared to 2′-O-methyl modifications. This result indicates that specific chemical interactions are involved between the converting oligonucleotide and the proteins involved in the conversion. The effect of other such chemical interactions to produce nuclease resistant termini using modifications other than LNA (including LNA derivatives or analogs), phosphorothioate linkages, or 2′-O-methyl analog incorporation into an oligonucleotide can not yet be predicted because the proteins involved in the alteration process and their particular chemical interaction with the oligonucleotide substituents are not yet known and cannot be predicted.
- In the examples, oligonucleotides of defined sequence are provided for alteration of genes in particular plants. Provided the teachings of the instant application, one of skill in the art could readily design oligonucleotides to introduce analogous alterations in homologous genes from any plant. Furthermore, in the tables of these examples, the oligonucleotides of the invention are not limited to the particular sequences disclosed. The oligonucleotides of the invention include extensions of the appropriate sequence of the longer 120 base oligonucleotides which can be added base by base to the smallest disclosed oligonucleotides of 17 bases. Thus the oligonucleotides of the invention include for each correcting change, oligonucleotides of
length - The present invention, however, is not limited to oligonucleotides that contain any particular nuclease resistant modification. Oligonucleotides of the invention may be altered with any combination of additional LNAs (including LNA derivatives and analogs), phosphorothioate linkages or 2′-O-methyl analogs to maximize conversion efficiency. For oligonucleotides of the invention that are longer than about 17 to about 25 bases in length, internal as well as terminal region segments of the backbone may be altered. Alternatively, simple fold-back structures at each end of a oligonucleotide or appended end groups may be used in addition to a modified backbone for conferring additional nuclease resistance.
- The different oligonucleotides of the present invention preferably contain more than one of the aforementioned backbone modifications at each end. In some embodiments, the backbone modifications are adjacent to one another. However, the optimal number and placement of backbone modifications for any individual oligonucleotide will vary with the length of the oligonucleotide and the particular type of backbone modification(s) that are used. If constructs of identical sequence having phosphorothioate linkages are compared, 2, 3, 4, 5, or 6 phosphorothioate linkages at each end are preferred. If constructs of identical sequence having 2′-O-methyl base analogs are compared, 1, 2, 3 or 4 analogs are preferred. The optimal number and type of backbone modifications for any particular oligo-nucleotide useful for altering target DNA may be determined empirically by comparing the alteration efficiency of the oligonucleotide comprising any combination of the modifications to a control molecule of comparable sequence using any of the assays described herein. The optimal position(s) for oligonucleotide modifications for a maximally efficient altering oligonucleotide can be determined by testing the various modifications as compared to control molecule of comparable sequence in one of the assays disclosed herein. In such assays, a control molecule includes, e.g., a completely 2′-O-methyl substituted molecule, a completely complementary oligonucleotide, or a chimeric RNA-DNA double hairpin.
- Increasing the number of phosphorothioate linkages, LNAs or 2′-O-methyl bases beyond the preferred number generally decreases the gene repair activity of a 25 nucleotide long oligonucleotide. Based on analysis of the concentration of oligonucleotide present in the extract after different time periods of incubation, it is believed that the terminal modifications impart nuclease resistance to the oligo-nucleotide thereby allowing it to survive within the cellular environment. However, this may not be the only possible mechanism by which such modifications confer greater efficiency of conversion. For example, as disclosed herein, certain modifications to oligonucleotides confer a greater improvement to the efficiency of conversion than other modifications.
- Efficiency of conversion is defined herein as the percentage of recovered substrate molecules that have undergone a conversion event. Depending on the nature of the target genetic material, e.g. the genome of a cell, efficiency could be represented as the proportion of cells or clones containing an extrachromosomal element that exhibit a particular phenotype. Alternatively, representative samples of the target genetic material can be sequenced to determine the percentage that have acquired the desire change. The oligonucleotides of the invention in different embodiments can alter DNA two, three, four, five, six, seven, eight, nine, ten, twelve, fifteen, twenty, thirty, and fifty or more fold more than control oligonucleotides. Such control oligonucleotides are oligonucleotides with fully phosphorothiolated linkages, oligonucleotides that are fully substituted with 2′-O-methyl analogs, a perfectly matched oligonucleotide that is fully complementary to a target sequence or a chimeric DNA-RNA double hairpin oligonucleotide such as disclosed in U.S. Pat. No. 5,565,350.
- In addition, for a given oligonucleotide length, additional modifications interfere with the ability of the oligonucleotide to act in concert with the cellular recombination or repair enzyme machinery which is necessary and required to mediate a targeted substitution, addition or deletion event in DNA. For example, fully phosphorothiolated or fully 2-O-methylated molecules are inefficient in targeted gene alteration.
- The oligonucleotides of the invention as optimized for the purpose of targeted alteration of genetic material, including gene knockout or repair, are different in structure from antisense oligo-nucleotides that may possess a similar mixed chemical composition backbone. The oligonucleotides of the invention differ from such antisense oligonucleotides in chemical composition, structure, sequence, and in their ability to alter genomic DNA. Significantly, antisense oligonucleotides fail to direct targeted gene alteration. The oligonucleotides of the invention may target either strand of DNA and can include any component of the genome including, for example, intron and exon sequences. The preferred embodiment of the invention is a modified oligonucleotide that binds to the non-transcribed strand of a genomic DNA duplex. In other words, the preferred oligonucleotides of the invention target the sense strand of the DNA, i.e. the oligonucleotides of the invention are complementary to the non-transcribed strand of the target duplex DNA. The sequence of the non-transcribed strand of a DNA duplex is found in the mRNA produced from that duplex, given that mRNA uses uracil-containing nucleotides in place of thymine-containing nucleotides.
- Moreover, the initial observation that single-stranded oligonucleotides comprising these modifications and lacking any particular triplex forming domain have reproducibly enhanced gene alteration activity in a variety of assay systems as compared to a chimeric RNA-DNA double-stranded hairpin control or single-stranded oligonucleotides comprising other backbone modifications was surprising. The single-stranded molecules of the invention totally lack the complementary RNA binding structure that stabilizes a normal chimeric double-stranded hairpin of the type disclosed in U.S. Pat. No. 5,565,350 yet is more effective in producing targeted base conversion as compared to such a chimeric RNA-DNA double-stranded hairpin. In addition, the molecules of the invention lack any particular triplex forming domain involved in Hoogsteen interactions with the DNA double helix and required by other known oligonucleotides in other oligonucleotide-dependant gene conversion systems. Although the lack of these functional domains was expected to decrease the efficiency of an alteration in a sequence, just the opposite occurs: the efficiency of sequence alteration using the modified oligonucleotides of the invention is higher than the efficiency of sequence alteration using a chimeric RNA-DNA hairpin targeting the same sequence alteration. Moreover, the efficiency of sequence alteration or gene conversion directed by an unmodified oligonucleotide is many times lower as compared to a control chimeric RNA-DNA molecule or the modified oligonucleotides of the invention targeting the same sequence alteration. Similarly, molecules containing at least 3 2′-O-methyl base analogs are about four to five fold less efficient as compared to an oligonucleotide having the same number of phosphorothioate linkages.
- The oligonucleotides of the present invention for alteration of a single base are about 17 to about 121 nucleotides in length, preferably about 17 to about 74 nucleotides in length. Most preferably, however, the oligonucleotides of the present invention are at least about 25 bases in length, unless there are self-dimerization structures within the oligonucleotide. If the oligonucleotide has such an unfavorable structure, lengths longer than 35 bases are preferred. Oligonucleotides with modified ends both shorter and longer than certain of the exemplified, modified oligonucleotides herein function as gene repair or gene knockout agents and are within the scope of the present invention.
- Once an oligomer is chosen, it can be tested for its tendency to self-dimerize, since self-dimerization may result in reduced efficiency of alteration of genetic information. Checking for self-dimerization tendency can be accomplished manually or, preferably, using a software program. One such program is Oligo Analyzer 2.0, available through Integrated DNA Technologies (Coralville, Iowa 52241) (http://www.idtdna.com); this program is available for use on the world wide web at http://www.idtdna.com/program/oligoanalyzer/oligoanalyzer.asp.
- For each oligonucleotide sequence input into the program, Oligo Analyzer 2.0 reports possible self-dimerized duplex forms, which are usually only partially duplexed, along with the free energy change associated with such self-dimerization. Delta G-values that are negative and large in magnitude, indicating strong self-dimerization potential, are automatically flagged by the software as “bad”. Another software program that analyzes oligomers for pair dimer formation is Primer Select from DNASTAR, Inc., 1228 S. Park St., Madison, Wis. 53715, Phone: (608) 258-7420 (http://www.dnastar.com/products/PrimerSelect.html).
- If the sequence is subject to significant self-dimerization, the addition of further sequence flanking the “repair” nucleotide can improve gene correction frequency.
- Generally, the oligonucleotides of the present invention are identical in sequence to one strand of the target DNA, which can be either strand of the target DNA, with the exception of one or more targeted bases positioned within the DNA domain of the oligonucleotide, and preferably toward the middle between the modified terminal regions. Preferably, the difference in sequence of the oligonucleotide as compared to the targeted genomic DNA is located at about the middle of the oligo-nucleotide sequence. In a preferred embodiment, the oligonucleotides of the invention are complementary to the non-transcribed strand of a duplex. In other words, the preferred oligonucleotides target the sense strand of the DNA, i.e. the oligonucleotides of the invention are preferably complementary to the strand of the target DNA the sequence of which is found in the mRNA.
- The oligonucleotides of the invention can include more than a single base change. In an oligonucleotide that is about a 70-mer, with at least one modified residue incorporated on the ends, as disclosed herein, multiple bases can be simultaneously targeted for change. The target bases may be up to 27 nucleotides apart and may not be changed together in all resultant plasmids in all cases. There is a frequency distribution such that the closer the target bases are to each other in the central DNA domain within the oligonucleotides of the invention, the higher the frequency of change in a given cell. Target bases only two nucleotides apart are changed together in every case that has been analyzed. The farther apart the two target bases are, the less frequent the simultaneous change. Thus, oligonucleotides of the invention may be used to repair or alter multiple bases rather than just one single base. For example, in a 74-mer oligonucleotide having a central base targeted for change, a base change event up to about 27 nucleotides away can also be effected. The positions of the altering bases within the oligonucleotide can be optimized using any one of the assays described herein. Preferably, the altering bases are at least about 8 nucleotides from one end of the oligonucleotide.
- The oligonucleotides of the present invention can be introduced into cells by any suitable means. According to certain preferred embodiments, the modified oligonucleotides may be used alone. Suitable means, however, include the use of polycations, cationic lipids, liposomes, polyethylenimine (PEI), electroporation, biolistics, microinjection and other methods known in the art to facilitate cellular uptake. For plant cells, biolistic or particle bombardment methods are typically used. According to certain preferred embodiments of the present invention, isolated plant cells are treated in culture according to the methods of the invention, to mutate or repair a target gene. Alternatively, plant target DNA may be modified in vitro or in another cell type, including for example, yeast or bacterial cells and then introduced into a plant cell as, for example, a T-DNA. Plant cells thus modified may be used to regenerate the whole organism as, for example, in a plant having a desired targeted genomic change. In other instances, targeted genomic alteration, including repair or mutagenesis, may take place in vivo following direct administration of the modified, single-stranded oligonucleotides of the invention to a subject.
- The single-stranded, modified oligonucleotides of the present invention have numerous applications as gene repair, gene modification, or gene knockout agents. Such oligonucleotides may be advantageously used, for example, to introduce or correct multiple point mutations. Each mutation leads to the addition, deletion or substitution of at least one base pair. The methods of the present invention offer distinct advantages over other methods of altering the genetic makeup of an organism, in that only the individually targeted bases are altered. No additional foreign DNA sequences are added to the genetic complement of the organism. Such agents may, for example, be used to develop plants with improved traits by rationally changing the sequence of selected genes in isolated cells and using these modified cells to regenerate whole plants having the altered gene. See, e.g., U.S. Pat. No. 6,046,380 and U.S. Pat. No. 5,905,185 incorporated herein by reference. Such plants produced using the compositions of the invention lack additional undesirable selectable markers or other foreign DNA sequences. Targeted base pair substitution or frameshift mutations introduced by an oligonucleotide in the presence of a cell-free extract also provides a way to modify the sequence of extrachromosomal elements, including, for example, plasmids, cosmids and artificial chromosomes. The oligonucleotides of the invention also simplify the production of plants having particular modified or inactivated genes. Altered plant model systems such as those produced using the methods and oligonucleotides of the invention are invaluable in determining the function of a gene and in evaluating drugs. The oligonucleotides and methods of the present invention may also be used to introduce molecular markers, including, for example, SNPs, RFLPs, AFLPs and CAPs.
- The purified oligonucleotide compositions may be formulated in accordance with routine procedures depending on the target. For example, purified oligonucleotide can be used directly in a standard reaction mixture to introduce alterations into targeted DNA in vitro or where cells are the target as a composition adapted for bathing cells in culture or for microinjection into cells in culture. The purified oligonucleotide compositions may also be provided on coated microbeads for biolistic delivery into plant cells. Where necessary, the composition may also include a solubilizing agent. Generally, the ingredients will be supplied either separately or mixed together in single-use form, for example, as a dry, lyophilized powder or water-free concentrate. In general, dosage required for efficient targeted gene alteration will range from about 0.001 to 50,000 μg/kg target tissue, preferably between 1 to 250 μg/kg, and most preferably at a concentration of between 30 and 60 micromolar.
- For cell administration, direct injection into the nucleus, biolistic bombardment, electroporation, liposome transfer and calcium phosphate precipitation may be used. In yeast, lithium acetate or spheroplast transformation may also be used. In a preferred method, the administration is performed with a liposomal transfer compound, e.g., DOTAP (Boehringer-Mannheim) or an equivalent such as lipofectin. The amount of the oligonucleotide used is about 500 nanograms in 3 micrograms of DOTAP per 100,000 cells. For electroporation, between 20 and 2000 nanograms of oligonucleotide per million cells to be electroporated is an appropriate range of dosages which can be increased to improve efficiency of genetic alteration upon review of the appropriate sequence according to the methods described herein. For biolistic delivery, microbeads are generally coated with resuspended oligonucleotides, which range of oligonucleotide to microbead concentration can be similarly adjusted to improve efficiency as determined using one of the assay methods described herein, starting with about 0.05 to 1 microgram of oligonucleotide to 25 microgram of 1.0 micrometer gold beads or similar microcarrier.
- Another aspect of the invention is a kit comprising at least one oligonucleotide of the invention. The kit may comprise an additional reagent or article of manufacture. The additional reagent or article of manufacture may comprise a delivery mechanism, cell extract, a cell, or a plasmid, such as one of those disclosed in the Figures herein, for use in an assay of the invention. Alternatively, the invention includes a kit comprising an isogenic set of cells in which each cell in the kit comprises a different altered amino acid for a target protein encoded by a targeted altered gene within the cell produced according to the methods of the invention.
- FIG. 1. Flow diagram for the generation of modified single-stranded oligonucleotides. The upper strands of chimeric oligonucleotides I and II are separated into pathways resulting in the generation of single-stranded oligonucleotides that contain (A) 2′-O-methyl RNA nucleotides or (B) phosphorothioate linkages. Fold changes in repair activity for correction of kans in the HUH7 cell-free extract are presented in parenthesis. HUH7 cells are described in Nakabayashi et al., Cancer Research 42: 3858-3863 (1982). Each single-stranded oligonucleotide is 25 bases in length and contains a G residue mismatched to the complementary sequence of the kans gene. The
numbers oligo 12S/25G contains an all phosphorothioate backbone, displayed as a dotted line. Smooth lines indicate DNA residues, wavy lines indicate 2′-O-methyl RNA residues and the carat indicates the mismatched base site (G). FIG. 1(C) provides a schematic plasmid indicating the sequence of the kan chimeric double-stranded hairpin oligonucleotide (left; SEQ ID NO: 2673) and the sequence the tet chimeric double-stranded hairpin oligonucleotide used in other experiments (right; SEQ ID NO: 2674). FIG. 1(D) provides a flow chart of a kan experiment in which a chimeric double-stranded hairpin oligonucleotide (SEQ ID NO: 2673) is used. In FIG. 1(D), the Kan mutant sequence corresponds to SEQ ID NO: 2675 and SEQ ID NO: 2676; the Kan converted sequence corresponds to SEQ ID NO: 2677 and SEQ ID NO: 2678; the mutant sequence in the sequence trace corresponds to SEQ ID NO: 2679 and the converted sequences in the sequence trace correspond to SEQ ID NO: 2680. - FIG. 2. Genetic readout system for correction of a point mutation in plasmid pKsm4021. A mutant kanamycin gene harbored in plasmid pKsm4021 is the target for correction by oligonucleotides. The mutant G is converted to a C by the action of the oligo. Corrected plasmids confer resistance to kanamycin in E.coli (DH10B) after electroporation leading to the genetic readout and colony counts. The wild type sequence corresponds to SEQ ID NO: 2681.
- FIG. 3: Target plasmid and sequence correction of a frameshift mutation by chimeric and single-stranded oligonucleotides. (A) Plasmid pTsΔ208 contains a single base deletion mutation at
position 208 rendering it unable to confer tet resistance. The target sequence presented below indicates the insertion of a T directed by the oligonucleotides to re-establish the resistant phenotype. (B) DNA sequence confirming base insertion directed byTet 3S/25G; the yellow highlight indicates the position of frameshift repair. The wild type sequence corresponds to SEQ ID NO: 2682, the mutant sequence corresponds to SEQ ID NO: 2683 and the converted sequence corresponds to SEQ ID NO: 2684. The control sequence in the sequence trace corresponds to SEQ ID NO: 2685 and the 3S/25A sequence in the sequence trace corresponds to SEQ ID NO: 2686. - FIG. 4. DNA sequences of representative kanr colonies. Confirmation of sequence alteration directed by the indicated molecule is presented along with a table outlining codon distribution. Note that 10S/25G and 12S/25G elicit both mixed and unfaithful gene repair. The number of clones sequenced is listed in parentheses next to the designation for the single-stranded oligonucleotide. A plus (+) symbol indicates the codon identified while a figure after the (+) symbol indicates the number of colonies with a particular sequence. TAC/TAG indicates a mixed peak. Representative DNA sequences are presented below the table with yellow highlighting altered residues. The sequences in the sequence traces have been assigned numbers as follows: 3S/25G, 6S/25G and 8S/25G correspond to SEQ ID NO: 2687, 10S/25G corresponds to SEQ ID NO: 2688, 25S/25G on the lower left corresponds to SEQ ID NO: 2689 and 25S/25G on the lower right corresponds to SEQ ID NO: 2690.
- FIG. 5. Gene correction in HeLa cells. Representative oligonucleotides of the invention are co-transfected with the pCMVneo(−)FIAsH plasmid (shown in FIG. 9) into HeLa cells. Ligand is diffused into cells after co-transfection of plasmid and oligonucleotides. Green fluorescence indicates gene correction of the mutation in the antibiotic resistance gene. Correction of the mutation results in the expression of a fusion protein that carries a marker ligand binding site and when the fusion protein binds the ligand, a green fluorescence is emitted. The ligand is produced by Aurora Biosciences and can readily diffuse into cells enabling a measurement of corrected protein function; the protein must bind the ligand directly to induce fluorescence. Hence cells bearing the corrected plasmid gene appear green while “uncorrected” cells remain colorless.
- FIG. 6. Z-series imaging of corrected cells. Serial cross-sections of the HeLa cell represented in FIG. 5 are produced by Zeiss 510 LSM confocal microscope revealing that the fusion protein is contained within the cell.
- FIG. 7. Hygromycin-eGFP target plasmids. (A) Plasmid pAURHYG(ins)GFP contains a single base insertion mutation between nucleotides 136 and 137, at codon 46, of the Hygromycin B coding sequence (cds) which is transcribed from the constitutive ADH1 promoter. The target sequence presented below indicates the deletion of an A and the substitution of a C for a T directed by the oligonucleotides to re-establish the resistant phenotype. In FIG. 7A, the sequence of the normal allele corresponds to SEQ ID NO: 2691, the sequence of the targe/existing mutation corresponds to SEQ ID NO: 2692 and the sequence of the desired alteration corresponds to SEQ ID NO: 2693. (B) Plasmid pAURHYG(rep)GFP contains a base substitution mutation introducing a G at nucleotide 137, at codon 46, of the Hygromycin B coding sequence (cds). The target sequence presented below the diagram indicates the amino acid conservative replacement of G with C, restoring gene function. In FIG. 7B, the sequence of the normal allele correspond to SEQ ID NO: 2691, the sequence of the targe/existing mutation corresponds to SEQ ID NO: 2694 and the sequence of the desired alteration corresponds to SEQ ID NO: 2693.
- FIG. 8. Oligonucleotides for correction of hygromycin resistance gene. The sequence of the oligonucleotides used in experiments to assay correction of a hygromycin resistance gene are shown. DNA residues are shown in capital letters, RNA residues are shown in lowercase and nucleotides with a phosphorothioate backbone are capitalized and underlined. In FIG. 8, the sequence of HygE3T/25 corresponds to SEQ ID NO: 2695, the sequence of HygE3T/74 corresponds to SEQ ID NO: 2696, the sequence of HygE3T/74a corresponds to SEQ ID NO: 2697, the sequence of HygGG/Rev corresponds to SEQ ID NO: 2698 and the sequence of Kan70T corresponds to SEQ ID NO: 2699.
- FIG. 9. pAURNeo(−)FIAsH plasmid. This figure describes the plasmid structure, target sequence, oligonucleotides, and the basis for detection of the gene alteration event by fluorescence. In FIG. 9, the sequence of the Neo/kan target mutant corresponds to SEQ ID NO: 2675 and SEQ ID NO: 2676, the converted sequence corresponds to SEQ ID NO: 2677 and SEQ ID NO: 2678 and the FIAsH peptide sequence corresponds to SEQ ID NO: 2700.
- FIG. 10. pYESHyg(x)eGFP plasmid. This plasmid is a construct similar to the pAURHyg(x)eGFP construct shown in FIG. 7, except the promoter is the inducible GAL1 promoter. This promoter is inducible with galactose, leaky in the presence of raffinose, and repressed in the presence of dextrose.
- FIG. 11. pBI-HygeGFP plasmid. This plasmid is a construct based on the plasmids pBI101, pBI 101.2, pBI101.3 or pBI 121 available from Clontech in which HygeGFP replaces the beta-glucuronidase gene of the Clontech plasmids. The different Clontech plasmids vary by a reading frame shift relative to the polylinker, or the presence of the Cauliflower mosaic virus promoter.
- The following examples are provided by way of illustration only, and are not intended to limit the scope of the invention disclosed herein.
- In this example, single-stranded and double-hairpin oligonucleotides with chimeric backbones (see FIG. 1 for structures (A and B) and sequences (C and D) of assay oligonucleotides) are used to correct a point mutation in the kanamycin gene of pKsm4021 (FIG. 2) or the tetracycline gene of pTsΔ208 (FIG. 3). All kan oligonucleotides share the same 25 base sequence surrounding the target base identified for change, just as all tet oligonucleotides do. The sequence is given in FIG. 1C and FIG. 1D. Each plasmid contains a functional ampicillin gene. Kanamycin gene function is restored when a G at
position 4021 is converted to a C (via a substitution mutation); tetracycline gene function is restored when a deletion atposition 208 is replaced by a C (via frameshift mutation). A separate plasmid, pAURNeo(−)FIAsH (FIG. 9), bearing the kans gene is used in the cell culture experiments. This plasmid was constructed by inserting a synthetic expression cassette containing a neomycin phosphotransferasea (kanamycin resistance) gene and an extended reading frame that encodes a receptor for the FIAsH ligand into the pAUR123 shuttle vector (Panvera Corp., Madison, Wis.). The resulting construct replicates in S. cerevisiae at low copy number, confers resistance to aureobasidinA and constitutively expresses either the Neo+/FIAsH fusion product (after alteration) or the truncated Neo−/FIAsH product (before alteration) from the ADH1 promoter. By extending the reading frame of this gene to code for a unique peptide sequence capable of binding a small ligand to form a fluorescent complex, restoration of expression by correction of the stop codon can be detected in real time using confocal microscopy. - Additional constructs can be made to test additional gene alteration events or for specific use in different expression systems. For example, alternative comparable plant plasmids or integration vectors such as, e.g. those based on T-DNA, can be constructed for stable expression in plant cells according to the disclosures herein. Such constructs would use a plant specific promoter such as, e.g., cauliflower mosaic virus 35S promoter, to replace the promoters directing expression of the neo, hyg or aureobasidinA resistance gene disclosed herein, including for example, in FIGS. 7B, 9 and10 herein. Moreover, the green fluorescent protein (GFP) sequence used herein may be modified to increase expression in plant cells such as Arabidopsis and the other plants disclosed herein as described in Haseloff et al., Proc. Natl.Acad. Sci. 94(6): 2122-7 (1997), Rouwendal et al. Plant Mol. Biol. 33(6): 989-99 (1997) and Hu et al. FEBS Lett. 369(2-3): 331-4 (1995). Codon usage for optimal expression of GFP in plants results from increasing the frequency of codons with a C or a G in the third position from 32 to about 60%. Specific constructs are disclosed and can be used as follows with such plant specific alterations.
- We also construct three mammalian expression vectors, pHyg(rep)eGFP, pHyg(Δ)eGFP, pHyg(ins)eGFP, that contain a substitution mutation at nucleotide 137 of the hygromycin-B coding sequence. (rep) indicates a T1374→G replacement, (Δ) represents a deletion of the G137 and (ins) represents an A insertion between nucleotides 136 and 137. All point mutations create a nonsense termination codon at residue 46. We use pHYGeGFP plasmid (Invitrogen, CA) DNA as a template to introduce the mutations into the hygromycin-eGFP fusion gene by a two step site-directed mutagenesis PCR protocol. First, we generate overlapping 5′ and a 3′ amplicons surrounding the mutation site by PCR for each of the point mutation sites. A 215
bp 5′ amplicon for the (rep), (Δ) or (ins) was generated by polymerization from oligonucleotide primer HygEGFPf (5′-AATACGACTCACTATAGG-3′; SEQ ID NO: 2701) to primer Hygrepr (5′GACCTATCCACGCCCTCC-3′; SEQ ID NO: 2702), HygΔr (5′-GACTATCCACGCCCTCC-3′; SEQ ID NO: 2703), or Hyginsr (5′-GACATTATCCACGCCCTCC-3′; SEQ ID NO: 2704), respectively. We generate a 300bp 3′ amplicon for the (rep), (Δ) or (ins) by polymerization from oligonucleotide primers Hygrepf (5′-CTGGGATAGGTCCTGCGG-3′; SEQ ID NO: 2705), HygΔf (5′-CGTGGATAGTCCTGCGG-3′; SEQ ID NO: 2706), Hyginsf (5′-CGTGGATAATGTCCTGCGG-3′; SEQ ID NO: 2707), respectively to primer HygEGFPr (5′-AAATCACGCCATGTAGTG-3′; SEQ ID NO: 2708). We mix 20 ng of each of the resultant 5′ and 3′ overlapping amplicon mutation sets and use the mixture as a template to amplify a 523 bp fragment of the Hygromycin gene spanning the KpnI and RsrII restriction endonuclease sites. We use the Expand PCR system (Roche) to generate all amplicons with 25 cycles of denaturing at 94° C. for 10 seconds, annealing at 55° C. for 20 seconds and elongation at 68° C. for 1 minute. We digest 10 μg of vector pHYGeGFP and 5 μg of the resulting fragments for each mutation with KpnI and RsrII (NEB) and gel purify the fragment for enzymatic ligation. We ligate each mutated insert into pHYGeGFP vector at 3:1 molar ratio using T4 DNA ligase (Roche). We screen clones by restriction digest, confirm the mutation by Sanger dideoxy chain termination sequencing and purify the plasmid using a Qiagen maxiprep kit. - Oligonucleotide synthesis and cells. Chimeric oligonucleotides and single-stranded oligonucleotides (including those with the indicated modifications) are synthesized using available phosphoramidites on controlled pore glass supports. After deprotection and detachment from the solid support, each oligonucleotide is gel-purified using, for example, procedures such as those described in Gamper et al.,Biochem. 39, 5808-5816 (2000) and the concentrations determined spectrophotometrically (33 or 40 μg/ml per A260 unit of single-stranded or hairpin oligomer). HUH7 cells are grown in DMEM, 10% FBS, 2 mM glutamine, 0.5% pen/strep. The E.coli strain, DH10B, is obtained from Life Technologies (Gaithersburg, Md.); DH10B cells contain a mutation in the RECA gene (recA).
- Cell-free extracts. Although this portion of this example is directed to mammalian systems, similar extracts from plants can be prepared as disclosed elsewhere in this application and used as disclosed in this example. We prepare cell-free extracts from HUH7 cells or other mammalian cells, as follows. We employ this protocol with essentially any mammalian cell including, for example, H1299 cells (human epithelial carcinoma, non-small cell lung cancer), C127I (immortal murine mammary epithelial cells), MEF (mouse embryonic fibroblasts), HEC-1-A (human uterine carcinoma), HCT15 (human colon cancer), HCT116 (human colon carcinoma), LoVo (human colon adenocarcinoma), and HeLa (human cervical carcinoma). We harvest approximately 2×108 cells. We then wash the cells immediately in cold hypotonic buffer (20 mM HEPES, pH7.5; 5 mM KCl; 1.5 mM MgCl2; 1 mM DTT) with 250 mM sucrose. We then resuspend the cells in cold hypotonic buffer without sucrose and after 15 minutes we lyse the cells with 25 strokes of a Dounce homogenizer using a tight fitting pestle. We incubate the lysed cells for 60 minutes on ice and centrifuge the sample for 15 minutes at 12000×g. The cytoplasmic fraction is enriched with nuclear proteins due to the extended co-incubation of the fractions following cell breakage. We then immediately aliquote and freeze the supernatant at −80° C. We determine the protein concentration in the extract by the Bradford assay.
- We also perform these experiments with cell-free extracts obtained from fungal cells, including, for example,S. cerevisiae (yeast), Ustilago maydis, and Candida albicans. For example, we grow yeast cells into log phase in 2L YPD medium for 3 days at 30° C. We then centrifuge the cultures at 5000×g, resuspend the pellets in a 10% sucrose, 50 mM Tris, 1 mM EDTA lysis solution and freeze them on dry ice. After thawing, we add KCl, spermidine and lyticase to final concentrations of 0.25 mM, 5 mM and 0.1 mg/ml, respectively. We incubate the suspension on ice for 60 minutes, add PMSF and Triton X100 to final concentrations of 0.1 mM and 0.1% and continue to incubate on ice for 20 minutes. We centrifuge the lysate at 3000×g for 10 minutes to remove larger debris. We then remove the supernatant and clarify it by centrifuging at 30000×g for 15 minutes. We then add glycerol to the clarified extract to a concentration of 10% (v/v) and freeze aliquots at −80° C. We determine the protein concentration of the extract by the Bradford assay.
- Reaction mixtures of 50 μl are used, consisting of 10-30 μg protein of cell-free extract, which can be optionally substituted with purified proteins or enriched fractions, about 1.5 μg chimeric double-hairpin oligonucleotide or 0.55 μg single-stranded molecule (3S/25G or 6S/25G, see FIG. 1), and 1 μg of plasmid DNA (see FIGS. 2 and 3) in a reaction buffer of 20 mM Tris, pH 7.4, 15 mM MgCl2, 0.4 mM DTT, and 1.0 mM ATP. Reactions are initiated with extract and incubated at 30° C. for 45 min. The reaction is stopped by placing the tubes on ice and then immediately deproteinized by two phenol/chloroform (1:1) extractions. Samples are then ethanol precipitated. The nucleic acid is pelleted at 15,000 r.p.m. at 4° C. for 30 min., is washed with 70% ethanol, resuspended in 50 μl H2O, and is stored at −20° C. 5 μl of plasmid from the resuspension (˜100 ng) was transfected in 20 μl of DH10B cells by electroporation (400 V, 300 μF, 4 kΩ) in a Cell-Porator apparatus (Life Technologies). After electroporation, cells are transferred to a 14 ml Falcon snap-cap tube with 2 ml SOC and shaken at 37° C. for 1 h. Enhancement of final kan colony counts is achieved by then adding 3 ml SOC with 10 μg/ml kanamycin and the cell suspension is shaken for a further 2 h at 37° C. Cells are then spun down at 3750×g and the pellet is resuspended in 500 μl SOC. 200 μl is added undiluted to each of two kanamycin (50 μg/ml) agar plates and 200 μl of a 105 dilution is added to an ampicillin (100 μg/ml) plate. After overnight 37° C. incubation, bacterial colonies are counted using an Accucount 1000 (Biologics). Gene conversion effectiveness is measured as the ratio of the average of the kan colonies on both plates per amp colonies multiplied by 10−5 to correct for the amp dilution.
- The following procedure can also be used. 5 μl of resuspended reaction mixtures (total volume 50 μl) are used to transform 20 μl aliquots of electro-competent DH10B bacteria using a Cell-Porator apparatus (Life Technologies). The mixtures are allowed to recover in 1 ml SOC at 37° C. for 1 hour at which time 50 μg/ml kanamycin or 12 μg/ml tetracycline is added for an additional 3 hours. Prior to plating, the bacteria are pelleted and resuspended in 200 μl of SOC. 100 μl aliquots are plated onto kan or tet agar plates and 100 μl of a 1031 4 dilution of the cultures are concurrently plated on agar plates containing 100 μg/ml of ampicillin. Plating is performed in triplicate using sterile Pyrex beads. Colony counts are determined by an Accu-count 1000 plate reader (Biologics). Each plate contains 200-500 ampicillin resistant colonies or 0-500 tetracycline or kanamycin resistant colonies. Resistant colonies are selected for plasmid extraction and DNA sequencing using an ABI Prism kit on an ABI 310 capillary sequencer (PE Biosystems).
- Chimeric single-stranded oligonucleotides. In FIG. 1 the upper strands of chimeric oligonucleotides I and II are separated into pathways resulting in the generation of single-stranded oligo-nucleotides that contain (FIG. 1A) 2′-O-methyl RNA nucleotides or (FIG. 1B) phosphorothioate linkages. Fold changes in repair activity for correction of kans in the HUH7 cell-free extract are presented in parenthesis. Each single-stranded oligonucleotide is 25 bases in length and contains a G residue mismatched to the complementary sequence of the kans gene.
- Molecules bearing 3, 6, 8, 10 and 12 phosphorothioate linkages in the terminal regions at each end of a backbone with a total of 24 linkages (25 bases) are tested in the kans system. Alternatively, molecules bearing 2, 4, 5, 7, 9 and 11 in the terminal regions at each end are tested. The results of one such experiment, presented in Table 1 and FIG. 1B, illustrate an enhancement of correction activity directed by some of these modified structures. In this illustrative example, the most efficient molecules contained 3 or 6 phosphorothioate linkages at each end of the 25-mer; the activities are approximately equal (molecules IX and X with results of 3.09 and 3.7 respectively). A reduction in alteration activity may be observed as the number of modified linkages in the molecule is further increased. Interestingly, a single-strand molecule containing 24 phosphorothioate linkages is minimally active suggesting that this backbone modification when used throughout the molecule supports only a low level of targeted gene repair or alteration. Such a non-altering, completely modified molecule can provide a baseline control for determining efficiency of correction for a specific oligonucleotide molecule of known sequence in defining the optimum oligonucleotide for a particular alteration event.
- The efficiency of gene repair directed by phosphorothioate-modified, single-stranded molecules, in a length dependent fashion, led us to examine the length of the RNA modification used in the original chimera as it relates to correction. Construct III represents the “RNA-containing” strand of chimera I and, as shown in Table 1 and FIG. 2A, it promotes inefficient gene repair. But, as shown in the same figure, reducing the RNA residues on each end from 10 to 3 increases the frequency of repair. At equal levels of modification, however, 25-mers with 2′-O-methyl ribonucleotides were less effective gene repair agents than the same oligomers with phosphorothioate linkages. These results reinforce the fact that an RNA containing oligonucleotide is not as effective in promoting gene repair or alteration as a modified DNA oligonucleotide.
- Repair of the kanamycin mutation requires a G→C exchange. To confirm that the specific desired correction alteration was obtained, colonies selected at random from multiple experiments are processed and the isolated plasmid DNA is sequenced. As seen in FIG. 4, colonies generated through the action of the single-stranded
molecules 3S/25G (IX), 6S/25G (X) and 8S/25G (XI) respectively contained plasmid molecules harboring the targeted base correction. While a few colonies appeared on plates derived from reaction mixtures containing 25-mers with 10 or 12 thioate linkages on both ends, the sequences of the plasmid molecules from these colonies contain nonspecific base changes. In these illustrative examples, the second base of the codon is changed (see FIG. 3). These results show that modified single-strands can direct gene repair, but that efficiency and specificity are reduced when the 25-mers contain 10 or more phosphorothioate linkages at each end. - In FIG. 1, the
numbers oligo 12S/25G represents a 25-mer oligonucleotide which contains 12 phosphorothioate linkages on each side of the central G target mismatch base producing a fully phosphorothioate linked backbone, displayed as a dotted line. The dots are merely representative of a linkage in the figure and do not depict the actual number of linkages of the oligonucleotide. Smooth lines indicate DNA residues, wavy lines indicate 2′-O-methyl RNA residues and the carat indicates the mismatched base site (G). - Correction of a mutant kanamycin gene in cultured mammalian cells. Although this portion of this example is directed to cultured mammalian cells, comparable methods may be used using cultured plant cells or protoplasts of those cells from the plant species disclosed herein. The experiments are performed using different eukaryotic cells including plant and mammalian cells, including, for example, 293 cells (transformed human primary kidney cells), HeLa cells (human cervical carcinoma), and H1299 (human epithelial carcinoma, non-small cell lung cancer). HeLa cells are grown at 37° C. and 5% CO2 in a humidified incubator to a density of 2×105 cells/ml in an 8 chamber slide (Lab-Tek). After replacing the regular DMEM with Optimem, the cells are co-transfected with 10 μg of plasmid pAURNeo(−) FIAsH and 5 μg of modified single-stranded oligonucleotide (3S/25G) that is previously complexed with 10 μg lipofectamine, according to the manufacturer's directions (Life Technologies). The cells are treated with the liposome-DNA-oligo mix for 6 hrs at 37° C. Treated cells are washed with PBS and fresh DMEM is added. After a 16-18 hr recovery period, the culture is assayed for gene repair. The same oligonucleotide used in the cell-free extract experiments is used to target transfected plasmid bearing the kans gene. Correction of the point mutation in this gene eliminates a stop codon and restores full expression. This expression can be detected by adding a small non-fluorescent ligand that bound to a C-C-R-E-C-C sequence (SEQ ID NO: 2717) in the genetically modified carboxy terminus of the kan protein, to produce a highly fluorescent complex (FIAsH system, Aurora Biosciences Corporation). Following a 60 min incubation at room temperature with the ligand (FIAsH-EDT2), cells expressing full length kan product acquire an intense green fluorescence detectable by fluorescence microscopy using a fluorescein filter set. Similar experiments are performed using the HygeGFP target as described in Example 2 with a variety of mammalian cells, including, for example, COS-1 and COS-7 cells (African green monkey), and CHO-K1 cells (Chinese hamster ovary). The experiments are also performed with PG12 cells (rat pheochromocytoma) and ES cells (human embryonic stem cells).
- Summary of experimental results. Tables 1, 2 and 3 respectively provide data on the efficiency of gene repair directed by single-stranded oligonucleotides. Table 1 presents data using a cell-free extract from human liver cells (HUH7) to catalyze repair of the point mutation in plasmid pkansm4021 (see FIG. 1). Table 2 illustrates that the oligomers are not dependent on MSH2 or MSH3 for optimal gene repair activity. Table 3 illustrates data from the repair of a frameshift mutation (FIG. 3) in the tet gene contained in plasmid pTetΔ208. Table 4 illustrates data from repair of the pkansm4021 point mutation catalyzed by plant cell extracts prepared from canola and musa (banana). Colony numbers are presented as kanr or tetr and fold increases (single strand versus double hairpin) are presented for kanr in Table 1.
- FIG. 5A is a confocal picture of HeLa cells expressing the corrected fusion protein from an episomal target. Gene repair is accomplished by the action of a modified single-stranded oligonucleotide containing 3 phosphorothioate linkages at each end (3S/25G). FIG. 5B represents a “Z-series” of HeLa cells bearing the corrected fusion gene. This series sections the cells from bottom to top and illustrates that the fluorescent signal is “inside the cells”.
- Results. In summary, we have designed a novel class of single-stranded oligonucleotides with backbone modifications at the termini and demonstrate gene repair/conversion activity in mammalian and plant cell-free extracts. We confirm that the all DNA strand of the RNA-DNA double-stranded double hairpin chimera is the active component in the process of gene repair. In some cases, the relative frequency of repair by the novel oligonucleotides of the invention is elevated approximately 3-4-fold in certain embodiments when compared to frequencies directed by chimeric RNA-DNA double hairpin oligonucleotides.
- This strategy centers around the use of extracts from various sources to correct a mutation in a plasmid using a modified single-stranded or a chimeric RNA-DNA double hairpin oligonucleotide. A mutation is placed inside the coding region of a gene conferring antibiotic resistance in bacteria, here kanamycin or tetracycline. The appearance of resistance is measured by genetic readout inE.coli grown in the presence of the specified antibiotic. The importance of this system is that both phenotypic alteration and genetic inheritance can be measured. Plasmid pKsm4021 contains a mutation (T→G) at
residue 4021 rendering it unable to confer antibiotic resistance in E.coli. This point mutation is targeted for repair by oligonucleotides designed to restore kanamycin resistance. To avoid concerns of plasmid contamination skewing the colony counts, the directed correction is from G→C rather than G→T (wild-type). After isolation, the plasmid is electroporated into the DH10B strain of E.coli, which contains inactive RecA protein. The number of kanamycin colonies is counted and normalized by ascertaining the number of ampicillin colonies, a process that controls for the influence of electroporation. The number of colonies generated from three to five independent reactions was averaged and is presented for each experiment. A fold increase number is recorded to aid in comparison. - The original RNA-DNA double hairpin chimera design, e.g., as disclosed in U.S. Pat. No. 5,565,350, consists of two hybridized regions of a single-stranded oligonucleotide folded into a double hairpin configuration. The double-stranded targeting region is made up of a 5 base pair DNA/DNA segment bracketed by 10 base pair RNA/DNA segments. The central base pair is mismatched to the corresponding base pair in the target gene. When a molecule of this design is used to correct the kans mutation, gene repair is observed (I in FIG. 1A). Chimera II (FIG. 1B) differs partly from chimera I in that only the DNA strand of the double hairpin is mismatched to the target sequence. When this chimera was used to correct the kans mutation, it was twice as active. In the same study, repair function could be further increased by making the targeting region of the chimera a continuous RNA/DNA hybrid.
- Frame shift mutations are repaired. By using plasmid pTsΔ208, described in FIG. 1(C) and FIG. 3, the capacity of the modified single-stranded molecules that showed activity in correcting a point mutation, can be tested for repair of a frameshift. To determine efficiency of correction of the mutation, a chimeric oligonucleotide (Tet I), which is designed to insert a T residue at
position 208, is used. A modified single-stranded oligonucleotide (Tet IX) directs the insertion of a T residue at this same site. FIG. 3 illustrates the plasmid and target bases designated for change in the experiments. When all reaction components are present (extract, plasmid, oligomer), tetracycline resistant colonies appear. The colony count increases with the amount of oligonucleotide used up to a point beyond which the count falls off (Table 3). No colonies above background are observed in the absence of either extract or oligonucleotide, nor when a modified single-stranded molecule bearing perfect complementarity is used. FIG. 3 represents the sequence surrounding the target site and shows that a T residue is inserted at the correct site. We have isolated plasmids from fifteen colonies obtained in three independent experiments and each analyzed sequence revealed the same precise nucleotide insertion. These data suggest that the single-stranded molecules used initially for point mutation correction can also repair nucleotide deletions. - Comparison of phosphorothioate oligonucleotides to 2′-O-methyl substituted oligonucleotides. From a comparison of molecules VII and XI, it is apparent that gene repair is more subject to inhibition by RNA residues than by phosphorothioate linkages. Thus, even though both of these oligonucleotides contain an equal number of modifications to impart nuclease resistance, XI (with 16 phosphorothioate linkages) has good gene repair activity while VII (with 16 2′-O-methyl RNA residues) is inactive. Hence, the original chimeric double hairpin oligonucleotide enabled correction directed, in large part, by the strand containing a large region of contiguous DNA residues.
- Oligonucleotides can target multiple nucleotide alterations within the same template. The ability of individual single-stranded oligonucleotides to correct multiple mutations in a single target template is tested using the plasmid pKsm4021 and the following single-stranded oligonucleotides modified with 3 phosphorothioate linkages at each end (indicated as underlined nucleotides): Oligo1 is a 25-mer with the sequence TTCGATAAGCCTATGCTGACCCGTG (SEQ ID NO: 2709) corrects the original mutation present in the kanamycin resistance gene of pKsm4021 as well as directing another
alteration 2 basepairs away in the target sequence (both indicated in boldface); Oligo2 is a 70-mer with the 5′-end sequence TTCGGCTACGACTGGGCACAACAGACAATTGGC (SEQ ID NO: 2710) with the remaining nucleotides being completely complementary to the kanamycin resistance gene and also ending in 3 phosphorothioate linkages at the 3′ end. Oigo2 directs correction of the mutation in pKsm4021 as well as directing another alteration 21 basepairs away in the target sequence (both indicated in boldface). - We also use additional oligonucleotides to assay the ability of individual oligonucleotides to correct multiple mutations in the pKsM4021 plasmid. These include, for example, a second 25-mer that alters two nucleotides that are three nucleotides apart with the
sequence 5′-TTGTGCCCAGTCGTATCCGAATAGC-3′ (SEQ ID NO: 2711); a 70-mer that alters two nucleotides that are 21 nucleotides apart with thesequence 5′-CATCAGAGCAGCCAATTGTCTGTTGTGCCCAGTCGTAGCCGAATAGCCTCTCCACCCAAGCGGCCGGAGA-3′ (SEQ ID NO: 2712); and another 70-mer that alters two nucleotides that are 21 nucleotides apart with thesequence 5′-GCTGACAGCCGGAACACGGCGGCATCAGAGCAGCCAATTGTCTGTTGTGCCCAGTCGTAGCCGMTAGCCT-3′ (SEQ ID NO: 2713). The nucleotides in the oligonucleotides that direct alteration of the target sequence are underlined and in boldface. These oligonucleotides are modified in the same way as the other oligonucleotides of the invention. - We assay correction of the original mutation in pKsm4021 by monitoring kanamycin resistance (the second alterations which are directed by Oligo2 and Oligo3 are silent with respect to the kanamycin resistance phenotype). In addition, in experiments with Oligo2, we also monitor cleavage of the resulting plasmids using the restriction enzyme Tsp5091 which cuts at a specific site present only when the second alteration has occurred (at ATT in Oligo2). We then sequence these clones to determine whether the additional, silent alteration has also been introduced. The results of an analysis are presented below:
Oligo 1 (25-mer) Oligo 2 (70-mer) Clones with both sites changed 9 7 Clones with a single site changed 0 2 Clones that were not changed 4 1 - Nuclease sensitivity of unmodified DNA oligonucleotide. Electrophoretic analysis of nucleic acid recovered from the cell-free extract reactions conducted here confirm that the unmodified single-stranded 25-mer did not survive incubation whereas greater than 90% of the terminally modified oligos did survive (as judged by photo-image analyses of agarose gels).
- Plant extracts direct repair. The modified single-stranded constructs can be tested in plant cell extracts. We have observed gene alteration using extracts from multiple plant sources, including, for example, Arabidopsis, tobacco, banana, maize, soybean, canola, wheat, spinach as well as spinach chloroplast extract or extracts made from other plant cells disclosed herein. We prepare the extracts by grinding plant tissue or cultured cells under liquid nitrogen with a mortar and pestle. We extract 3 ml of the ground plant tissue with 1.5 ml of extraction buffer (20 mM HEPES, pH7.5; 5 mM KCl; 1.5 mM MgCl2; 10 mM DTT; and 10% [v/v] glycerol). Some plant cell-free extracts also include about 1% (w/v) PVP. We then homogenize the samples with 15 strokes of a Dounce homogenizer. Following homogenization, we incubate the samples on ice for 1 hour and centrifuge at 3000×g for 5 minutes to remove plant cell debris. We then determine the protein concentration in the supernatants (extracts) by Bradford assay. We dispense 100 μg (protein) aliquots of the extracts which we freeze in a dry ice-ethanol bath and store at −80° C.
- We describe experiments using two sources here: a dicot (canola) and a monocot (banana,Musa acuminata cv. Rasthali). Each vector directs gene repair of the kanamycin mutation (Table 4); however, the level of correction is elevated 2-3 fold relative to the frequency observed with the chimeric oligonucleotide. These results are similar to those observed in the mammalian system wherein a significant improvement in gene repair occurred when modified single-stranded molecules were used.
- Tables are attached hereto.
TABLE I Gene repair activity is directed by single-stranded oligonucleotides. Oligonucleotide Plasmid Extract (ug) kanr colonies Fold increase I pKSm4021 10 300 I ↓ 20 418 1.0 × II ↓ 10 537 II ↓ 20 748 1.78 × III ↓ 10 3 III ↓ 20 5 0.01 × IV ↓ 10 112 IV ↓ 20 96 0.22 × V ↓ 10 217 V ↓ 20 342 0.81 × VI ↓ 10 6 VI ↓ 20 39 0.093 × VII ↓ 10 0 VII ↓ 20 0 0 × VIII ↓ 10 3 VIII ↓ 20 5 0.01 × IX ↓ 10 936 IX ↓ 20 1295 3.09 × X ↓ 10 1140 X ↓ 20 1588 3.7 × XI ↓ 10 480 XI ↓ 20 681 1.6 × XII ↓ 10 18 XII ↓ 20 25 0.059 × XIII ↓ 10 0 XIII ↓ 20 4 0.009 × — ↓ 20 0 I ↓ — 0 - Plasmid pKSm4021 (1 μg), the indicated oligonucleotide (1.5 μg chimeric oligonucleotide or 0.55 μg single-stranded oligonucleotide; molar ratio of oligo to plasmid of 360 to 1) and either 10 or 20 μg of HUH7 cell-free extract were incubated 45 min at 37° C. Isolated plasmid DNA was electroporated into E. coli (strain DH10B) and the number of kanr colonies counted. The data represent the number of kanamycin resistant colonies per 106 ampicillin resistant colonies generated from the same reaction and is the average of three experiments (standard deviation usually less than +/−15%). Fold increase is defined relative to 418 kanr colonies (second reaction) and in all reactions was calculated using the 20 μg sample.
TABLE II Modified single-stranded oligomers are not dependent on MSH2 or MSH3 for optimal gene repair activity. A. Oligonucleotide Plasmid Extract kanr colonies IX (3S/25G) ↓ HUH7 637 X (6S/25G) ↓ HUH7 836 IX ↓ MEF2−/− 781 X ↓ MEF2−/− 676 IX ↓ MEF3−/− 582 X ↓ MEF3−/− 530 IX ↓ MEF+/+ 332 X ↓ MEF+/+ 497 — ↓ MEF2−/− 10 — ↓ MEF3 −/−5 — ↓ MEF+/+ 14 - Chimeric oligonucleotide (1.5 μg) or modified single-stranded oligonucleotide (0.55 μg) was incubated with 1 μg of plasmid pKSm4021 and 20 μg of the indicated extracts. MEF represents mouse embryonic fibroblasts with either MSH2 (2−/−) or MSH3 (3−/−) deleted. MEF+/+ indicates wild-type mouse embryonic fibroblasts. The other reaction components were then added and processed through the bacterial readout system. The data represent the number of kanamycin resistant colonies per 106 ampicillin resistant colonies.
TABLE III Frameshift mutation repair is directed by single-stranded oligonucleotides Oligonucleotide Plasmid Extract tetr colonies Tet IX (3S/25A; 0.5 μg) pTSΔ208 (1 μg) — 0 — ↓ 20 μg 0 Tet IX (0.5 μg) ↓ ↓ 48 Tet IX (1.5 μg) ↓ ↓ 130 Tet IX (2.0 μg) ↓ ↓ 68 Tet I (chimera; 1.5 μg) ↓ ↓ 48 - Each reaction mixture contained the indicated amounts of plasmid and oligonucleotide. The extract used for these experiments came from HUH7 cells. The data represent the number of tetracycline resistant colonies per 106 ampicillin resistant colonies generated from the same reaction and is the average of 3 independent experiments. Tet I is a chimeric oligonucleotide and Tet IX is a modified single-stranded oligonucleotide that are designed to insert a T residue at
position 208 of pTsΔ208. The oligonucleotides are equivalent to structures I and IX in FIG. 2.TABLE IV Plant cell-free extracts support gene repair by single-stranded oligonucleotides Oligonucleotide Plasmid Extract kanr colonies II (chimera) pKSm402l 30 μg Canola 337 IX (3S/25G) ↓ Canola 763 X (6S/25G) ↓ Canola 882 II ↓ Musa 203 IX ↓ Musa 343 X ↓ Musa 746 — ↓ Canola 0 — ↓ Musa 0 IX ↓ — Canola 0 X ↓ — Musa 0 - Canola or Musa cell-free extracts were tested for gene repair activity on the kanamycin-sensitive gene as previously described in (18). Chimeric oligonucleotide II (1.5 μg) and modified single-stranded oligonucleotides IX and X (0.55 μg) were used to correct pKSm4021. Total number of kanr colonies are present per 107 ampicillin resistant colonies and represent an average of four independent experiments.
TABLE V Gene repair activity in cell-free extracts prepared from yeast (Saccharomyces cerevisiae) Cell-type Plasmid Chimeric Oligo SS Oligo kanr/ampr × 106 Wild type pKansm4021 1 μg 0.36 Wild type ↓ 1 μg 0.81 ΔRAD52 ↓ 1 μg 10.72 ΔRAD52 ↓ 1 μg 17.41 ΔPMS1 ↓ 1 μg 2.02 ΔPMS1 ↓ 1 μg 3.23 - In this example, single-stranded oligonucleotides with modified backbones and double-hairpin oligonucleotides with chimeric, RNA-DNA backbones are used to measure gene repair using two episomal targets with a fusion between a hygromycin resistance gene and eGFP as a target for gene repair. These plasmids are pAURHYG(rep)GFP, which contains a point mutation in the hygromycin resistance gene (FIG. 7), pAURHYG(ins)GFP, which contains a single-base insertion in the hygromycin resistance gene (FIG. 7) and pAURHYG(Δ)GFP which has a single base deletion. We also use the plasmid containing a wild-type copy of the hygromycin-eGFP fusion gene, designated pAURHYG(wt)GFP, as a control. These plasmids also contain an aureobasidinA resistance gene. In pAURHYG(rep)GFP, hygromycin resistance gene function and green fluorescence from the eGFP protein are restored when a G at position 137, at codon 46 of the hygromycin B coding sequence, is converted to a C thus removing a premature stop codon in the hygromycin resistance gene coding region. In pAURHYG(ins)GFP, hygromycin resistance gene function and green fluorescence from the eGFP protein are restored when an A inserted between nucleotide positions 136 and 137, at codon 46 of the hygromycin B coding sequence, is deleted and a C is substituted for the T at position 137, thus correcting a frameshift mutation and restoring the reading frame of the hygromycin-eGFP fusion gene.
- We synthesize the set of three yeast expression constructs pAURHYG(rep)eGFP, pAURHYG(Δ)eGFP, pAURHYG(ins)eGFP, that contain a point mutation at nucleotide 137 of the hygromycin-B coding sequence as follows. (rep) indicates a T137→G replacement, (Δ) represents a deletion of the G137 and (ins) represents an A insertion between nucleotides 136 and 137. We construct this set of plasmids by excising the respective expression cassettes by restriction digest from pHyg(x)EGFP and ligation into pAUR123 (Panvera, Calif.). We digest 10 μg pAUR123 vector DNA, as well as, 10 μg of each pHyg(x)EGFP construct with KpnI and SaII (NEB). We gel purify each of the DNA fragments and prepare them for enzymatic ligation. We ligate each mutated insert into pHygEGFP vector at 3:1 molar ratio using T4 DNA ligase (Roche). We screen clones by restriction digest, confirm by Sanger dideoxy chain termination sequencing and purify using a Qiagen maxiprep kit.
- We use this system to assay the ability of five oligonucleotides (shown in FIG. 8) to support correction under a variety of conditions. The oligonucleotides which direct correction of the mutation in pAURHYG(rep)GFP can also direct correction of the mutation in pAURHYG(ins)GFP. Three of the four oligonucleotides (HygE3T/25, HygE3T/74 and HygGG/Rev) share the same 25-base sequence surrounding the base targeted for alteration. HygGG/Rev is an RNA-DNA chimeric double hairpin oligonucleotide of the type described in the prior art. One of these oligonucleotides, HygE3T/74, is a 74-base oligonucleotide with the 25-base sequence centrally positioned. The fourth oligonucleotide, designated HygE3T/74α, is the reverse complement of HygE3T/74. The fifth oligonucleotide, designated Kan70T, is a non-specific, control oligonucleotide which is not complementary to the target sequence. Alternatively, an oligonucleotide of identical sequence but lacking a mismatch to the target or a completely thioate modified oligonucleotide or a completely 2-O-methylated modified oligonucleotide may be used as a control. Alternatively, oligonucleotides containing one, two, three, four, five, six, eight, ten or more LNA modifications on at least one of the two termini (and preferrably the 3′ terminus) may be used in different embodiments.
- Oligonucleotide synthesis and cells. We synthesized and purified the chimeric, double-hairpin oligonucleotides and single-stranded oligonucleotides (including those with the indicated modifications) as described in Example 1. Plasmids used for assay were maintained stably in yeast (Saccharomyces cerevisiae) strain LSY678 MAT α at low copy number under aureobasidin selection. Plasmids and oligonucleotides are introduced into yeast cells by electroporation as follows: to prepare electrocompetent yeast cells, we inoculate 10 ml of YPD media from a single colony and grow the cultures overnight with shaking at 300 rpm at 30° C. We then add 30 ml of fresh YPD media to the overnight cultures and continue shaking at 30° C. until the OD600 was between 0.5 and 1.0 (3-5 hours). We then wash the cells by centrifuging at 4° C. at 3000 rpm for 5 minutes and twice resuspending the cells in 25 ml ice-cold distilled water. We then centrifuge at 4° C. at 3000 rpm for 5 minutes and resuspend in 1 ml ice-cold 1M sorbitol and then finally centrifuge the cells at 4° C. at 5000 rpm for 5 minutes and resuspend the cells in 120 μl 1M sorbitol. To transform electrocompetent cells with plasmids or oligonucleotides, we mix 40 μl of cells with 5 μg of nucleic acid, unless otherwise stated, and incubate on ice for 5 minutes. We then transfer the mixture to a 0.2 cm electroporation cuvette and electroporate with a BIO-RAD Gene Pulser apparatus at 1.5 kV, 25 μF, 200 Ω for one five-second pulse. We then immediately resuspend the cells in 1 ml YPD supplemented with 1M sorbitol and incubate the cultures at 30° C. with shaking at 300 rpm for 6 hours. We then spread 200 μl of this culture on selective plates containing 300 μg/ml hygromycin and spread 200 μl of a 105 dilution of this culture on selective plates containing 500 ng/ml aureobasidinA and/or and incubate at 30° C. for 3 days to allow individual yeast colonies to grow. We then count the colonies on the plates and calculate the gene conversion efficiency by determining the number of hygromycin resistance colonies per 105 aureobasidinA resistant colonies.
- Frameshift mutations are repaired in yeast cells. We test the ability of the oligonucleotides shown in FIG. 8 to correct a frameshift mutation in vivo using LSY678 yeast cells containing the plasmid pAURHYG(ins)GFP. These experiments, presented in Table 6, indicate that these oligonucleotides can support gene correction in yeast cells. These data reinforce the results described in Example 1 indicating that oligonucleotides comprising phosphorothioate linkages facilitate gene correction much more efficiently than control duplex, chimeric RNA-DNA oligonucleotides. This gene correction activity is also specific as transformation of cells with the control oligonucleotide Kan70T produced no hygromycin resistant colonies above background and thus Kan70T did not support gene correction in this system. In addition, we observe that the 74-base oligonucleotide (HygE3T/74) corrects the mutation in pAURHYG(ins)GFP approximately five-fold more efficiently than the 25-base oligonucleotide (HygE3T/25). We also perform control experiments with LSY678 yeast cells containing the plasmid pAURHYG(wt)GFP. With this strain we observed that even without added oligonucleotides, there are too many hygromycin resistant colonies to count.
- We also use additional oligonucleotides to assay the ability of individual oligonucleotides to correct multiple mutations in the pAURHYG(x)eGFP plasmid. These include, for example, one that alters two basepairs that are 3 nucleotides apart is a 74-mer with the
sequence 5′-CTCGTGCTTTCAGCTTCGATGTAGGAGGGCGTGGGTACGTCCTGCGGGTAAATAGCTGCGCCGATGGTTTCTAC-3′ (SEQ ID NO: 2714); a 74-mer that alters two basepairs that are 15 nucleotides apart with thesequence 5′-CTCGTGCTTTCAGCTTCGATGTAGGAGGGCGTGGATACGTCCTGCGGGTAAACAGCTGCGCCGATGGTTTCTAC-3′ (SEQ ID NO: 2715); and a 74-mer that alters two basepairs that are 27 nucleotides apart with thesequence 5′-CTCGTGCTTTCAGCTTCGATGTAGGAGGGCGTGGATACGTCCTGCGGGTAAATAGCTGCGCCGACGGTTTCTAC (SEQ ID NO: 2716). The nucleotides in these oligonucleotides that direct alteration of the target sequence are underlined and in boldface. These oligonucleotides are modified in the same ways as the other oligonucleotides of the invention. - Oligonucleotides targeting the sense strand direct gene correction more efficiently. We compare the ability of single-stranded oligonucleotides to target each of the two strands of the target sequence of both pAURHYG(ins)GFP and pAURHYG(rep)GFP. These experiments, presented in Tables 7 and 8, indicate that an oligonucleotide, HygE3T/74α, with sequence complementary to the sense strand (i.e. the strand of the target sequence that is identical to the mRNA) of the target sequence facilitates gene correction approximately ten-fold more efficiently than an oligonucleotide, HygE3T/74, with sequence complementary to the non-transcribed strand which serves as the template for the synthesis of RNA. As indicated in Table 7, this effect was observed over a range of oligonucleotide concentrations from 0-3.6 μg, although we did observe some variability in the difference between the two oligonucleotides (indicated in Table 7 as a fold difference between HygE3T/74α and HygE3T/74). Furthermore, as shown in Table 8, we observe increased efficiency of correction by HygE3T/74α relative to HygE3T/74 regardless of whether the oligonucleotides were used to correct the base substitution mutation in pAURHYG(rep)GFP or the insertion mutation in pAURHYG(ins)GFP. The data presented in Table 8 further indicate that the single-stranded oligonucleotides correct a base substitution mutation more efficiently than an insertion mutation. However, this last effect was much less pronounced and the oligonucleotides of the invention are clearly able efficiently to correct both types of mutations in yeast cells. In addition, the role of transcription is investigated using plasmids with inducible promoters such as that described in FIG. 10.
- Optimization of oligonucleotide concentration. To determine the optimal concentration of oligonucleotide for the purpose of gene alteration, we test the ability of increasing concentrations of Hyg3T/74α to correct the mutation in pAURHYG(rep)GFP contained in yeast LSY678. We chose this assay system because our previous experiments indicated that it supports the highest level of correction. However, this same approach could be used to determine the optimal concentration of any given oligonucleotide. We test the ability of Hyg3T/74α to correct the mutation in pAURHYG(rep)GFP contained in yeast LSY678 over a range of oligonucleotide concentrations from 0-10.0 μg. As shown in Table 9, we observe that the correction efficiency initially increases with increasing oligonucleotide concentration, but then declines at the highest concentration tested.
- Tables are attached hereto.
TABLE 6 Correction of an insertion mutation in pAURHYG(ins)GFP by HygGG/Rev, HygE3T/25 and HygE3T/74 Colonies on Colonies on Correction Oligonucleotide Tested Hygromycin Aureobasidin (/105) Efficiency HygGG/ Rev 3 157 0.02 HygE3T/25 64 147 0.44 HygE3T/74 280 174 1.61 Kan70T 0 — — -
TABLE 7 An oligonucleotide targeting the sense strand of the target sequence corrects more efficiently. Colonies per hygromycin plate Amount of Oligonucleotide (μg) HygE3T/74 HygE3T/74α 0 0 0 0.6 24 128 (8.4x)* 1.2 69 140 (7.5x)* 2.4 62 167 (3.8x)* 3.6 29 367 (15x)* -
TABLE 8 Correction of a base substitution mutation is more efficient than correction of a frame shift mutation. Oligonucleotide Plasmid tested (contained in LSY678) Tested (5 μg) pAURHYG(ins)GFP pAURHYG(rep)GFP HygE3T/74 72 277 HygE3T/74α 1464 2248 Kan70T 0 0 -
TABLE 9 Optimization of oligonucleotide concentration in electroporated yeast cells. Colonies on Colonies on Correction Amount (μg) hygromycin aureobasidin (/105) efficiency 0 0 67 0 1.0 5 64 0.08 2.5 47 30 1.57 5.0 199 33 6.08 7.5 383 39 9.79 10.0 191 33 5.79 - Although disclosure in this example is directed to use of stem cells or human blood cells and microinjection, the microinjection procedures may also be used with cultured plant cells or protoplasts using any plant species, including those disclosed herein. Mononuclear cells are isolated from human umbilical cord blood of normal donors using Ficoll Hypaque (Pharmacia Biotech, Uppsala, Sweden) density centrifugation. CD34+ cells are immunomagnetically purified from mononuclear cells using either the progenitor or Multisort Kits (Miltenyi Biotec, Auburn, Calif.). Lin−CD38− cells are purified from the mononuclear cells using negative selection with StemSep system according to the manufacturer's protocol (Stem Cell Technologies, Vancouver, Calif.). Cells used for microinjection are either freshly isolated or cryopreserved and cultured in Stem Medium (S Medium) for 2 to 5 days prior to microinjection. S Medium contains Iscoves' Modified Dulbecc's Medium without phenol red (IMDM) with 100 μg/ml glutamine/penicillin/streptomycin, 50 mg/ml bovine serum albumin, 50 μg/ml bovine pancreatic insulin, 1 mg/ml human transferrin, and IMDM; Stem Cell Technologies), 40 μg/ml low-density lipoprotein (LDL; Sigma, St. Louis, Mo.), 50 mM HEPEs buffer and 50 μM 2-mercaptoethanol, 20 ng/ml each of thrombopoietin, flt-3 ligand, stem cell factor and human IL-6 (Pepro Tech Inc., Rocky Hill, N.J.). After microinjection, cells are detached and transferred in bulk into wells of 48 well plates for culturing.
- 35 mm dishes are coated overnight at 4° C. with 50 μg/ml Fibronectin (FN) fragment CH-296 (Retronectin; TaKaRa Biomedicals, Panvera, Madison, Wis.) in phosphate buffered saline and washed with IMDM containing glutamine/penicillin/streptomycin. 300 to 2000 cells are added to cloning rings and attached to the plates for 45 minutes at 37° C. prior to microinjection. After incubation, cloning rings are removed and 2 ml of S Medium are added to each dish for microinjection. Pulled injection needles with a range of 0.22 μm to 0.3 μm outer tip diameter are used. Cells are visualized with a microscope equipped with a temperature controlled stage set at 37° C. and injected using an electronically interfaced Eppendorf Micromanipulator and Transjector. Successfully injected cells are intact, alive and remain attached to the plate post injection. Molecules that are flourescently labeled allow determination of the amount of oligonucleotide delivered to the cells.
- For in vitro erythropoiesis from Lin−CD38− cells, the procedure of Malik, 1998 can be used. Cells are cultured in ME Medium for 4 days and then cultured in E Medium for 3 weeks. Erythropoiesis is evident by glycophorin A expression as well as the presence of red color representing the presence of hemoglobin in the cultured cells. The injected cells are able to retain their proliferative capacity and the ability to generate myeloid and erythoid progeny. CD34+ cells can convert a normal A (βA) to sickle T (βS) mutation in the β-globin gene or can be altered using any of the oligonucleotides of the invention herein for correction or alteration of a normal gene to a mutant gene. Alternatively, stem cells can be isolated from blood of humans having genetic disease mutations and the oligonucleotides of the invention can be used to correct a defect or to modify genomes within those cells.
- Alternatively, non-stem cell populations of cultured cells can be manipulated using any method known to those of skill in the art including, for example, the use of polycations, cationic lipids, liposomes, polyethylenimine (PEI), electroporation, biolistics, calcium phosphate precipitation, or any other method known in the art.
- Biolistic delivery of oligonucleotide into plant cells may be accomplished according to the following method. One milliliter of packed cell volume of plant cell suspensions are subcultured onto plates containing solid medium [with Murashige and Skoog salts from Gibco/BRL, 500 mg/liter Mes, 1 mg/liter thiamin, 100 mg/liter myo-inositol, 180 mg/liter KH2PO4, 2.21 mg/
liter 2,4-dichlorophenoxyacetic acid (2,4-D), and 30 g/liter sucrose (pH 5.7) and having 8 g/liter agar-agar from Sigma added before autoclaving]. By using a helium-driven particle gun such as that from BioRad and following manufacturers directions, oligonucleotides may be introduced to cells after precipitation onto 1 micrometer or comparable gold microcarriers (Bio-Rad). To precipitate onto microcarriers, 35 microliters of a particle suspension (60 mg of microcarriers per ml of 100% ethanol) is transferred to a 1.5 ml microcentrifuge tube, which is agitated on a vortex mixer. Then 40 microliter of resuspended oligonucleotide (60 ng/microliter water) is added; then 75 microliter of ice-cold 2.5 M CaCl2 is added; then 75 microliter of ice-cold 0.1 M spermidine is added. The tube is mixed vigorously or a vortex mixer for 10 min at room temperature. The particles are allowed to settle for 10 min and are centrifuged at 11,750 g for 30 sec. The supernatant is removed and the particles are resuspended in 50 microliter of 100% ethanol. An aliquot of 10 microliter of the resuspended particles are applied to each macro-projectile which is used to bombard each plate once at 900 psi (1 psi=6.89 kPa) with a gap distance (distance from power source to macroprojectile) of 1 cm and a target distance (distance from microprojectile launch site to target material) of 10 cm. - An alternative method of delivery can be used as follows. Cultured cells are suspended in liquid N6 medium and then plated on a VWR Scientific glass fiber filter. About 0.4 microgram of oligonucleotide are precipitated with 15 microliter of 2.5 mM CaCl2 and 5 microliter of 0.1 M spermidine onto 25 microgram of 1.0 micrometer gold particles. Microprojectile bombardment is performed by using a Bio-Rad PDS-1000 He particle delivery system or comparable machine following manufacturers instructions. Alterations in oligonucleotide concentrations can be employed to determine the optimum concentration of oligonucleotide according to the procedures described herein for any particular oligonucleotide of the invention.
- Alternatively, the oligonucleotide of the invention may be delivered to a plant cell by electroporation of a protoplast derived from a plant part. The protoplasts may be formed by enzymatic treatment of a plant part, particularly a leaf, according to techniques such as those in Gallois et al., Methods in Molecular Biology 55: 89-107 by Humana Press. Such conditions for electroporation use about 3×105 protoplasts in a total volume of about 0.3 ml with a concentration of oligonucleotide of between 0.6 to 4 microgram per ml.
- The oligonucleotides of the invention can also be used to repair or direct a mutagenic event in plants and animal cells. Although little information is available on plant mutations amongst natural cultivars, the oligonucleotides of the invention can be used to produce “knock out” mutations by modification of specific amino acid codons to produce stop codons (e.g., a CAA codon specifying Gln can be modified at a specific site to TAA; a AAG codon specifying Lys can be modified to UAG at a specific site; and a CGA codon for Arg can be modified to a UGA codon at a specific site). Such base pair changes will terminate the reading frame and produce a defective truncated protein, shortened at the site of the stop codon.
- Alternatively, frameshift additions or deletions can be directed into the genome at a specific sequence to interrupt the reading frame and produce a garbled downstream protein. Such stop or frameshift mutations can be introduced to determine the effect of knocking out the protein in either plant or animal cells.
- For introduction of a T-DNA, including the T-DNA in the plasmid of FIG. 11, into a plant cell,Agrobacterium tumefaciens is used. These techniques are routine standard techniques known in the art. For example, one method follows. We transform A. tumefaciens is transformed by electroporation (using a BioRad Gene Pulser™). Competent A. tumefaciens is prepared using a method similar to that of preparing competent E. coli by suspending a freshly grown culture three times in ice-cold water and a final resuspension in 10% glycerol. Electroporation conditions are a 0.2 cm gap cuvette at a setting of 25 μF,200 Ω and2.5 kV.
-
- All publications and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
- Notes on the Tables Presented Below:
- Each of the following tables presents, for the specified gene, a plurality of mutations that are known to confer a relevant phenotype and, for each mutation, the oligonucleotides that can be used to correct the respective mutation site-specifically in the genome according to the present invention.
- The left-most column identifies each alteration or mutation and the phenotype that the alteration/mutation confers.
- For most entries, the mutation/alteration is identified at both the nucleic acid and protein level. At the amino acid level, mutations are presented according to the following standard nomenclature. The centered number identifies the position of the mutated codon in the protein sequence; to the left of the number is the wild type residue and to the right of the number is the mutant codon. Terminator codons are shown as “TERM”. At the nucleic acid level, the entire triplet of the wild type and mutated codons is shown.
- The middle column presents, for each mutation, four oligonucleotides capable of repairing the mutation site-specifically in the genome or in cloned DNA including DNA in artificial chromosomes, episomes, plasmids, or other types of vectors. The oligonucleotides of the invention, however, may include any of the oligonucleotides sharing portions of the sequence of the 121 base sequence. Thus, oligonucleotides of the invention for each of the depicted targets may be 18, 19, 20 up to about 121 nucleotides in length. Sequence may be added non-symmetrically.
- All oligonucleotides are presented, per convention, in the 5′ to 3′ orientation. The nucleotide that effects the change in the genome is underlined and presented in bold.
- The first of the four oligonucleotides for each mutation is a 121 nt oligonucleotide centered about the repair/altering nucleotide. The second oligonucleotide, its reverse complement, targets the opposite strand of the DNA duplex for repair/alteration. The third oligonucleotide is the minimal 17 nt domain of the first oligonucleotide, also centered about the repair/alteration nucleotide. The fourth oligonucleotide is the reverse complement of the third, and thus represents the minimal 17 nt domain of the second.
- The third column of each table presents the SEQ ID NO: of the respective repair oligonucleotide.
- Chemical weed control is an important tool of modern agriculture and many herbicides have been developed for this purpose. Their use has resulted in substantial increases in the yields of many crops, including, for example, maize, soybeans, and cotton. Thus while the use of fertilizers and new high-yielding crop varieties have contributed greatly to the “green revolution,” chemical weed control has also been at the forefront of technological achievement.
- Herbicides having broad-spectrum activity are particularly useful because they obviate the need for multiple herbicides targeting different classes of weeds. The problem with such herbicides is that they typically also affect crops which are exposed to the herbicide. One way to overcome this is to generate plants which are resistant to one or more broad-spectrum herbicides. Such herbicide-tolerant plants may reduce the need for tillage to control weeds, thereby effectively reducing soil erosion and can reduce the quantity and number of different herbicides applied in the field.
- Common herbicides used, for example, include those that inhibit the enzyme 5-enolpyruvyl-3-phosphoshikimic acid synthase (EPSPS), for example N-phosphonomethyl-glycine (e.g. glyphosate), those that inhibit acetolactate synthase (ALS) activity, for example the sulfonylureas and related herbicides, and those that inhibit dihydropteroate synthase, for example methyl[(4-amino-phenyl)sulfonyl]carbamate (e.g. Asulam). Herbicide-tolerant plants can be produced by several methods, including, for example, introducing into the genome of the plant the ability to degrade the herbicide, the capacity to produce a higher level of the targeted enzyme, and/or expressing an herbicide-tolerant allele of the enzyme.
- The attached tables disclose exemplary oligonucleotides base sequences which can be used to generate site-specific mutations in plant genes that confer herbicide resistance.
TABLE 10 Genome-Altering Oligos Conferring Glyphosate Resistance Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Glyphosate Resistance AAGCGTCGGAGATTGTACTTCAACCCATTTAGAGAAATCTCCGGTC 1 EPSPS TTATTAAGCTTCCTGCCTCCAAGTCTCTATCAAATCGGATCCTGC Arabidopsis thaliana TTCTCGCTGCTCTGTCTGAGGTATATATCAC Gly97Ala GTGATATATACCTCAGACAGAGCAGCGAGAAGCAGGATCCGATT 2 GGC-GCC TGATAGAGACTTGGAGGCAGGAAGCTTAATAAGACCGGAGATTT CTCTAATGGGTTGAAGTACAATCTCCGACGCTT GCTTCCTG C CTCCAAGT 3 ACTTGGAG G CAGGAAGC 4 Glyphosate Resistance AAGCTTCAGAGATTGTGCTTCAACCAATCAGAGAAATCTCGGGTC 5 EPSPS TCATTAAGCTACCCGCATCCAAATCTCTCTCCAATCGGATCCTCC Brassica napus TTCTTGCCGCTCTATCTGAGGTACATATACT Gly93AIa AGTATATGTACCTCAGATAGAGCGGCAAGAAGGAGGATCCGATT 6 GGA-GCA GGAGAGAGATTTGGATGCGGGTAGCTTAATGAGACCCGAGATTT CTCTGATTGGTTGAAGCACAATCTCTGAAGCTT GCTACCCG C ATCCAAAT 7 ATTIGGAT G CGGGTAGC 8 Glyphosate Resistance AGCCCAACGAGATTGTGCTGCAACCCATCAAAGATATATCAGGC 9 EPSPS 1 ACTGTTAAATTGCCTGCTTCTAAATCCCTTTCCAATCGTATTCTCC Nicotiana tabacum TTCTTGCTGCCCTTTCTAAGGGAAGGACTGT Gly95Ala ACAGTCCTTCCCTTAGAAAGGGCAGCAAGAAGGAGAATACGATT 10 GGT-GCT GGAAAGGGATTTAGAA G CAGGCAATTTAACAGTGCCTGATATATC TTTGATGGGTTGCAGCACAATCTCGTIGGGCT ATTGCCTG C TTCTAAAT 11 ATTTAGAA G CAGGCAAT 12 Glyphosate Resistance ATTGTTTCCTTGGTACGAAATGTCCTCCTGTTCGAATTGTCAGCA 13 EPSPS 2 AGGGAGGCCTTCCCGCAGGGAAGGTAAAGCTCTCTGGATCAATT Nicotiana tabacum AGCAGCCAGTACTTGACTGCTCTGCTTATGGC Gly62Ala GCCATAAGCAGAGCAGTCAAGTACTGGCTGCTAATTGATCCAGA 14 GGA-GCA GAGCTTTACCTTCCCT G CGGGAAGGCCTCCCTTGCTGACAATTC GAACAGGAGGACATTTCGTACCAAGGAAACAAT CCTTCCCG C AGGGAAGG 15 CCTTCCCG C GGGAAGG 16 Glyphosate Resistance ATTGTTTCCTTGGCACTGACTGGCCACCTGTTCGTGTCAATGGAA 17 EPSPS TCGGAGGGCTACCTG C TGGCAAGGTCAAGCTGTCTGGCTCCATC Zea mays AGCAGTCAGTACTTGAGTGCCTTGCTGATGGC Gly168Ala GCCATCAGCAAGGCACTCAAGTACTGACTGCTGATGGAGCCAGA 18 GGT-GCT CAGCTTGACCTTGCCA G CAGGTAGCCCTCCGATTCCATTGACAC GAACAGGTGGGCAGTCAGTGCCAAGGAAACAAT GCTACCTG C TGGCAAGG 19 CCTTGCCA G CAGGTAGC 20 Glyphosate Resistance ACTGTTTCCTTGGCACTGAATGCCCACCTGTTCGTGTCAAGGGA 21 EPSPS ATTGGAGGACTTCCTG C TGGCAAGGTTAAGCTCTCTGGTTCCAT Cryza sativa CAGCAGTCAGTACTTGAGTGCCTTGCTGATGGC Gly115Ala GCCATCAGCAAGGCACTCAAGTACTGACTGCTGATGGAACCAGA 22 GGT-GCT GAGCTTAACCTTGCCAGCAGGAAGTCCTCCAATTCCCTTGACAC GAACAGGTGGGCATTCAGTGCCAAGGAAACAGT ACTTCCTG C TGGCAAGG 23 CCTTGCCA G CAGGAAGT 24 Glyphosate Resistance AGCCTTCTGAGATAGTGTTGCAACCCATTAAAGAGATTTCAGGCA 25 EPSPS CTGTTAAATTGCCTGCCTCTAAATCATTATCTAATAGAATTCTCCT Petunia x hybrida TCTTGCTGCCTTATCTGAAGGMCAACTGT Gly93Ala ACAGTTGTTCCTTCAGATAAGGCAGCAAGAAGGAGAATTCTATTA 26 GGC-GCC GATAATGATTTAGAGGCAGGCAATTTAACAGTGCCTGAAATCTCT TTAATGGGTTGCAACACTATCTCAGAAGGCT ATTGCCTG CCTCTAAAT 27 ATTTAGAG G CAGGCAAT 28 Glyphosate Resistance AACCCCATGAGATTGTGCTAGNACCCATCAAAGATATATCTGGTA 29 EPSPS CTGTTAAATTACCCG C TTCGAAATCCCTTTCCAATCGTATTCTCCT Lycopersicon TCTTGCTGCCCTTTCTGAGGGAAGGACTGT esculentum ACAGTCCTTCCCTCAGAAAGGGCAGCAAGAAGGAGAATACGATT 30 Gly97Ala GGAAAGGGATTTCGAA G CGGGTAATTTAACAGTACCAGATATATC GGT-GCT TTTGATGGGTNCTAGCACAATCTGATGGGGTT ATTACCCG C TTCGAAAT 31 ATTTCGAA G CGGGTAAT 32 Glyphosate Resistance ATTGTTTCCTTGGCACTGACTGCCCACCTGTTCGKATCAACGGGA 33 EPSPS TTGGAGGGCTACCTGCTGGCAAGGTTAAGCTGTCTGGTTCCAIT Lolium rigidum AGCAGCCAATACTTGAGTTCCTTGCTGATGGC Gly107Ala GCCATCAGCAAGGAACTCAAGTATTGGCTGCTGATGGAACCAGA 34 GGT-GCT CAGCTTAACCTTGCCA G CAGGTAGCCCTCCAATGCCGTTGATCG AACAGGTGGGCAGTCAGTGCCAAGGAAACAAT GCTACCTG C TGGCAAGG 35 CCTTGCCA G CAGGTAGC 36 -
TABLE 11 Genome-Altering Oligos Conferring Imidazolinone and Sulfonylurea Herbicide Resistance Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Sulfonylurea AGCGGATTAGCCGATGCGTTGTTAGATAGTGTTCCTCTTGTAGCA 37 Resistance ATCACAGGACAAGTC T CTCGTCGTATGATTGGTACAGATGCGTTT ALS CAAGAGACTCCGATTGTTGAGGTAACGCGTT Arabidopsis thaliana AACGCGTTACCTCAACAATCGGAGTCTCTTGAAACGCATCTGTAC 38 Pro197Ser CAATCATACGACGAG A GACTTGTCCTGTGATTGCTACAAGAGGAA CCT-TCT CACTATCTAACAACGCATCGGCTAATCCGCT GACAAGTCTC T CGTCGT 39 ACGACGAG A GACTTGTC 40 Sulfonylurea AGCGGATTAGCCGATGCGTTGTTAGATAGTGTTCCTCTTGTAGCA 41 Resistance ATCACAGGACAAGTCC AG CGTCGTATGATTGGTACAGATGCGTTT ALS CAAGAGACTCCGATTGTTGAGGTAACGCGTT Arabidopsis thaliana AACGCGTTACCTCAACAATCGGAGTCTCTTGAAACGCATCTGTAC 42 Pro197GLN CAATCATACGACG C TGGACTTGTCCTGTGATTGCTACAAGAGGAA CCT-CAG CACTATCTAACAACGCATCGGCTAATCCGCT ACAAGTCC AG CGTCGTC 43 TACGACG CT GGACTTGT 44 Sulfonylurea AGCGGATTAGCCGATGCGTTGTTAGATAGTGTTCCTCTTGTAGCA 45 Resistance ATCACAGGACAAGTCC AA CGTCGTATGATTGGTACAGATGCGTTT ALS CAAGAGACTCCGATTGTTGAGGTAACGCGTT Arabidopsis thaliana AACGCGTTACCTCAACAATCGGAGTCTCTTGAAACGCATCTGTAC 46 Pro197GLN CAATCATACGACG TT GGACTTGTCCTGTGATTGCTACAAGAGGAA CCT-CAA CACTATCTAACAACGCATCGGCTAATCCGCT ACAAGTCC AA CGTCGTA 47 TACGACG TT GGACTTGT 48 Imidazolinone GACCTTACCTGTTGGATGTGATTTGTCCGCACCAAGAACATGTGT 49 Resistance TGCCGATGATCCCGA AC GGTGGCACTTTCAACGATGTCATAACGG ALS AAGGAGATGGCCGGATTAAATACTGAGAGAT Arabidopsis thaliana ATCTCTCAGTATTTAATCCGGCCATCTCCTTCCGTTATGACATCGT 50 Ser653Asn TGAAAGTGCCACC GT TCGGGATCATCGGCAACACATGTTCTTGGT AGT-AAC GCGGACAAATCACATCCAACAGGTAAGGTC GATCCCGA AC GGTGGCA 51 TGCCACC GT TCGGGATC 52 Imidazolinone GACCTTACCTGTTGGATGTGATTTGTCCGCACCAAGAACATGTGT 53 Resistance TGCCGATGATCCCGA AT GGTGGCACTTTCAACGATGTCATAACGG ALS AAGGAGATGGCCGGATTAAATACTGAGAGAT Arabidopsis thaliana ATCTCTCAGTATTTAATCCGGCCATCTCCTTCCGTTATGACATCGT 54 Ser653Asn TGAAAGTGCCACC AT TCGGGATCATCGGCAACACATGTTCTTGGT AGT-AAT GCGGACAAATCACATCCAACAGGTAAGGTC GATCCCGA AT GGTGGCA 55 TGCCACC AT TCGGGATC 56 Sulfonylurea TCCGCGCTCGCCGACGCGCTGCTCGACTCCGTCCCGATGGTCGC 57 Resistance CATCACGGGCCAGGTC T CCCGCCGCATGATCGGCACCGACGCCT ALS TCCAGGAGACGCCCATAGTCGAGGTCACCCGCT Oryza saliva AGCGGGTGACCTCGACTATGGGCGTCTCCTGGAAGGCGTCGGTG 58 Pro171Ser CCGATCATGCGGCGGG A GACCTGGCCCGTGATGGCGACCATCG CCC-TCC GGACGGAGTCGAGCAGCGCGTCGGCGAGCGCGGA GCCAGGTC T CCCGCCGC 59 GCGGCGGG A GACCTGGC 60 Sulfonylurea CCGCGCTCGCCGACGCGCTGCTCGACTCCGTCCCGATGGTCGCC 61 Resistance ATCACGGGCCAGGTCC AA CGCCGCATGATCGGCACCGACGCCTT ALS CCAGGAGACGCCCATAGTCGAGGTCACCCGCTC Oryza saliva GAGCGGGTGACCTCGACTATGGGCGTCTCCTGGAAGGCGTCGGT 62 Pro171Gln GCCGATCATGCGGCG TT GGACCTGGCCCGTGATGGCGACCATCG CCC-CAA GGACGGAGTCGAGCAGCGCGTCGGCGAGCGCGG CCAGGTCC AA CGCCGCA 63 TGCGGCG TT GGACCTGG 64 Sulfonylurea CCGCGCTCGCCGACGCGCTGCTCGACTCCGTCCCGATGGTCGCC 65 Resistance ATCACGGGCCAGGTCC AG CGCCGCATGATCGGCACCGACGCCTT ALS CCAGGAGACGCCCATAGTCGAGGTCACCCGCTC Oryza saliva GAGCGGGTGACCTCGACTATGGGCGTCTCCTGGAAGGCGTCGGT 66 Pro171Gln GCCGATCATGCGGCG CT GGACCTGGCCCGTGATGGCGACCATCG CCC-CAG GGACGGAGTCGAGCAGCGCGTCGGCGAGCGCGG CCAGGTCC AG CGCCGCA 67 TGCGGCG CT GGACCTGG 68 Imidazolinone GGCCATACTTGTTGGATATCATCGTCCCGCACCAGGAGCATGTGC 69 Resistance TGCCTATGATCCCAA A TGGGGGCGCATTCAAGGACATGATCCTGG ALS ATGGTGATGGCAGGACTGTGTATTAATCTAT Oryza saliva ATAGATTAATACACAGTCCTGCGATCACCATCCAGGATCATGTCCT 70 Ilee627Asn TGAATGCGCCCCCA T TTGGGATCATAGGCAGCACATGCTCCTGGT ATT-AAT GCGGGACGATGATATCCAACAAGTATGGCC GATCCCAA A TGGGGGCG 71 CGCCCCCA T TTGGGATC 72 Sulfonylurea TCCGCGCTCGCCGACGCGCTGCTCGATTCCGTCCCCATGGTCGC 73 Resistance CATCACGGGACAGGTG T CGCGACGCATGATTGGCACCGACGCCT ALS TCCAGGAGACGCCCATCGTCGAGGTCACCCGCT Zea mays AGCGGGTGACCTCGACGATGGGCGTCTCCTGGAAGGCGTCGGT 74 Pro165Ser GCCAATCATGCGTCGCG A CACCTGTCCCGTGATGGCGACCATGG CCG-TCG GGACGGAATCGAGCAGCGCGTCGGCGAGCGCGGA GACAGGTG T CGCGACGC 75 GCGTCGCG A CACCTGTC 76 Sulfonylurea CCGCGCTCGCCGACGCGCTGCTCGATTCCGTCCCCATGGTCGCC 77 Resistance ATCACGGGACAGGTGC A GCGACGCATGATTGGCACCGACGCCTT ALS CCAGGAGACGCCCATCGTCGAGGTCACCCGCTC Zea mays GAGCGGGTGACCTCGACGATGGGCGTCTCCTGGAAGGCGTCGG 78 Pro165Gln TGCCAATCATGCGTCGC T GCACCTGTCCCGTGATGGCGACCATG CCG-CAG GGGACGGAATCGAGCAGCGCGTCGGCGAGCGCGG ACAGGTGC A GCGACGCA 79 TGCGTCGC T GCACCTGT 80 Imidazolinone GGCCGTACCTCTTGGATATAATCGTCCCACACCAGGAGCATGTGT 81 Resistance TGCCTATGATCCCTA AT GGTGGGGCTTTCAAGGATATGATCCTGG ALS ATGGTGATGGCAGGACTGTGTACTGATCTAA Zea mays TTAGATCAGTACACAGTCCTGCCATCACCATCCAGGATCATATCCT 82 Ser621Asn TGAAAGCCCCACC AT TAGGGATCATAGGCAACACATGCTCCTGGT AGT-AAT GTGGGACGATTATATCCAAGAGGTACGGCC GATCCCTA AT GGTGGGG 83 CCCCACC AT TAGGGATC 84 Imidazolinone GGCCGTACCTCTTGGATATAATCGTCCCACACCAGGAGCATGTGT 85 Resistance TGCCTATGATCCCTA AC GGTGGGGCTTTCAAGGATATGATCCTGG ALS ATGGTGATGGCAGGACTGTGTACTGATCTAA Zea mays TTAGATCAGTACACAGTCCTGCCATCACCATCCAGGATCATATCCT 86 Ser621Asn TGAAAGCCCCACC GT TAGGGATCATAGGCAACACATGCTCCTGGT AGT-AAC GTGGGACGATTATATCCAAGAGGTACGGCC GATCCCTA AC GGTGGGG 87 CCCCACC GT TAGGGATC 88 Sulfonylurea TCCGCGCTCGCCGACGCCGTCCTCGACTCCATCCCCATGGTGGC 89 Resistance CATCACGGGGCAGGTC T CGCGCCGCATGATCGGCACGGACGCCT ALS TCCAGGAGACGCCCATCGTCGAGGTCACCCGCT Lolium multiflorum AGCGGGTGACCTCGACGATGGGCGTCTCCTGGAAGGCGTCCGTG 90 Pro167Ser CCGATCATGCGGCGCG A GACCTGCCCCGTGATGGCCACCATGG CCG-TCC GGATGGAGTVGAGGAGGGCCTCGGCGACCCCCCA GGCAGGTC T CGCGCCGC 91 GCGGCGCG A GACCTGCC 92 Sulfonylurea CCGCGCTCGCCGACGCCCTCCTCGACTCCATCCCCATGGTGGCC 93 Resistance ATCACGGGGCAGGTCC A GCGCCGCATGATCGGCACGGACGCCTT ALS CCAGGAGACGCCCATCGTCGAGGTCACCCGCTC Lolium multiflorum GAGCGGGTGACCTCGACGATGGGCGTCTCCTGGAAGGCGTCCGT 94 Pro167Gln GCCGATCATGCGGCGC T GGACCTGCCCCGTGATGGCCACCATGG CCG-CAG GGATGGAGTCGAGGAGGGCGTCGGCGAGCGCGG GCAGGTCC A GCGCCGCA 95 TGCGGCGC T GGACCTGC 96 Imidazolinone CTGGGCCATACTTGTTGGATATCATCGTCCCTCACCAGGAGCATG 97 Resistance TGCTGCCTATGATCCCTA A CGGTGGTGCTTTCAAGGACATTATCA ALS TGGAAGGTGATGGCAGGATTTCGTATTAAAC Lolium multiflorum GTTTAATACGAAATCCTGCCATCACCTTCCATGATAATGTCGTTGA 98 Ser623Asn AAGCACCACCG T TAGGGATCATAGGCAGCACATGCTCCTGGTGA AGC-AAC GGGACGATGATATCCAACAAGTATGGCCCAG GATCCCTA A CGGTGGTG 99 CACCACCG T TAGGGATC 100 Sulfonylurea TCCGCGCTCGCCGACGGTCTCCTCGACTCCATCGCCATGGTCGC 101 Resistance CATCACGGGCCAGGTC T CACGCCGCATGATCGGCACGGACGCGT ALS TCCAGGAGACGCCCATAGTGGAGGTCACGCGCT Hordeum vulgare AGCGCGTGACCTCCACTATGGGCGTCTCCTGGAACGCGTCCGTG 102 Pro68Ser CGGATCATGCGGCGTG A GACCTGGCCCGTGATGGCGACCATGG CCA-TCA GGATGGAGTCGAGGAGAGCGTCGGCGAGCGCGGA GCCAGGTC T CACGCCGC 103 GCGGCGTG A GACCTGGC 104 Sulfonyurea CCGCGCTCGCCGACGCTCTCCTCGACTCCATCCCCATGGTCGCC 105 Resistance ATCACGGGCCAGGTCC A ACGCCGCATGATCGGCACGGACGCGTT ALS CCAGGAGACGCCCATAGTGGAGGTCACGCGCTC Hordeum vulgare GAGCGCGTGACCTCCACTATGGGCGTCTCCTGGAACGCGTCCGT 106 Pro68Gln GCCGATCATGCGGCGT T GGACCTGGCCCGTGATGGCGACCATGG CCA-CAA GGATGGAGTCGAGGAGAGCGTCGGCGAGCGCGG CCAGGTCC A ACGCCGCA 107 TGCGGCGT T GGACCTGG 108 Imidazolinone CCCAGGGCCGTACCTGCTGGATATCATTGTCCCGCATCAGGAGC 109 Resistance ACGTGCTGCCTATGATCCCAA A CGGTGGTGCTTTCAAGGACATGA ALS TCATGGAGGGTGATGGCAGGACCTCGTACTGA Hordeum vulgare TCAGTACGAGGTCCTGCCATTCACCCTCCATGATCATGTCCTTGAA 110 Ser524Asn AGCACCACCG T TTGGGATCATAGGCAGCACGTGCTCCTGATGCG AGC-AAC GGACAATGATATCCAGCAGGTACGGCCCTGGG GATCCCAA A CGGTGGTG 111 CACCACCG T TTGGGATC 112 Sulfonylurea AGTGGTCTCGCTGATGCAATGCTCGATAGTATCCCTCTCGTGGCG 113 Resistance ATCACTGGTCAAGTC T CTCGTCGGATGATCGGTACCGATGCTTTC ALS CAGGAAACTCCAATTGTTGAGGTAACAAGGT Gossypium hirsutum ACCTTGTTACCTCAACAATTGGAGTTTCCTGGAAAGCATCGGTAC 114 Pro186Ser CGATCATCCGACGAG A GACTTGACCAGTGATCGCCACGAGAGGG CCT-TCT ATACTATCGAGCATTGCATCAGCGAGACCACT GTCAAGTC T CTCGTCGG 115 CCGACGAG A GACTTGAC 116 Sulfonylurea GTGGTCTCGCTGATGCAATGGTCGATAGTATCCCTCTCGTGGCGA 117 Resistance TCACTGGTCAAGTCC AA CGTCGGATGATCGGTACCGATGCTTTCC ALS AGGAAACTCCAATTGTTGAGGTAACAAGGTC Gossypium hirsutum GACCTTGTTACCTCAACAATTGGAGTTICCTGGAAAGCATCGGTA 118 Pro186Gln CCGATCATCCGACG TT GGACTTGACCAGTGATCGCCACGAGAGG CCT-CAA GATACTATCGAGCATTGCATCAGCGAGACCAC TCAAGTCC AA CGTCGGA 119 TCCGACG TT GGACTTGA 120 Sulfonylurea GTGGTCTCGCTGATGCAATGCTCGATAGTATCCCTCTCGTGGCGA 121 Resistance TCACIGGTCAAGTCC AG CGTCGGATGATCGGTACCGATGCTTTCC ALS AGGAAACTCCAATTGTTGAGGTAACAAGGTC Gossypium hirsutum GACCTTGTTACCTCAACAATTGGAGTTTCCTGGAAAGCATCGGTA 122 Pro186Gln CCGATCATCCGACG CT GGACTTGACCAGTGATCGCCACGAGAGG CCT-CAG GATACTATCGAGCATTGCATCAGCGAGACCAC TCAAGTCC AG CGTCGGA 123 TCCGACG CT GGACTTGA 124 Imidazolinone GACCTTACTTGTTGGATGTGATTGTCCCACATCAAGAACATGTCCT 125 Resistance GCCTATGATCCCCA A TGGAGGCGCTTTCAAAGATGTGATCACAGA ALS GGGTGATGGAAGAACACAATATTGACCTCA Gossypium hirsutum TGAGGTCAATATTGTGTTCTTCCATCACCCTCTGTGATCACATCTT 126 Ser642Asn TGAAAGCGCCTCCA T TGGGGATCATAGGCAGGACATGTTCTTGAT AGT-AAT GTGGGACAATCACATCCAACAAGTAAGGTC GATCCCCA A TGGAGGCG 127 CGCCTCCA T TGGGGATC 128 Sulfonylurea TCTGGTCTTGCTGATGCACTTCTTGACTCAGTCCCTCTTGTCGCCA 129 Resistance TTACTGGGCAAGTT T CCCGGCGTATGATTGGTACTGATGCTTTTCA ALS AGAGACTCCAATTGTTGAGGTAACTCGAT Amaranthus ATCGAGTTACCTCAACAATTGGAGTCTCTTGAAAAGCATCAGTACC 130 retroflexus AATCATACGCCGGG A AACTTGCCCAGTAATGGCGACAAGAGGGA Pro192Ser CTGAGTCAAGAAGTGCATCAGCAAGACCAGA CCC-TCC GGCAAGTT T CCCGGCGT 131 ACGCCGGG A AAGTTGCC 132 Sulfonylurea CTGGTCTTGCTGATGCACTTCTTGACTCAGTCCCTCTTGTCGCCAT 133 Resistance TACTGGGCAAGTTC AA CGGCGTATGATTGGTACTGATGCTTTTCA ALS AGAGACTCCAATTGTTGAGGTAACTCGATC Amaranthus GATCGAGTTACCTCAACAATTGGAGTCTCTTGAAAAGCATCAGTAC 134 retroflexus CAATCATACGCCG TT GAACTTGCCCAGTAATGGCGACAAGAGGGA Pro192Gln CTGAGTCAAGAAGTGCATCAGCAAGACCAG CCC-CAA GCAAGTTC AA CGGCGTA 135 TACGCCG TT GAACTTGC 136 Sulfonylurea CTGGTCTTGCTGATGCACTTCTTGACTCAGTCCCTCTTGTCGCCAT 137 Resistance TACTGGGCAAGtTC AG CGGCGTATGATTGGTACTGATGCTTTTCA ALS AGAGACTCCAATTGTTGAGGTAACTCGATC Amaranthus GATCGAGTTACCTCAACAATTGGAGTCTCTTGAAAAGCATCAGTAC 138 retroflexus CAATCATACGCCG CT GAACTTGCCCAGTAATGGCGACAAGAGGG Pro192Gln ACTGAGTCAAGAAGTGCATCAGCAAGACCAG CCC-CAG GCAAGTTC AG CGGCGTA 139 TACGCCG CT GAACTTGC 140 Imidazolinone GACCGTATCTTGCTGGATGTTAATCGTACCACATCAGGAGCATGTGC 141 Resistance TGCCTAIGATCCCTA A CGGTGCCGCCTTCAAGGACACCATAACAG ALS AGGGTGATGGAAGAAGGGGTTATTAGTTGGT Amaranthus ACCAACTAATAAGCCCTTCTTCCATTCACCCTCTGTTATGGTGTCCT 142 retroflexus TGAAGGCGGCACCG T TAGGGATCATAGGCAGCACATGCTCCTGA Ser652Asn TGTGGTACGATTACATCCAGCAGATACGGTC AGC-AAC GATCCCTA A CGGTGCCG 143 CGGCACCG T TAGGGATC 144 Sulfonylurea AGCGGCCTCGCTGACGCGCTACTGGATAGCGTCCCCATTGTTGC 145 Resistance TATAACAGGTCAAGTG T CACGTAGGATGATAGGTACTGATGCTTTT ALS 1 CAGGAAACTCCTATTGTITGAGGTAACTAGAT Nicotiana tabacum ATCTAGTTACCTCAACAATAGGAGTTTCCTGAAAAGCATCAGTACC 146 Pro194Ser TATCATCCTACGTG A CACTTGACCTGTTATAGCAACAATGGGGAC CCA-TCA GCTATCCAGTAGCGCGTCAGCGAGGCCGCT GTCAAGTG T CACGTAGG 147 CCTACGTG A CACTTGAC 148 Sulfonylurea GCGGCCTCGCTGACGCGCTACTGGATAGCGTCCCCATTGTTGCT 149 Resistance ATAACAGGTCAAGTGC AA CGTAGGATGATAGGTACTGATGCTTTT ALS 1 CAGGAAACTCCTATTGTTGAGGTAACTAGATC Nicotiana tabacum GATCTAGTTACCTCAACAATAGGAGTTTCCTGAAAAGCATCAGTAC 150 Pro194Gln CTATCATCCTACGT T GCACTTGACCTGTTATAGCAACAATGGGGA CCA-CAA CGCTATCCAGTAGCGCGTCAGCGAGGCCGC TCAAGTGC A ACGTAGGA 151 TCCTACGT T GCACTTGA 152 Imidazolinone GGCCATACTTGTTGGATGTGATTGTACCTCATCAGGAACATGTTTT 153 Resistance ACCTATGATTCCCA A TGGCGGAGCTTTCAAAGATGTGATCACAGA ALS 1 GGGTGACGGGAGAAGTTCCTATTGAGTTTG Nicotiana tabacum CAAACTGAATAGGAACTTCTCCCGTCACCCTCTGTGATCACATCTT 154 Ser650Asn TGAAAGCTCCGCCA T TGGGAATCATAGGTAAAACATGTTCCTGAT AGT-AAT GAGGTACAATCACATCCAACAAGTATGGCC GATTCCCA A TGGCGGAG 155 CTCCGCCA T TGGGAATC 156 Sulfonylurea AGTGGCCTCGCGGACGCCCTACTGGATAGCGTCCCCATTGTTGC 157 Resistance TATAACCGGTCAAGTG T CACGTAGGATGATCGGTACTGATGCTTT ALS 2 TCAGGAAACTCCGATTGTTGAGGTAACTAGAT Nicotiana tabacum ATCTAGTTACCTCAACAATCGGAGTTTCCTGAAAAGCATCAGTACC 158 Pro191Ser GATCATCCTACGTG A CACTTGACCGGTTATAGCAACAATGGGGAC CCA-TCA GCTATCCAGTAGGGCGTCCGCGAGGCCACT GICAAGTG T CACGTAGG 159 CCTACGTG A CACTTGAC 160 Sulfonylurea GTGGCCTCGCGGACGCCCTACTGGATAGCGTCCCCATTGTTGCT 161 Resistance ATAACCGGTCAAGTGC A ACGTAGGATGATCGGTACTGATGCTTTT ALS 2 CAGGAAACTCCGATTGTTGAGGTAACTAGATC Nicotiana tabacum GATCTAGTTACCTCAACAATCGGAGTTTCCTGAAAAGCATCAGTAC 162 Pro191Gln CGATCATCCTACGT T GCACTTGACCGGTTATAGCAACAATGGGGA CCA-CAA CGCTATCCAGTAGGGCGTCCGCGAGGCCAC TCAAGTGC A ACGTAGGA 163 TCCTACGT T GCACTTGA 164 Imidazolinone GGCCATACTTGTTGGATGTGATTGTACCTCATCAGGAACATGTTCT 165 Resistance ACCTATGATTCCCA A TGGCGGGGCTTTCAAAGATGTGATCACAGA ALS 2 GGGTGACGGGAGAAGTTCCTATTGACTTTG Nicotiana tabacum CAAAGTCAATAGGAACTTCTCCCGTCACCCTCTGTGATCACATCTT 166 Ser647Asn TGAAAGCCCCGCCA T TGGGAATCATAGGTAGAACATGTTCCTGAT AGT-AAT GAGGTACAATCACATCCAACAAGTATGGCC GATTCCCA A TGGCGGGG 167 CCCCGCCA T TGGGAATC 168 Sulfonylurea AGTGGTCTTGCTGATGCTTTATTAGACAGTGTTCCAATGGTTGCTA 169 Resistance TTACTGGTCAAGTT T CCAGGAGAATGATTGGAACAGATGCGTTTC ALS AAGAAACCCCTATTGTTGAGGTAACACGTT Xanthium spp. AACGTGTTACCTCAACAATAGGGGTTTCTTGAAACGCATCTGTTCC 170 Pro175Ser AATCATTCTCCTGG A AACTTGACCAGTAATAGCAACCATTGGAACA CCC-TCC CTGTCTAATAAAGCATCAGCAAGACCACT GTCAAGTT T CCAGGAGA 171 TCTCCTGG A AACTTGAC 172 Sulfonylurea GTGGTCTTGCTGATGCTTTATTAGACAGTGTTCCAATGGTTGCTAT 173 Resistance TACTGGTCAAGTTC AA AGGAGAATGATTGGAACAGATGCGTTTCA ALS AGAAACCCCTATTGTTGAGGTAACACGTTC Xanthium spp. GAACGTGTTACCTCAACAATAGGGGTTTCTTGAAACGCATCTGTTC 174 Pro175Gln CAATCATTCTCCT TT GAACTTGACCAGTAATAGCAACCATTGGAAC CCC-CAA ACTGTCTAATAAAGCATCAGCAAGACCAC TCAAGTTC AA AGGAGAA 175 TTCTCCT TTGAACTTGA 176 Sulfonylurea GTGGTCTTGCTGATGCTTTATTAGACAGTGTTCCAATGGTTGCTAT 177 Resistance TACTGGTCAAGTTC AGAGGAGAATGATTGGAACAGATGCGTTTCA ALS AGAAACCCCTATTGTTGAGGTAACACGTTC Xanthium spp. GAACGTGTTACCTCAACAATAGGGGTTTCTTGAAACGCATCTGTTC 178 Pro175Gln CAATCATTCTCCT CT GAACTTGACCAGTAATAGCAACCATTGGAAC CCC-CAG ACTGTCTAATAAAGCATCAGCAAGACCAC TCAAGTTC AG AGGAGAA 179 TTCTCCT CT GAACTTGA 180 Imidazolinone GGGCCTTACTTGTTGGATGTGATCGTGCCCCATCAAGAACATGTG 181 Resistance TTGCCCATGATCCCG AA TGGTGGAGGTTTCATGGATGTGATCACC ALS GAAGGCGACGGCAGAATGAAATATTGAGCTT Xanthium spp. AAGCTCAATATTTCATTCTGCCGTCGCCTTCGGTGATCACATCCAT 182 Ala631Asn GAAACCTCCACCA TT CGGGATCATGGGCAACACATGTTCTTGATG GCT-AAT GGGCACGATCACATCCAACAAGTAAGGCCC TGATCCCG AA TGGTGGA 183 TCCACCA TT CGGGATCA 184 Sulfonylurea TCCGGGTTTGCTGATGCTTTGCTCGATTCCGTTCCACTGGTGGCG 185 Resistance ATCACGGGGCAGGTG T CGCGGCGAATGATTGGGACGGATGCTTT ALS TCAGGAGACTCCTATTGTTGAGGTAACACGGT Bassia scoparia ACCGTGTTACCTCAACAATAGGAGTCTCCTGAAAAGCATCCGTCC 186 Pro189Ser CAATCATTCGCCGCG A CACCTGCCCCGTGATCGCCACCAGTGGA CCG-TCG ACGGAATCGAGCAAAGCATCAGCAAACCCGGA GGCAGGTG T CGCGGCGA 187 TCGCCGCG A CACCTGCC 188 Sulfonylurea CCGGGTTTGGTGATGCTTTGCTCGATTCCGTTCCACTGGTGGCGA 189 Resistance TCACGGGGCAGGTGC A GCGGCGAATGATTGGGACGGATGCTTTT ALS CAGGAGACTCCTATTGTTGAGGTAACACGGTC Bassia scoparia GACCGTGTTACCTCAACAATAGGAGTCTCCTGAAAAGCATCCGTC 190 Pro189Gln CCAATCATTCGCCGC T GCACCTGCCCCGTGATCGCCACCAGTGG CCG-CAG AACGGAATCGAGCAAAGCATCAGCAAACCCGG GCAGGTGC A GCGGCGAA 191 TTCGCCGC T GCAGCTGC 192 Imidazolinone GACCTTACCTGCTTGATGTGATTGTACCTCATCAGGAGCATGTGC 193 Resistance TGCCTATGATTCCTA A TGGTGCAGCCTTCAAGGATATCATTAACGA ALS AGGTGATGGAAGAACAAGTTATTGATGTTC Bassia scoparia GAACATCAATAACTTGTTCTTCCATCACCTTCGTTAATGATATCCTT 194 Ser649Asn GAAGGCTGCACCA T TAGGAATCATAGGCAGCACATGCTCCTGATG AGT-AAT AGGTACAATCACATCAAGCAGGTAAGGTC GATTCGTA A TGGTGCAG 195 CTGCACCA T TAGGAATC 196 Sulfonylurea AGCGGGTTAGCAGACGCGATGCTTGACAGTGTTCCTCTTGTCGCC 197 Resistance ATTACAGGACAGGTC T CTCGCCGGATGATCGGTACTGACGCCTTC ALS 1 CAAGAGACACCAATCGTTGAGGTAACGAGGT Brassica napus ACCTCGTTACCTCAACGATTGGTGTCTCTTGGAAGGCGTCAGTAC 198 Pro182Ser CGATCATCCGGCGAG A GACCTGTCCTGTAATGGCGACAAGAGGA CCT-TCT ACACTGTCAAGCATCGCGTCTGCTAACCCGCT GACAGGTC T CTCGCCGG 199 CCGGCGAG A GACCTGTC 200 Sulfonylurea GCGGGTTAGCAGACGCGATGCTTGACAGTGTTCCTCTTGTCGCCA 201 Resistance TTACAGGACAGGTCC AA CGCCGGATGATCGGTACTGACGCCTTC ALS 1 CAAGAGACACCAATCGTTGAGGTAACGAGGTC Brassica napus GACCTCGTTACCTCAACGATTGGTGTCTCTTGGAAGGCGTCAGTA 202 Pro182Gln CCGATCATCCGGCG TT GGACCTGTCCTGTAATGGCGACAAGAGG CCT-CAA AACACTGTCAAGCATCGCGTCTGCTAACCCGC ACAGGTCC AA CGCCGGA 203 TCCGGCG TT GGACCTGT 204 Sulfonylurea GCGGGTTAGCAGACGCGATGCTTGACAGTGTTCCTCTTGTCGCCA 205 Resistance TTACAGGACAGGTCC AG CGCCGGATGATCGGTACTGACGCCTTC ALS 1 CAAGAGACACCAATCGTTGAGGTAACGAGGTC Brassica napus GACCTCGTTACCTCAACGATTGGTGTCTCTTGGAAGGCGTCAGTA 206 Pro182Gln CCGATCATCCGGCG CT GGACCTGTCCTGTAATGGCGACAAGAGG CCT-CAG AACACTGTCAAGCATCGCGTCTGCTAACCCGC ACAGGTCC AG CGCCGGA 207 TCCGGCG CT GGACCTGT 208 Imidazolinone GACCATACCTGTTGGATGTGATATGTCCGCACCAAGAACATGTGT 209 Resistance TACCGATGATCCCAA A TGGTGGCACTTTCAAAGATGTAATAACAG ALS 1 AAGGGGATGGTCGCACTAAGTACTGAGAGAT Brassica napus ATCTCTCAGTACTTAGTGCGACCATCCCCTTCTGTTATTACATCTTT 210 Ser638Asn GAAAGTGCCACCA T TTGGGATCATCGGTAACACATGTTCTTGGTG AGT-AAT CGGACATATCACATCCAACAGGTATGGTC GATCCCAA A TGGTGGCA 211 TGCCACCA T TTGGGATC 212 Sulfonylurea CAGCGGGTTAGCAGACGCGATGCTTGACAGTGTTCCTCTTGTCGC 213 Resistance CATTACAGGACAGGT T CCTCGCCGGATGATCGGTACTGACGCCTT ALS 2 CCAAGAGACACCAATCGTTGAGGTAACGAGG Brassica napus CCTCGTTACCTCAACGATTGGTGTCTCTTGGAAGGCGTCAGTACC 214 Pro126Ser GATCATCCGGCGAGG A ACCTGTCCTGTAATGGCGACAAGAGGAA CCC-TCC CACTGTCAAGCATCGCGTCTGCTAACCCGCTG GGACAGGT T CCTCGCCG 215 CGGCGAGG A ACCTGTCC 216 Sulfonylurea AGCGGGTTAGCAGACGCGATGCTTGACAGTGTTCCTCTTGTCGCC 217 Resistance ATTACAGGACAGGTC A CTCGCCGGATGATCGGTACTGACGCCTTC ALS 2 CAAGAGACACCAATCGTTGAGGTAACGAGGT Brassica napus ACCTCGTTACCTCAACGATTGGTGTCTCTTGGAAGGCGTCAGTAC 218 Pro126Gln CGATCATCCGGCGAG T GACCTGTCCTGTAATGGCGACAAGAGGA CCC-CAG ACACTGTCAAGCATCGCGTCTGCTAACCCGCT GACAGGTC A CTCGCCGG 219 CCGGCGAG T GACCTGTC 220 Imidazolinone GACCATACCTGTTGGATGTGATATGTCCGCACCAAGAACATGTGT 221 Resistance TACCGATGATCCCAA A TGGTGGCACTTTCAAAGATGTAATAACAG ALS 2 AAGGGGATGGTCGCACTAAGTACTGAGAGAT Brassica napus ATCTCTCAGTACTTAGTGCGACCATCCCCTTCTGTTATTACATCTTT 222 Ser582Asn GAAAGTGCCACCA T TTGGGATCATCGGTAACACATGTTCTTGGTG AGT-AAT CGGACATATCACATCCAACAGGTATGGTC GATCCCAA A TGGTGGCA 223 TGCCACCA T TTGGGATC 224 Sulfonylurea AGCGGGTTAGCCGACGCGATGCTTGACAGTGTTCCTCTCGTCGC 225 Resistance CATCACAGGACAGGTC T CTCGCCGGATGATCGGTACTGACGCGT ALS 3 TCCAAGAGACGCCAATCGTTGAGGTAACGAGGT Brassica napus ACCTCGTTACCTCAACGATTGGCGTCTCTTGGAACGCGTCAGTAC 226 Pro179Ser CGATCATCCGGCGAG A GACCTGTCCTGTGATGGCGACGAGAGGA CCT-TCT ACACTGTCAAGCATCGCGTCGGCTAACCCGCT GACAGGTC T CTCGCCGG 227 CCGGCGAG A GACCTGTC 228 Sulfonylurea GCGGGTTAGCCGACGCGATGCTTGACAGTGTTCCTCTCGTCGCC 229 Resistance ATCACAGGACAGGTCC AA CGCCGGATGATCGGTACTGACGCGTT ALS 3 CCAAGAGACGCCAATCGTTGAGGTAACGAGGTC Brassica napus GACCTCGTTACCTCAACGATTGGCGTCTCTTGGAACGCGTCAGTA 230 Pro179Gln CCGATCATCCGGCG TT GGACCTGTCCTGTGATGGCGACGAGAGG CCT-CAA AACACTGTCAAGCATCGCGTCGGCTAACCCGC ACAGGTCC AAee CGCCGGA 231 TCCGGCG TT GGACCTGT 232 Sulfonylurea GCGGGTTAGCCGACGCGATGCTTGACAGTGTTCCTCTCGTCGCC 233 Resistance ATCACAGGACAGGTCC AG CGCCGGATGATCGGTACTGACGCGTT ALS 3 CCAAGAGACGCCAATCGTTGAGGTAACGAGGTC Brassica napus GACCTCGTTACCTCAACGATTGGCGTCTCTTGGAACGCGTCAGTA 234 Pro179Gln CCGATCATCCGGCG CT GGACCTGTCCTGTGATGGCGACGAGAGG CCT-CAG AACACTGTCAAGCATCGCGTCGGCTAACCCGC ACAGGTCC AG CGCCGGA 235 TCCGGCG CT GGACCTGT 236 Imidazolinone GACCGTACCTGTTGGATGTCATCTGTCCGCACCAAGAACATGTGT 237 Resistance TACOGATGATCCCAA A TGGTGGCACTTTCAAAGATGTAATAACCG ALS 3 AAGGGGATGGTCGCACTAAGTACTGAGAGAT Brassica napus ATCTCTCAGTACTTAGTGCGACCATCCCCTTCGGTTATTACATCTT 238 Ser635Asn TGAAAGTGCCACCA T TTGGGATCATCGGTAACACATGTTCTTGGT AGT-AAT GCGGACAGATGACATCCAACAGGTACGGTC GATCCCAA A TGGTGGCA 239 TGCCACCA T TTGGGATC 240 Sultonylurea TCCGCGCTCGCCGACGCGCTGCTCGACTCCGTCCCGATGGTCGC 241 Resistance CATCACGGGCCAGGTC T CCCGCCGCATGATCGGCACCGACGCCT ALS TCCAGGAGACGCCCATAGTCGAGGTCACCCGCT Oryza sativa AGCGGGTGACCTCGACTATGGGCGTCTCCTGGAAGGCGTCGGTG 242 Prol7l Ser CCGATCATGCGGCGGG A GACCTGGCCCGTGATGGCGACCATCG CCC-TCC GGACGGAGTCGAGCAGCGCGTCGGCGAGCGCGGA GCCAGGTC T CCCGCCGC 243 GCGGCGGG A GACCTGGC 244 Sulfonylurea CCGCGCTCGCCGACGCGCTGCTCGACTCCGTCCCGATGGTCGCC 245 Resistance ATCACGGGCCAGGTCC AA CGCCGCATGATCGGCACCGACGCCTT ALS CCAGGAGACGCCCATAGTCGAGGTCACCCGCTC Oryza sativa GAGCGGGTGACCTCGACTATGGGCGTCTCCTGGAAGGCGTCGGT 246 Pro171Gln GCCGATCATGCGGCG Tee TGGACCTGGCCCGTGATGGCGACCATCG CCC-CAA GGACGGAGTCGAGCAGCGCGTCGGCGAGCGCGG CCAGGTCC AA CGCCGCA 247 TGCGGCG TT GGACCTGG 248 Sulfonylurea CCGCGCTCGCCGACGCGCTGCTCGACTCCGTCCCGATGGTCGCC 249 Resistance ATCACGGGCCAGGTCC AG CGCCGCATGATCGGCACCGACGCCTT ALS CCAGGAGACGCCCATAGTCGAGGTCACCCGCTC Oryza sativa GAGCGGGTGACCTCGACTATGGGCGTCTCCTGGAAGGCGTCGGT 250 Pro171Gln GCCGATCATGCGGCG CT GGACCTGGCCCGTGATGGGGACCATCG CCC-CAG GGACGGAGTCGAGCAGCGCGTCGGCGAGCGCGG CCAGGTCC AG CGCCGCA 251 TGCGGCG CT GGACCTGG 252 Imidazolinone GGCCATACTTGTTGGATATCATCGTCCCGCACCAGGAGCATGTGC 253 Resistance TGCCTATGATCCCAA A TGGGGGCGCATTCAAGGACATGATCCTGG ALS ATGGTGATGGCAGGACTGTGTATTAATCTAT Oryza sativa ATAGATTAATACACAGTCCTGCCATCACCATCCAGGATCATGTCCT 254 Ser627Asn TGAATGCGCCCCCA T TTGGGATCATAGGCAGCACATGCICCTGGI AGT-AAT GCGGGACGATGATATCCAACAAGTATGGCC GATCCCAA A TGGGGGCG 255 CGCCCCGA T TTGGGATC 256 Sulfonylurea TCTGCGCTCGCAGACGCGTTGCTCGACTCCGTCCCCATGGTCGC 257 Resistance CATCACGGGACAGGTG T CGCGACGCATGATTGGCACCGACGCCT ALS TTCAGGAGACGCCCATCGTCGAGGTCACCCGCT Zea mays AGCGGGTGACCTCGACGATGGGCGTCTCCTGAAAGGCGTCGGTG 258 Pro165Ser CCAATCATGCGTCGCG A CACCTGTCCCGTGATGGCGACCATGGG CCG-TCG GACGGAGTCGAGCAACGCGTCTGCGAGCGCAGA GACAGGTG T CGCGACGC 259 GCGTCGCG A CACCTGTC 260 Sulfonylurea CTGCGCTCGCAGACGCGTTGCTCGACTCCGTCCCCATGGTCGCC 261 Resistance ATCACGGGACAGGTGC A GCGACGCATGATTGGCACCGACGCCTT ALS TCAGGAGACGCCCATCGTCGAGGTCACCCGCTC Zea mays GAGCGGGTGACCTCGACGATGGGCGTCTCCTGAAAGGCGTCGGT 262 Pro165Gln GCCAATCATGCGTCGC T GCACCTGTCCCGTGATGGCGACCATGG CCG-CAG GGACGGAGTCGAGCAACGCGTCTGCGAGCGCAG ACAGGTGC A GCGACGCA 263 TGCGTCGC T GCACCTGT 264 Imidazolinone GGCCGTACCTCTTGGATATAATCGTCCCGCACCAGGAGCATGTGT 265 Resistance TGCCTATGATCCCTA A TGGTGGGGCTTTCAAGGATATGATCCTGG ALS ATGGTGATGGCAGGACTGTGTATTGATCCGT Zea mays ACGGATCAATACACAGTCCTGCCATCACCATCCAGGATCATATCC 266 Ser621Asn TTGAAAGCCCCACCA T TAGGGATCATAGGCAACACATGCTCCTGG AGT-AAT TGCGGGACGATTATATCCAAGAGGTACGGCC GATCCCTA A TGGTGGGG 267 CCCCACCA T TAGGGATC 268 Sulfonylurea AGTGGTCTCGCTGATGCAATGCTCGATAGTATCCCTCTCGTGGCG 269 Resistance ATCACTGGICAAGTC T CTCGTCGGATGATCGGTACCGATGCTTTC ALS CAGGAAACTCCAATTGTTGAGGTAACAAGGT Gossypium hirsutum ACCTTGTTACCTCAACAATTGGAGTTTCCTGGAAAGCATCGGTAC 270 Pro186Ser CGATCATCCGACGAG A GACTTGACCAGTGATCGCCACGAGAGGG CCT-TCT ATACTATGGAGCATTGCATCAGCGAGACCACT GTCAAGTCTC T CGTCGG 271 CCGACGAGAG A CTTGAC 272 Sulfonylurea GTGGTCTCGCTGATGCAATGCTCGATAGTATCCCTCTCGTGGCGA 273 Resistance TCACTGGTCAAGTCC AA CGTCGGATGATCGGTACCGATGCTTTCC ALS AGGAAACTCCAATTGTTGAGGTAACAAGGTC Gossypium hirsutum GACCTTGTTACCTTAACAATTGGAGTTTCCTGGAAAGCATCGGTA 274 Pro186Gln CCGATCATCCGACG TT GGACTTGACCAGTGATCGCCACGAGAGG CCT-CAA GATACTATCGAGCATTGCATCAGCGAGACCAC TCAAGTCC AA CGTCGGA 275 TTCCGACG TT GGACTTGA 276 Sulfonylurea GTGGTCTCGCTGATGCAATGCTCGATAGTATCCCTCTCGTGCCGA 277 Resistance TCACTGGTCAAGTCC AG CGTCGGATGATCGGTACCGATGCTTTCC ALS AGGAAACTCCAATTGTTGAGGTAACAAGGTC Gossypium hirsutum GACCTTGTTACCTCAACAATTGGAGTTTCCTGGAAAGCATCGGTA 278 Pro186Gln CCGATCATCCGACG CT GGACTTGACCAGTGATCGCCACGAGAGG CCT-CAG GATACTATCGAGCATTGCATCAGCGAGACCAC TCAAGTCC AG CGTCGGA 279 TCCGACG CT GGACTTGA 280 Imidazolinone GACCTTACTTGTTGGATGTGATTGTCCCACATCAAGAACATGTCCT 281 Resistance GCCTATGATCCCCA A TGGAGGGGCTTTCAAAGATGTGATCACAGA ALS GGGTGATGGAAGAACACAATATTGACCTCA Gossypium hirsutum TGAGGTCAATATTGTGTTCTTCCATCACCCTCTGTGATCACATCTT 282 Ser642Asn TGAAAGCCCCTCCA T TGGGGATCATAGGCAGGACATGTTCTTGAT AGT-AAT GTGGGACAATCACATCCAACAAGTAAGGTC GATCCCCA A TGGAGGGG 283 CCCCTCCA Tee TGGGGATC 284 Sulfonylurea TCTGGTCTTGCTGATGCACTTCTTGACTCAGTCCCTCTTGTCGCCA 285 Resistance TTACTGGGCAAGTT T CCCGGCGTATGATTGGTACTGATGCTTTTCA ALS AGAGACTCCAATTGTTGAGGTAACTCGAT Amaranthus powellii ATCGAGTTACCTCAACAATTGGAGTCTCTTGAAAAGCATCAGTACC 286 Pro192Ser AATCATACGCCGGG A AACTTGCCCAGTAATGGCGACAAGAGGGA CCC-TCC CTGAGTCAAGAAGTGCATCAGCAAGACCAGA GGCAAGTT T CCCGGCGT 287 ACGCCGGG A AACTTGCC 288 Sulfonymurea CTGGTCTTGCTGATGCACTTCTTGACTCAGTCCCTCTTGTCGCCAT 289 Resistance TACTGGGC AA GTTCAACGGCGTATGATTGGTACTGATGCTTTTCA ALS AGAGACTCCAATTGTTGAGGTAACTCGATC Amaranthus powellii GATCGAGTTACCTCAACAATTGGAGTCTCTTGAAAAGCATCAGTAC 290 Pro192Gln CAATCATACGCCG TT GAACTTGCCCAGTAATGGCGACAAGAGGGA CCC-CAA CTGAGTCAAGAAGTGCATCAGCAAGACCAG GCAAGTTC AA CGGCGTA 291 TACGCCG TT GAACTTGC 292 Sulfonylurea CTGGTCTTGCTGATGCACTTCTTGACTCAGTCCCTCTTGTCGCCAT 293 Resistance TACTGGGCAAGTTC AG CGGCGTATGATTGGTACTGATGCTTTTCA ALS AGAGACTCCAATTGTTGAGGTAACTCGATC Amaranthus powellii GATCGAGTTACCTCAACAATTGGAGTCTCTTGAAAAGCATCAGTAC 294 Pro192Gln CAATCATACGCCG CT GAACTTGCCCAGTAATGGCGACAAGAGGG CCC-CAG ACTGAGTCAAGAAGTGCATCAGCAAGACCAG GCAAGTTC AG CGGCGTA 295 TACGCCG CT GAACTTGC 296 Imidazolinone GACCGTATCTGCTGGATGTAATCGTACCACATCAGGAGCATGTGC 297 Resistance TGCCTATGATCCCTA A CGGTGCCGCCTTCAAGGACACCATAACAG ALS AGGGTGATGGAAGAAGGGCTTATTAGTTGGT Amaranthus powellii ACCAACTAATAAGCCCTTCTTCCATCACCCTCTGTTATGGIGTCCT 298 Ser652Asn TGAAGGCGGCACCG T TAGGGATCATAGGCAGCACATGCTCCTGA AGC-AAC TGTGGTACGATTACATCCAGCAGATACGGTG GATCCCTA A CGGTGCCG 299 CGGCACCG T TAGGGATC 300 -
TABLE 12 Genome-Altering Oligos Conferring Porphyric Herbicide Resistance Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Porphyric Herbicide TCTTGCGCCCTCTTTCTGAATCTGCTGCAAATGCACTCTCAAAACT 301 Resistant ATATTACCCACCA ATG GCAGCAGTATCTATCTCGTACCCGAAAGA PPO AGCAATCCGAACAGAATGTTTGATAGATGG Arabidopsis thaliana CCATCTATCAAACATTCTGTTCGGATTGCTTCTTTCGGGTACGAGA 302 Val365Met TAGATACTGCTG C CA T TGGTGGGTAATATAGTTTTGAGAGTGCATT GTT-ATG TGCAGCAGATTCAGAAAGAGGGCGCAAGA CCCACCA A T G GCAGCAG 303 CTGCTGC C A T TGGTGGG 304 Porphyric Herbicide TATTACGTCCTCTTTCGGTTGCCGCAGCAGATGCACTTTCAAATTT 305 Resistant CTACTAICCCCCA A T G GGAGCAGTCACAATTTCATATCCTCAAGAA PPO GCTATTCGTGATGAGCGTCTGGTTGATGG Nicotiana tabacum CCATCAACCAGACGCTCATCACGAATAGCTTCTTGAGGATATGAA 306 Val376Met ATTGTGACTGCTCC C A TT GGGGGATAGTAGAAATTTGAAAGTGCA GTT-ATG TCTGCTGCGGCAACCGAAAGAGGACGTAATA TCCCCCA A T GGGAGCAG 307 CTGCTCC C A T TGGGGGA 308 Porphyric Herbicide TGTTGCGTCCGCTTTCGTTGGGTGCAGCAGATGCATTGTCAAAAT 309 Resistant TTTATTATCCTCCG A T G GCAGCTGTATCAATTTCATATCCAAAAGA PPO CGGAATTCGTGCTGACCGGCTGATTGATGG Cichorium intybus CCATCAATCAGCCGGTCAGCACGAATTGCGTCTTTTGGATATGAA 310 Val383Met ATTGATACAGCTGC C A T CGGAGGATAATAAAATTTTGACAATGCAT GTT-ATG CTGCTGCACCCAACGAAAGCGGACGCAACA TCCTCCG A T GGCAGCTG 311 CAGCTGC C A T CGGAGGA 312 Porphyric Herbicide TCCTTCGTCCACTTTCAGATGTCGCCGCAGAATCTCTTTCAAAATT 313 Resistant TCATTATCCACCA A T G GCAGCTGTGTCACTTTCCTATCCTAAAGAA PPO GCAATTAGATCAGAGTGCTTGATTGACGG Spinacia oleracea CCGTCAATCAAGCACTCTGATCTAATTGCTTCTTTAGGATAGGAAA 314 Val390Met GTGACACAGCTGC C A T TGGTGGATAATGAAATTTTGAAAGAGATT GTT-ATG CTGCGGCGACATCTGAAAGTGGACGAAGGA TCCACCA A T G GCAGCTG 315 CAGCTGC C A T TGGTGGA 316 Porphyric Herbicide TTTTGCGTCCACTTTCAAGCGATGCTGCAGATGCTCTATCAAGATT 317 Resistant CTATTATCCACCG A T G GCTGCIGTAACTGTTTCGTATCCAAAGGAA PPO GCAATTAGAAAAGAATGCTTAATTGATGG Zea mays CGATCAATTAAGCATTCTTTTCTAATTGCTTCCTTTGGATACGAAAC 318 Val363Met AGTTACAGCAGC C A T CGGTGGATAATAGAATCTTGATAGAGCATC GTT-ATG TGCAGCATCGCTTGAAAGTGGACGCAAAA TCCACCG A T G GCTGCTG 319 CAGCAGC C A T CGGTGGA 320 Porphyric Herbicide TCTTGCGGCCACTTTCAAGTGATGGAGCAGATGCTCTGTCAATATT 321 Resistant CTATTATCCACCA A T G GCTGCTGTAACTGTTTCATATCCAAAAGAA PPO GCAATTAGAAAAGAATGCTTAATTGACGG Oryza sativa CCGTCAATTAAGCATTCTTTTCTAATTGCTTCTTTTGGATATGAAAC 322 Val364Met AGTTACAGCAGC C A T TGGTGGATAATAGAATATTGACAGAGCATC GTT-ATG TGCTGCATCACTTGAAAGTGGCCGCAAGA TCCACCA A T G GCTGCTG 323 CAGCAGCCA T TGGTGGA 324 Porphyric Herbicide CTGGTCAAGGAGCAGGCGCCCGCCGCCGCCGAGGCCCTGGGCT 325 Resistant CCTTCGACTACCCGCCG A TGGGCGCCGTGACGCTGTCGTACCCG PPO CTGAGCGCCGTGCGGGAGGAGCGCAAGGCCTCGG Chlamydomonas CCGAGGCCTTGCGCTCCTCCCGCACGGCGCTCAGCGGGTACGAC 326 reinhardtii AGCGTCACGGCGCCCA T CGGCGGGTAGTCGAAGGAGCCCAGGG Val389Met CCTCGGCGGCGGCGGGCGCCTGCTCCTTGACCAG GTG-ATG ACCCGCCG A TGGGCGCC 327 GGCGCCCA T CGGGGGGT 328 -
TABLE 13 Genome-Altering Oligos Conferring Triazine Resistance Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Triazine Resistant AAACTTACAACATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 329 D1 Protein TTTCCAATATGCTA C TTTCAACAATTCTCGTTCTTTACATTTCTTCTT Arabidopsis thaliana AGCGGCTTGGCCGGTAGTAGGTATTTG Ser264Thr CAAATACCTACTACCGGCCAAGCCGCTAAGAAGAAATGTAAAGAA 330 AGT-ACT CGAGAATIGTTGAAA G TAGCATATTGGAAAATCAATCGGCCAAAAT AACCGTGAGCAGCTACAATGTTGTAAGTTT ATATGCTA C TTTCAACA 331 TGTTGAAA G TAGCATAT 332 Triazine Resistant AAACTTATAACATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 333 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCGTTACACTTCTTCC Nicotiana tabacum TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAG GCCAAGCAGCTAGGAAGAAGTGTAACGAA 334 AGT-ACT CGAGAGtTGTIGAAA G TAGCATATTGGAAGATCAAtCGGCCAAAA TAACCATGAGCGGCTACGATGTTATAAGTTT ATATGCTA C TTTCAACA 335 TGTTGAAA G TAGCATAT 336 Triazine Resistant AAACTTATAATATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 337 D1Protein CTTCCAATATGCTA C TTTTAACAACTCTCGCTCTTTACATTTCTTCT Populus deltoides TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAAGAAGAAATGTAAAGAG 338 AGT-ACT CGAGAGTTGTTAAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCGGCTACGATATTATAAGTTT ATATGCTA C TTTTAACA 339 TGTTAAAA G TAGCATAT 340 Triazine Resistant AAACTTATAATATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 341 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCGTTACACTTCTTCC Petunia x hybrida TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAGTGTAACGAA 342 AGT-ACT CGAGAGTTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCGGCTACGATATTATAAGTTT ATATGCTA C TTTCAACA 343 TGTTGAAA G TAGCATAT 344 Triazine Resistant AAACTTATAAIATCGTAGCTGCTCATGGTTATTTTGGCCGATTGAT 345 D1Protein CTTCCAATATGCTA C TTTCAACAATTCTCGTTCTTTACATTTCTTCC Magnolia pyramidata TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAATGTAAAGAA 346 AGT-ACT CGAGAATTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCAGCTACGATATTATAAGTTT ATATGCTA C TTTCAACA 347 TGTTGAAA G TAGCATAT 348 Triazine Resistant AAACCTATAATATTGTAGCAGCTCATGGTTATTTTGGCCGATTGAT 349 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCTTTACATTTCTTCC Medicago sativa TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAATGTAAAGAA 350 AGT-ACT CGAGAGTTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAAGCATGAGCTGCTACAATATTATAGGTTT ATATGCTA C TTTCAACA 351 TGTTGAAA+E,us GTAGCATAT 1352 Triazine Resistant AAACCTATAATATTGTAGCTGCTCATGGTTATTTGGCCGATTGAT 353 D1Protein CTTCCAATATGCAA C TTTCAACAATTCTCGTTCTTTACATTTCTTCT Glycine max TAGCTGCTTGGCCTGTAGTAGGTATTTG Ser264Thr CAAATACCTACTACAGGCCAAGCAGCTAAGAAGAAATGTAAAGAA 354 AGT-ACT CGAGAATTGTTGAAA G TTGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCAGCTACAATATTATAGGTTT ATATGCAA C TTTCAACA 355 TGTTGAAA G TTGCATAT 356 Triazine Resistant AAACTTACAACATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 357 D1Protein CTTCCAATATGCT AC TTTCAACAATTCTCGTTCTTTACATTTCTTCT Brassica napus TAGCGGCTTGGCCGGTAGTAGGTATTTG Gly264Thr CAAATACCTACTACCGGCCAAGCCGCTAAGAAGAAATGTAAAGAA 358 GGT-ACT CGAGAAITGTTGAAA GT AGCATATTGGAAGATCAATCGGCCAAAA TAACCGTGAGCAGCTACAATGTTGTAAGTTT ATATGCT AC TTTCAACA 359 TGTTGAAA GT AGCATAT 360 Triazine Resistant AAACTTATAATATTGTGGCCGCTCATGGTTATTTTGGCCGATTAAT 361 D1Protein CTTCCAATATGCTA C TTTTAACAACTCTCGTTCTTTACACTTCTTCT Oryza sativa TGGCTGCTTGGCCTGTAGTAGGGATTTG Ser264Thr CAAATCCCTACTACAGGCCAAGCAGCCAAGAAGAAGTGTAAAGAA 362 AGT-ACT CGAGAGTTGTTAAAA G TAGCATATTGGAAGATTAATCGGCCAAAAT AACCATGAGCGGCCACAATATTATAAGTTT ATATGCTA C TTTTAACA 363 TGTTAAAA G TAGCATAT 364 Triazine Resistant AGACTTATAATATTGTGGCTGCTCACGGTTATTTTGGTCGATTAAT 365 D1Protein CTTCCAATATGCTA C TTTCAACAATTCTCGTTCTTTACACTTCTTCT Zea mays TGGCTGCTtGGCCTGTAGTAGGGATCtG Ser264Thr CAGATCCCTACTACAGGCCAAGCAGCCAAGAAGAAGTGTAAAGAA 366 AGT-ACT CGAGAATTGTTGAAA G TAGCATATTGGAAGATTAATCGACCAAAAT AACCGTGAGCAGCCACAATATTATAAGTCT ATATGCTA C TTTCAACA 367 TGTTGAAAGTAGCATAT 368 Triazine Resistant AAACTTACAACATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 369 D1Protein TTTCCAATATGCTA C TTTCAACAATTCTCGTTCTTTACATTTCTTCTT Arabidopsis thaliana AGCGGCTTGGCCGGTAGTAGGTATTTG Ser264Thr CAAATACCTACTACCGGCCAAGCCGCTAAGAAGAAATGTAAAGAA 370 AGT-ACT CGAGAATTGITGAAA G TAGCATATTGGAAAATCAATCGGCCAAAAT AACCGTGAGCAGCTACAATGTTGTAAGTTT ATATGCTA C TTTCAACA 371 TGTTGAAA G TAGCATAT 372 Triazine Resistant AAACTTATAACATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 373 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCGTTACACTTCTTCC Nicotiana tabacum TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAGTGTAACGAA 374 AGT-ACT CGAGAGTTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCGGCTACGATGTTATAAGTTT ATATGCTA C TTTCAACA 375 TGTTGAAA GTAGCATAT 376 Triazine Resistant AAACTTATAATATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 377 D1Protein CTTCCAATATGCTA C TTTTAACAACTCTCGCTCTTTACATTTCTTCT Papulus deltoides TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGGTAAGAAGAAATGTAAAGAG 378 AGT-AGT CGAGAGTTGTTAAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCGGCTACGATATTATAAGTTT ATATGCTA C TTTTAACA 379 TGTTAAAA G TAGCATAT 380 Triazine Resistant AAACTTATAATATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 381 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCGTTACACTTCTTCC Petunia x hybrida TAGCTGGTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAGTGTAACGAA 382 AGT-ACT CGAGAGTTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCGGCTACGATATTATAAGTTT ATATGCTA C TTTCAACA 383 TGTTGAAA G TAGCATAT 384 Triazine Resistant AAACTTATAATATCGTAGCTGCTCATGGTTATTTTGGCCGATTGAT 385 D1Protein CTTCCAATATGCTA C TTTCAACAATTCTCGTTCTTTACATTTCTTCC Magnolia pyramidata TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAATGTAAAGAA 386 AGT-ACT CGAGAATTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCAGCTACGATATTATAAGTTT ATATGCTA C TTTCAACA 387 TGTTGAAA G TAGCATAT 388 Triazine Resistant AAACCTATAATATTGTAGCAGCTCATGGTTATTTTGGCCGATTGAT 389 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCTTTACATTTGTTCC Medicago sativa TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAATGTAAAGAA 390 AGT-ACT CGAGAGTTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCTGCTACAATATTATAGGTTT ATATGCTA C TTTCAACA 391 TGTTGAAA G TAGCATAT 392 Triazine Resistant AAACCTATAATATTGTAGCTGCTCATGGTTATTTTGGCCGATTGAT 393 D1Protein CTTCCAATATGCAA C TTTCAACAATTCTCGTTCTTTACATTTCTTCT Glycine max TAGCTGCTTGGCCTGTAGTAGGTATTTG Ser264Thr CAAATACCTACTACAGGCCAAGCAGCTAAGAAGAAATGTAAAGAA 394 AGT-ACT CGAGAATTGTTGAAA G TTGCATATTGGAAGATCAATCGGGCAAAA TAACCATGAGCAGCTACAATATTATAGGTTT ATATGCAA C TTTCAACA 395 TGTTGAAA G TTGCATAT 396 Triazine Resistant AAACTTACAACATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 397 D1Protein CTTCCAATATGCT AC TTTCAACAATTCTCGTTCTTTACATTTCTTCT Brassica napus TAGCGGCTTGGCCGGTAGTAGGTATTTG Gly264Thr CAAATACCTACTACCGGCCAAGCCGCTAAGAAGAAATGTAAAGAA 398 GGT-ACT CGAGAATTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCGTGAGCAGCTACAATGTTGTAAGTTT ATATGCT AC TTTCAACA 399 TGTTGAAA GT AGCATAT 400 Triazine Resistant AAACTTATAATATTGTGGCCGCTCATGGTTATTTTGGCCGATTAAT 401 D1Protein CTTCCAATATGCTA C TTTTAACAACTCTCGTTCTTTACACTTCTTCT Oryza sativa TGGCTGCTTGGCCTGTAGTAGGGATTTG Ser264Ihr CAAATCCCTACTACAGGCCAAGCAGCCAAGAAGAAGTGTAAAGAA 402 AGT-ACT CGAGAGTTGTTAAAA G TAGCATATTGGAAGATTAATCGGCCAAAAT AACCATGAGCGGCCACAATATTATAAGTTT ATATGCTA C TTTTAACA 403 TGTTAAAA G TAGCATAT 404 Triazine Resistant AGACTTATAATATTGTGGCTGCTCACGGTTATTTTGGTCGATTAAT 405 D1Protein CTTCCAATATGCTA C TTTCAACAATTCTCGTTCTTTACACTTCTTCT Zea mays TGGCTGCTTGGCCTGTAGTAGGGATCTG Ser264Thr CAGATCCCTACTACAGGCCAAGCAGCCAAGAAGAAGTGTAAAGAA 406 AGT-ACT CGAGAATTGTTGAAA G TAGCATATTGGAAGATTAATCGACCAAAAT AACCGTGAGCAGCCACAATATTATAAGTCT ATATGCTA C TTTCAACA 407 TGTTGAAAGTAGCATAT 408 Triazine Resistant AAACTTACAACATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 409 D1Protein TTTCCAATATGCTA C TTTCAACAATTCTCGTTCTTTACATTTCTTCTT Arabidopsis thaliana AGCGGCTTGGCCGGTAGTAGGTATTTG Ser264Thr CAAATACCTACTACCGGCCAAGCCGCTAAGAAGAAATGTAAAGAA 410 AGT-ACT CGAGAATTGTTGAAA G TAGCATATTGGAAAATCAATCGGCCAAAAT AACCGTGAGCAGCTACAATGTTGTAAGTTT ATATGCTA C TTTCAACA 411 TGTTGAAA G TAGCATAT 412 Triazine Resistant AAACCTACAATATTGTGGCTGCTCACGGTTATTTCGGCCGATTGAT 413 D1Protein CTTCCAGTATGCTA C TTTCAACAACTCCCGTTCTTTACATTTCTTCT Picea abies TAGCTGCTTGGCCCGTAGCAGGTATCTG Ser264Thr CAGATACCTGCTACGGGCCAAGCAGCTAAGAAGAAATGTAAAGAA 414 AGT-ACT CGGGAGTTGTTGAAA G TAGCATACTGGAAGATCAATCGGCCGAAA TAACCGTGAGCAGCCACAATATTGTAGGTTT GTATGCTA C TTTCAACA 415 TGTTGAAA G TAGCATAC 416 Triazine Resistant AAACCTATAATATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 417 D1Protein CTTCCAATATGCTA C TTTCAACAATTCTCGCTCTTTACATTTCTTCC Vicia faba TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAATGTAAAGAG 418 AGT-ACT CGAGAATTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCGTGAGCAGCTACAATATTATAGGTTT ATATGCTA C TTTCAACA 419 TGTTGAAA G TAGCATAT 420 Triazine Resistant AGACTTATAATATTGTGGCTGCTCATGGTTATTTTGGCCGATTAAT 421 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCTTTACACTTCTTCT Hordeum vulgare TGGCTGCTTGGCCTGTAGTAGGAATCTG Ser264Thr CAGATTCCTACTACAGGCCAAGCAGCCAAGAAGAAGTGTAAAGAA 422 AGT-ACT CGAGAGTTGTTGAAAGTAGCATATTGGAAGATTAATCGGCCAAAA TAACCATGAGCAGCCACAATATTATAAGTCT ATATGCTACTTTCAACA 423 TGTTGAAAGTAGCATAT 424 Triazine Resistant AAACTTATAATATTGTGGCTGCTCATGGTTATTTTGGCCGATTAAT 425 D1Protein CTTCCAATATGCTACTTTCAACAACTCTCGTTCTTTACACTTCTTCT Triticum aestivum TGGCTGCTTGGCCTGTAGTAGGAATCTG Ser264Thr CAGATTCCTACTACAGGCCMGCAGCCAAGAAGAAGTGTAAAGAA 426 AGT-ACT CGAGAGTTGTTGAAA G TAGCATATTGGAAGATTAATCGGCCAAAA TAACCATGAGCAGCCACAATATTATAAGTTT ATATGCTA C TTTCAACA 427 TGTTGAAA G+E TAGCATAT 428 Triazine Resistant AAACTTATAATATTGTAGCTGCTCATGGTTATTTTGGCCGATTAATC 429 D1Protein TTCCAATATGCAA C TTTCMCAATTCTCGTTCTTTACATTTCTTCCT Vigna unguiculata AGCTGCTTGGCCTGTAGTAGGTATTTG Ser264Thr CAAATACCTACTACAGGCCAAGCAGCTAGGAAGAAATGTAAAGAA 430 AGT-ACT CGAGAATTGTTGAAA G TTGCATATTGGAAGATTAATCGGCCAAAAT AACCATGAGCAGCTACAATATTATAAGTTT ATATGCAA C TTTCAACA 431 TGTTGAAA G TTGCATAT 432 Triazine Resistant AAACCTATAATATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 433 D1Protein CTTCCAATATGCAA C TTTCAACAACTCTCGTTCTTTACACTTCTTCT Lotus japonicus TAGCTGCTTGGCCTGTTGTAGGTATCTG Ser264Thr CAGATACCTACAACAGGCCAAGCAGCTAAGAAGAAGTGTAAAGAA 434 AGT-ACT CGAGAGTTGTTGAAA G TTGCATATTGGAAGATCAATCGGCCAAAA TAACCGTGAGCAGCTACAATATTATAGGTTT ATATGCAA C TTTCAACA 435 TGTTGAAA G TTGCATAT 436 Triazine Resistant AAACTTACAACATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 437 D1Protein CTTCCAATATGCTA C TTTCAACAATTCTCGTTCTTTACATTTCTTCT Sinapis alba TAGCGGCTTGGCCGGTAGTAGGTATTTG Ser264Thr CAAATACCTACTACCGGCCAAGCCGCTAAGAAGAAATGTAAAGAA 438 AGT-ACT CGAGAATTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCGTGAGCAGCTACAATGTTGTAAGTTT ATATGCTA C TTTCAACA 439 TGTTGAAA G TAGCATAT 440 Triazine Resistant AAACCTATAATATTGTAGCTGCTCACGGTTATTTTGGCCGATTGAT 441 D1Protein CTTCCAATATGCTA C TTTCAACAATTCTCGCTCTTTACATTTCTTCC Pisum sativum TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTIAGGAAGAAATGTAAAGAG 442 AGt-ACT CGAGAATTGTTGAAAGTAGCAtATTGGAAGATCAATCGGCCAAAA TAACCGTGAGCAGCTACAATATTATAGGTTT ATATGCTA C TTTCAACA 443 TGTTGAAA G TAGCATAT 444 Triazine Resistant AAACTTATAATATCGTAGGTGCTCATGGTTATTTTGGTCGATTGAT 445 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCTTTACACTTCTTCT Spinacia oleracea TAGCTGCTTGGCCTGIAGTAGGTATTTG Ser264Thr CAAATACCTACTACAGGCCAAGCAGCTAAGAAGAAGTGTAAAGAA 446 AGT-ACT CGAGAGTTGTTGAAA G TAGCATATTGGAAGATCAATCGACCAAAA TAACCATGAGCAGGTACGATATTATAAGTTT ATATGCTA C TTTCAACA 447 TGTTGAAA G TAGCATAT 448 Triazine Resistant AAACTTATAACATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 449 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCGTTACACTTCTTCC Nicotiana debneyi TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGAtACCtACTACAGGCGAAGCAGCtAGGAAGAAGTGTAACGAA 450 AGT-ACT CGAGAGtTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCGGCTACGATGTTATAAGTTT ATATGCTA C TTTCAACA 451 TGTTGAAA G TAGCATAT 452 Triazine Resistant AAACTTATAATATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 453 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTTCGTTACACTTCTTCC Solanum nigrum TAGCTGCTTGGCCTGTAGTAGGTATCTG Ser264Thr CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAGTGTAACGAA 454 AGT-ACT CGAGAGTTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA TAACCATGAGCGGCTACGATATTATAAGTTT ATATGCTA C TTTCAACA 455 TGTTGAAA G TAGCATAT 456 Triazine Resistant AAACTTATAACATCGTAGCCGCTCATGGTTATTTTGGCCGATTGAT 457 D1Protein CTTCCAATATGCTA C TTTCAACAACTCTCGTICGTTACACTTCTTCC Nicotiana TAGCTGCTTGGCCTGTAGTAGGTATCTG plumbaginifolia CAGATACCTACTACAGGCCAAGCAGCTAGGAAGAAGTGTAACGAA 458 Ser264Thr CGAGAGTTGTTGAAA G TAGCATATTGGAAGATCAATCGGCCAAAA AGT-ACT TAACCATGAGCGGCTACGATGTTATAAGTTT ATATGCTA C TTTCAACA 459 TGTTGAAA G TAGCATAT 460 - Flower development in distantly related dicot plant species is increasingly better understood and appears to be regulated by a family of genes which encode regulatory proteins. These genes include, for example, AGAMOUS (AG), APETALA1 (AP1), and APETALA3 (AP3) and PISTILLATA (PI) inArabidopsis thaliana, and DEFICIENS A (DEFA), GLOBOSA (GLO), SQUAMOSA (SQUA), and PLENA (PLE) in Antirrhinum majus. Genetic studies have shown that the DEFA, GLO and AP3 genes are essential for petal and stamen development. Sequence analysis of these genes revealed that the gene products contain a conserved MADS box region, a DNA-binding domain. Using these clones as probes, MADS box genes have also been isolated from other species including tomato, tobacco, petunia, Brassica napus, and maize.
- Altering the expression of these genes results in altered floral morphology. For example, mutations in AP3 and PI result in male-sterile flowers because petals develop in place of stamens.
- The attached tables disclose exemplary oligonucleotide base sequences which can be used to generate site-specific mutations that confer altered floral structures in plants.
TABLE 14 Oligonucleotides to produce male-sterile plants Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Male-sterile TTGTCCTCTCCACCAAATCTCTTCAACAAAAAGATTAAACAAAGAG 461 AP3 AGAAGAATATGGCG T GAGGGAAGATCCAGATCAAGAGGATAGAGA Arabidopsis thaliana ACCAGACAAACAGACAAGTGACGTATTCAA Arg3Term TTGAATACGTCACTTGTCTGTTTGTCTGGTTCTCTATCCTCTTGATC 462 AGA-TGA TGGATCTTCCCTC A CGCCATATTCTTCTCTCTTIGTTTAATCTTTTT GTTGAAGAGATTTGGTGGAGAGGACAA ATATGGCG T GAGGGAAG 463 CTTCCCTC A CGCCATAT 464 Male-sterile TCTCCACCAAATCTCTTCAACAAAAAGATTAAACAAAGAGAGAAGA 465 AP3 ATATGGCGAGAGGG T AGATCCAGATCAAGAGGATAGAGAACCAGA Arabidopsis thaliana CAAACAGACAAGTGACGTATTCAAAGAGAA Lys5Term TTCTCTTTGAATACGTCACTTGTCTGTTTGTCTGGTTCTCTATCCTC 466 AAG-TAG TTGATCTGGATCT A CCCTCTCGCCATATTCTTCTCTCTTTGTTTAAT CTTTTTGTTGAAGAGATTTGGTGGAGA CGAGAGGG T AGATCCAG 467 CTGGATCT A CCGTCTCG 468 Male-sterile CCAAATCTCTTCAACAAAAAGATTAAACAAAGAGAGAAGAATATGG 469 AP3 CGAGAGGGAAGATC T AGATCAAGAGGATAGAGAAGCAGACAAACA Arabidopsis thaliana GACAAGTGACGTATTCAAAGAGAAGGAATG Gln7Term CATTCCTTCTCTTTGAATACGTCACTTGTCTGTTTGTCTGGTTCTCT 470 CAG-TAG ATCCTCTTGATCT A GATCTTCCCTCTCGCCATATTCTTCTCTCTTTG TTTAATCTTTTTGTTGAAGAGATTTGG GGAAGATC T AGATCAAG 471 CTTGATCT A GATCTTCC 472 Male-sterile CTCTTCAACAAAAAGATTAAACAAAGAGAGAAGAATATGGCGAGAG 473 AP3 GGAAGATCCAGATC T AGAGGATAGAGAACCAGACAAACAGAGAAG Arabidopsis thaliana TGACGTATTCAAAGAGAAGGAATGGTTTAT Lys9Term ATAAACCATTCGTTCTCTTTGAATACGTCACTTGTCTGTTTGTCTGG 474 AAG-TAG TTCTCTATCCTCT A GATCTGGATCTTCCCTCTCGCCATATTCTTCTC TCTTTGTTTAATCTTTTTGTTGAAGAG TCCAGATC T AGAGGATA 475 TATCCTCT A GATCTGGA 476 Male-sterile AGAGGGAAGATCGAGATGAAGAGGATAGAGAACGAGAGGAACCG 477 AP3 ACAAGTGACGTATTCT T AGAGAAGAAATGGTTTGTTCAAGAAAGCT Brassica oleracea CACGAGCTTACAGTTTTATGTGATGCTAGGG Lys23Term CCCTAGCATCACATAAAACTGTAAGCTCGTGAGCTTTCTTGAACAA 478 AAG-TAG ACCATTTCTTCTCT A AGAATACGTCACTTGTCGGTTGGTCTGGTTC TCTATCCTCTTGATCTGGATCTTCCCTCT CGTATTCT T AGAGAAGA 479 TCTTCTCT A AGAATACG 480 Male-sterile GGGAAGATCCAGATCAAGAGGATAGAGAACCAGACCAACCGACAA 481 AP3 GTGACGTATTCTAAG T GAAGAAATGGTTTGTTCAAGAAAGCTCACG Brassica oleracea AGCTTACAGTTTTATGTGATGCTAGGGTTT Arg24Term AAACCCTAGCATCACATAAAACTGTAAGCTCGTGAGCTTTCTTGAA 482 AGA-TGA CAAACCATTTCTTC A CTTAGAATACGTCACTTGTGGGTTGGTCTGG TTCTCTATCCTCTTGATCTGGATCTTCCC ATTCTAAG T GAAGAAAT 483 ATTTCTTC A CTTAGAAT 484 Male-sterile AAGATCCAGATCAAGAGGATAGAGAACCAGACCAACCGACAAGTG 485 AP3 ACGTATTCTAAGAGA T GAAATGGTTTGTTCAAGAAAGCTCACGAGC Brassica oleracea TTACAGTTTTATGTGATGCTAGGGTTTCGA Arg25Term TCGAAACCCTAGCATCACATAAAACTGTAAGCTCGTGAGCTTTCTT 486 AGA-TGA GAACAAACCATTTC A TCTCTTAGAATACGTCACTTGTCGGTTGGTC TGGTTCTCTATGCTCTTGATCTGGATCTT CTAAGAGA T GAAATGGT 487 ACCATTTC A TCTCTTAG 488 Male-sterile TCAAGAGGATAGAGAACCAGACCAACCGACAAGTGACGTATTCTA 489 AP3 AGAGAAGAAATGGTT A GTTCAAGAAAGCTCACGAGCTTACAGTTTT Brassica oleracea ATGTGATGCTAGGGTTTCGATTATCATGTT Leu28Term AACATGATAATCGAAACCCTAGCATCACATAAAACTGTAAGCTCGT 490 TTG-TAG GAGCTTTCTTGAAC T AACCATTTCTTCTCTTAGAATACGTCACTTGT CGGTTGGTCTGGTTCTCTATCCTCTTGA AAATGGTT A GTTCAAGA 491 TCTTGAAC T AACCATTT 492 Male-sterile GGCTCGAGGGAAGATCCAGATTAAGAGGATAGAGAACCAAACAAA 493 AP3 CAGGCAGGTCACCTA G TCCAAGAGAAGAAATGGTTTGTTCAAGAA Brassica napus AGCACACGAGCTCTCTGTTCTCTGTGATGCT Tyr21Term AGCATCACAGAGAACAGAGAGCTCGTGTGCTTTCTTGAACAAACC 494 TAC-TAG ATTTCTTCTCTTGGA C TAGGTGACCTGCCTGTTTGTTTGGTTCTCTA TCCTCTTAATCTGGATCTTCCCTCGAGCC GTCACCTA G TCCAAGAG 495 CTCTTGGA C TAGGTGAC 496 Male-sterile CGAGGGAAGATCCAGATTAAGAGGATAGAGAACCAAACAAACAGG 497 AP3 CAGGTCACCTACTCC T AGAGAAGAAATGGTTTGTTCAAGAAAGCAC Brassica napus ACGAGCTCTCTGTTCTCTGTGATGCTAAAG Lys23Term CTTTAGCATCACAGAGAACAGAGAGCTCGTGTGCTTTCTTGAACAA 498 AAG-TAG ACCATTTCTTCTCT A GGAGTAGGTGACCTGCCTGTTTGTTTGGTTC TCTATCCTCTTAATCTGGATCTTCCCTCG CCTACTCC T AGAGAAGA 499 TCTTCTCT A GGAGTAGG 500 Male-sterile GGGAAGATCCAGATTAAGAGGATAGAGAACCAAACAAACAGGCAG 501 AP3 GTCACCTACTCCAAG T GAAGAAATGGTTTGTTCAAGAAAGCACACG Brassica napus AGCTCTCTGTTCTCTGTGATGCTAAAGTTT Arg24Term AAACTTTAGCATCACAGAGAACAGAGAGCTCGTGTGCTTTCTTGAA 502 AGA-TGA CAAACCATTTGTTC A CTTGGAGTAGGTGACCTGCCTGTTTGTTTGG TTCTCTATCCTCTTAATCTGGATCTTCCC ACTCCAAG T GAAGAAAT 503 ATTTCTTC A CTTGGAGT 504 Male-sterile AAGATCCAGATTAAGAGGATAGAGAACCAAACAAACAGGCAGGTC 505 AP3 ACCTACTCCAAGAGA T GAAATGGTTTGTTCAAGAAAGCACACGAG Brassica napus CTCTCTGTTCTCTGTGATGCTAAAGTTTCCA Arg25Term TGGAAACTTTAGCATCACAGAGAACAGAGAGCTCGTGTGCTTTCTT 506 AGA-TGA GAACAAACCATTTC A TCTCTTGGAGTAGGTGACCTGCCTGTTTGTT TGGTTCTCTATCCTCTTAATCTGGATCTT CCAAGAGA T GAAATGGT 507 ACCATTTC A TCTCTTGG 508 Male-sterile GGAGAGAAAGGAAAGCTGGAAGAAGAAAACAAGAGCAGTAGTGG 509 DEFA TAGTGGTTCGATGGCT T GAGGGAAGATCCAGATTAAGAGGATAGA Antirrhinum majus GAACCAAACAAACAGGCAGGTCACCTACTCCA Arg3Term TGGAGTAGGTGACCTGCCTGTTTGTTTGGTTCTCTATCCTCTTAAT 510 CGA-TGA CTGGATCTTCCCTC A AGCCATCGAACCACTACCACTACTGCTCTTG TTTTCTTCTTCCAGCTTTCCTTTCTCTCC CGATGGCT T GAGGGAAG 511 CTTCCCTC A AGCCATCG 512 Male-sterile AAAGGAAAGCTGGAAGAAGAAAACAAGAGCAGTAGTGGTAGTGGT 513 DEFA TCCATGGCTCGAGGG T AGATCCAGATTAAGAGGATAGAGAACCAA Antirrhinum majus ACAAACAGGCAGGTCACCTACTCCAAGAGAA Lys5Term TTCTCTTGGAGTAGGTGACCTGCCTGTTTGTTTGGTTCTCTATCCT 514 AAG-TAG CTTAATCTGGATCT A CCCTCGAGCCATCGAACCACTAGCACTACTG CTCTTGTTTTCTTCTTCCAGCTTTCCTTT CTCGAGGG T AGATCCAG 515 CTGGATCT A CCCTCGAG 516 Male-sterile AAGCTGGAAGAAGAAAACAAGAGCAGTAGTGGTAGTGGTTCGATG 517 DEFA GCTCGAGGGAAGATC T AGATTAAGAGGATAGAGAACCAAACAAAC Antirrhinum majus AGGCAGGTCACCTACTCCAAGAGAAGAAATG Gln7Term CATTTCTTCTCTTGGAGTAGGTGACCTGCCTGTTTGTTTGGTTCTC 518 CAG-TAG TATCCTCTTAATCT A GATCTTCCCTCGAGCCATCGAACCACTACCA CTACTGCTCTTGTTTTCTTCTTCCAGCTT GGAAGATC T AGATTAAG 519 CTTAATCT A GATCTTCC 520 Male-sterile GAAGAAGAAAACAAGAGCAGTAGTGGTAGTGGTTCGATGGCTCGA 521 DEFA GGGAAGATCCAGATT T AGAGGATAGAGAACCAAACAAACAGGCAG Antirrhinum majus GTCACCTACTCCAAGAGAAGAAATGGTTTGT Lys9Term ACAAACCATTTCTTCTCTTGGAGTAGGTGACCTGCCTGTTTGTTTG 522 AAG-TAG GTTCTCTATCCTCT A AATCTGGATCTTCCCTCGAGCCATCGAACCA CTACCACTACTGCTCTTGTTTTCTTCTTC TCCAGATT T AGAGGATA 523 TATCCTCT A AATCTGGA 524 Male-sterile TCAGTAATTCTTAAGATCTCAAACTTTGAGCAAAAAGAAAAAAAAAC 525 AP3 TATGGCTCGTGGG T AGATCCAGATCAAGAGAATAGAGAACCAAAC Nicotiana tabacum AAACAGACAAGTCACTTATTCTAAGAGAA Lys5Term TTCTCTTAGAATAAGTGACTTGTCTGTTTGTTTGGTTCTCTATTCTC 526 AAG-TAG TTGATCTGGATCT A CCCACGAGCCATAGTTTTTTTTTCTTTTTGCTC AAAGTTTGAGATCTTAAGAATTACTGA CTCGTGGG T AGATCCAG 527 CTGGATCT A CCCACGAG 528 Male-sterile ATTCTTAAGATCTCAAACTTTGAGCAAAAAGAAAAAAAAACTATGGC 529 AP3 TCGTGGGAAGATC T AGATCAAGAGAATAGAGAACCAAACAAACAG Nicotiana tabacum ACAAGTCACTTATTCTAAGAGAAGAAATG Gln7Term CATTTCTTCTCTTAGAATAAGTGACTTGTCTGTTTGTTTGGTTCTCT 530 CAG-TAG ATTCTCTTGATCT A GATCTTCCCACGAGCCATAGTTTTTTTTTCTTT TTGCTCAAAGTTTGAGATCTTAAGAAT GGAAGATC T AGATCAAG 531 CTTGATCT A GATCTTCC 532 Male-sterile AAGATCTCAAACTTTGAGCAAAAAGAAAAAAAAACTATGGCTCGTG 533 AP3 GGAAGATCCAGATC T AGAGAATAGAGAACCAAACAAACAGACAAG Nicotiana tabacum TCACTTATTCTAAGAGAAGAAATGGACTTT Lys9Term AAAGTCCATTTCTTCTCTTAGAATAAGTGACTTGTCTGTTTGTTTGG 534 AAG-TAG TTCTCTATTCTCT A GATCTGGATCTTCCCACGAGCCATAGTTTTTTT TTCTTTTTGCTCAAAGTTTGAGATCTT TCCAGATC T AGAGAATA 535 TATTCTCT+E,un AGATCTGGA 536 Male-sterile ATCTCAAACTTTGAGCAAAAAGAAAAAAAAACTATGGCTCGTGGGA 537 AP3 AGATCCAGATCAAG T GAATAGAGAACCAAACAAACAGACAAGTCA Nicotiana tabacum CTTATTCTAAGAGAAGAAATGGACTTTTCA Arg10Term TGAAAAGTCCATTTCTTCTCTTAGAATAAGTGACTTGTCTGTTTGTT 538 AGA-TGA TGGTTCTCTATTC A CTTGATCTGGATCTTCCCACGAGCCATAGTTT TTTTTTCTTTTTGCTCAAAGTTTGAGAT AGATCAAG T GAATAGAG 539 CTCTATTC A CTTGATCT 540 Male-sterile GGCTCGAGGAAAGATCCAGATCAAGAGAATAGAGAACACAACGAA 541 AP3 CAGACAAGTAACTTA G TCAAAACGAAGGGATGGTCTTTTCAAGAAG Medicago sativa GCCAATGAGCTCACTGTTCTTTGTGATGCT Tyr21Term AGCATCACAAAGAACAGTGAGCTCATTGGCCTTCTTGAAAAGACCA 542 TAC-TAG TCCCTTCGTTTTGA C TAAGTTACTTGTCTGTTCGTTGTGTTCTCTAT TCTCTTGATCTGGATCTTTCCTCGAGCC GTAACTTA G TCAAAACG 543 CGTTTTGA C TAAGTTAC 544 Male-sterile CTCGAGGAAAGATCCAGATCAAGAGAATAGAGAACACAACGAACA 545 AP3 GACAAGTAACTTACT G AAAACGAAGGGATGGTCTTTTCAAGAAGG Medicago sativa CCAATGAGCTCACTGTTCTTTGTGATGCTAA Ser22Term TTAGCATCACAAAGAACAGTGAGCTCATTGGCCTTCTTGAAAAGAC 546 TCA-TGA CATCCCTTCGTTTT C AGTAAGTTACTTGTCTGTTCGTTGTGTTCTCT ATTCTCTTGATCTGGATCTTTCCTCGAG AACTTACT G AAAACGAA 547 TTCGTTTT+E,un CAGTAAGTT 548 Male-sterile CGAGGAAAGATCCAGATCAAGAGAATAGAGAACACAACGAACAGA 549 AP3 CAAGTAACTTACTCA T AACGAAGGGATGGTCTTTTCAAGAAGGCCA Medicago sativa ATGAGCTCACTGTTCTTTGTGATGCTAAGG Lys23Term CCTTAGCATCACAAAGAACAGTGAGCTCATTGGCCTTCTTGAAAAG 550 AAA-TAA ACCATCCCTTCGTT A TGAGTAAGTTACTTGTCTGTTCGTTGTGTTCT CTATTCTCTTGATCTGGATCTTTCCTCG CTTACTCA T AACGAAGG 551 CCTTCGTT A TGAGTAAG 552 Male-sterile GGAAAGATCCAGATCAAGAGAATAGAGAACACAACGAACAGACAA 553 AP3 GTAACTTACTCAAAA T GAAGGGATGGTCTTTTCAAGAAGGCCAATG Medicago sativa AGCTCACTGTTCTTTGTGATGCTAAGGTTT Arg24Term AAACCTTAGCATCACAAAGAACAGTGAGCTCATTGGCCTTCTTGAA 554 CGA-TGA AAGACCATCCCTTC A TTTTGAGTAAGTTACTTGTCTGTTCGTTGTGT TCTCTATTCTCTTGATCTGGATCTTTCC ACTCAAAA T GAAGGGAT 555 ATCCCTTC A TTTTGAGT 556 Male-sterile GGCTCGTGGTAAGATCCAGATCAAGAAAATAGAAAACCAAACAAAT 557 DEF4 AGGCAAGTGACTTA G TCAAAGAGAAGAAATGGGCTATTCAAGAAG Solanum tuberosum GCTAATGAACTTACAGTTCTTTGTGATGCT Tyr21Term AGCATCACAAAGAACTGTAAGTTCATTAGCCTTCTTGAATAGCCCA 558 TAT-TAG TTTCTTCTCTTTGA C TAAGTCACTTGCCTATTTGTTTGGTTTTCTATT TTCTTGATCTGGATCTTACCACGAGCC GTGACTTA G TCAAAGAG 559 CTCTTTGA C TAAGTCAC 560 Male-sterile CTCGTGGTAAGATCCAGATCAAGAAAATAGAAAACCAAACAAATAG 561 DEF4 GCAAGTGACTTATT G AAAGAGAAGAAATGGGCTATTCAAGAAGGC Solanum tuberosum TAATGAACTTACAGTTCTTTGTGATGCTAA Ser22Term TTAGCATCACAAAGAACTGTAAGTTCATTAGCCTTCTTGAATAGCC 562 TCA-TGA CATTTCTTCTCTTT C AATAAGTCACTTGCCTATTTGTTTGGTTTTCTA TTTTCTTGATCTGGATCTTACCACGAG GACTTATT G AAAGAGAA 563 TTCTCTTT C AATAAGTC 564 Male-sterile CGTGGTAAGATCCAGATCAAGAAAATAGAAAACCAAACAAATAGG 565 DEF4 CAAGTGACTTATTCA T AGAGAAGAAATGGGCTATTCAAGAAGGCTA Solanum tuberosum ATGAACTTACAGTTCTTTGTGATGCTAAAG Lys23Term CTTTAGCATCACAAAGAACTGTAAGTTCATTAGCCTTCTTGAATAG 566 AAG-TAG CCCATTTCTTCTCT A TGAATAAGTCACTTGCCTATTTGTTTGGTTTT CTATTTTCTTGATCTGGATCTTACCACG CTTATTCA T AGAGAAGA 567 TCTTCTCT A TGAATAAG 568 Male-sterile GGTAAGATCCAGATCAAGAAAATAGAAAACCAAACAAATAGGCAA 569 DEF4 GTGACTTATTCAAAG T GAAGAAATGGGCTATTCAAGAAGGCTAATG Solanum tuberosum AACTTACAGTTCTTTGTGATGCTAAAGTTT Arg24Term AAACTTTAGCATCACAAAGAACTGTAAGTTCATTAGCCTTCTTGAAT 570 AGA-TGA AGCCCATTTCTTC A CTTTGAATAAGTCACTTGCCTATTTGTTTGGTT TTCTATTTTCTTGATCTGGATCTTACC ATTCAAAG T GAAGAAAT 571 ATTTCTTC A GTTTGAAT 572 Male-sterile GCTAATGAACTTACTGTTCTTTGTGATGCTAAAGTTTCAATTGTTAT 573 AP3 GATTTCTAGTACT T GAAAACTTCATGAGTTTATAAGTCCCTCTATCA Lycopersicon CGACCAAACAATTGTTCGATCTGTACC esculentum GGTACAGATCGAACAATTGTTTGGTCGTGATAGAGGGACTTATAAA 574 Gly27Term CTCATGAAGTTTTC A AGTACTAGAAATCATAACAATTGAAACTTTAG GGA-TGA CATCACAAAGAACAGTAAGTTCATTAGC CTAGTACT T GAAAACTT 575 AAGTTTTC A AGTACTAG 576 Male-sterile AATGAACTTACTGTTCTTTGTGATGCTAAAGTTTCAATTGTTATGAT 577 AP3 TTCTAGTACTGGA T AACTTCATGAGTTTATAAGTCCCTCTATCACGA Lycopersicon CCAAACAATTGTTCGATCTGTACCAGA esculentum TCTGGTACAGATCGAACAATTGTTTGGTCGTGATAGAGGGACTTAT 578 Lys28Term AAACTCATGAAGTT A TCCAGTACTAGAAATCATAACAATTGAAACTT AAA-TAA TAGCATCACAAAGAACAGTAAGTTCATT GTACTGGA T AACTTCAT 579 ATGAAGTT A TCCAGTAC 580 Male-sterile ACTGTTCTTTGTGATGCTAAAGTTTCAATTGTTATGATTTCTAGTAC 581 AP3 TGGAAAACTTCAT T AGTTTATAAGTCCCTCTATCACGACCAAACAAT Lycopersicon TGTTCGATCTGTACCAGAAGACTATTG esculentum CAATAGTCTTCTGGTACAGATCGAACAATTGTTTGGTCGTGATAGA 582 Glu31Term GGGACTTATAAACT A ATGAAGTTTTCCAGTACTAGAAATCATAACA GAG-TAG ATTGAAACTTTAGCATCACAAAGAACAGT AACTTCAT T AGTTTATA 583 TATAAACT A ATGAAGTT 584 Male-sterile ATTGTTATGATTTCTAGTACTGGAAAACTTCATGAGTTTATAAGTCC 585 AP3 CTCTATCACGACC T AACAATTGTTCGATCTGTACCAGAAGACTATT Lycopersicon GGAGTTGATATTTGGACTACTCACTATG esculentum CATAGTGAGTAGTCCAAATATCAACTCCAATAGTCTTCTGGTACAG 586 Lys40Term ATCGAACAATTGTT A GGTCGTGATAGAGGGACTTATAAACTCATGA AAA-TAA AGTTTTCCAGTACTAGAAATCATAACAAT TCACGACC T AACAATTG 587 CAATTGTT A GGTCGTGA 588 Male-sterile GGGGCGGGGGAAGATTGAGATAAAGCGGATCGAGAACGCCACCA 589 AP3 ACAGGCAGGTGACCTA G TCCAAGCGCCGGTCGGGGATCATGAAG Triticum aestivum AAGGCGCGGGAGCTCACCGTGCTCTGCGACGCC Tyr21Term GGCGTCGCAGAGCACGGTGAGCTCCCGCGCCTTCTTCATGATCC 590 TAC-TAG CCGACCGGCGCTTGGA C TAGGTCACCTGCCTGTTGGTGGCGTTCT CGATCCGCTTTATCTCAATCTTCCCCCGCCCC GTGACCTA G TCCAAGCG 591 CGCTTGGA C TAGGTCAC 592 Male-sterile CGGGGGAAGATTGAGATAAAGCGGATCGAGAACGCCACCAACAG 593 AP3 GCAGGTGACCTACTCC T AGCGCCGGTCGGGGATCATGAAGAAGG Triticum aestivum CGCGGGAGCTCACCGTGCTCTGCGACGCCCAGG Lys23Term CCTGGGCGTCGCAGAGCACGGTGAGCTCCCGCGCCTTCTTCATG 594 AAG-TAG ATCCCCGACCGGCGCT A GGAGTAGGTCACCTGCCTGTTGGTGGC GTTCTCGATCCGCTTTATCTCAATCTTCCCCCG CCTACTCC T AGCGCCGG 595 CCGGCGCT A GGAGTAGG 596 Male-sterile TTGAGATAAAGCGGATCGAGAACGCCACCAACAGGCAGGTGACCT 597 AP3 ACTCGAAGCGCCGGT A GGGGATCATGAAGAAGGCGCGGGAGCTC Triticum aestivum ACCGTGCTCTGCGACGCCCAGGTCGCCATCAT Ser26Term ATGATGGCGACCTGGGCGTCGCAGAGCACGGTGAGCTCCCGCGC 598 TCG-TAG CTTCTTCATGATCCCC T ACCGGCGCTTGGAGTAGGTCACCTGCCT GTTGGTGGCGTTGTCGATCCGCTTTATCTCAA GCGCCGGT A GGGGATCA 599 TGATCCCC T ACCGGCGC 600 Male-sterile CGGATCGAGAACGCCACCAACAGGCAGGTGACCTACTCCAAGCG 601 AP3 CCGGTCGGGGATCATG T AGAAGGCGCGGGAGCTCACCGTGCTCT Triticum aestivum GCGACGCCCAGGTCGCCATCATCATGTTCTCCT Lys30Term AGGAGAACATGATGATGGCGACCTGGGCGTCGCAGAGCACGGTG 602 AAG-TAG AGCTCCCGCGCCTTCT A CATGATCCCCGACCGGCGCTTGGAGTAG GTCACCTGCCTGTTGGTGGCGTTGTCGATCCG GGATCATG T AGAAGGCG 603 CGCCTTCT A CATGATCC 604 Male-sterile GGGGCGCGGCAAGATCGAGATCAAGCGGATCGAGAACGCCACCA 605 Silky1 ACCGCCAGGTGACCTA G TCCAAGCGCCGGACGGGGATCATGAAG Zea mays AAGGCACGCGAGCTCACCGTGCTCTGCGACGCC Tyr21Term GGCGTCGCAGAGCACGGTGAGCTCGCGTGCCTTCTTCATGATCCC 606 TAG-TAG CGTCCGGCGCTTGGA C TAGGTCACCTGGCGGTTGGTGGCGTTCT CGATCGGCTTGATCTCGATCTTGCCGCGCCCC GTGACCTA G TCCAAGCG 607 CGCTTGGA C TAGGTCAC 608 Male-sterile CGCGGCAAGATCGAGATCAAGCGGATCGAGAACGCCACCAACCG 609 Silky1 CCAGGTGACCTACTCC T AGCGCCGGACGGGGATCATGAAGAAGG Zea mays CACGCGAGCTCACCGTGCTCTGCGACGCCCAGG Lys23Term CCTGGGCGTCGCAGAGCACGGTGAGCTCGCGTGCCTTCTTCATG 610 AAG-TAG ATCCCCGTCCGGCGCT A GGAGTAGGTCACCTGGCGGTTGGTGGC GTTCTCGATCCGCTTGATCTCGATCTTGCCGCG CCTACTCC T AGCGCCGG 611 CCGGCGCT A GGAGTAGG 612 Male-sterile CGGATCGAGAACGCCACCAACCGCCAGGTGACCTACTCCAAGCG 613 Silky1 CCGGACGGGGATCATG T AGAAGGCACGCGAGCTCACCGTGCTCT Zea mays GCGACGCCCAGGTCGCCATCATCATGTTCTCCT Lys30Term AGGAGAACATGATGATGGCGACCTGGGCGTCGCAGAGCACGGTG 614 AAG-TAG AGCTCGCGTGCCTTCT A CATGATCCCGGTCCGGCGCTTGGAGTAG GTCACCTGGCGGTTGGTGGCGTTCTCGATCCG GGATCATG T AGAAGGCA 615 TGCCTTCT A CATGATCC 616 Male-sterile ATCGAGAACGCCACCAACCGCCAGGTGACGTACTCCAAGCGCCG 617 Silky1 GACGGGGATCATGAAG T AGGCACGCGAGCTCACCGTGCTCTGCG Zea mays ACGCCCAGGTCGCCATCATCATGTTCTCCTCCA Lys31Term TGGAGGAGAACATGATGATGGCGACCTGGGCGTCGCAGAGCACG 618 AAG-TAG GTGAGCTCGCGTGCCT A CTTCATGATCCCCGTCCGGCGCTTGGAG TAGGTCACCTGGCGGTTGGTGGCGTTCTCGAT TCATGAAG T AGGCACGC 619 GCGTGCCT A CTTCATGA 620 Male-sterile GCTAGCTGCATTGTCCGGCGAGAGAGATAGCTGCTGCAGGGGGC 621 AP3 GGCCATGGGGAGGGGC T AGATCGAGATCAAGCGGATCGAGAACG Oryza sativa CGACCAACAGGCAGGTGACCTACTCGAAGCGCC Lys5Term GGCGCTTGGAGTAGGTCACCTGCCTGTTGGTCGCGTTCTCGATCC 622 AAG-TAG GCTTGATCTCGATCT A GCCCGTCCCCATGGCGGCCCCCTGCAGCA GCTATCTCTCTCGCCGGACAATGCAGCTAGC GGAGGGGC T AGATCGAG 623 CTCGATCT A GCCCCTCC 624 Male-sterile TGCATTGTCCGGCGAGAGAGATAGCTGCTGCAGGGGGCGGCCAT 625 AP3 GGGGAGGGGCAAGATC T AGATCAAGCGGATCGAGAACGCGACCA Oryza sativa ACAGGCAGGTGACCTACTCGAAGCGCCGCACGG Glu7Term CCGTGCGGCGCTTCGAGTAGGTCACCTGCCTGTTGGTCGCGTTCT 626 GAG-TAG CGATCCGCTTGATCT A GATCTTGCCCCTCCCCATGGCCGCCCCCT GCAGCAGCTATCTCTCTCGCCGGACAATGCA GCAAGATC T AGATCAAG 627 CTTGATCT A GATCTTGC 628 Male-sterile GTCCGGCGAGAGAGATAGCTGCTGCAGGGGGCGGCCATGGGGA 629 AP3 GGGGCAAGATCGAGATC T AGCGGATCGAGAACGCGACCAACAGG Oryza sativa CAGGTGACCTACTCGAAGCGCCGCACGGGGATCA Lys9Term TGATCCCCGTGCGGCGCTTCGAGTAGGTCACCTGCCTGTTGGTCG 630 AAG-TAG CGTTCTCGATCCGCT A GATCTCGATCTTGCCCCTCCCCATGGCCG CCCCCTGCAGCAGCTATCTCTCTCGCCGGAC TCGAGATC T AGCGGATC 631 GATCCGCT A GATCTCGA 632 Male-sterile GAGAGATAGCTGCTGCAGGGGGCGGCCATGGGGAGGGGCAAGA 633 AP3 TCGAGATCAAGCGGATCT A GAACGCGACCAACAGGCAGGTGACCT Oryza sativa ACTCGAAGCGCCGCACGGGGATCATGAAGAAGG Glu12Term CCTTCTTCATGATCCCCGTGCGGCGCTTCGAGTAGGTCACCTGCC 634 GAG-TAG TGTTGGTCGCGTTCT A GATCCGCTTGATCTCGATCTTGCCCCTCCC CATGGCGGCCCCCTGCAGCAGCTATCTCTC AGCGGATC T AGAACGCG 635 CGCGTTCT A GATCCGCT 636 -
TABLE 15 Oligonucleotides to produce male-sterile plants Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Male-sterile TCTGTACTAATCAAATTTTGCCCTAAACGTTTTTGGCTTTGGAGCA 637 AG GCAATCACGGCGTA G CAATCGGAGCTAGGAGGAGATTCCTCTCC Arabidopsis thaliana CTTGAGGAAATCTGGGAGAGGAAAGATCGAA Tyr35Term TTCGATCTTTCCTCTCCCAGATTTCCTCAAGGGAGAGGAATCTCCT 638 TAG-TAG CCTAGGTCCGATTG C TACGCCGTGATTGCTGCTCCAAAGCCAAAA ACGTTTAGGGCAAAATTTGATTAGTACAGA ACGGCGTA G CAATCGGA 639 TCCGATTG C TACGCCGT 640 Male-sterile CTGTACTAATCAAATTTTGCCCTAAACGTTTTTGGCTTTGGAGCAG 641 AG CAATCACGGCGTAC T AATCGGAGCTAGGAGGAGATTCCTCTCCCT Arabidopsis thaliana TGAGGAAATCTGGGAGAGGAAAGATCGAAA Gln36Term TTTCGATCTTTCCTCTCCCAGATTTCCTCAAGGGAGAGGAATCTCC 642 CAA-TAA TCCTAGCTCCGATT A GTACGCCGTGATTGCTGCTCCAAAGCCAAA AACGTTTAGGGCAAAATTTGATTAGTACAG CGGCGTAC T AATCGGAG 643 CTCCGATT A GTACGCCG 644 Male-sterile ACTAATCAAATTTTGCCCTAAACGTTTTTGGCTTTGGAGCAGCAAT 645 AG CACGGCGTACCAAT A GGAGCTAGGAGGAGATTCCTCTCCCTTGA Arabidopsis thaliana GGAAATCTGGGAGAGGAAAGATCGAAATCAA Ser37Term TTGATTTCGATCTTTCCTCTCCCAGATTTCCTCAAGGGAGAGGAAT 646 TCG-TAG CTCCTCCTAGCTCC T ATTGGTACGCCGTGATTGCTGCTCCAAAGC CAAAAACGTTTAGGGCAAAATTTGATTAGT GTACCAAT A GGAGCTAG 647 CTAGCTCC T ATTGGTAC 648 Male-sterile TAATCAAATTTTGCCCTAAACGTTTTTGGCTTTGGAGCAGCAATCA 649 AG CGGCGTACCAATCG T AGCTAGGAGGAGATTCCTCTCCCTTGAGGA Arabidopsis thalana AATCTGGGAGAGGAAAGATCGAAATCAAAC Glu38Term GTTTGATTTCGATCTTTCCTCTCCCAGATTTCCTCAAGGGAGAGGA 650 GAG-TAG ATCTCCTCCTAGCT A CGATTGGTACGCCGTGATTGCTGCTCCAAA GCCAAAAACGTTTAGGGCAAAATTTGATTA ACCAATCG T AGCTAGGA 651 TCCTAGCT A CGATTGGT 652 Male-sterile CTCTCCCACTTCTTTTCGGTGGTTTATTCATTTGGTGACGATATCA 653 AG CAGAAGCAATGGAT T AAGGTGGGAGTAGTCACGATGCAGAGAGT Brassica napus AGCAAGAAGATAGGTAGAGGGAAGATAGAGA Glu3Term TCTCTATCTTCCCTCTACCTATCTTCTTGCTACTCTCTGCATCGTGA 654 GAA-TAA CTACTCCCACCTT A ATCCATTGCTTCTGTGATATCGTCACCAAATG AATAAACCACCGAAAAGAAGTGGGAGAG CAATGGAT T AAGGTGGG 655 CCCACCTT A ATCCATTG 656 Male-sterile TATTCATTTGGTGACGATATCACAGAAGCAATGGATGAAGGTGGG 657 AG AGTAGTCACGATGCA T AGAGTAGCAAGAAGATAGGTAGAGGGAA Brassica napus GATAGAGATAAAGAGGATAGAGAACACAACAA Glu11Term TTGTTGTGTTCTCTATCCTCTTTATCTCTATCTTCCCTCTACCTATC 658 GAG-TAG TTCTTGCTACTCT A TGCATCGTGACTACTCCCACCTTCATCCATTG CTTCTGTGATATCGTCACCAAATGAATA ACGATGCA T AGAGTAGC 659 GCTACTCT A TGCATCGT 660 Male-sterile GGTGACGATATCACAGAAGCAATGGATGAAGGTGGGAGTAGTCA 661 AG CGATGCAGAGAGTAGC T AGAAGATAGGTAGAGGGAAGATAGAGA Brassica napus TAAAGAGGATAGAGAACACAACAAATCGTCAAG Lys14Term CTTGACGATTTGTTGTGTTCTCTATCCTCTTTATCTCTATCTTCCCT 662 AAG-TAG GTACCTATCTTCT A GCTACTCTCTGCATCGTGACTACTCCCACCTT CATCCATTGCTTCTGTGATATCGTCACC AGAGTAGC T AGAAGATA 663 TATCTTCT A GCTAGTCT 664 Male-sterile GACGATATCACAGAAGCAATGGATGAAGGTGGGAGTAGTCACGA 665 AG TGCAGAGAGTAGCAAG T AGATAGGTAGAGGGAAGATAGAGATAAA Brassica napus GAGGATAGAGAACACAACAAATCGTCAAGTAA Lys15Term TTACTTGACGATTTGTTGTGTTCTCTATCCTCTTTATCTCTATCTTC 666 AAG-TAG CCTCTACCTATCT A CTTGCTACTCTCTGCATCGTGACTACTCCCAC CTTCATCCATTGCTTCTGTGATATCGTC GTAGCAAG T AGATAGGT 667 ACCTATCT A CTTGCTAC 668 Male-sterile CAACCAAAAAACTTAAAAATCTTCTCTTTCCTTTCCTTACAAGGTGA 669 AG AGTAATGGACTTC T AAAGTGATCTAACCAGAGAGATCTCACCACAA Lycopersicon AGGAAACTAGGAAGGGGGAAAATTGAGA esculentum TCTCAATTTTCCCCCTTCCTAGTTTCCTTTGTGGTGAGATCTCTCT 670 Glu4Term GGTTAGATCACTTT A GAAGTCCATTACTTCACCTTGTAAGGAAAGG CAA-TAA AAAGAGAAGATTTTTAAGTTTTTTGGTTG TGGACTTC+E,unc TAAAGTGAT 671 ATCACTTT A GAAGTCCA 672 Male-sterile AAAATCTTCTCTTTCCTTTCCTTACAAGGTGAAGTAATGGACTTCC 673 AG AAAGTGATCTAACC T GAGAGATCTCACCACAAAGGAAACTAGGAA Lycopersicon GGGGGAAAATTGAGATCAAAAGGATCGAAA esculentum TTTCGATCCTTTTGATCTCAATTTTCCCCCTTCCTAGTTTCCTTTGT 674 Arg9Term GGTGAGATCTCTC A GGTTAGATCACTTTGGAAGTCCATTACTTCAC AGA-TGA CTTGTAAGGAAAGGAAAGAGAAGATTTT ATCTAACC T GAGAGATC 675 GATCTCTC A GGTTAGAT 676 Male-sterile ATCTTCTCTTTCCTTTCCTTACAAGGTGAAGTAATGGACTTCCAAA 677 AG GTGATCTAACCAGA T AGATCTCACCACAAAGGAAACTAGGAAGGG Lycopersicon GGAAAATTGAGATCAAAAGGATCGAAAACA esculentum TGTTTTCGATCCTTTTGATCTCAATTTTCCCCCTTCCTAGTTTCCTT 678 Glu10Term TGTGGTGAGATCT A TCTGGTTAGATCACTTTGGAAGTCCATTACTT GAG-TAG CACCTTGTAAGGAAAGGAAAGAGAAGAT TAACCAGA T AGATCTCA 679 TGAGATCT A TCTGGTTA 680 Male-sterile CTTTCCTTTCCTTACAAGGTGAAGTAATGGACTTCCAAAGTGATCT 681 AG AACCAGAGAGATCT G ACCACAAAGGAAACTAGGAAGGGGGAAAA Lycopersicon TTGAGATCAAAAGGATCGAAAACACGACGAA esculentum TTCGTCGTGTTTTCGATCCTTTTGATCTCAATTTTCCCCCTTCCTAG 682 Ser12Term TTTCCTTTGTGGT C AGATCTCTGTGGTTAGATCACTTTGGAAGTCC TCA-TGA ATTACTTCACCTTGTAAGGAAAGGAAAG AGAGATCT G ACCACAAA 683 TTTGTGGT C AGATCTCT 684 Male-sterile GTACTCTCTATTTTCATCTTCCAACCCTTTCTTTCCTTACCAGGTGA 685 NAG1 AAGTATGGACTTC T AAAGTGATCTAACAAGAGAGATCTCTCCACAA Nicotiana tabacum AGGAAACTGGGAAGAGGAAAGATTGAGA Gln4Term TCTCAATCTTTCCTCTTCCCAGTTTCCTTTGTGGAGAGATCTCTCTT 686 CAA-TAA GTTAGATCACTTT A GAAGTCCATACTTTCACCTGGTAAGGAAAGAA AGGGTTGGAAGATGAAAATAGAGAGTAC TGGACTTC T AAAGTGAT 687 ATCACTTT A GAAGTCCA 688 Male-sterile ATCTTCCAACCCTTTCTTTCCTTACCAGGTGAAAGTATGGACTTCC 689 NAG1 AAAGTGATCTAACA T GAGAGATCTCTCCACAAAGGAAACTGGGAA Nicotiana tabacum GAGGAAAGATTGAGATCAAACGGATCGAAA Arg9Term TTTCGATCCGTTTGATCTCAATCTTTCCTCTTCCCAGTTTCCTTTGT 690 AGA-TGA GGAGAGATCTCTC A TGTTAGATCACTTTGGAAGTCCATACTTTCAC CTGGTAAGGAAAGAAAGGGTTGGAAGAT ATCTAACA T GAGAGATC 691 GATCTCTC A TGTTAGAT 692 Male-sterile TTCCAACCCTTTCTTTCCTTAGCAGGTGAAAGTATGGACTTCCAAA 693 NAG1 GTGATCTAACAAGA T AGATCTCTCCACAAAGGAAACTGGGAAGAG Nicotiana tabacum GAAAGATTGAGATCAAACGGATCGAAAACA Glu10Term TGTTTTCGATCCGTTTGATCTCAATCTTTCCTCTTCCCAGTTTCCTT 694 GAG-TAG TGTGGAGAGATCT A TCTTGTTAGATGACTTTGGAAGTCCATACTTT CACCTGGTAAGGAAAGAAAGGGTTGGAA TAACAAGA T AGATCTCT 695 AGAGATCT A TCTTGTTA 696 Male-sterile CTTTCCTTACCAGGTGAAAGTATGGACTTCCAAAGTGATCTAACAA 697 NAG1 GAGAGATCTCTCCA T AAAGGAAACTGGGAAGAGGAAAGATTGAGA Nicotiana tabacum TCAAACGGATCGAAAACACAACGAATCGTC Gln14Term GACGATTCGTTGTGTTTTCGATCCGTTTGATCTCAATCTTTCCTCTT 698 CAA-TAA CCCAGTTTCCTTT A TGGAGAGATCTCTCTTGTTAGATCACTTTGGA AGTCCATACTTTCACCTGGTAAGGAAAG TCTCTCCA T AAAGGAAA 699 TTTCCTTT A TGGAGAGA 700 Male-sterile GCCTATGAAAACAAACCCAACACGGTCCTGGACGCTGATGCCCAA 701 AG AGAAGATTGGGAAGG T GAAAGATCGAGATCAAGCGGATCGAAAA Rosa hybrida CACCACCAATCGTCAAGTCACCTTCTGCAAAA Gly22Term TTTTGCAGAAGGTGACTTGACGATTGGTGGTGTTTTCGATCCGCT 702 GGA-TGA TGATCTGGATCTTTC A CCTTCCCAATCTTCTTTGGGCATCAGCGTC CAGGACCGTGTTGGGTTTGTTTTCATAGGC TGGGAAGG T GAAAGATC 703 GATCTTTC A CCTTCCCA 704 Male-sterile TATGAAAACAAACCCAACACGGTCCTGGACGCTGATGCCCAAAGA 705 AG AGATTGGGAAGGGGA T AGATCGAGATCAAGCGGATCGAAAACAC Rosa hybrida CACCAATCGTCAAGTCACCTTCTGCAAAAGGC Lys23Term GCCTTTTGCAGAAGGTGACTTGACGATTGGTGGTGTTTTCGATCC 706 AAG-TAG GCTTGATCTCGATCT A TCCCCTTCCCAATCTTCTTTGGGCATCAGC GTCCAGGACCGTGTTGGGTTTGTTTTCATA GAAGGGGA T AGATCGAG 707 CTCGATCT A TCCCCTTC 708 Male-sterile AACAAACCCAACACGGTCCTGGACGCTGATGCCCAAAGAAGATTG 709 AG GGAAGGGGAAAGATC T AGATCAAGCGGATCGAAAACACCACCAA Rosa hybrida TCGTCAAGTCACCTTCTGCAAAAGGCGCAATG Glu25Term CATTGCGCCTTTTGCAGAAGGTGACTTGACGATTGGTGGTGTTTT 710 GAG-TAG CGATCCGCTTGATCT A GATCTTTCCCCTTCCCAATCTTCTTTGGGC ATCAGCGTCCAGGACCGTGTTGGGTTTGTT GAAAGATC T AGATCAAG 711 CTTGATCT A GATCTTTC 712 Male-sterile CCCAACACGGTCCTGGACGCTGATGCCCAAAGAAGATTGGGAAG 713 AG GGGAAAGATCGAGATC T AGCGGATCGAAAACACCACCAATCGTCA Rosa hybrida AGTCACCTTCTGCAAAAGGCGCAATGGTTTGC Lys27 GCAAACCATTGCGCCTTTTGCAGAAGGTGACTTGACGATTGGTGG 714 AAG-TAG TGTTTTCGATCCGCT A GATCTCGATCTTTCCCCTTCCCAATCTTCT TTGGGCATCAGCGTCCAGGACCGTGTTGGG TCGAGATC T AGCGGATC 715 GATCCGCT A GATCTCGA 716 Male-sterile CAATTGCGTGTTTTTATTTTTTTTGTTTTTGACTAAGTAGAAATGGC 717 far GTCTCTAAGCGAT T AATCGACCGAGGTATCGCGCGAGAGGAAAAT Antirrhinum majus CGGGAGAGGAAAGATCGAGATCAAACGGA Gln7Term TCCGTTTGATCTCGATCTTTCCTCTCCCGATTTTCCTCTCGGGCGA 718 CAA-TAA TACCTCGGTCGATT A ATCGCTTAGAGACGCCATTTCTACTTAGTCA AAAAGAAAAAAAATAAAAACAGGCAATTG TAAGCGAT T AATCGACC 719 GGTCGATT A ATCGCTTA 720 Male-sterile GTTTTTATTTTTTTTCTTTTTGACTAAGTAGAAATGGCGTCTCTAAG 721 far CGATCAATCGACC T AGGTATCGCCCGAGAGGAAAATCGGGAGAG Antirrhinum majus GAAAGATCGAGATCAAACGGATCGAAAACA Glu10Term TGTTTTCGATCCGTTTGATCTCGATCTTTCCTCTCCCGATTTTCCTC 722 GAG-TAG TCGGGCGATACCT A GGTCGATTGATCGCTTAGAGACGCCATTTCT ACTTAGTCAAAAAGAAAAAAAATAAAAAC AATCGACC T AGGTATCG 723 CGATACCT A GGTCGATT 724 Male-sterile TTTCTTTTTGACTAAGTAGAAATGGCGTCTCTAAGCGATCAATCGA 725 far CCGAGGTATCGCCC T AGAGGAAAATCGGGAGAGGAAAGATCGAG Antirrhinum majus ATCAAACGGATCGAAAACAAAACAAATCAAC Glu14Term GTTGATTTGTTTTGTTTTCGATCCGTTTGATCTCGATCTTTCCTCTC 726 GAG-TAG CCGATTTTCCTCT A GGGCGATACCTCGGTCGATTGATCGCTTAGA GACGCCATTTCTACTTAGTCAAAAAGAAA TATCGCCC T AGAGGAAA 727 TTTCCTCT A GGGCGATA 728 Male-sterile TTTGACTAAGTAGAAATGGCGTCTCTAAGCGATCAATCGACCGAG 729 far GTATCGCCCGAGAGG T AAATCGGGAGAGGAAAGATCGAGATCAA Antirrhinum majus ACGGATCGAAAACAAAACAAATCAACAGGTTA Lys16Term TAACCTGTTGATTTGTTTTGTTTTCGATCCGTTTGATCTCGATCTTT 730 AAA-TAA CCTCTCCCGATTT A CCTCTCGGGCGATACCTCGGTCGATTGATCG CTTAGAGACGCCATTTCTACTTAGTCAAA CCGAGAGG T AAATCGGG 731 CCCGATTT A CCTCTCGG 732 Male-sterile TGTCCAAGCATTATCAGTCACCACTCACAAGAATGATTAAGGAAGA 733 AG AGGAAAGGGTAAGT A GCAAATAAAGGGGATGTTCCAGAATCAAGA Cucumis sativus AGAGAAGATGTCAGACTCGCCTCAGAGGAA Leu21Term TTCCTCTGAGGCGAGTCTGACATCTTCTCTTCTTGATTCTGGAACA 734 TTG-TAG TCCCCTTTATTTGC T ACTTACCCTTTCCTTCTTCCTTAATCATTCTT GTGAGTGGTGACTGATAATGCTTGGACA GGGTAAGT A GCAAATAA 735 TTATTTGC T ACTTACCC 736 Male-sterile TCCAAGCATTATCAGTCACCACTCACAAGAATGATTAAGGAAGAA 737 AG GGAAAGGGTAAGTTG T AAATAAAGGGGATGTTCCAGAATCAAGAA Cucumis sativus GAGAAGATGTCAGACTCGCCTCAGAGGAAGA Gln22Term TCTTCCTCTGAGGCGAGTCTGACATCTTCTCTTCTTGATTCTGGAA 738 CAA-TAA CATCCCCTTTATTT A CAACTTACCCTTTCCTTCTTCCTTAATCATTC TTGTGAGTGGTGACTGATAATGCTTGGA GTAAGTTG T AAATAAAG 739 CTTTATTT A CAACTTAC 740 Male-sterile CATTATCAGTCACCACTCACAAGAATGATTAAGGAAGAAGGAAAG 741 AG GGTAAGTTGCAAAT A TAGGGGATGTTCCAGAATCAAGAAGAGAAG Cucumis sativus ATGTCAGACTCGCCTCAGAGGAAGATGGGAA Lys24Term TTCCCATCTTCCTCTGAGGCGAGTCTGACATCTTCTCTTCTTGATT 742 AAG-TAG CTGGAACATCCCCT A TATTTGCAACTTACCCTTTCCTTCTTCCTTAA TCATTCTTGTGAGTGGTGACTGATAATG TGCAAATA T AGGGGATG 743 CATCCCCT A TATTTGCA 744 Male-sterile CCACTCACAAGAATGATTAAGGAAGAAGGAAAGGGTAAGTTGCAA 745 AG ATAAAGGGGATGTTC T AGAATCAAGAAGAGAAGATGTCAGACTCG Cucumis sativus CCTCAGAGGAAGATGGGAAGAGGAAAGATTG Gln28Term CAATCTTTCCTCTTCCCATCTTCCTCTGAGGCGAGTCTGACATCTT 746 CAG-TAG CTCTTCTTGATTCT A GAACATCCCCTTTATTTGCAACTTACCCTTTC CTTCTTCCTTAATCATTCTTGTGAGTGG GGATGTTC T AGAATCAA 747 TTGATTCT A GAACATCC 748 Male-sterile CCACCACCACCACCACCACCACCACCACACCATGCTCAACATGAT 749 AG GACTGATCTGAGCTG A GGGCCGTCGTCCAAGGTCAAGGAGCAGG Zea mays TGGCGGCGGCGCCGACGGGCTCCGGCGACAGG Cys10Term CCTGTCGCCGGAGCCCGTCGGCGCCGCCGCCACCTGCTCCTTGA 750 TGC-TGA CCTTGGACGACGGCCC T CAGCTCAGATCAGTCATCATGTTGAGCA TGGTGTGGTGGTGGTGGTGGTGGTGGTGGTGG CTGAGCTG A GGGCCGTC 751 GACGGCCC T CAGCTCAG 752 Male-sterile ACCACCACCACCACCACCACACCATGCTCAACATGATGACTGATC 753 AG TGAGCTGCGGGCCGT A GTCCAAGGTCAAGGAGCAGGTGGCGGC Zea mays GGCGCCGACGGGCTCCGGCGACAGGCAGGGGCA Ser13Term TGCCCCTGCCTGTCGCCGGAGCCCGTCGGCGCCGCCGCCACCT 754 TCG-TAG GCTCCTTGACCTTGGAC T ACGGCCCGCAGCTCAGATCAGTCATCA TGTTGAGCATGGTGTGGTGGTGGTGGTGGTGGT CGGGCCGT A GTCCAAGG 755 CCTTGGAC T ACGGCCCG 756 Male-sterile CACCACCACCACCACACCATGCTCAACATGATGACTGATCTGAGC 757 AG TGCGGGCCGTCGTCC T AGGTCAAGGAGCAGGTGGCGGCGGCGC Zea mays CGACGGGCTCCGGCGACAGGCAGGGGCAGGGGA Lys15Term TCCCCTGCCCCTGCCTGTCGCCGGAGCCCGTCGGCGCCGCCGC 758 AAG-TAG CACCTGCTCCTTGACCT A GGACGACGGCCCGCAGCTCAGATCAG TCATCATGTTGAGCATGGTGTGGTGGTGGTGGTG CGTCGTCC T AGGTCAAG 759 CTTGACCT A GGACGACG 760 Male-sterile CACCACCACACCATGCTCAACATGATGACTGATCTGAGCTGCGGG 761 AG CCGTCGTCCAAGGTC T AGGAGCAGGTGGCGGCGGCGCCGACGG Zea mays GCTCCGGCGACAGGCAGGGGCAGGGGAGAGGCA Lys17Term TGCCTCTCCCCTGCCCCTGCCTGTCGCCGGAGCCCGTCGGCGCC 762 AAG-TAG GCCGCCACCTGCTCCT A GACCTTGGACGACGGCCCGCAGCTCAG ATCAGTCATCATGTTGAGCATGGTGTGGTGGTG CCAAGGTC T AGGAGCAG 763 CTGCTCCT A GACCTTGG 764 Male-sterile TCCTACCTTTTCTCCTTCAGACCTCAAAATCTGTGTGATAGGAACA 765 AG AGAGCATGCACATC T GAGAAGAGGAGGCTACACCATCCACAGTAA Zea mays CAGGCATCATGTCGACCCTGACTTCGGCGG Arg4Term CCGCCGAAGTCAGGGTCGACATGATGCCTGTTACTGTGGATGGT 766 CGA-TGA GTAGCCTCCTCTTCTC A GATGTGCATGCTCTTGTTCCTATCACACA GATTTTGAGGTCTGAAGGAGAAAAGGTAGGA TGCACATC T GAGAAGAG 767 CTCTTCTC A GATGTGCA 768 Male-sterile TACCTTTTCTCCTTCAGACCTCAAAATCTGTGTGATAGGAACAAGA 769 AG GCATGCACATCCGA T AAGAGGAGGCTACACCATCCACAGTAACAG Zea mays GCATCATGTCGACCCTGACTTCGGCGGGGC Glu5Term GCCCCGCCGAAGTCAGGGTCGACATGATGCCTGTTACTGTGGAT 770 GAA-TAA GGTGTAGCCTCCTCTT A TCGGATGTGCATGCTCTTGTTCCTATCAC ACAGATTTTGAGGTCTGAAGGAGAAAAGGTA ACATCCGA T AAGAGGAG 771 CTCCTCTT A TCGGATGT 772 Male-sterile CTTTTCTCCTTCAGACCTCAAAATCTGTGTGATAGGAACAAGAGCA 773 AG TGCACATCCGAGAA T AGGAGGCTACACCATCCACAGTAACAGGCA Zea mays TCATGTCGACCCTGACTTCGGCGGGGCAGC Glu6Term GCTGCCCCGCCGAAGTGAGGGTCGACATGATGCCTGTTACTGTG 774 GAG-TAG GATGGTGTAGCCTCCT A TTCTCGGATGTGCATGCTCTTGTTCCTAT CACACAGATTTTGAGGTCTGAAGGAGAAAAG TCCGAGAA T AGGAGGCT 775 AGCCTCCT A TTCTCGGA 776 Male-sterile TTCTCCTTCAGACCTCAAAATCTGTGTGATAGGAACAAGAGCATG 777 AG CACATCCGAGAAGAG T AGGCTACACCATCCACAGTAACAGGCATC Zea mays ATGTCGACCCTGACTTCGGCGGGGCAGCAGA Glu7Term TCTGCTGCCCCGCCGAAGTCAGGGTCGACATGATGCCTGTTACT 778 GAG-TAG GTGGATGGTGTAGCCT A CTCTTCTCGGATGTGCATGCTCTTGTTC CTATCACACAGATTTTGAGGTCTGAAGGAGAA GAGAAGAG T AGGCTACA 779 TGTAGCCT A CTCTTCTC 780 Male-sterile GCTGGGTCAGGATCGTCGGCGGCGGTGGCGGCGGGGAGCAGC 781 AG GAGAAGATGGGGAGGGGG T AGATCGAGATAAAGCGGATCGAGAA Oryza sativa CACGACGAACCGGCAGGTGACCTTCTGCAAGCGCC Lys5Term GGCGCTTGCAGAAGGTCACCTGCCGGTTCGTCGTGTTCTCGATC 782 AAG-TAG CGCTTTATCTCGATCT A CCCCCTCCCCATCTTCTCGCTGCTCCCC GCCGCCACCGCCGCCGACGATCCTGACCCAGC GGAGGGGG T AGATCGAG 783 CTCGATCT A CCCCCTCC 784 Male-sterile TCAGGATCGTCGGCGGGGGTGGCGGCGGGGAGCAGCGAGAAGA 785 AG TGGGGAGGGGGAAGATC T AGATAAAGCGGATCGAGAACACGACG Oryza sativa AACCGGCAGGTGACCTTCTGCAAGCGCCGCAATG GTu7Term CATTGCGGCGCTTGCAGAAGGTCACCTGCCGGTTCGTCGTGTTCT 786 GAG-TAG CGATCCGCTTTATCT A GATCTTCCCCCTCCCCATCTTCTCGCTGCT CCCCGCCGCCACCGCCGCCGACGATCCTGA GGAAGATC T AGATAAAG 787 CTTTATCT A GATCTTCC 788 Male-sterile TCGTCGGCGGCGGTGGCGGCGGGGAGCAGCGAGAAGATGGGG 789 AG AGGGGGAAGATCGAGATA T AGCGGATCGAGAACACGACGAACCG Oryza sativa GCAGGTGACCTTCTGCAAGCGCCGCAATGGCCTCC Lys9Term GGAGGCCATTGCGGCGCTTGCAGAAGGTCACCTGCCGGTTCGTC 790 AAG-TAG GTGTTCTCGATCCGCT A TATCTCGATCTTCCCCCTCCCCATCTTCT CGCTGCTCCCCGCCGCCACCGCCGCCGACGA TCGAGATA T AGCGGATC 791 GATCCGCT A TATCTCGA 792 Male-sterile GCGGTGGCGGCGGGGAGCAGCGAGAAGATGGGGAGGGGGAAG 793 AG ATCGAGATAAAGCGGATC T AGAACACGACGAACCGGCAGGTGAC Oryza sativa CTTCTGCAAGCGCCGCAATGGCCTCCTGAAGAAGG Glu12Term CCTTCTTCAGGAGGCCATTGCGGCGCTTGCAGAAGGTCACCTGC 794 GAG-TAG CGGTTCGTCGTGTTCT A GATCCGCTTTATCTCGATCTTCCCCCTCC CCATCTTCTCGCTGCTCCCCGCCGCCACCGC AGCGGATC T AGAACACG 795 CGTGTTCT A GATCCGCT 796 -
TABLE 16 Oligonucleotides to produce male-sterile plants Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Male-sterile GGGAAGAGGGAAAATAGAAATAAAAAGAATAGAGAACTCAAGCAA 797 P1 TAGACAAGTTACATA G TCAAAGAGAAGAAATGGTATCATCAAAAAA Cucumis sativus GCCAAAGAAATTACTGTTCTTTGCGATGCT Tyr21Term AGCATCGCAAAGAACAGTAATTTCTTTGGCTTTTTTGATGATACCAT 798 TAT-TAG TTCTTCTCTTTGA C TATGTAACTTGTCTATTGCTTGAGTTCTCTATTC TTTTTATTTCTATTTTCCCTCTTCCC GTTACATA G TCAAAGAG 799 CTCTTTGA C TATGTAAC 800 Male-sterile GAAGAGGGAAAATAGAAATAAAAAGAATAGAGAACTCAAGCAATA 801 P1 GACAAGTTACATATT G AAAGAGAAGAAATGGTATCATCAAAAAAGC Cucumis sativus CAAAGAAATTACTGTTCTTTGCGATGCTCA Ser22Term TGAGCATCGCAAAGAACAGTAATTTCTTTGGCTTTTTTGATGATAC 802 TCA-TGA CATTTCTTCTCTTT C AATATGTAACTTGTCTATTGCTTGAGTTCTCTA TTGTTTTTATTTCTATTTTCCCTCTTC TACATATT G AAAGAGAA 803 TTCTCTTT+E,un CAATATGTA 804 Male-sterile AGAGGGAAAATAGAAATAAAAAGAATAGAGAACTCAAGCAATAGAC 805 P1 AAGTTAGATATTCA T AGAGAAGAAATGGTATCATCAAAAAAGCCAA Cucumis sativus AGAAATTACTGTTCTTTGCGATGCTCAAG Lys23Term CTTGAGCATCGCAAAGAACAGTAATTTCTTTGGCTTTTTTGATGATA 806 AAG-TAG CCATTTCTTCTCT A TGAATATGTAACTTGTCTATTGCTTGAGTTCTC TATTCTTTTTATTTCTATTTTCCCTCT CATATTCA T AGAGAAGA 807 TCTTCTCT A TGAATATG 808 Male-sterile GGGAAAATAGAAATAAAAAGAATAGAGAACTCAAGCAATAGACAAG 809 P1 TTACATATTCAAAG T GAAGAAATGGTATCATCAAAAAAGCCAAAGA Cucumis sativus AATTACTGTTCTTTGCGATGCTCAAGTTT Arg24Term AAACTTGAGCATCGCAAAGAACAGTAATTTCTTTGGCTTTTTTGATG 810 AGA-TGA ATACCATTTCTTC A CTTTGAATATGTAACTTGTCTATTGCTTGAGTT CTCTATTCTTTTTATTTCTATTTTCCC ATTCAAAG T GAAGAAAT 811 ATTTCTTC A CTTTGAAT 812 Male-sterile GGGACGTGGGAAGGTTGAGATCAAGAGGATTGAGAACTGAAGTAA 813 P1 CAGGCAGGTGACCTA G TCCAAGAGGAGGAATGGGATTATCAAGAA Malus domestica GGCAAAGGAGATCACTGTTCTATGTGATGCT Tyr21Term AGCATCACATAGAACAGTGATCTCCTTTGCCTTCTTGATAATCCCA 814 TAG-TAG TTCCTCCTCTTGGA C TAGGTGACCTGCCTGTTACTTGAGTTCTCAA TCCTCTTGATCTCAACCTTCCCACGTCGC GTGACCTA G TGCAAGAG 815 CTCTTGGA C TAGGTCAC 816 Male-sterile CGTGGGAAGGTTGAGATCAAGAGGATTGAGAACTCAAGTAACAGG 817 P1 CAGGTGACCTACTCC T AGAGGAGGAATGGGATTATCAAGAAGGCA Malus domestica AAGGAGATCACTGTTCTATGTGATGCTAAAG Lys23Term CTTTAGCATCACATAGAACAGTGATCTCCTTTGCCTTCTTGATAATC 818 AAG-TAG CCATTCCTCCTCT A GGAGTAGGTCACCTGCCTGTTACTTGAGTTCT CAATCCTCTTGATCTCAACCTTCCCACG CCTACTCC T AGAGGAGG 819 CCTCCTCT A GGAGTAGG 820 Male-sterile AGGATTGAGAAGTCAAGTAACAGGCAGGTGACCTACTCCAAGAGG 821 P1 AGGAATGGGATTATC T AGAAGGCAAAGGAGATGACTGTTCTATGT Malus domestica GATGCTAAAGTATCTCTTATCATTTATTCTA Lys30Term TAGAATAAATGATAAGAGATACTTTAGCATCACATAGAACAGTGAT 822 AAG-TAG CTCCTTTGCCTTCT A GATAATCGCATTCCTCCTCTTGGAGTAGGTC ACCTGCCTGTTACTTGAGTTCTCAATCCT GGATTATC T AGAAGGCA 823 TGCCTTCT A GATAATCC 824 Male-sterile ATTGAGAACTCAAGTAACAGGCAGGTGACCTACTCCAAGAGGAGG 825 P1 AATGGGATTATCAAG T AGGCAAAGGAGATCACTGTTCTATGTGATG Malus domestica CTAAAGTATCTCTTATCATTTATTCTAGCT Lys31Term AGCTAGAATAAATGATAAGAGATACTTTAGCATCACATAGAACAGT 826 AAG-TAG GATCTCCTTTGCCT A CTTGATAATGCCATTCCTCCTCTTGGAGTAG GTCACCTGCCTGTTACTTGAGTTCTCAAT TTATCAAG T AGGCAAAG 827 CTTTGCCT A CTTGATAA 828 Male-sterile CATTTTTACAATAGTTATCTGCAAACAAAAACAAGAGAGAAAAACAA 829 globosa AAACAAAAAAATG T GAAGAGGAAAAATTGAGATCAAAAGAATTGAG Antirrhinum majus AACTCAAGCAACAGGCAGGTTACTTACT Gly2Term AGTAAGTAACCTGCCTGTTGCTTGAGTTCTCAATTCTTTTGATCTCA 830 GGA-TGA ATTTTTCCTCTTC A CATTTTTTTGTTTTTGTTTTTCTCTCTTGTTTTTG TTTGCAGATAACTATTGTAAAAATG AAAAAATG T GAAGAGGA 831 TCCTCTTC A CATTTTTT 832 Male-sterile TTTTACAATAGTTATCTGCAAACAAAAACAAGAGAGAAAAACAAAAA 833 globosa CAAAAAAATGGGA T GAGGAAAAATTGAGATCAAAAGAATTGAGAAC Antirrhinum majus TCAAGCAACAGGCAGGTTACTTACTCAA Arg3Term TTGAGTAAGTAACCTGCCTGTTGCTTGAGTTCTCAATTCTTTTGATC 834 AGA-TGA TCAATTTTTCCTC A TCCCATTTTTTTGTTTTTGTTTTTCTCTCTTGTTT TTGTTTGCAGATAACTATTGTAAAA AAATGGGA T GAGGAAAA 835 TTTTCCTC A TCCCATTT 836 Male-sterile TACAATAGTTATCTGCAAACAAAAACAAGAGAGAAAAACAAAAACA 837 globosa AAAAAATGGGAAGA T GAAAAATTGAGATCAAAAGAATTGAGAACTC Antirthinum majus AAGCAACAGGCAGGTTACTTACTCAAAGA Gly4Term TCTTTGAGTAAGTAACCTGCCTGTTGCTTGAGTTCTCAATTCTTTTG 838 GGA-TGA ATCTCAATTTTTC A TCTTCCCATTTTTTTGTTTTTGTTTTTCTCTCTTG TTTTTGTTTGCAGATAACTATTGTA TGGGAAGA T GAAAAATT 839 AATTTTTC A TCTTCCCA 840 Male-sterile AATAGTTATCTGCAAACAAAAACAAGAGAGAAAAACAAAAACAAAA 841 globosa AAATGGGAAGAGGA T AAATTGAGATCAAAAGAATTGAGAACTCAAG Antirrhinum majus CAACAGGCAGGTTACTTACTCAAAGAGAA Lys5Term TTCTCTTTGAGTAAGTAACCTGCCTGTTGCTTGAGTTCTCAATTGTT 842 AAA-TAA TTGATCTCAATTT A TCCTCTTCCCATTTTTTTGTTTTTGTTTTTCTCT CTTGTTTTTGTTTGCAGATAACTATT GAAGAGGA T AAATTGAG 843 CTCAATTT A TCCTCTTC 844 Male-sterile GCTGAGCTCTTGCTGCCCTTGGATCTGTTTGGGAGTGGAGAACGC 845 P1 AGTATGGGGCGCGGC T AGATCAAGATCAAGAGGATCGAGAACTCT Zea mays ACCAACCGGCAGGTGACCTTCTCCAAGCGCC Lys5Term GGCGCTTGGAGAAGGTCACCTGCCGGTTGGTAGAGTTCTCGATCC 846 AAG-TAG TCTTGATCTTGATCT A GCCGCGCCCCATACTGCGTTCTCCACTCCC AAACAGATCCAAGGGCAGCAAGAGCTCAGC GGCGCGGC T AGATGAAG 847 CTTGATCT A GCCGCGCC 848 Male-sterile CTCTTGCTGCCCTTGGATCTGTTTGGGAGTGGAGAACGCAGTATG 849 P1 GGGCGCGGCAAGATC T AGATCAAGAGGATCGAGAACTCTACCAAC Zea mays CGGCAGGTGACCTTCTCCAAGCGCCGGGCCG Lys7Term CGGCCCGGCGCTTGGAGAAGGTCACCTGCCGGTTGGTAGAGTTC 850 AAG-TAG TCGATCCTCTTGATCT A GATCTTGCCGCGCCCCATACTGCGTTCTC CACTCCCAAACAGATCCAAGGGCAGCAAGAG GCAAGATC T AGATCAAG 851 CTTGATCT A GATCTTGC 852 Male-sterile CTCTTGCTGCCCTTGGATCTGTTTGGGAGTGGAGAACGCAGTATG 853 P1 GGGCGCGGCAAGATC T AGATCAAGAGGATCGAGAACTCTACCAAC Zea mays CGGCAGGTGACCTTCTCCAAGCGCCGGGCCG Lys9Term CGGCCCGGCGCTTGGAGAAGGTCACCTGCCGGTTGGTAGAGTTC 854 AAG-TAG TCGATCCTCTTGATCT A GATCTTGCCGCGCCCCATACTGCGTTCTC CACTCCCAAACAGATCCAAGGGCAGCAAGAG GCAAGATC T AGATCAAG 855 GTTGATCT A GATCTTGC 856 Male-sterile GATCTGTTTGGGAGTGGAGAACGCAGTATGGGGCGCGGCAAGAT 857 P1 CAAGATCAAGAGGATC T AGAACTCTACCAACCGGCAGGTGACCTT Zea mays CTCCAAGCGCCGGGCCGGACTGGTCAAGAAGG Glu12Term CCTTCTTGACGAGTCCGGCCCGGCGCTTGGAGAAGGTCACCTGC 858 GAG-TAG CGGTTGGTAGAGTTCT A GATCCTCTTGATCTTGATCTTGCCGCGCC CCATACTGCGTTCTCCACTCCCAAACAGATC AGAGGATC T AGAACTCT 859 AGAGTTCT A GATGCTCT 860 Male-sterile GCTGAGCTCTTGCTGCCCTTGAATCTGTTAGGGAGTGGAGAACGG 861 P1 AGTATGGGGCGCGGC T AGATCGAGATCAAGAGGATCGAGAACTCT Zea mays ACCAACCGGCAGGTGACCTTCTCCAAGCGCC Lys5Term GGCGCTTGGAGAAGGTCACCTGCCGGTTGGTAGAGTTCTCGATCC 862 AAG-TAG TCTTGATCTCGATCT A GCCGCGCCCCATACTCCGTTCTCCACTCCC TAACAGATTCAAGGGCAGCAAGAGCTCAGC GGCGCGGC T AGATCGAG 863 CTCGATCT A GCCGCGCC 864 Male-sterile CTCTTGCTGCCCTTGAATCTGTTAGGGAGTGGAGAACGGAGTATG 865 P1 GGGCGCGGCAAGATC T AGATCAAGAGGATCGAGAACTCTACCAAC Zea mays CGGCAGGTGACCTTCTCCAAGCGCCGGGCCG Glu7Term CGGCCCGGCGCTTGGAGAAGGTCACCTGCCGGTTGGTAGAGTTC 866 GAG-TAG TCGATCCTCTTGATCT A GATCTTGCCGCGCCCCATACTCCGTTCTC CACTCCCTAACAGATTCAAGGGCAGCAAGAG GCAAGATC T AGATCAAG 867 CTTGATCT A GATCTTGC 868 Male-sterile CTGCCCTTGAATCTGTTAGGGAGTGGAGAACGGAGTATGGGGCG 869 P1 CGGCAAGATCGAGATC T AGAGGATCGAGAACTCTACCAACCGGCA Zea mays GGTGACCTTCTCCAAGCGCCGGGCCGGACTGG Lys9Term CCAGTCCGGCCCGGCGCTTGGAGAAGGTCACCTGCCGGTTGGTA 870 AAG-TAG GAGTTCTCGATCCTCT A GATCTCGATCTTGCCGCGCCCCATACTC CGTTCTCCACTCCCTAACAGATTCAAGGGCAG TCGAGATC T AGAGGATC 871 GATCCTCT A GATCTCGA 872 Male-sterile AATCTGTTAGGGAGTGGAGAACGGAGTATGGGGCGCGGCAAGAT 873 P1 GGAGATGAAGAGGATC T AGAACTCTACCAACCGGCAGGTGACCTT Zea mays CTCCAAGCGCCGGGCCGGACTGGTCAAGAAGG Glu12Term CCTTCTTGACCAGTCCGGCCCGGCGCTTGGAGAAGGTCACCTGC 874 GAG-TAG CGGTTGGTAGAGTTCT A GATCCTCTTGATCTCGATCTTGCCGCGC CCCATACTCCGTTCTCCACTCCCTAACAGATT AGAGGATC T AGAACTCT 875 AGAGTTCT A GATCCTCT 876 Male-sterile TTGCTGCTAAGCTAGCTGGAGGAAGGAGGAGGAGGAGGAGGAGG 877 P1 CGGGATGGGGCGCGGG+E,un TAGATCGAGATCAAGAGGATCGAGAACT Oryza sativa CCACCAACCGCCAGGTGACCTTCTCCAAGCGCA Lys5Term TGCGCTTGGAGAAGGTCACCTGGCGGTTGGTGGAGTTCTCGATCC 878 AAG-TAG TCTTGATGTCGATGT A CCCGCGCCCCATCCCGCCTCCTCCTCCTC CTCCTCCTTCCTCCAGCTAGCTTAGCAGCAA GGCGCGGG T AGATCGAG 879 CTCGATCT A CCCGCGCC 880 Male-sterile CTAAGCTAGCTGGAGGAAGGAGGAGGAGGAGGAGGAGGCGGGA 881 P1 TGGGGCGCGGGAAGATC T AGATCAAGAGGATCGAGAACTCCACC Oryza sativa AACCGCCAGGTGACCTTCTCCAAGCGCAGGAGCG Glu7Term CGCTCCTGCGCTTGGAGAAGGTCACCTGGCGGTTGGTGGAGTTCT 882 GAG-TAG CGATCCTCTTGATCT A GATCTTCCCGCGCCCCATCCCGCCTCCTC CTCCTCCTCCTCCTTCCTCCAGCTAGCTTAG GGAAGATC T AGATCAAG 883 CTTGATCT A GATCTTCC 884 Male-sterile TAGCTGGAGGAAGGAGGAGGAGGAGGAGGAGGCGGGATGGGGC 885 P1 GCGGGAAGATCGAGATC T AGAGGATCGAGAACTCCACCAACCGC Oryza sativa CAGGTGACCTTCTCCAAGCGCAGGAGCGGGATCC Lys9Term GGATCCCGCTCCTGCGCTTGGAGAAGGTCACCTGGCGGTTGGTG 886 AAG-TAG GAGTTCTCGATCCTCT A GATCTCGATCTTCCCGCGCCCCATCCCG CCTCCTCCTCCTCCTCCTCCTTCCTCCAGCTA TCGAGATC T AGAGGATC 887 GATCCTCT A GATCTCGA 888 Male-sterile GAAGGAGGAGGAGGAGGAGGAGGCGGGATGGGGCGCGGGAAG 889 P1 ATCGAGATCAAGAGGATC T AGAACTCCACCAACCGCCAGGTGACC Oryza sativa TTCTCCAAGCGCAGGAGCGGGATCCTCAAGAAGG Glu12Term CCTTCTTGAGGATCCCGCTCCTGCGCTTGGAGAAGGTCACCTGGC 890 GAG-TAG GGTTGGTGGAGTTCT A GATCCTCTTGATCTCGATCTTCCCGCGCC CCATCCCGCCTCCTCCTCCTCCTCCTCCTTC AGAGGATC T AGAACTCC 891 GGAGTTCT A GATCCTCT 892 - Environmental stresses, such as drought, increased soil salinity, soil contamination with heavy meals, and extreme temperature, are major factors limiting plant growth and productivity. The worldwide loss in yield of three major cereal crops, rice, maize, and wheat due to water stress (drought) has been estimated to be over ten billion dollars annually and many currently marginal soils could be brought into cultivation if suitable plant varieties were available.
- Physiological and biochemical responses to high levels of ionic or nonionic solutes and decreased water potential have been studied in a variety of plants. It is known, for example, that increasing levels of alcohol dehydrogenase can confer enhances flooding resistance in plants. There are also several possible mechanisms to enhance plant salt tolerance. For example, one mechanism underlying the adaptation or tolerance of plants to osmotic stresses is the accumulation of compatible, low molecular weight osmolytes such as sugar alcohols, special amino acids, and glycinebetaine. Such accumulation can be engineered, for example, by removing feedback inhibition on 1-pyrroline-t-carboxylate synthetase, which results in accumulation of proline. Additionally, recent experiments suggest that altering the expression or activity of specific sodium or potassium transporters can confer enhanced salt tolerance.
- Plant tolerance of contamination by heavy metals such as lead and aluminum in soils has also been investigated and one mechanism underlying tolerance is the production of dicarboxylic acids such as oxalate and citrate. In addition, individual genes involved in heavy metal sensitivity have been identified.
- The attached tables disclose exemplary oligonucleotide base sequences which can be used to generate site-specific mutations that confer stress tolerance in plants.
TABLE 17 Genome-Altering Oligos Conferring Stress Tolerance Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Salt Tolerance CGTCTTTTTGTGTGGTAGTTGGATGTGACGGTTGCTCAAATGCTT 893 P5CS GTGACCGATAGCAGT GC TAGAGATAAGGATTTCAGGAAGCAACTT Arabidopsis thaliana AGTGAAACTGTCAAAGCGATGCTGAGGATGA Phe128Ala TCATCCTCAGCATCGCTTTGACAGTTTCACTAAGTTGCTTCCTGAA 894 TTT-GCT ATCCTTATGTCTA GC ACTGCTATCGGTCACAAGCATTTGAGCAACC GTCACATCCAACTACCACACAAAAAGACG ATAGCAGT GC TAGAGAT 895 ATCTCTA GC ACTGCTAT 896 Salt Tolerance GAGAGTATGTTTGACCAGCTGGATGTGACGGCTGCTCAGCTGCTG 897 P5CS 1 GTGAATGACAGTAGT GC CAGAGACAAGGAGTTCAGGAAGCAACTT Brassica napus AATGAGACAGTGAAGTCCATGCTTGATTTGA Phe128Ala TCAAATCAAGCATGGACTTCACTGTCTCATTAAGTTGCTTCCTGAA 898 TTC-GCC CTCCTTGTCTCTG GC ACTACTGTCATTCACCAGCAGCTGAGCAGC CGTCACATCCAGCTGGTCAAACATAGTGTC ACAGTAGT GC CAGAGAC 899 GTCTCTG GC ACTACTGT 900 Salt Tolerance GAGACTATGTTTGACCAGATGGATGTGACGGTGGCTCAAATGCTG 901 P505 2 GTGACTGATAGCAGT G TCAGAGATAAGGATTTCAGGAAGCAACTT Brassica napus AGTGAGACAGTCAAAGCTATGCTGAAAATGA Phe129Ala TCATTTTCAGCATAGCTTTGACTGTCTCACTAAGTTGCTTCCTGAA 902 TTC-GCC ATCCTTATCTCTGA C ACTGCTATCAGTCACCAGCATTTGAGCCACC GTCACATCCATCTGGTCAAACATAGTCTC ATAGCAGT G TCAGAGAT 903 ATCTCTGA C ACTGCTAT 904 Salt Tolerance GATATGTTGTTTAACCAACTGGATGTCTCGTCATCTCAACTTCTTG 905 P5GS TCACCGACAGTGAT GC TGAGAACCCAAAGTTCCGGGAGCAACTCA Oryza sativa CTGAAACTGTTGAGTCATTATTAGATCTTA Phe128Ala TAAGATCTAATAATGACTCAACAGTTTCAGTGAGTTGCTCCCGGAA 906 TTT-GCT CTTTGGGTTCTCA GC ATCACTGTCGGTGACAAGAAGTTGAGATGA CGAGACATCCAGTTGGTTAAACAACATATC ACAGTGAT GC TGAGAAC 907 GTTCTCA GC ATCACTGT 908 Salt Tolerance GATATTTTGTTTAGTCAGCTGGATGTGACATCTGCTCAGCTTCTTG 909 P5CS TTACTGACAATGAT GC TAGAGACCAAGATTTTAGAAAGCAACTTTC Medicago sativa TGAAACTGTGAGATCACTTCTAGCACTAA Phe128Ala TTAGTGCTAGAAGTGATCTCACAGTTTCAGAAAGTTGCTTTCTAAA 910 TTT-GCT ATCTTGGTCTCTA GC ATCATTGTCAGTAAGAAGAAGCTGAGCAGAT GTCACATCCAGCTGACTAAACAAAATATC ACAATGAT GC TAGAGAC 911 GTCTCTA GC ATCATTGT 912 Salt Tolerance GATACATTGTTTAGTCAGCTGGATGTGACATCAGCTCAGCTACTC 913 P5CS GTTACTGATAATGAT GC TAGGGATCCAGAATTCAGGAAGCAACTT Actinidia deliciosa ACTGAAACTGTAGAATCACTATTGAATTTGA Phe128Ala TCAAATTCAATAGTGATTCTACAGTTTCAGTAAGTTGCTTCCTGAAT 914 TTT-GCT TCTGGATCCCTA GC ATCATTATCAGTAACGAGTAGCTGAGCTGAT GTCACATCCAGCTGACTAAACAATGTATC ATAATGAT GC TAGGGAT 915 ATCCCTA GC ATCATTAT 916 Salt Tolerance GACACACTCTTCAGTCAACTGGATGTGACATCAGCACAGCTTCTT 917 P5CS GTAACAGATAATGAC GC CAGAAGTCCAGAATTTAGAAAACAACTTA Cichorium intybus CTGAAACAGTCGATTCTTTATTATCTTATA Phe122Ala TATAAGATAATAAAGAATCGACTGTTTCAGTAAGTTGTTTTCTAAAT 918 TTC-GCC TCTGGACTTCTG GC GTCATTATCTGTTACAAGAAGCTGTGCTGAT GTCACATCCAGTTGACTGAAGAGTGTGTC ATAATGAC GC CAGAAGT 919 ACTTCTG GC GTCATTAT 920 Salt Tolerance GATTCTTTGTTCAGTCAGTTGGATGTGACATCAGCTCAGCTTCTGG 921 P5CS TGACTGATAATGAC GC TAGAGATCCAGATTTTAGGAGACAACTCA Lycopersicon ATGACACAGTAAATTCGTTGCTTTCTCTAA esculentum TTAGAGAAAGCAACGAATTTACTGTGTCATTGAGTTGTCTCCTAAA 922 Phe12BAla ATCTGGATCTCTA GC GTCATTATCAGTCACCAGAAGCTGAGCTGA TTT-GCT TGTCACATCCAACTGACTGAACAAAGAATC ATAATGAC GC TAGAGAT 923 ATCTCTA GC GTCATTAT 924 Salt Tolerance GATACCATGTTCAGCCAGCTTGATGTGACTTCTTCCCAACTTCTTG 925 P5CS TGAATGATGGATTT GC TAGGGATGCTGGCTTCAGAAAACAACTTT Vigna unguiculata CGGACACAGTGAACGCGTTATTAGATTTAA Phe162Ala TTAAATCTAATAACGCGTTCACTGTGTCCGAAAGTTGTTTTCTGAA 926 TTT-GCT GCCAGCATCCCTA GC AAATCCATCATTCACAAGAAGTTGGGAAGA AGTCACATCAAGCTGGCTGAACATGGTATC ATGGATTT GC TAGGGAT 927 ATCCCTA GC AAATCCAT 928 Salt Tolerance GACACCTTGTTTAGTCAGTTGGATCTGACTGCTGCTCAGCTGCTT 929 P5CS GTGACGGACAACGAC GC TAGAGATCCAAGTTTTAGAACACAACTA Mesembryanthemum ACTGAAACAGTGTATCAGTTGTTGGATCTAA crystallinum TTAGATCCAACAACTGATACACTGTTTCAGTTAGTTGTGTTCTAAA 930 Phe125Ala ACTTGGATCTCTA GC GTCGTTGTCCGTCACAAGCAGCTGAGCAGC TTT-GCT AGTCAGATCCAACTGACTAAACAAGGTGTC ACAACGAC GC TAGAGAT 931 ATCTCTA GC GTCGTTGT 932 Salt Tolerance GACACATTATTTAGCCAGCTGGATGTGACATCAGCTCAGCTTCTT 933 P5CS GTGACTGATAATGAT GC TAGGGATGAAGCTTTCCGAAATCAACTTA Vitis vinifera CTCAAACAGTGGATTCATTGTTAGCTTTGA Phe130Ala TCAAAGCTAACAATGAATCCACTGTTTGAGTAAGTTGATTTCGGAA 934 TTT-GCT AGCTTCATCCCTA GC ATCATTATCAGTCACAAGAAGCTGAGCTGAT GTCACATCCAGCTGGCTAAATAATGTGTC ATAATGAT GC TAGGGAT 935 ATCCCTA GC ATCATTAT 936 Salt Tolerance GATACGCTGTTCACTCAGCTCGATGTGACATCGGCTCAGCTTCTT 937 P5CS GTGACGGATAACGAT GC TCGAGATAAGGATTTCAGGAAGCAGCTT Vigna aconitifolia ACTGAGACTGTGAAGTCGCTGTTGGGGCTGA Phe129Ala TCAGCGCCAACAGCGACTTCACAGTCTCAGTAAGCTGCTTCCTGA 938 TTT-GCT AATCCTTATCTCGA GC ATCGTTATCCGTCACAAGAAGCTGAGCCG ATGTCACATCGAGCTGAGTGAACAGCGTATC ATAACGAT GC TCGAGAT 939 ATCTCGA GC ATCGTTAT 940 Salt Tolerance AGAGATGTTCTTAGTTCCAAAGAAATCTCACCTCTCAGTTTCTCCG 941 HKT1 TCTTCACAACAGTT GT CACGTTTGCAAACTGCGGATTTGTCCCCAC Arabidopsis thaliana GAATGAGAACATGATCATCTTTCGCAAAA Ser207Val TTTTGCGAAAGATGATCATGTTCTCATTCGTGGGGACAAATCCGC 942 TCC-GTC AGTTTGCAAACGTG AC AACTGTTGTGAAGACGGAGAAAGTGAGAG GTGAGATTTCTTTGGAACTAAGAACATCTCT CAACAGTT GT CACGTTT 943 AAACGTG AC AACTGTTG 944 Salt Tolerance CGAATGAGAACATGATCATCTTTCGCAAAAACTCTGGTCTCATCTG 945 HKT1 GCTCCTAATCCCTC T AGTACTGATGGGAAACACTTTGTTCCCTTGC Arabidopsis thaliana TTCTTGGTTTTGCTCATATGGGGACTTTA Gln237Leu TAAAGTCCCCATATGAGCAAAACCAAGAAGCAAGGGAACAAAGTG 946 CAA-CTA TTTCCCATCAGTACT A GAGGGATTAGGAGCCAGATGAGACCAGAG TTTTTGCGAAAGATGATCATGTTCTCATTCG AATCCCTC T AGTACTGA 947 TCAGTACT A GAGGGATT 948 Salt Tolerance AGTCTCTAGAAGGAATGAGTTCGTACGAGAAGTTGGTTGGATCGT 949 HKT1 TGTTTCAAGTGGTGA G TTCGCGACACACCGGAGAAACTATAGTAG Arabidopsis thaliana ACCTCTCTACACTTTCCCCAGCTATCTTGGT Asn332Ser ACCAAGATAGCTGGGGAAAGTGTAGAGAGGTCTACTATAGTTTCT 950 AAT-AGT CCGGTGTGTCGCGAA C TCACCACTTGAAACAACGATCCAACCAAC TTCTCGTACGAACTCATTCCTTCTAGAGACT AGTGGTGA G TTCGCGAC 951 GTCGCGAA C TCACCACT 952 Salt Tolerance AGAGATGTGCTAAAGAAGAAAGGTCTCAAAATGGTGACCTTTTCC 953 HKT1 GTCTTCACCACCGTG GT GACCTTTGCCAGTTGTGGGTTTGTCCCG Eucalyptus ACCAATGAAAACATGATTATCTTCAGCAAAA camaldulensis TTTTGCTGAAGATAATCATGTTTTCATTGGTCGGGACAAACCCACA 954 Ser256Val ACTGGCAAAGGTC AC CACGGTGGTGAAGACGGAAAAGGTCACCA TCG-GTG TTTTGAGACCTTTCTTCTTTAGCACATCTCT CCACCGTG GT GACCTTT 955 AAAGGTC AC CACGGTGG 956 Salt Tolerance CCAATGAAAACATGATTATCTTCAGCAAAAACTCTGGCCTCCTCCT 957 HKT1 GATTCTCATCCCTC T GGCCCTTCTTGGGAACATGCTGTTCCCATC Eucalyptus GAGCCTACGTTTGACGCTTTGGCTCATCGG camaldulensis CCGATGAGCCAAAGCGTCAAACGTAGGCTCGATGGGAACAGCAT 958 Gln286Leu GTTCCCAAGAAGGGCCA G AGGGATGAGAATCAGGAGGAGGCCA CAG-CTG GAGTTTTTGCTGAAGATAATCATGTTTTCATTGG CATCCCTC T GGCCCTTC 959 GAAGGGCC A GAGGGATG 960 Salt Tolerance AATCGTTGAATGGACTAAGCTCCTGTGAGAAAATCGTGGGCGCGC 961 HKT1 TGTTTCAGTGCGTGA G CAGCAGACATACCGGCGAGACGGTCGTC Eucalyptus GATCTGTCCACAGTTGCTCCCGCCATCTTGGT camaldulensis ACCAAGATGGCGGGAGCAACTGTGGACAGATCGACGACCGTCTC 962 Asn381Ser GCCGGTATGTCTGCTG C TCACGCACTGAAACAGCGCGCCCACGA AAC-AGC TTTTCTCACAGGAGCTTAGTCCATTCAACGATT GTGCGTGA G CAGCAGAC 963 GTCTGCTG+E,un CTCACGCAC 964 Salt Tolerance AAAGCTCCACTGAAGAAGAAAGGGATCAACATTGCACTCTTCTCA 965 HKT1 TTCTCGGTCACGGTC GT CTCGTTTGCGAATGTGGGGCTCGTGCC Oryza sativa GACAAATGAGAACATGGCAATCTTCTCCAAGA Ser238Val TCTTGGAGAAGATTGCCATGTTCTCATTTGTCGGCACGAGCCCCA 966 TCC-GTC CATTCGCAAACGAG AC GACCGTGACCGAGAATGAGAAGAGTGCA ATGTTGATCCCTTTCTTCTTCAGTGGAGCTTT TCACGGTC GT CTCGTTT 967 AAACGAG AC GACCGTGA 968 Salt Tolerance CAAATGAGAACATGGCAATCTTCTCCAAGAACCCGGGCCTCCTCC 969 HKT1 TCCTGTTCATCGGCC T GATTGTTGCAGGCAATACACTTTACCCTCT Oryza sativa CTTCCTAAGGCTATTGATATGGTTCCTGGG Gln268Leu CCCAGGAACCATATCAATAGCCTTAGGAAGAGAGGGTAAAGTGTA 970 CAG-CTG TTGCCTGCAAGAATC A GGCCGATGAACAGGAGGAGGAGGCCCGG GTTCTTGGAGAAGATTGCCATGTTCTCATTTG CATCGGCC T GATTCTTG 971 CAAGAATC A GGCCGATG 972 Salt Tolerance CAGTCTTTGATGGACTCAGCTCTTACCAGAAGATTATCAATGCATT 973 HKT1 GTTCATGGCAGTGA G CGCAAGGCACTCGGGGGAGAACTCCATCG Oryza sativa ACTGCTCACTCATCGCCCCTGCTGTTCTAGT Asn363Ser ACTAGAACAGCAGGGGCGATGAGTGAGCAGTCGATGGAGTTCTC 974 AAC-AGC CCCCGAGTGCCTTGCG C TCACTGCCATGAACAATGCATTGATAAT CTTCTGGTAAGAGCTGAGTCCATCAAAGACTG GGCAGTGA G CGCAAGGC 975 GCCTTGCG C TCACTGCC 976 Salt Tolerance GTGCCCCACTGAACAAGAAAGGGATCAACATCGTGCTCTTCTCAC 977 HKT1 TATCAGTCACCGTTG T CTCCTGTGCGAATGCAGGACTCGTGCCCA Triticum aestivum CAAATGAGAACATGGTCATCTTCTCAAAGAA Ala240Val TTCTTTGAGAAGATGACCATGTTCTCATTTGTGGGCACGAGTCCT 978 GCC-GTC GCATTCGCACAGGAG A CAACGGTGAGTGATAGTGAGAAGAGCAC GATGTTGATCCCTTTCTTGTTCAGTGGGGCAC CACCGTTG T CTCCTGTG 979 CACAGGAG A CAACGGTG 980 Salt Tolerance CAAATGAGAACATGGTCATCTTCTCAAAGAATTCAGGCCTCTTGTT 981 HKT1 GCTGCTGAGTGGCC T GATGCTCGCAGGCAATACATTGTTCCCTCT Triticum aestivum CTTCCTGAGGCTACTGGTGTGGTTCCTGGG Gln270Leu CCCAGGAACCACACCAGTAGCCTCAGGAAGAGAGGGAACAATGT 982 CAG-CTG ATTGCCTGCGAGCATC A GGCCACTCAGCAGCAACAAGAGGCCTG AATTCTTTGAGAAGATGACCATGTTCTCATTTG GAGTGGCC T GATGCTCG 983 CGAGCATC A GGCCACTC 984 Salt Tolerance CAGTCTTTGATGGGCTCAGCTCTTATCAGAAGACTGTCAATGCATT 985 HKT1 CTTCATGGTGGTGA G TGCGAGGCACTCAGGGGAGAATTCCATCG Triticum aestivum ACTGCTCGCTCATGTCCCCTGCCATTATAGT Asn365Ser ACTATAATGGCAGGGGACATGAGCGAGCAGTCGATGGAATTCTCC 986 AAT-AGT CCTGAGTGCCTCGCA C TCACCACCATGAAGAATGCATTGACAGTC TTCTGATAAGAGCTGAGCCCATCAAAGACTG GGTGGTGA G TGCGAGGC 987 GCCTCGCA C TCACCACC 988 Freezing Tolerance TTTTTTTTGTTTTCGTTTTCAAAAAGAAAATCTTTGAATTTTATGGCA 989 praline oxidase ACCGGTCTTCTC T GAACAAACTTTATCCGGCGATCTTACCGTTTAG precursor CCGCTTTTAGCCCGGTGGGTCCTCCCA Arabidopsis thaliana TGGGAGGACCCACCGGGCTAAAAGCGGGTAAACGGTAAGATCGC 990 Arg7Term GGGATAAAGTTTGTTC A GAGAAGACGGGTTGCCATAAAATTCAAA CGA-TGA GATTTTGTTTTTGAAAACGAAAACAAAAAAAA GTCTTCTC T GAACAAAC 991 GTTTGTTC A GAGAAGAC 992 Freezing Tolerance TCAAAAACAAAATCTTTGAATTTTATGGCAACCCGTCTTCTCAGAA 993 proline oxidase CAAACTTTATCCGG T GATCTTACCGTTTACCGGCTTTTAGCCCGGT precursor GGGTCCTCCCACCGTGACTGCTTCCACCG Arabidopsis thaliana CGGTGGAAGCAGTCACGGTGGGAGGACCCAGCGGGCTAAAAGC 994 Arg13Term GGGTAAACGGTAAGATC A CCGGATAAAGTTTGTTCTGAGAAGACG CGA-TGA GGTTGCCATAAAATTCAAAGATTTTGTTTTTGA TTATCCGG T GATCTTAC 995 GTAAGATC A CCGGATAA 996 Freezing Tolerance AAAATCTTTGAATTTTATGGCAACCCGTCTTCTCCGAACAAACTTT 997 praline oxidase ATCCGGCGATCTTA G CGTTTACCCGCTTTTAGCCCGGTGGGTCCT precursor CCCACCGTGACTGCTTCCACCGCCGTCGTC Arabidopsis thaliana GACGACGGCGGTGGAAGCAGTCACGGTGGGAGGACCCACCGGG 998 Tyr15Term CTAAAAGCGGGTAAACG C TAAGATCGCCGGATAAAGTTTGTTCGG TAG-TAG AGAAGAGGGGTTGCCATAAAATTCAAAGATTTT CGATCTTA G CGTTTACC 999 GGTAAACG C TAAGATCG 1000 Freezing Tolerance CTTTGAATTTTATGGCAACCCGTCTTCTCCGAACAAACTTTATCCG 1001 praline oxidase GCGATCTTACCGTT A ACCCGCTTTTAGCCCGGTGGGTCCTCCCAC precursor CGTGACTGCTTCCACCGCCGTCGTCCCGGA Arabidopsis thaliana TCCGGGACGACGGCGGTGGAAGCAGTCACGGTGGGAGGACCCA 1002 Leu17Term CCGGGCTAAAAGCGGGT T AACGGTAAGATCGGCGGATAAAGTTT TTA-TAA GTTCGGAGAAGACGGGTTGCCATAAAATTCAAAG TTACCGTT A ACCCGCTT 1003 AAGCGGGT T AACGGTAA 1004 Freezing Tolerance CCGGTGGGTCCTCCCACCGTGACTGCTTCCAGCGCCGTGGTCCC 1005 proline oxidase GGAGATTCTCTCCTTT T GACAACAAGCACCGGAACCACCTCTTCA precursor CCACCCAAAACCCACCGAGCAATCTCACGATG Arabidopsis thaliana CATCGTGAGATTGCTCGGTGGGTTTTGGGTGGTGAAGAGGTGGT 1006 Gly42Term TCCGGTGCTTGTTGTC A AAAGGAGAGAATCTCCGGGACGACGGC GGA-TGA GGTGGAAGCAGTCACGGTGGGAGGACCCACCGG TCTCCTTT T GACAACAA 1007 TTGTTGTC A AAAGGAGA 1008 Lead Tolerance ACATGAAGCAGTGAAATCTCTGTTTGTATTGAATCTTATTAGTCTCT 1009 cyclic nucleotide- AAACTATGAATTTC T GACAAGAGAAGTTTGTAAGGTCAGTGTTCCA regulated ion channel GATTTGTCTCATTGAATTCTAAGTCGTGA Arabidopsis thaliana TCACGACTTAGAATTCAATGAGACAAATCTGGAACACTGACCTTAC 1010 Arg4Term AAACTTCTCTTGTC A GAAATTCATAGTTTGAGACTAATAAGATTCAA CGA-TGA TACAAACAGAGATTTCACTGCTTCATGT TGAATTTC T GACAAGAG 1011 CTCTTGTC A GAAATTCA 1012 Lead Tolerance TGAAGCAGTGAAATCTCTGTTTGTATTGAATCTTATTAGTCTCAAA 1013 cyclic nucleotide- CTATGAATTTCCGA T AAGAGAAGTTTGTAAGGTCAGTGTTCCAGAT regulated ion channel TTGTCTCATTGAATTCTAAGTCGTGAAGC Arabidopsis thaliana GCTTCACGACTTAGAATTCAATGAGACAAATCTGGAACACTGACCT 1014 Gln5Term TACAAACTTCTCTT A TCGGAAATTCATAGTTTGAGACTAATAAGATT CAA-TAA CAATACAAACAGAGATTTCACTGCTTCA ATTTCCGA T AAGAGAAG 1015 CTTCTCTT A TCGGAAAT 1016 Lead Tolerance AGCAGTGAAATCTCTGTTTGTATTGAATCTTATTAGTCTCAAACTAT 1017 cyclic nucleotide- GAATTTCCGACAA T AGAAGTTTGTAAGGTCAGTGTTCCAGATTTGT regulated ion channel CTCATTGAATTCTAAGTCGTGAAGCTTA Arabidopsis thaliana TAAGCTTCACGACTTAGAATTCAATGAGACAAATCTGGAACACTGA 1018 Glu6Term CCTTACAAACTTCT A TTGTCGGAAATTCATAGTTTGAGACTAATAA GAG-TAG GATTCAATACAAACAGAGATTTCACTGCT TCCGACAA T AGAAGTTT 1019 AAACTTCT A TTGTCGGA 1020 Lead Tolerance AGTGAAATCTCTGTTTGTATTGAATCTTATTAGTCTCAAACTATGAA 1021 cyclic nucleotide- TTTCCGACAAGAG T AGTTTGTAAGGTCAGTGTTCCAGATTTGTCTC regulated ion channel ATTGAATTCTAAGTCGTGAAGCTTAATT Arabidopsis thaliana AATTAAGCTTCACGACTTAGAATTCAATGAGACAAATCTGGAACAC 1022 Lys7Term TGACCTTACAAACT A CTCTTGTCGGAAATTCATAGTTTGAGACTAA AAG-TAG TAAGATTCAATACAAACAGAGATTTCACT GACAAGAG T AGTTTGTA 1023 TACAAACT A CTCTTGTC 1024 Lead Tolerance CATTGAATTCTAAGTCGTGAAGCTTAATTCGATTCTTCTTCACTTTC 1025 cyclic nucleotide- TCGGATCAGGTTT T AAGATTGGAAGTCGGATAAGACTTCCTCCGA regulated ion channel CGTGGAATATTCCGGTAAAAACGAGATTC Arabidopsis thaliana GAATCTCGTTTTTACCGGAATATTCCACGTCGGAGGAAGTCTTATC 1026 Gln12Term CGACTTCCAATCTT A AAACCTGATCCGAGAAAGTGAAGAAGAATC CAA-TAA GAATTAAGCTTCACGACTTAGAATTCAATG TCAGGTTT T AAGATTGG 1027 CCAATCTT A AAACCTGA 1028 Lead Tolerance TGGAAGTCAATCCCCCACGTTGAGCAGGTTGATGCATTGGGTAAA 1029 cyclic nucleotide- GTTATGAATCACCGC T AAGACGAGTTTGTGAGGTTTCAGGATTGG gated calmodulin- AAATCAGAGAGAAGCTCTGAGGGAAATTTTC binding ion channel GAAAATTTCCCTCAGAGCTTCTCTCTGATTTCCAATCCTGAAACCT 1030 (CBP4) CACAAACTCGTCTT A GCGGTGATTCATAACTTTAGCCAATGCATCA Nicotiana Tabacum ACCTGCTCAACGTGGGGGATTGACTTCCA Gln5Term ATCACCGC T AAGACGAG 1031 CAA-TAA CTCGTCTT A GCGGTGAT 1032 Lead Tolerance TCAATCCCCCACGTTGAGCAGGTTGATGCATTGGCTAAAGTTATG 1033 cyclic nucleotide- AATCACCGCCAAGAC T AGTTTGTGAGGTTTCAGGATTGGAAATCA gated calmodulin- GAGAGAAGCTCTGAGGGAAATTTTCATGCTA binding ion channel TAGCATGAAAATTTCCCTCAGAGCTTCTCTCTGATTTCCAATCCTG 1034 (CBP4) AAACCTCACAAACT A GTCTTGGCGGTGATTCATAACTTTAGCCAAT Nicotiana Tabacum GCATCAACCTGCTCAACGTGGGGGATTGA Gly7Term GCCAAGAC T AGTTTGTG 1035 GAG-TAG CACAAACT A GTCTTGGC 1036 Lead Tolerance GAGCAGGTTGATGCATTGGCTAAAGTTATGAATCACCGCCAAGAC 1037 cyclic nucleotide- GAGTTTGTGAGGTTT T AGGATTGGAAATCAGAGAGAAGCTCTGAG gated calmodulin- GGAAATTTTCATGCTAAAGGTGGAGTCCACC binding ion channel GGTGGACTCCACCTTTAGCATGAAAATTTCCCTCAGAGCTTCTCTC 1038 (CBP4) TGATTTCCAATCCT A AAACCTCACAAACTCGTCTTGGCGGTGATTC Nicotiana Tabacum ATAACTTTAGCCAATGCATCAACCTGCTC Gln12Term TGAGGTTT T AGGATTGG 1039 CAG-TAG CCAATCCT A AAACCTCA 1040 Lead Tolerance TGATGCATTGGCTAAAGTTATGAATCACCGCCAAGACGAGTTTGT 1041 cyclic nucleotide- GAGGTTTCAGGATTG T AAATCAGAGAGAAGCTCTGAGGGAAATTT gated calmodulin- TCATGCTAAAGGTGGAGTCCACCGAAGTAAA binding ion channel TTTACTTCGGTGGACTCCACCTTTAGCATGAAAATTTCCCTCAGAG 1042 (CBP4) CTTCTCTCTGATTT A CAATCCTGAAACCTCACAAACTCGTCTTGGC Nicotiana Tabacum GGTGATTCATAACTTTAGCCAATGCATCA Trp14Term CAGGATTG T AAATCAGA 1043 TGG-TGA TCTGATTT A CAATCCTG 1044 Lead Tolerance GATGCATTGGCTAAAGTTATGAATCACCGCCAAGACGAGTTTGTG 1045 cyclic nucleotide- AGGTTTCAGGATTGG T AATCAGAGAGAAGCTGTGAGGGAAATTTT gated calmoduin- CATGCTAAAGGTGGAGTCCACCGAAGTAAAG binding ion channel CTTTACTTCGGTGGACTCCACCTTTAGCATGAAAATTTCCCTCAGA 1046 (CBP4) GCTTCTCTCTGATT A CCAATCCTGAAACCTCACAAACTCGTCTTGG Nicotiana Tabacum CGGTGATTCATAACTTTAGCCAATGCATC Lys15Term AGGATTGG T AATCAGAG 1047 AAA-TAA CTCTGATT A CCAATCCT 1048 Lead Tolerance CTTGAAGAATTGATCTACCACTCTTAGCTGCTAACTGTTCGCCTGG 1049 calmoduin binding TGGAGATAATGATG T AAAGAGAGGACAGATATGTTAGATTTCAGG transport protein ACTGCAAATCAGAGCAATCTGTTATCTCAG Hordeum vulgare CTGAGATAACAGATTGCTCTGATTTGCAGTCCTGAAATGTAACATA 1050 Glu2Term TCTGTCCTCTCTTT A CATCATTATCTCCACCAGGCGAACAGTTAGC GAA-TAA AGCTAAGAGTGGTAGATCAATTCTTCAAG TAATGATG T AAAGAGAG 1051 CTCTCTTT A CATCATTA 1052 Lead Tolerance GAAGAATTGATCTACCACTCTTAGCTGCTAACTGTTCGCCTGGTG 1053 calmodulin binding GAGATAATGATGGAA T GAGAGGACAGATATGTTAGATTTCAGGAC transport protein TGCAAATCAGAGCAATCTGTTATCTCAGAGA Hordeum vulgare TCTCTGAGATAACAGATTGCTCTGATTTGCAGTCCTGAAATCTAAC 1054 Arg3Term ATATCTGTCCTCTC A TTCCATCATTATCTCCACCAGGCGAACAGTT AGA-TGA AGCAGCTAAGAGTGGTAGATCAATTCTTC TGATGGAA T GAGAGGAC 1055 GTCCTCTC A TTCCATCA 1056 Lead Tolerance GAATTGATCTACCACTCTTAGCTGCTAACTGTTCGCCTGGTGGAG 1057 calmodulin binding ATAATGATGGAAAGA T AGGACAGATATGTTAGATTTCAGGACTGC transport protein AAATCAGAGCAATCTGTTATCTCAGAGAACG Hordeum vulgare CGTTCTCTGAGATAACAGATTGCTCTGATTTGCAGTCCTGAAATCT 1058 Glu4Term AACATATCTGTCCT A TCTTTCCATCATTATCTCCACCAGGCGAACA GAG-TAG GTTAGCAGCTAAGAGTGGTAGATCAATTC TGGAAAGA T AGGACAGA 1059 TCTGTCCT A TCTTTCCA 1060 Lead Tolerance ATCTACCACTCTTAGCTGCTAACTGTTCGCCTGGTGGAGATAATG 1061 calmodulin binding ATGGAAAGAGAGGAC T GATATGTTAGATTTCAGGACTGCAAATCA transport protein GAGCAATCTGTTATCTCAGAGAACGCAGTTT Hordeum vulgare AAACTGCGTTCTCTGAGATAACAGATTGCTCTGATTTGCAGTCCTG 1062 Arg6Term AAATCTAACATATC A GTCCTCTCTTTCCATCATTATCTCCACCAGG AGA-TGA CGAACAGTTAGCAGCTAAGAGTGGTAGAT GAGAGGAC T GATATGTT 1063 AACATATC A GTCCTCTC 1064 Lead Tolerance CCACTCTTAGCTGCTAACTGTTCGCCTGGTGGAGATAATGATGGA 1065 calmodulin binding AAGAGAGGACAGATA G GTTAGATTTCAGGAGTGCAAATCAGAGCA transport protein ATCTGTTATCTCAGAGAACGCAGTTTCACCA Hordeum vulgare TGGTGAAACTGCGTTCTCTGAGATAACAGATTGCTCTGATTTGCA 1066 Tyr7Term GTCCTGAAATCTAAC C TATCTGTCCTCTCTTTCCATCATTATCTCCA TAT-TAG CCAGGCGAACAGTTAGCAGCTAAGAGTGG GACAGATA G GTTAGATT 1067 AATCTAAC C TATCTGTC 1068 2,4-DB resistance ATCCTTCTCTGAGAAAAAACAACAGATCCGAATTTTATCTTTAATCA 1069 3-ketoacyl-CoA GCCGGAAAAAATG T AGAAAGCGATCGAGAGACAACGCGTTCTTCT thiolase TGAGCATCTCCGACCTTCTTCTTCTTCTT Arabidopsis thaliana AAGAAGAAGAAGAAGGTCGGAGATGCTCAAGAAGAACGCGTTGT 1070 Glu2Term CTCTCGATCGCTTTCT A CATTTTTTCCGGCTGATTAAAGATAAAATT GAG-TAG CGGATCTGTTGTTTTTTCTCAGAGAAGGAT AAAAAATG T AGAAAGCG 1071 CGCTTTCT A CATTTTTT 1072 2,4-DB resistance CTTCTCTGAGAAAAAACAACAGATCCGAATTTTATCTTTAATCAGC 1073 3-ketoacyl-CoA CGGAAAAAATGGAG T AAGCGATCGAGAGACAACGCGTTCTTCTTG thiolase AGCATCTCCGACCTTCTTCTTCTTCTTCGC Arabidopsis thaliana GCGAAGAAGAAGAAGAAGGTCGGAGATGCTCAAGAAGAACGCGT 1074 Lys3Term TGTCTCTCGATCGCTT A CTCCATTTTTTCCGGCTGATTAAAGATAA AAA-TAA AATTCGGATCTGTTGTTTTTTCTCAGAGAAG AAATGGAG T AAGCGATC 1075 GATCGCTT A CTCCATTT 1076 2,4-DB resistance GAAAAAACAACAGATCCGAATTTTATCTTTAATCAGCCGGAAAAAA 1077 3-ketoacyl-CoA TGGAGAAAGCGATC T AGAGACAACGCGTTCTTCTTGAGCATCTCC thiolase GACCTTCTTCTTCTTCTTCGCACAATTACG Arabidopsis thaliana CGTAATTGTGCGAAGAAGAAGAAGAAGGTCGGAGATGCTCAAGA 1078 Glu6Term AGAACGCGTTGTCTCT A GATCGCTTTCTCCATTTTTTCCGGCTGAT GAG-TAG TAAAGATAAAATTCGGATCTGTTGTTTTTTC AAGCGATC T AGAGACAA 1079 TTGTCTCT A GATCGCTT 1080 2,4-DB resistance AAAACAACAGATCCGAATTTTATCTTTAATCAGCCGGAAAAAATGG 1081 3-ketoacyl-CoA AGAAAGCGATCGAG T GACAACGCGTTCTTCTTGAGCATCTCCGAC thiolase CTTCTTCTTCTTCTTCGCACAATTACGAGG Arabidopsis thaliana CCTCGTAATTGTGGGAAGAAGAAGAAGAAGGTCGGAGATGCTCAA 1082 Arg7Term GAAGAACGCGTTGTC A CTCGATCGCTTTCTCCATTTTTTCCGGCT AGA-TGA GATTAAAGATAAAATTCGGATCTGTTGTTTT CGATCGAG T GACAACGC 1083 GCGTTGTC A CTCGATCG 1084 2,4-DB resistance ACAACAGATCCGAATTTTATCTTTAATCAGCCGGAAAAAATGGAGA 1085 3-ketoacyl-CoA AAGCGATCGAGAGA T AACGCGTTCTTCTTGAGCATCTCCGACCTT thiolase CTTCTTCTTCTTCGCACAATTACGAGGCTT Arabidopsis thaliana AAGCCTCGTAATTGTGCGAAGAAGAAGAAGAAGGTCGGAGATGC 1086 Gln8Term TCAAGAAGAACGCGTT A TCTCTCGATCGCTTTCTCCATTTTTTCCG CAA-TAA GCTGATTAAAGATAAAATTCGGATCTGTTGT TCGAGAGA T AACGCGTT 1087 AACGCGTT A TCTCTCGA 1088 2,4-DB resistance GAGAGACAAAGAGTTCTTCTTGAACATCTCCGTCCTTCTTCTTCTT 1089 glyoxysomal beta- CCTCTCACAGCTTT T AAGGCTCTCTCTCTGCTTCAGCTTGCTTGGC ketoacyol-thiolase TGGGGACAGTGCTGCGTATCAGAGGACCT precursor AGGTCGTCTGATACGCAGCACTGTCCCCAGCCAAGCAAGCTGAA 1090 Brassica napus GCAGAGAGAGAGCCTT A AAAGCTGTGAGAGGAAGAAGAAGAAGG Glu26Term ACGGAGATGTTCAAGAAGAACTCTTTGTCTCTC GAA-TAA ACAGCTTT T AAGGCTCT 1091 AGAGCCTT A AAAGCTGT 1092 2,4-DB resistance TTGAACATCTCCGTCCTTCTTCTTCTTCCTCTCACAGCTTTGAAGG 1093 glyoxysomal beta- CTCTCTCTCTGCTT G AGCTTGCTTGGCTGGGGACAGTGCTGCGTA ketoacyol-thiolase TCAGAGGACCTCTCTCTATGGAGATGATGT precursor ACATCATCTCCATAGAGAGAGGTCCTCTGATACGCAGCACTGTCC 1094 Brassica napus CCAGCCAAGCAAGCT C AAGCAGAGAGAGAGCCTTCAAAGCTGTG Ser32Term AGAGGAAGAAGAAGAAGGACGGAGATGTTCAA TCA-TGA CTCTGCTT G AGCTTGCT 1095 AGCAAGCT C AAGCAGAG 1096 2,4-DB resistance TCTCCGTCCTTCTTCTTCTTCCTCTCACAGCTTTGAAGGCTCTCTC 1097 glyoxysomal beta- TCTGCTTCAGCTTG A TTGGCTGGGGACAGTGCTGCGTATCAGAG ketoacyol-thiolase GACCTCTCTCTATGGAGATGATGTAGTCATT precursor AATGACTACATCATCTCCATAGAGAGAGGTCCTCTGATACGCAGC 1098 Brassica napus ACTGTCCCCAGCCAA T CAAGCTGAAGCAGAGAGAGAGCCTTCAAA Cys34Term GCTGTGAGAGGAAGAAGAAGAAGGACGGAGA TGC-TGA TCAGCTTG A TTGGCTGG 1099 CCAGCCAA T CAAGCTGA 1100 2,4-DB resistance TCCGTCCTTCTTCTTGTTCCTCTCACAGCTTTGAAGGCTCTCTCTC 1101 glyoxysomal beta- TGCTTCAGCTTGCT A GGCTGGGGACAGTGCTGCGTATCAGAGGA ketoacyol-thiolase CCTCTCTCTATGGAGATGATGTAGTCATTGT precursor ACAATGACTACATCATCTCCATAGAGAGAGGTCGTCTGATACGCA 1102 Brassica napus GCACTGTCCCCAGCC T AGCAAGCTGAAGCAGAGAGAGAGCCTTC Leu35Term AAAGCTGTGAGAGGAAGAAGAAGAAGGACGGA TTG-TAG AGCTTGCT A GGCTGGGG 1103 CCCCAGCC T AGCAAGCT 1104 2,4-DB resistance TCACAGCTTTGAAGGCTCTCTCTCTGCTTCAGCTTGCTTGGCTGG 1105 glyoxysomal beta- GGACAGTGCTGCGTA G CAGAGGACCTCTCTCTATGGAGATGATGT ketoacyol-thiolase AGTCATTGTTGCGGCACATAGGACTGCACTA precursor TAGTGCAGTCCTATGTGCCGCAACAATGACTACATCATCTCCATA 1106 Brassica napus GAGAGAGGTCGTCTG C TACGCAGCACTGTCCCCAGCCAAGCAAG Tyr42Term CTGAAGCAGAGAGAGAGCCTTCAAAGCTGTGA TAT-TAG GCTGCGTA G CAGAGGAC 1107 GTCCTCTG C TACGCAGC 1108 2,4-DB resistance CAACAGACAGGAAGTGTTGCTCCAGCATCTCCGCCCTTCTAATTC 1109 3-ketoacyl-CoA TTCTTCTCACAATTA Gee GAGTCCGCTCTTGCCGCATCAGTATGTGCT thiolase B GCAGGGGATAGCGCCGCATATCATAGGGCT Mangifera indica AGCCCTATGATATGCGGCGCTATCCCCTGCAGCACATACTGATGC 1110 Tyr25Term GGCAAGAGCGGACTC C TAATTGTGAGAAGAAGAATTAGAAGGGC TAC-TAG GGAGATGCTGGAGCAACACTTGCTGTCTGTTG CACAATTA G GAGTCCGC 1111 GCGGACTC C TAATTGTG 1112 2,4-DB resistance AACAGACAGCAAGTGTTGCTCCAGCATCTCCGCCCTTCTAATTCTT 1113 3-ketoacyol-CoA CTTCTCACAATTAC T AGTCCGCTCTTGCCGCATCAGTATGTGCTGC thiolase B AGGGGATAGCGCCGCATATCATAGGGCTT Magnifera indica AAGCCCTATGATATGCGGCGCTATCCCCTGCAGCACATACTGATG 1114 Glu26Term CGGCAAGAGCGGACT A GTAATTGTGAGAAGAAGAATTAGAAGGG GAG-TAG CGGAGATGCTGGAGCAACACTTGCTGTCTGTT ACAATTAC T AGTCCGCT 1115 AGCGGACT A GTAATTGT 1116 2,4-DB resistance TCCAGCATCTCCGCCCTTCTAATTCTTCTTCTCACAATTACGAGTC 1117 3-ketoacy\to-CoA CGCTCTTGCCGCAT G AGTATGTGCTGCAGGGGATAGCGCCGCAT thioblase B ATCATAGGGCTTCTGTTTATGGAGACGATGT Mangifera indica ACATCGTCTCCATAAACAGAAGCCCTATGATATGCGGCGCTATCC 1118 Ser32Term CCTGCAGCACATACT C ATGCGGCAAGAGCGGACTCGTAATTGTGA TCA-TGA GAAGAAGAATTAGAAGGGCGGAGATGCTGGA TGCCGCAT G AGTATGTG 1119 CACATACT C ATGCGGCA 1120 2,4-DB resistance TCTCCGCCCTTCTAATTCTTCTTCTCACAATTACGAGTCCGCTCTT 1121 3-ketoacyl-CoA GCCGCATCAGTATG A GCTGCAGGGGATAGCGCCGGATATCATAG thiolase B GGCTTCTGTTTATGGAGACGATGTGGTGATT Mangifera indica AATCACCACATCGTCTCCATAAACAGAAGCCCTATGATATGCGGC 1122 Cys34Term GCTATCCCCTGCAGC T CATACTGATGCGGCAAGAGCGGACTCGT TGT-TGA AATTGTGAGAAGAAGAATTAGAAGGGCGGAGA TCAGTATG A GCTGCAGG 1123 CCTGCAGC T CATACTGA 1124 2,4-DB resistance TCACAATTACGAGTCCGCTCTTGCCGCATCAGTATGTGCTGCAGG 1125 3-ketoacyl-CoA GGATAGCGCCGCATA G CATAGGGCTTGTGTTTATGGAGACGATGT thiolase B GGTGATTGTGGCAGGTCATCGTACTGCACTT Mangifera indica AAGTGCAGTAGGATGAGCTGCCACAATCACCACATCGTCTCCATA 1126 Tyr42Term AACAGAAGCCCTATG C TATGCGGCGCTATCCCCTGCAGCACATAC TAT-TAG TGATGCGGCAAGAGCGGACTCGTAATTGTGA GCCGCATA G CATAGGGC 1127 GCCCTATG C TATGCGGC 1128 2,4-DB resistance GAAGGCGATCAACAGGCAGAGCATTTTGCTACATCATCTCCGGCC 1129 3-ketoacyl-CoA TTCTTCTTCCGCTTA G ACAAATGAATCTTCGCTCTCTGCATCGGTT thiolase TGTGCAGCTGGGGATAGTGCTTCGTATCAA Cucumis sativus TTGATACGAAGCACTATCCCCAGCTGCACAAACCGATGCAGAGAG 1130 Tyr22Term CGAAGATTCATTTGT C TAAGCGGAAGAAGAAGGCCGGAGATGATG TAG-TAG TAGCAAAATGCTCTGGCTGTTGATCGCCTTC TCCGCTTA G ACAAATGA 1131 TCATTTGT C TAAGCGGA 1132 2,4-DB resistance ATCAACAGGCAGAGCATTTTGCTACATCATCTCCGGCCTTCTTCTT 1133 3-ketoacyl-CoA CCGCTTACACAAAT T AATCTTCGCTCTCTGCATCGGTTTGTGCAGC thiolase TGGGGATAGTGCTTCGTATCAAAGGACAT Cucumis sativus ATGTCCTTTGATACGAAGCAGTATCCCCAGCTGCACAAACCGATG 1134 Glu25Term CAGAGAGCGAAGATT A ATTTGTGTAAGCGGAAGAAGAAGGCCGG GAA-TAA AGATGATGTAGCAAAATGCTCTGCCTGTTGAT ACACAAAT T AATCTTCG 1135 CGAAGATT A ATTTGTGT 1136 2,4-DB resistance GGCAGAGCATTTTGCTACATCATCTCCGGCCTTCTTCTTCCGCTTA 1137 3-ketoacyl-CoA CACAAATGAATCTT A GCTCTCTGCATCGGTTTGTGCAGCTGGGGA thiolase TAGTGCTTCGTATCAAAGGACATCGGTGTT Cucumis sativus AACACCGATGTCCTTTGATACGAAGCACTATCCCCAGCTGCACAA 1138 Ser27Term ACCGATGCAGAGAGC T AAGATTCATTTGTGTAAGCGGAAGAAGAA TCG-TAG GGCCGGAGATGATGTAGCAAAATGCTCTGCC TGAATCTT A GCTCTCTG 1139 CAGAGAGC T AAGATTCA 1140 2,4-DB resistance TGCTACATCATCTCCGGCCTTCTTCTTCCGCTTACACAAATGAATC 1141 3-ketoacyl-CoA TTCGCTCTCTGCAT A GGTTTGTGCAGCTGGGGATAGTGCTTCGTA thiolase TCAAAGGACATCGGTGTTTGGAGATGATGT Cucumis sativus ACATCATCTCCAAACACCGATGTCCTTTGATACGAAGCACTATCCC 1142 Ser31Term CAGCTGCACAAACC T ATGCAGAGAGCGAAGATTCATTTGTGTAAG TCG-TAG CGGAAGAAGAAGGCCGGAGATGATGTAGCA CTCTGCAT A GGTTTGTG 1143 CACAAACC T ATGCAGAG 1144 2,4-DB resistance TCATCTCCGGCCTTCTTCTTCCGCTTACACAAATGAATCTTCGCTC 1145 3-ketoacyl-CoA TCTGCATCGGTTTG A GCAGCTGGGGATAGTGCTTCGTATCAAAGG thiolase ACATCGGTGTTTGGAGATGATGTCGTGATT Cucumis sativus AATCACGACATCATCTCCAAACACCGATGTCCTTTGATACGAAGCA 1146 Cys33Term CTATCCCCAGCTGC T CAAACCGATGCAGAGAGCGAAGATTCATTT TGT-TGA GTGTAAGCGGAAGAAGAAGGCCGGAGATGA TCGGTTTG A GCAGCTGG 1147 CCAGCTGC T CAAACCGA 1148 2A-DB resistance GAAGGCAATCAACAGGCAGAGCATTCTGCTACATCATCTCCGGCC 1149 3-ketoacyl-CoA TTCATCTTCGGCTTA G ACCCATGAATCTTCGCTCTCTGCATCGGTT thiolase TGTGCAGCTGGGGATAGTGCGTCGTATCAA Cucurbita sp. TTGATACGACGCACTATCCCCAGCTGCACAAACCGATGCAGAGAG 1150 Tyr22Term CGAAGATTCATGGCT C TAAGCCGAAGATGAAGGCCGGAGATGAT TAT-TAG GTAGCAGAATGCTCTGCCTGTTGATTGCCTTC TCGGCTTA G AGCCATGA 1151 TCATGGCT C TAAGCCGA 1152 2,4-DB resistance ATCAACAGGCAGAGCATTCTGCTACATCATCTCCGGCCTTCATCTT 1153 3-ketoacyl-CoA CGGCTTATAGCCAT T AATCTTCGCTCTCTGCATCGGTTTGTGCAGC thiolase TGGGGATAGTGCGTCGTATCAAAGAACGT Cucurbita sp. ACGTTCTTTGATACGACGCACTATCCCCAGCTGCACAAACCGATG 1154 Glu25Term CAGAGAGCGAAGATT A ATGGCTATAAGCCGAAGATGAAGGCCGG GAA-TAA AGATGATGTAGCAGAATGCTCTGCCTGTTGAT ATAGCCAT T AATCTTCG 1155 CGAAGATT A ATGGCTAT 1156 2,4-DB resistance GGCAGAGCATTCTGCTACATCATCTCCGGCCTTCATCTTCGGCTT 1157 3-ketoacyl-CoA ATAGCCATGAATCTT A GCTCTCTGCATCGGTTTGTGCAGCTGGGG thiolase ATAGTGCGTCGTATCAAAGAACGTCGGTGTT Cucurbita sp. AACACCGACGTTCTTTGATACGACGCACTATCCCCAGCTGCACAA 1158 Ser27Term ACCGATGCAGAGAGCTAAGATTCATGGCTATAAGCCGAAGATGAA TCG-TAG GGCCGGAGATGATGTAGCAGAATGCTCTGCC TGAATCTT A GCTCTCTG 1159 CAGAGAGC T AAGATTCA 1160 2,4-DB resistance TGCTACATCATCTCCGGCCTTCATCTTCGGCTTATAGCCATGAATC 1161 3-ketoacyl-CoA TTCGCTCTCTGCAT A GGTTTGTGCAGCTGGGGATAGTGCGTCGTA thiolase TCAAAGAACGTCGGTGTTTGGAGATGATGT Cucurbita sp. ACATCATCTCCAAACACCGACGTTCTTTGATACGACGCACTATCCC 1162 Ser31Term CAGCTGCACAAACC T ATGCAGAGAGCGAAGATTCATGGCTATAAG TCG-TAG CCGAAGATGAAGGCCGGAGATGATGTAGCA CTCTGCAT A GGTTTGTG 1163 CACAAACC T ATGCAGAG 1164 2,4-DB resistance TCATCTCCGGCCTTCATCTTCGGCTTATAGCCATGAATCTTCGCTC 1165 3-ketoacyl-CoA TCTGCATCGGTTTG A GCAGCTGGGGATAGTGCGTCGTATCAAAGA thiolase ACGTCGGTGTTTGGAGATGATGTCGTGATA Cucurbita sp. TATCACGACATCATCTCCAAACACCGACGTTCTTTGATACGACGCA 1166 Cys33Term CTATCCCCAGCTGC T CAAACCGATGCAGAGAGCGAAGATTCATGG TGT-TGA CTATAAGCCGAAGATGAAGGCCGGAGATGA TCGGTTTG A GCAGCTGG 1167 CCAGCTGC T CAAACCGA 1168 2,4 DB resistance TCATAGTCTCTTTTGCCGCTTGGATTCTTCCAAGGTTAGTGAGCTG 1169 Pex14 CTATGGCAACTCAT T AGCAAACGCAACCTCCTTCCGATTTTCCCGC Arabidopsis thaliana TCTTGCCGATGAAAATTCCCAGATTCCAG Gln5Term CTGGAATCTGGGAATTTTCATCGGCAAGAGCGGGAAAATCGGAA 1170 CAG-TAG GGAGGTTGCGTTTGCT A ATGAGTTGCCATAGCAGCTCACTAACCT TGGAAGAATCCAAGCGGCAAAAGAGACTATGA CAACTCAT T AGCAAACG 1171 CGTTTGCT A ATGAGTTG 1172 2,4 DB resistance TAGTCTCTTTTGCCGCTTGGATTCTTCCAAGGTTAGTGAGCTGCTA 1173 Pex14 TGGCAACTCATCAG T AAACGCAACCTCCTTCCGATTTTCCCGCTCT Arabidopsis thaliana TGCCGATGAAAATTCCCAGATTGCAGGTT Gln6Term AACCTGGAATCTGGGAATTTTCATCGGCAAGAGCGGGAAAATCGG 1174 CAA-TAA AAGGAGGTTGCGTTT A CTGATGAGTTGCCATAGCAGCTCACTAAC CTTGGAAGAATCCAAGCGGCAAAAGAGACTA CTCATCAG T AAACGCAA 1175 TTGCGTTT A CTGATGAG 1176 2,4 DB resistance CTTTTGCCGCTTGGATTCTTCCAAGGTTAGTGAGCTGCTATGGCA 1177 Pex14 ACTCATCAGCAAACG T AACCTCCTTCCGATTTTCCCGCTCTTGCCG Arabidopsis thaliana ATGAAAATTCCGAGATTCCAGGTTCAATTT Gln8Term AAATTGAACCTGGAATCTGGGAATTTTCATCGGCAAGAGCGGGAA 1178 CAA-TAA AATCGGAAGGAGGTT A CGTTTGCTGATGAGTTGCCATAGCAGCTC ACTAACCTTGGAAGAATCCAAGCGGCAAAAG AGCAAACG T AACCTCCT 1179 AGGAGGTT A CGTTTGCT 1180 2,4 DB resistance GCTGCTATGGCAACTGATGAGCAAACGCAACCTCCTTCCGATTTT 1181 Pex14 CCCGCTCTTGCCGAT T AAAATTCCCAGATTCCAGGTTCAATTTACA Arabidopsis thaliana CCTTCTAATCATTATTTCTTAATTTTTCTT Glu19Term AAGAAAAATTAAGAAATAATGATTAGAAGGTGTAAATTGAACCTGG 1182 GAA-TAA AATCTGGGAATTTT A ATCGGCAAGAGCGGGAAAATCGGAAGGAG GTTGCGTTTGCTGATGAGTTGCCATAGCAGC TTGCCGAT T AAAATTCC 1183 GGAATTTT A ATCGGCAA 1184 2,4 DB resistance GCAACTCATCAGCAAACGCAACCTCCTTCCGATTTTCCCGCTCTT 1185 Pex14 GCCGATGAAAATTCC T AGATTCCAGGTTCAATTTACACCTTCTAAT Arabidopsis thaliana CATTATTTCTTAATTTTTCTTTGGTGGATT Gln22Term AATCCACCAAAGAAAAATTAAGAAATAATGATTAGAAGGTGTAAAT 1186 CAG-TAG TGAACCTGGAATCT A GGAATTTTCATCGGCAAGAGCGGGAAAATC GGAAGGAGGTTGCGTTTGCTGATGAGTTGC AAAATTCC T AGATTCCA 1187 TGGAATCT A GGAATTTT 1188 - Plant productivity is limited by resources available and the ability of plants to harness these resources. The conversion of light to chemical energy, which is then used to synthesize carbohydrates, fatty acids, sugars, amino acids and other compounds, requires a complex system which combines the light harvesting apparatus of pigments and proteins. The value of light energy to the plant can only be realized when it is efficiently converted into chemical energy by photosynthesis and fed into various biochemical processes. Significant effort has therefore been directed at studying photosynthetic processes in plants in order to improve productivity and/or the efficiency of photosynthesis. The analysis of the photosynthetic process is substantially aided by the ability to produce albino plants.
- The attached table discloses exemplary oligonucleotide base sequences which can be used to generate site-specific mutations in genes involved in starch metabolism.
TABLE 18 Oligonucleotides to produce albino plants Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: White leaves TTCTTTCCTGTGAAATTATCTGCTCAAATCTTTGGTTCCTGACGGAG 1189 Immutans ATGGCGGCGATTT G AGGCATCTCCTCTGGTACGTTGACGATTTCA Arabidopsis thaliana CGGCCTTTGGTTACTCTTCGACGCTCTAG Ser5Term CTAGAGCGTCGAAGAGTAACCAAAGGCCGTGAAATCGTCAACGTA 1190 TCA-TGA CCAGAGGAGATGCCT C AAATCGCCGCCATCTCCGTCAGGAACCAA AGATTTGAGCAGATAATTTCACAGGAAAGAA GGCGATTT G AGGCATCT 1191 AGATGCCT C AAATCGCC 1192 White leaves GCTCAAATCTTTGGTTCCTGACGGAGATGGCGGCGATTTCAGGCA 1193 Immutans TCTCCTCTGGTACGT A GACGATTTCACGGCCTTTGGTTACTCTTCG Arabidopsis thaliana ACGCTCTAGAGCCGCCGTTTCGTACAGCTC Leu12Term GAGCTGTACGAAACGGCGGCTCTAGAGCGTCGAAGAGTAACCAAA 1194 TTG-TAG GGCCGTGAAATCGTC T ACGTACCAGAGGAGATGCCTGAAATCGCC GCCATCTCCGTCAGGAACCAAAGATTTGAGC TGGTACGT A GACGATTT 1195 AAATCGTC T ACGTACCA 1196 White leaves TTTGGTTCCTGACGGAGATGGCGGCGATTTCAGGCATCTCCTCTG 1197 Immutans GTACGTTGACGATTTGACGGCCTTTGGTTACTCTTCGACGCTCTAG Arabidopsis thaliana AGCCGCCGTTTCGTACAGCTCCTCTCACCG Ser15Term CGGTGAGAGGAGCTGTACGAAACGGCGGCTCTAGAGCGTCGAAG 1198 TCA-TGA AGTAACCAAAGGCCGT C AAATCGTCAACGTACCAGAGGAGATGCC TGAAATCGCCGCCATCTCCGTCAGGAACCAAA GACGATTT G ACGGCCTT 1199 AAGGCCGT C AAATCGTC 1200 White leaves GCGGCGATTTCAGGCATCTCCTCTGGTACGTTGACGATTTCACGG 1201 Immutans CCTTTGGTTACTCTT T GACGCTCTAGAGCCGCCGTTTCGTACAGCT Arabidopsis thaliana CCTCTCACCGATTGCTTCATCATCTTCCTC Arg22Term GAGGAAGATGATGAAGCAATCGGTGAGAGGAGCTGTACGAAACG 1202 CGA-TGA GCGGCTCTAGAGCGTC A AAGAGTAACCAAAGGCCGTGAAATCGTC AACGTACCAGAGGAGATGCCTGAAATCGCCGC TTACTCTT T GACGCTCT 1203 AGAGCGTC A AAGAGTAA 1204 White leaves TCAGGCATCTCCTCTGGTACGTTGACGATTTCACGGCCTTTGGTTA 1205 Immutans CTCTTCGACGCTCT T GAGCCGCCGTTTCGTACAGCTCCTCTCACC Arabidopsis thaliana GATTGCTTCATCATCTTCCTCTCTCTTCTC Arg25Term GAGAAGAGAGAGGAAGATGATGAAGCAATCGGTGAGAGGAGCTG 1206 AGA-TGA TACGAAACGGCGGCTC A AGAGCGTCGAAGAGTAACCAAAGGCCG TGAAATCGTCAACGTACCAGAGGAGATGCCTGA GACGCTCT T GAGCCGCC 1207 GGCGGCTC A AGAGCGTC 1208 White leaves GATTCTTGTGGGAAGGAAGAAGGATCAAGAATGGCGATTTCGATT 1209 Immutans TCTGCTATGAGTTTT T GAACCTCAGTTTCTTCATATTCTTGTTTTAG Lycopersicon AGCTAGGAGTTTTGAGAAGTCATCAGTTT esculentum AAACTGATGACTTCTCAAAACTCCTAGCTCTAAAACAAGAATATGA 1210 Gly11Term AGAAACTGAGGTTC A AAAACTCATAGCAGAAATCGAAATCGCCATT GGA-TGA CTTGATCCTTCTTCCTTCCCACAAGAATC TGAGTTTT T GAACCTCA 1211 TGAGGTTC A AAAACTCA 1212 White leaves GTGGGAAGGAAGAAGGATCAAGAATGGCGATTTCGATTTCTGCTA 1213 Immutans TGAGTTTTGGAACCT G AGTTTCTTCATATTCTTGTTTTAGAGCTAGG Lycopersicon AGTTTTGAGAAGTCATCAGTTTTATGCAA esculentum TTGCATAAAACTGATGACTTCTCAAAACTCCTAGCTCTAAAACAAG 1214 Ser13Term AATATGAAGAAACT C AGGTTCCAAAACTCATAGCAGAAATCGAAAT TCA-TGA CGCCATTCTTGATCCTTCTTCCTTCCCAC TGGAACCT G AGTTTCTT 1215 AAGAAACT C AGGTTCCA 1216 White leaves AAGAAGGATCAAGAATGGCGATTTCGATTTCTGCTATGAGTTTTGG 1217 Immutans AACCTCAGTTTCTTGATATTCTTGTTTTAGAGCTAGGAGTTTTGAGA Lycopersicon AGTCATCAGTTTTATGCAATTCCCAGAA esculentum TTCTGGGAATTGCATAAAACTGATGACTTCTCAAAACTCCTAGCTC 1218 Ser16Term TAAAACAAGAATAT C AAGAAACTGAGGTTCCAAAACTCATAGCAGA TCA-TGA AATCGAAATCGCCATTCTTGATCCTTCTT AGTTTCTT G ATATTCTT 1219 AAGAATAT C AAGAAACT 1220 White leaves AGGATCAAGAATGGCGATTTCGATTTCTGCTATGAGTTTTGGAACC 1221 Immutans TCAGTTTCTTCATA G TCTTGTTTTAGAGCTAGGAGTTTTGAGAAGTC Lycopersicon ATCAGTTTTATGCAATTCCCAGAACCCA esculentum TGGGTTCTGGGAATTGCATAAAACTGATGACTTCTCAAAACTCCTA 1222 Tyr17Term GCTCTAAAACAAGA C TATGAAGAAACTGAGGTTCCAAAACTCATAG TAT-TAG CAGAAATCGAAATCGCCATTCTTGATCCT TCTTCATA G TCTTGTTT 1223 AAACAAGA C TATGAAGA 1224 White leaves AAGAATGGCGATTTCGATTTCTGCTATGAGTTTTGGAACCTCAGTT 1225 Immutans TCTTCATATTCTTG A TTTAGAGCTAGGAGTTTTGAGAAGTCATCAGT Lycopersicon TTTATGCAATTCCCAGAACCCATGTCGG esculentum CCGACATGGGTTCTGGGAATTGCATAAAACTGATGACTTCTCAAAA 1226 Cys19Term CTCCTAGCTCTAAA T CAAGAATATGAAGAAACTGAGGTTCCAAAAC TGT-TGA TCATAGCAGAAATCGAAATCGCCATTCTT TATTCTTG A TTTAGAGC 1227 GCTCTAAA T CAAGAATA 1228 White leaves CGCGTCCGATAAAAAAATCAAGAATGGCGATTTCCATATCTGCTAT 1229 Immutans GAGTTTTCGAACTT G AGTTTCTTCTTCATATTCAGCATTTTTGTGCA Capsicum annuum ATTCCAAGAACCCATTTTGTTTGAATTC Ser13Term GAATTCAAACAAAATGGGTTCTTGGAATTGCACAAAAATGCTGAAT 1230 TCA-TGA ATGAAGAAGAAACT C AAGTTCGAAAACTCATAGCAGATATGGAAAT CGCCATTCTTGATTTTTTTATCGGACGCG TCGAACTT G AGTTTCTT 1231 AAGAAACT C AAGTTCGA 1232 White leaves AAAAATCAAGAATGGCGATTTCCATATCTGCTATGAGTTTTCGAAC 1233 Immutans TTCAGTTTCTTCTT G ATATTCAGCATTTTTGTGCAATTCCAAGAACC Capsicum annuum CATTTTGTTTGAATTCTCTATTTTCACT Ser17Term AGTGAAAATAGAGAATTCAAACAAAATGGGTTCTTGGAATTGCACA 1234 TCA-TGA AAAATGCTGAATAT C AAGAAGAAACTGAAGTTCGAAAACTCATAGC AGATATGGAAATCGCCATTCTTGATTTTT TTCTTCTT G ATATTCAG 1235 CTGAATAT C AAGAAGAA 1236 White leaves CAAGAATGGCGATTTCCATATCTGCTATGAGTTTTCGAACTTCAGT 1237 Immutans TTCTTCTTCATATT G AGCATTTTTGTGCAATTCCAAGAACCCATTTT Capsicum annuum GTTTGAATTCTCTATTTTCACTTAGGAA Ser19Term TTCCTAAGTGAAAATAGAGAATTCAAACAAAATGGGTTCTTGGAAT 1238 TCA-TGA TGCACAAAAATGCT C AATATGAAGAAGAAACTGAAGTTCGAAAACT CATAGCAGATATGGAAATCGCCATTCTTG TTCATATT G AGCATTTT 1239 AAAATGCT C AATATGAA 1240 White leaves CGATTTCCATATCTGCTATGAGTTTTCGAACTTCAGTTTCTTCTTCA 1241 Immutans TATTCAGCATTTT A GTGCAATTCCAAGAACCCATTTTGTTTGAATTC Capsicum annuum TCTATTTTCACTTAGGAATTCTCATAG Leu21Term CTATGAGAATTCCTAAGTGAAAATAGAGAATTCAAACAAAATGGGT 1242 TTG-TAG TCTTGGAATTGCAC T AAAATGCTGAATATGAAGAAGAAACTGAAGT TCGAAAACTCATAGCAGATATGGAAATCG AGCATTTT A GTGCAATT 1243 AATTGCAC T AAAATGCT 1244 White leaves TTCCATATCTGCTATGAGTTTTCGAACTTCAGTTTCTTCTTCATATT 1245 Immutans CAGCATTTTTGTG A AATTCCAAGAACCCATTTTGTTTGAATTCTCTA Capsicum annuum TTTTCACTTAGGAATTCTCATAGAACT Cys22Term AGTTCTATGAGAATTCCTAAGTGAAAATAGAGAATTCAAACAAAAT 1246 TGC-TGA GGGTTCTTGGAATT T CACAAAAATGCTGAATATGAAGAAGAAACTG AAGTTCGAAAACTCATAGCAGATATGGAA TTTTTGTG A AATTCCAA 1247 TTGGAATT T CACAAAAA 1248 White leaves TTCGGCACGAGGGAGAAGGAGCAGACCGAGGTGGCCGTCGAGG 1249 Immutans AGTCCTTCCCCTTCAGG T AGACGGCTCCTCCTGACGAGCCACTGG Oryza sativa TCACCGCCGAGGAGAGCTGGGTGGTTAAGCTCG Glu22Term CGAGCTTAACCACCCAGCTCTCCTCGGCGGTGACCAGTGGCTCGT 1250 GAG-TAG CAGGAGGAGCCGTCT A CCTGAAGGGGAAGGACTCCTCGACGGCC ACCTCGGTCTGCTCCTTCTCCCTCGTGCCGAA CCTTCAGG T AGACGGCT 1251 AGCCGTCT A CCTGAAGG 1252 White leaves GAGCAGACCGAGGTGGCCGTCGAGGAGTCCTTCCCCTTCAGGGA 1253 Immutans GACGGCTCCTCCTGAC T AGCCACTGGTCACCGCCGAGGAGAGCT Oryza sativa GGGTGGTTAAGCTCGAGCAGTCCGTGAACATTT Glu28Term AAATGTTCACGGACTGCTCGAGCTTAACCACCCAGCTCTCCTCGG 1254 CAG-TAG CGGTGACCAGTGGCT A GTCAGGAGGAGCCGTCTCCCTGAAGGGG AAGGACTCCTCGACGGCCACCTCGGTCTGCTC CTCCTGAC T AGCCACTG 1255 CAGTGGCT A GTCAGGAG 1256 White leaves GTCGAGGAGTCCTTCCCCTTCAGGGAGACGGCTCCTCCTGACGA 1257 Immutans GCCACTGGTCACCGCC T AGGAGAGCTGGGTGGTTAAGCTCGAGC Oryza sativa AGTCCGTGAACATTTTCCTCACGGAGTCAGTCA Glu34Term TGACTGACTCCGTGAGGAAAATGTTCACGGACTGCTCGAGCTTAA 1258 GAG-TAG CCACCCAGCTCTCCTAGGCGGTGACCAGTGGCTCGTCAGGAGGA GCCGTCTCCCTGAAGGGGAAGGACTCCTCGAC TCACCGCC T AGGAGAGC 1259 GCTCTCCT A GGCGGTGA 1260 White leaves GAGGAGTCCTTCCCCTTCAGGGAGACGGCTCCTCCTGACGAGCC 1261 Immutans ACTGGTCACCGCCGAG T AGAGCTGGGTGGTTAAGCTCGAGCAGT Oryza sativa CCGTGAACATTTTCCTCACGGAGTCAGTCATCA Glu35Term TGATGACTGACTCCGTGAGGAAAATGTTCACGGACTGCTCGAGCT 1262 GAG-TAG TAACCACCCAGCTCT A CTCGGCGGTGACCAGTGGCTCGTCAGGA GGAGCCGTCTCCCTGAAGGGGAAGGACTCCTC CCGCCGAG T AGAGCTGG 1263 CCAGCTCT A CTCGGCGG 1264 White leaves CTTCCCCTTCAGGGAGACGGCTCCTCCTGACGAGCCACTGGTCAC 1265 Immutans CGCCGAGGAGAGCTG A GTGGTTAAGCTCGAGCAGTCCGTGAACA Oryza sativa TTTTCCTCACGGAGTCAGTCATCACGATACTT Trp37Term AAGTATCGTGATGACTGACTCCGTGAGGAAAATGTTCACGGACTG 1266 TGG-TGA CTCGAGCTTAACCAC T CAGCTCTCCTCGGCGGTGACCAGTGGCTC GTCAGGAGGAGCCGTCTCCCTGAAGGGGAAG GAGAGCTG A GTGGTTAA 1267 TTAACCAC T CAGCTCTC 1268 White leaves TCCGGAGGAGGAAGGGGGATTCGACGAGGAGCTCACCCTCGCCG 1269 Immutans GCGAGGACGGCGACTGAGTCGTCAGATTCGAGCAGTCCTTCAAC Triticum aestivum GTATTCCTCACGGATACTGTCATCTTTATACTC Trp22Term GAGTATAAAGATGACAGTATCCGTGAGGAATACGTTGAAGGACTG 1270 TGG-TGA CTCGAATCTGACGAC T CAGTCGCCGTCCTCGCCGGCGAGGGTGA GCTCCTCGTCGAATCCCCCTTCCTCCTCCGGA GGCGACTG A GTCGTCAG 1271 CTGACGAC T CAGTCGCC 1272 White leaves GAGGAAGGGGGATTCGACGAGGAGCTCACCCTCGCCGGCGAGG 1273 Immutans ACGGCGACTGGGTCGTC T GATTCGAGCAGTCCTTCAACGTATTCC Triticum aestivum TCACGGATACTGTCATCTTTATACTCGATATTC Arg25Term GAATATCGAGTATAAAGATGACAGTATCCGTGAGGAATACGTTGAA 1274 AGA-TGA GGACTGCTCGAATC A GACGACCCAGTCGCCGTCCTCGCCGGCGA GGGTGAGCTCCTCGTCGAATCCCCCTTCCTC GGGTCGTC T GATTCGAG 1275 CTCGAATC A GACGACCC 1276 White leaves GGGGGATTCGACGAGGAGCTCACCCTCGCCGGCGAGGACGGCG 1277 Immutans ACTGGGTCGTCAGATTCTAGCAGTCCTTCAACGTATTCCTCACGGA Triticum aestivum TACTGTCATCTTTATACTCGATATTCTGTATC Glu21Term GATACAGAATATCGAGTATAAAGATGACAGTATCCGTGAGGAATAC 1278 GAG-TAG GTTGAAGGACTGCT A GAATCTGACGACCCAGTCGCCGTCCTCGCC GGCGAGGGTGAGCTCCTCGTCGAATCCCCC TCAGATTC T AGCAGTCC 1279 GGACTGCT A GAATCTGA 1280 White leaves GGATTCGACGAGGAGCTCACCCTCGCCGGCGAGGACGGCGACTG 1281 Immutans GGTCGTCAGATTCGAG T AGTCCTTCAACGTATTCCTCACGGATACT Triticum aestivum GTCATCTTTATACTCGATATTCTGTATCGTG Gln28Term CACGATACAGAATATCGAGTATAAAGATGACAGTATCCGTGAGGAA 1282 CAG-TAG TACGTTGAAGGACTACTCGAATCTGACGACCCAGTCGCCGTCCTC GCCGGCGAGGGTGAGCTCCTCGTCGAATCC GATTCGAG T AGTCCTTC 1283 GAAGGACT A CTCGAATC 1284 White leaves CGAGCAGTCCTTCAACGTATTCCTCACGGATACTGTCATCTTTATA 1285 Immutans CTCGATATTCTGTA G CGTGACCGCGACTACGCAAGGTTCTTCGTG Triticum aestivum CTCGAGACCATCGCCAGGGTGCCCTATTTC Tyr46Term GAAATAGGGCACCCTGGCGATGGTCTCGAGCACGAAGAACCTTG 1286 TAT-TAG CGTAGTCGCGGTCACGCTACAGAATATCGAGTATAAAGATGACAG TATCCGTGAGGAATACGTTGAAGGACTGCTCG ATTCTGTA G CGTGACCG 1287 CGGTCACG C TACAGAAT 1288 - Another aim of biotechnology is to generate plants, especially crop plants, with added value traits. An example of such a trait is improved nutritional quality in food crops. For example, lysine, tryptophan and threonine, which are essential amino acids in the diet of humans and many animals, are limiting nutrients in most cereal crops. Consequently, grain-based diets, such as those based on corn, barley, wheat, rice, maize, millet, sorghum, and the like, must be supplemented with more expensive synthetic amino acids or amino-acid-containing oilseed protein meals. Increasing the lysine content of these grains or of any of the feed component crops would result in significant added value.
- Naturally occurring mutants of plants that have different levels of particular essential amino acids have been identified. However, these mutants are generally not the result of increased free amino acid, but are instead the result of shifts in the overall protein profile of the grain. For example, in maize, reduced levels of lysine-deficient endosperm proteins (prolamines) are complemented by elevated levels of more lysine-rich proteins (albumins, globulins and glutelins). While nutritionally superior, these mutants are associated with reduced yields and poor grain quality, limiting their agronomic usefulness.
- An alternative approach is to generate plants with mutations that render key amino acid biosynthetic enzymes insensitive to feedback inhibition. Many such mutations are known and mutation results in increased free amino acid. The increased production can optionally be coupled to increased expression of an abundant storage protein comprising the chosen amino acid. Alternatively, a normally abundant protein can be engineered to contain more of the target amino acid.
- The attached table discloses exemplary oligonucleotide base sequences which can be used to generate site-specific mutations that remove feedback inhibition in plant amino acid biosynthetic enzymes.
TABLE 19 Genome-Altering Oligos Conferring Amino Acid Overproduction Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Met Overproduction TATCCTCCAGGATCTTAAGATTTCCTCCTAATTTCGTCCGTCAGCT 1289 CGS GAGCATTAAAGCCC A TAGAAACTGTAGCAACATCGGTGTTGCACA Arabidopsis thaliana GATCGTGGCGGCTAAGTGGTCCAACAACCC Arg77His GGGTTGTTGGACCACTTAGCCGCCACGATCTGTGCAACACCGAT 1290 CGT-CAT GTTGCTACAGTTTCTA T GGGCTTTAATGCTCAGCTGACGGACGAA ATTAGGAGGAAATCTTAAGATCCTGGAGGATA TAAAGCCC A TAGAAACT 1291 AGTTTCTA T GGGCTTTA 1292 Met Overproduction TCTTAAGATTTCCTCCTAATTTCGTCCGTCAGCTGAGCATTAAAGC 1293 CGS CCGTAGAAACTGTA A CAACATCGGTGTTGCACAGATCGTGGCGG Arabidopsis thaliana CTAAGTGGTCCAACAACCCATCCTCCGCGTT Ser81Asn AACGCGGAGGATGGGTTGTTGGACCACTTAGCCGCCACGATCTG 1294 AGC-AAC TGCAACACCGATGTTG T TACAGTTTCTACGGGCTTTAATGCTCAGC TGACGGACGAAATTAGGAGGAAATCTTAAGA AAACTGTA A CAACATCG 1295 CGATGTTG T TACAGTTT 1296 Met Overproduction TTTCCTCCTAATTTCGTCCGTCAGCTGAGCATTAAAGCCCGTAGAA 1297 CGS ACTGTAGCAACATC A GTGTTGCACAGATCGTGGCGGCTAAGTGGT Arabidopsis thaliana CCAACAACCCATCCTCCGCGTTACCTTCGG Gly84Ser CCGAAGGTAACGCGGAGGATGGGTTGTTGGACCACTTAGCCGCC 1298 GGT-AGT ACGATCTGTGCAACAC T GATGTTGCTACAGTTTCTACGGGCTTTAA TGCTCAGCTGACGGACGAAATTAGGAGGAAA GCAACATC A GTGTTGCA 1299 TGCAACAC T GATGTTGC 1300 Met Overproduction TTCCTCCTAATTTCGTCCGTCAGCTGAGCATTAAAGCCCGTAGAAA 1301 CGS CTGTAGCAACATCG A TGTTGCACAGATCGTGGCGGCTAAGTGGTC Arabidopsis thaliana CAACAACCCATCCTCCGCGTTACCTTCGGC Gly84Asp GCCGAAGGTAACGCGGAGGATGGGTTGTTGGACCACTTAGCCGC 1302 GGT-GAT CACGATCTGTGCAACA T CGATGTTGCTACAGTTTCTACGGGCTTTA ATGCTCAGCTGACGGACGAAATTAGGAGGAA CAACATCG A TGTTGCAC 1303 GTGCAACA T CGATGTTG 1304 Met Overproduction TATCGTCACTCATCCTCCGCTTCCCTCCCAACTTCGTCCGCCAGC 1305 CGS TCAGCACCAAGGCCC A CCGCAACTGCAGCAACATCGGCGTCGCG Fragraria vesca CAGATCGTCGCGGCTTCGTGGTCCAACAAAGA Arg73His TCTTTGTTGGACCACGAAGCCGCGACGATCTGCGCGACGCCGAT 1306 CGC-CAC GTTGCTGCAGTTGCGG T GGGCCTTGGTGCTGAGCTGGCGGACGA AGTTGGGAGGGAAGCGGAGGATGAGTGACGATA CAAGGCCC A CCGCAACT 1307 AGTTGCGG T GGGCCTTG 1308 Met Overproduction TCCTCCGCTTCCCTCCCAACTTCGTCCGCCAGCTCAGCACCAAGG 1309 CGS CCCGCCGCAACTGCA A CAACATCGGCGTCGCGCAGATCGTCGCG Fragraria vesca GCTTCGTGGTCCAACAAAGACTCCGACCTTTC Ser77Asn GAAAGGTCGGAGTCTTTGTTGGACCACGAAGCCGCGACGATCTG 1310 AGC-AAC CGCGACGCCGATGTTG T TGCAGTTGCGGCGGGCCTTGGTGCTGA GCTGGCGGACGAAGTTGGGAGGGAAGCGGAGGA CAACTGCA A CAACATCG 1311 CGATGTTG T TGCAGTTG 1312 Met Overproduction TTCCCTCCCAACTTCGTCCGCCAGCTCAGCACCAAGGCCCGCCG 1313 CGS CAACTGCAGCAACATC A GCGTCGCGCAGATCGTCGCGGCTTCGT Fragraria vesca GGTCCAACAAAGACTCCGACCTTTCGGCGGTGC Gly80Ser GCACCGCCGAAAGGTCGGAGTCTTTGTTGGACCACGAAGCCGCG 1314 GGC-AGC ACGATCTGCGCGACGC T GATGTTGGTGCAGTTGCGGCGGGCCTT GGTGCTGAGCTGGCGGACGAAGTTGGGAGGGAA GCAACATC A GCGTCGCG 1315 CGCGACGC T GATGTTGC 1316 Met Overproduction TCCCTCCCAACTTCGTCCGCCAGCTCAGCACCAAGGCCCGCCGC 1317 CGS AACTGCAGCAACATCG A CGTCGCGCAGATCGTCGCGGCTTCGTG Fragraria vesca GTCCAACAAAGACTCCGACCTTTCGGCGGTGCC Gly80Asp GGCACCGCCGAAAGGTCGGAGTCTTTGTTGGACCACGAAGCCGC 1318 GGC-GAC GACGATCTGCGCGACG T CGATGTTGCTGCAGTTGCGGCGGGCCT TGGTGCTGAGCTGGCGGACGAAGTTGGGAGGGA CAACATCG A CGTCGCGC 1319 GCGCGACG T CGATGTTG 1320 Met Overproduction TCTCCTCCCTCATCCTCCGCTTCCCTCCCAACTTCCAGCGCCAGC 1321 CGS TAAGCACCAAGGCG A GCCGCAACTGCAGCAACATCGGCGTCGCG Glycine max CAAATCGTCGCCGCTTCGTGGTCGAACAACAG Arg68His CTGTTGTTCGACCACGAAGCGGCGACGATTTGCGCGACGCCGAT 1322 CGC-CAC GTTGCTGCAGTTGCGGC T CGCCTTGGTGCTTAGCTGGCGCTGGA AGTTGGGAGGGAAGCGGAGGATGAGGGAGGAGA CCAAGGCG A GCCGCAAC 1323 GTTGCGGC T CGCCTTGG 1324 Met Overproduction TCCTCCGCTTCCCTCCCAACTTCCAGCGCCAGCTAAGCACCAAGG 1325 CGS CGCGCCGCAACTGCA A CAACATCGGCGTCGCGCAAATCGTCGCC Glycine max GCTTCGTGGTCGAACAACAGCGACAACTCTCC Ser72Asn GGAGAGTTGTCGCTGTTGTTCGACCACGAAGCGGCGACGATTTG 1326 AGC-AAC CGCGACGCCGATGTTG T TGCAGTTGCGGCGCGCCTTGGTGCTTA GCTGGCGCTGGAAGTTGGGAGGGAAGCGGAGGA CAACTGCA A CAACATCG 1327 CGATGTTG T TGCAGTTG 1328 Met Overproduction TTCCCTCCCAACTTCCAGCGCCAGCTAAGCACCAAGGCGCGCCG 1329 CGS CAACTGCAGCAACATC A GCGTCGCGCAAATCGTCGCCGCTTCGT Glycine max GGTCGAACAACAGCGACAACTCTCCGGCCGCCG Gly75Ser CGGCGGCCGGAGAGTTGTCGCTGTTGTTCGACCACGAAGCGGCG 1330 GGC-AGC ACGATTTGCGCGACGC T GATGTTGCTGCAGTTGCGGCGCGCCTT GGTGCTTAGCTGGCGCTGGAAGTTGGGAGGGAA GCAACATC A GCGTCGCG 1331 CGCGACGC T GATGTTGC 1332 Met Overproduction TCCCTCCCAACTTCCAGCGCCAGCTAAGCACCAAGGCGCGCCGC 1333 CGS AACTGCAGCAACATCG A CGTCGCGCAAATCGTCGCCGCTTCGTG Glycine max GTCGAACAACAGCGACAACTCTCCGGCCGCCGG Gly75Asp CCGGCGGCGGGAGAGTTGTCGCTGTTGTTCGACCACGAAGCGGC 1334 GGC-GAC GACGATTTGCGCGACG T CGATGTTGCTGCAGTTGCGGCGCGCCT TGGTGCTTAGCTGGCGCTGGAAGTTGGGAGGGA CAACATCG A CGTCGCGC 1335 GCGCGACG T CGATGTTG 1336 Met Overproduction TGTCTTCTCTGATTTTCAGGTTTCCTCCTAATTTCGTGAGGCAGCT 1337 CGS AAGCATTAAGGCT CAC AGGAATTGCAGCAATATTGGCGTGGCTCA Solanum tuberosum AGTTGTGGCGGCTTCCTGGTCTAACAACCA Arg70His TGGTTGTTAGACCAGGAAGCCGCCACAACTTGAGCCACGCCAATA 1338 AGG-CAC TTGCTGCAATTCCT GTG AGCCTTAATGCTTAGCTGCCTCACGAAAT TAGGAGGAAACCTGAAAATCAGAGAAGACA TAAGGCT CAC AGGAATT 1339 AATTCCT GTG AGCCTTA 1340 Met Overproduction TTTTCAGGTTTCCTCCTAATTTCGTGAGGCAGCTAAGCATTAAGGC 1341 CGS TAGGAGGAATTGCA A CAATATTGGCGTGGCTCAAGTTGTGGCGG Solanum tuberosum CTTCCTGGTCTAACAACCAAGCCGGTCCTGA Ser74Asn TCAGGACCGGCTTGGTTGTTAGACCAGGAAGCCGCCACAACTTG 1342 AGC-AAC AGCCACGCCAATATTGTTGCAATTCCTCCTAGCCTTAATGCTTAGC TGCCTCACGAAATTAGGAGGAAACCTGAAAA GAATTGCA A CAATATTG 1343 CAATATTG T TGCAATTC 1344 Met Overproduction TTTCCTCCTAATTTCGTGAGGCAGCTAAGCATTAAGGCTAGGAGG 1345 CGS AATTGCAGCAATATT A GCGTGGCTCAAGTTGTGGCGGCTTCCTGG Solanum tuberosum TCTAACAACCAAGCCGGTCCTGAATTCACTC Gly77Ser GAGTGAATTCAGGACCGGCTTGGTTGTTAGACCAGGAAGCCGCC 1346 GGC-AGC ACAACTTGAGCCACGC T AATATTGCTGCAATTCCTCCTAGCCTTAA TGCTTAGCTGCCTCACGAAATTAGGAGGAAA GCAATATT A GCGTGGGT 1347 AGCCACGC T AATATTGC 1348 Met Overproduction TTCCTCCTAATTTCGTGAGGCAGCTAAGCATTAAGGCTAGGAGGA 1349 CGS ATTGCAGCAATATTG A CGTGGCTCAAGTTGTGGCGGCTTCCTGGT Solanum tuberosum CTAACAACCAAGCCGGTCCTGAATTCACTCC Gly77Asp GGAGTGAATTCAGGACCGGCTTGGTTGTTAGACCAGGAAGCCGC 1350 GGC-GAC CACAACTTGAGCCACG T CAATATTGCTGCAATTCCTCCTAGCCTTA ATGCTTAGCTGCCTCACGAAATTAGGAGGAA CAATATTG A CGTGGCTC 1351 GAGCCACG T CAATATTG 1352 Met Overproduction CTTCCTCTCTTATCCTTCGCTTTCCTCCCAACTTTGTCCGTCAGCT 1353 CGS CAGCACCAAGGCTCGCC A CAACTGCAGCAACATTGGTGTCGCAC Mesembryanthemum AGGTCGTCGCTGCCTCCTGGTCCAACAACTC crystallinum GAGTTGTTGGACCAGGAGGCAGCGACGACCTGTGCGACACCAAT 1354 Arg73His GTTGCTGCAGTTG T GGCGAGCCTTGGTGCTGAGCTGACGGACAA CGC-CAC AGTTGGGAGGAAAGCGAAGGATAAGAGAGGAAG GGCTCGCC A CAACTGCA 1355 TGCAGTTG T GGCGAGCC 1356 Met Overproduction TCCTTCGCTTTCCTCCCAACTTTGTCCGTCAGCTCAGCACCAAGG 1357 CGS CTCGCCGCAACTGCAACAACATTGGTGTCGCACAGGTCGTCGCT Mesembryanthemum GCCTCCTGGTCCAACAACTCCGATGCCGGCGC crystallinum GCGCCGGCATCGGAGTTGTTGGACCAGGAGGCAGCGACGACCT 1358 Ser77Asn GTGCGACACCAATG T TGTTGCAGTTGCGGCGAGCCTTGGTGCTG AGC-AAC AGCTGACGGACAAAGTTGGGAGGAAAGCGAAGGA CAACTGCA A CAACATTG 1359 CAATGTTG T TGCAGTTG 1360 Met Overproduction TTTCCTCCCAACTTTGTCCGTCAGCTCAGCACCAAGGCTCGCCGC 1361 CGS AACTGCAGCAACATT A GTGTCGCACAGGTCGTCGCTGCCTCCTG Mesembryanthemum GTCCAACAACTCCGATGCCGGCGCCACCTCTT crystallinum AAGAGGTGGCGCCGGCATCGGAGTTGTTGGACCAGGAGGCAGC 1362 Gly80Ser GACGACCTGTGCGACAC T AATGTTGCTGCAGTTGCGGCGAGCCT GGT-AGT TGGTGCTGAGCTGACGGACAAAGTTGGGAGGAAA GCAACATT A GTGTCGCA 1363 TGCGACAC T AATGTTGC 1364 Met Overproduction TTCCTCCCAACTTTGTCCGTCAGCTCAGCACCAAGGCTCGCCGCA 1365 CGS ACTGCAGCAACATTG A TGTCGCACAGGTCGTCGCTGCCTCCTGGT Mesembryanthemum CCAACAACTCCGATGCCGGCGCCACCTCTTG crystallinum CAAGAGGTGGCGCCGGCATCGGAGTTGTTGGACCAGGAGGCAG 1366 Gly80Asp CGACGACCTGTGCGACA T CAATGTTGCTGCAGTTGCGGCGAGCC GGT-GAT TTGGTGCTGAGCTGACGGACAAAGTTGGGAGGAA CAACATTG A TGTCGCAC 1367 GTGCGACA T CAATGTTG 1368 Met Overproduction CCTCTGCTACCATCCTCCGCTTTCCGCCAAACTTTGTCCGCCAGC 1369 CGS TTAGCACCAAGGCACACGGCAACTGCAGCAACATCGGCGTCGCG Zea mays CAGATCGTCGCCGCCGCGTGGTCCGACTGCCC Arg41His GGGCAGTCGGACCACGCGGCGGCGACGATCTGCGCGACGCCGA 1370 CGC-CAC TGTTGCTGCAGTTGCGG T GTGCCTTGGTGCTAAGCTGGCGGACA AAGTTTGGCGGAAAGCGGAGGATGGTAGCAGAGG CAAGGCAC A CCGCAACT 1371 AGTTGCGG T GTGCCTTG 1372 Met Overproduction TCCTCCGCTTTCCGCCAAACTTTGTCCGCCAGCTTAGCACCAAGG 1373 CGS CACGCCGCAACTGCA A CAACATCGGCGTCGCGCAGATCGTCGCC Zea mays GCCGCGTGGTCCGACTGCCCCGCCGCTCGCCC Ser45Asn GGGCGAGCGGCGGGGCAGTCGGACCACGCGGCGGCGACGATCT 1374 AGC-AAC GCGCGACGCCGATGTTG T TGCAGTTGCGGCGTGCCTTGGTGCTA AGCTGGCGGACAAAGTTTGGCGGAAAGCGGAGGA CAACTGCA A CAACATCG 1375 CGATGTTG T TGCAGTTG 1376 Met Overproduction TTTCCGCCAAACTTTGTCCGCCAGCTTAGCACCAAGGCACGCCGC 1377 CGS AACTGCAGCAACATC A GCGTCGCGCAGATCGTCGCCGCCGCGTG Zea mays GTCCGACTGCCCCGCCGCTCGCCCCCACTTAG Gly48Ser CTAAGTGGGGGCGAGCGGCGGGGCAGTCGGACCACGCGGCGG 1378 GGC-AGC CGACGATCTGCGCGACGC T GATGTTGCTGCAGTTGCGGCGTGCC TTGGTGCTAAGCTGGCGGACAAAGTTTGGCGGAAA GCAACATC A GCGTCGCG 1379 CGCGACGC T GATGTTGC 1380 Met Overproduction TTCCGCCAAACTTTGTCCGCCAGCTTAGCACCAAGGCACGCCGCA 1381 CGS ACTGCAGCAACATCG A CGTCGCGCAGATCGTCGCCGCCGCGTGG Zea mays TCCGACTGCCCCGCCGCTCGCCCCCACTTAGG Gly48Asp CCTAAGTGGGGGCGAGCGGCGGGGCAGTCGGACCACGCGGCG 1382 GGC-GAC GCGACGATCTGCGCGACG T CGATGTTGCTGCAGTTGCGGCGTGC CTTGGTGCTAAGCTGGCGGACAAAGTTTGGCGGAA CAACATCG A CGTCGCGG 1383 GCGCGACG T CGATGTTG 1384 Met Overproduction GTATGAATGATCTGTGGGTGAAACACTGTGGGATTAGTCATACAG 1385 TS GAAGTTTCAAGGATCGTGGAATGACTGTTTTGGTTAGTCAAGTTAA Arabidopsis thaliana TCGTCTGAGAAAGATGAAACGACCTGTGGT Leu205Arg ACCACAGGTCGTTTCATCTTTCTCAGACGATTAACTTGACTAACCA 1386 CTT-CGT AAACAGTCATTCCA C GATCCTTGAAACTTCCTGTATGACTAATCCC ACAGTGTTTCACCCACAGATCATTCATAC CAAGGATC G TGGAATGA 1387 TCATTCCA C GATCCTTG 1388 Met Overproduction GCATGACTGATTTGTGGGTCAAACACTGTGGGATTAGCCATACTG 1389 TS GTAGTTTTAAGGATCGTGGGATGACTGTTTTGGTGAGTCAAGTTAA Solanum tuberosum TCGCTTGCGGAAAATGCATAAACCGGTTGT Leu198Arg ACAACCGGTTTATGCATTTTCCGCAAGCGATTAACTTGACTCACCA 1390 CTT-CGT AAACAGTCATCCCACGATCCTTAAAACTACCAGTATGGCTAATCCC ACAGTGTTTGACCCACAAATCAGTCATGC TAAGGATC G TGGGATGA 1391 TCATCCCA C GATCCTTA 1392 Lys Overproduction TCATTGGGCACACAGTGAACTGCTTTGGCTCTAGAATCAAAGTGA 1393 DHPS TAGGCAACACAGGAA A CAACTCAACCAGAGAAGCCGTCCACGCA Zea mays ACAGAACAGGGATTTGCTGTTGGCATGCATGC Ser157Asn GCATGCATGCCAACAGCAAATCCCTGTTCTGTTGCGTGGACGGCT 1394 AGC-AAC TCTCTGGTTGAGTTG T TTCCTGTGTTGCCTATCACTTTGATTCTAG AGCCAAAGCAGTTCACTGTGTGCCCAATGA CACAGGAA A CAACTCAA 1395 TTGAGTTG T TTCCTGTG 1396 Lys Overproduction GCTCTAGAATCAAAGTGATAGGCAACACAGGAAGCAACTCAACCA 1397 DHPS GAGAAGCCGTCCACG A AACAGAACAGGGATTTGCTGTTGGCATG Zea mays CATGCGGCTCTCCACATCAATCCTTACTACGG Ala166Val CCGTAGTAAGGATTGATGTGGAGAGCCGCATGCATGCCAACAGC 1398 GCA-GAA AAATCCCTGTTCTGTT T CGTGGACGGCTTCTCTGGTTGAGTTGCTT CCTGTGTTGCCTATCACTTTGATTCTAGAGC CGTCCACG A AACAGAAC 1399 GTTCTGTT T CGTGGACG 1400 Lys Overproduction GGCTCTAGAATCAAAGTGATAGGCAACACAGGAAGCAACTCAACC 1401 DHPS AGAGAAGCCGTCCAC A CAACAGAACAGGGATTTGCTGTTGGCAT Zea mays GCATGCGGCTCTCCACATCAATCCTTACTACG Ala166Thr CGTAGTAAGGATTGATGTGGAGAGCCGCATGCATGCCAACAGCA 1402 GCA-ACA AATCCCTGTTCTGTTG T GTGGACGGCTTCTCTGGTTGAGTTGCTTC CTGTGTTGCCTATCACTTTGATTCTAGAGCC CCGTCCAC A CAACAGAA 1403 TTCTGTTG T GTGGACGG 1404 Lys Overproduction TTATTGGGCATACAGTTAACTGCTTTGGCACTAAAATTAAAGTGGT 1405 DHPS CGGCAACACAGGAA A TAACTCAACAAGGGAGGCTATTCACGCAAC Oryza sativa TGAGCAGGGATTCGCTGTAGGTATGCACGC Ser24Asn GCGTGCATACCTACAGCGAATCCCTGCTCAGTTGCGTGAATAGCC 1406 AGT-AAT TCCCTTGTTGAGTTA T TTCCTGTGTTGCCGACCACTTTAATTTTAGT GCCAAAGCAGTTAACTGTATGCCCAATAA CACAGGAA A TAACTCAA 1407 TTGAGTTA T TTCCTGTG 1408 Lys Overproduction GCACTAAAATTAAAGTGGTCGGCAACACAGGAAGTAACTCAACAA 1409 DHPS GGGAGGCTATTCACGTAACTGAGCAGGGATTCGCTGTAGGTATG Oryza sativa CACGCGGCTCTCCACATCAATCCTTACTACGG Ala133Val CCGTAGTAAGGATTGATGTGGAGAGCCGCGTGCATACCTACAGC 1410 GCA-GTA GAATCCCTGCTCAGTT A CGTGAATAGCCTCCCTTGTTGAGTTACTT CCTGTGTTGCCGACCACTTTAATTTTAGTGC TATTCACG T AACTGAGC 1411 GCTCAGTT A CGTGAATA 1412 Lys Overproduction GGCACTAAAATTAAAGTGGTCGGCAACACAGGAAGTAACTCAACA 1413 DHPS AGGGAGGCTATTCACACAACTGAGCAGGGATTCGCTGTAGGTAT Oryza sativa GCACGCGGCTCTCCACATCAATCCTTACTACG Ala133Thr CGTAGTAAGGATTGATGTGGAGAGCCGCGTGCATACCTACAGCG 1414 GCA-ACA AATCCCTGCTCAGTTG T GTGAATAGCCTCCCTTGTTGAGTTACTTC CTGTGTTGCCGACCACTTTAATTTTAGTGCC CTATTCAC A CAACTGAG 1415 CTCAGTTG T GTGAATAG 1416 Lys Overproduction TCATCGGGCATACTGTTAACTGCTTTGGAGCCAACATTAAAGTGAT 1417 DHPS 1 AGGCAACACGGGAA A TAACTCAACCAGAGAAGCTGTTCACGCGA Triticum aestivum CAGAGCAGGGATTTGCTGTTGGCATGCATGC Ser65Asn GCATGCATGCCAACAGCAAATCCCTGCTCTGTCGCGTGAACAGCT 1418 AGT-AAT TCTCTGGTTGAGTTA T TTCCCGTGTTGCCTATCACTTTAATGTTGG CTCCAAAGCAGTTAACAGTATGCCCGATGA CACGGGAA A TAACTCAA 1419 TTGAGTTA T TTCCCGTG 1420 Lys Overproduction GAGCCAACATTAAAGTGATAGGCAACACGGGAAGTAACTCAACCA 1421 DHPS 1 GAGAAGCTGTTCACGTGACAGAGCAGGGATTTGCTGTTGGCATG Triticum aestivum CATGCAGCTCTTCATGTCAATCCTTACTACGG Ala174Val CCGTAGTAAGGATTGACATGAAGAGCTGCATGCATGCCAACAGCA 1422 GCG-GTG AATCCCTGCTCTGTC A CGTGAACAGCTTCTCTGGTTGAGTTACTTC CCGTGTTGCCTATCACTTTAATGTTGGCTC TGTTCACG T GACAGAGC 1423 GCTCTGTC A CGTGAACA 1424 Lys Overproduction GGAGCCAACATTAAAGTGATAGGCAACACGGGAAGTAACTCAACC 1425 DHPS 1 AGAGAAGCTGTTCAC A CGACAGAGCAGGGATTTGCTGTTGGCAT Triticum aestivum GCATGCAGCTCTTCATGTCAATCCTTACTACG Ala174Thr CGTAGTAAGGATTGACATGAAGAGCTGCATGCATGCCAACAGCAA 1426 GCG-ACG ATCCCTGCTCTGTCG T GTGAACAGCTTCTCTGGTTGAGTTACTTCC CGTGTTGCCTATCACTTTAATGTTGGCTCC CTGTTCAC A GGACAGAG 1427 CTCTGTCG T GTGAACAG 1428 Lys Overproduction TCATCGGGCACACTGTTAACTGCTTTGGAACTAACATTAAAGTGAT 1429 DHPS 2 AGGCAACACGGGAA A TAACTCAACTAGAGAAGCGATTCACGCTTC Triticum aestivum AGAGCAGGGATTTGCTGTTGGCATGCATGC Ser154Asn GCATGCATGCCAACAGCAAATCCCTGCTCTGAAGCGTGAATCGCT 1430 AGT-AAT TCTCTAGTTGAGTTA T TTCCCGTGTTGCCTATCACTTTAATGTTAGT TCCAAAGCAGTTAACAGTGTGCCCGATGA CACGGGAA A TAACTCAA 1431 TTGAGTTA T TTCCCGTG 1432 Lys Overproduction GAACTAACATTAAAGTGATAGGCAACACGGGAAGTAACTCAACTA 1433 DHPS 2 GAGAAGCGATTCACGTTTCAGAGCAGGGATTTGCTGTTGGCATGC Triticum aestivum ATGCAGCTCTCCATGTCAATCCTTACTATGG Ala163Val CCATAGTAAGGATTGACATGGAGAGCTGCATGCATGCCAACAGCA 1434 GCT-GTT AATCCCTGCTCTGAA A CGTGAATCGCTTCTCTAGTTGAGTTACTTC CCGTGTTGCCTATCACTTTAATGTTAGTTC GATTCACG T TTCAGAGC 1435 GCTCTGAA A CGTGAATC 1436 Lys Overproduction GGAACTAACATTAAAGTGATAGGCAACACGGGAAGTAACTCAACT 1437 DHPS 2 AGAGAAGCGATTCACACTTCAGAGCAGGGATTTGCTGTTGGCATG Triticum aestivum CATGCAGCTCTCCATGTCAATCCTTACTATG Ala163Thr CATAGTAAGGATTGACATGGAGAGCTGCATGCATGCCAACAGCAA 1438 GCT-ACT ATCCCTGCTCTGAAG T GTGAATCGCTTCTCTAGTTGAGTTACTTCC CGTGTTGCCTATCACTTTAATGTTAGTTCC CGATTCAC A CTTCAGAG 1439 CTCTGAAG T GTGAATCG 1440 Lys Overproduction CTCATTGGGCATACTGTGAACTGCTTTGGCTCTAGAATTAAAGTGA 1441 DHPS TAGGCAACACAGGAA A TAACTCAACCAGAGAAGCTGTTCACGCAA Coix lacryma-jobi CAGAGCAGGGATTTGCTGTTGGCATGCATG Ser154Asn CATGCATGCCAACAGCAAATCCCTGCTCTGTTGCGTGAACAGCTT 1442 AGT-AAT CTCTGGTTGAGTTA T TTCCTGTGTTGCCTATCACTTTAATTCTAGA GCCAAAGCAGTTCACAGTATGCCCAATGAG CACAGGAA A TAACTCAA 1443 TTGAGTTA T TTCCTGTG 1444 Lys Overproduction GCTCTAGAATTAAAGTGATAGGCAACACAGGAAGTAACTCAACCA 1445 DHPS GAGAAGCTGTTCACG T AACAGAGCAGGGATTTGCTGTTGGCATGC Coix lacryma-jobi ATGCAGCTCTCCACATCAATCCTTACTATGG Ala163Val CCATAGTAAGGATTGATGTGGAGAGCTGCATGCATGCCAACAGCA 1446 GCA-GTA AATCCCTGCTCTGTT A CGTGAACAGCTTCTCTGGTTGAGTTACTTC CTGTGTTGCCTATCACTTTAATTCTAGAGC TGTTCACG T AACAGAGC 1447 GCTCTGTT A CGTGAACA 1448 Lys Overproduction GGCTCTAGAATTAAAGTGATAGGCAACACAGGAAGTAACTCAACC 1449 DHPS AGAGAAGCTGTTCAC A CAACAGAGCAGGGATTTGCTGTTGGCATG Coix lacryma-jobi CATGCAGCTCTCCACATCAATCCTTACTATG Ala163Thr CATAGTAAGGATTGATGTGGAGAGCTGCATGCATGCCAACAGCAA 1450 GCA-ACA ATCCCTGCTCTGTTG T GTGAACAGCTTCTCTGGTTGAGTTACTTCC TGTGTTGCCTATCACTTTAATTCTAGAGCC CTGTTCAC A CAACAGAG 1451 CTCTGTTG T GTGAACAG 1452 Lys Overproduction TCATTGGTCACACAGTCAATTGTTTTGGAGGGTCCATCAAAGTCAT 1453 DHPS CGGGAACACTGGAA A CAACTCCACAAGGGAAGCAATCCATGCAA Nicotiana tabacum CTGAACAGGGATTTGCTGTAGGTATGCATGC Ser136Asn GCATGCATACCTACAGCAAATCCCTGTTCAGTTGCATGGATTGCTT 1454 AGC-AAC CCCTTGTGGAGTTG T TTCCAGTGTTCCCGATGACTTTGATGGACC CTCCAAAACAATTGACTGTGTGACCAATGA CACTGGAA A CAACTCCA 1455 TGGAGTTG T TTCCAGTG 1456 Lys Overproduction GAGGGTCCATCAAAGTCATCGGGAACACTGGAAGCAACTCCACAA 1457 DHPS GGGAAGCAATCCATG T AACTGAACAGGGATTTGCTGTAGGTATGC Nicotiana tabacum ATGCAGCTCTTCACATTAATCCCTACTATGG Ala145Val CCATAGTAGGGATTAATGTGAAGAGCTGCATGCATACCTACAGCA 1458 GCA-GTA AATCCCTGTTCAGTT A CATGGATTGCTTCCCTTGTGGAGTTGCTTC CAGTGTTCCCGATGACTTTGATGGACCCTC AATCCATG T AACTGAAC 1459 GTTCAGTT A CATGGATT 1460 Lys Overproduction GGAGGGTCCATCAAAGTCATCGGGAACACTGGAAGCAACTCCAC 1461 DHPS AAGGGAAGCAATCCAT A CAACTGAACAGGGATTTGCTGTAGGTAT Nicotiana tabacum GCATGCAGCTCTTCACATTAATCCCTACTATG Ala145Thr CATAGTAGGGATTAATGTGAAGAGCTGCATGCATACCTACAGCAA 1462 GCA-ACA ATCCCTGTTCAGTTG T ATGGATTGCTTCCCTTGTGGAGTTGCTTCC AGTGTTCCCGATGACTTTGATGGACCCTCC CAATCCAT A CAACTGAA 1463 TTCAGTTG T ATGGATTG 1464 Lys Overproduction TTATAGGCCATACCGTTAACTGTTTTGGCGGAAGCATCAAAGTCAT 1465 DHPS TGGAAACACTGGAA A CAATTCGACTAGAGAAGCAATCCACGCGAC Arabidopsis thaliana TGAACAAGGATTCGCGGTTGGAATGCATGC Ser142Asn GCATGCATTCCAACCGCGAATCCTTGTTCAGTCGCGTGGATTGCT 1466 AGC-AAC TCTCTAGTCGAATTG T TTCCAGTGTTTCCAATGACTTTGATGCTTC CGCCAAAACAGTTAACGGTATGGCCTATAA CACTGGAA A CAATTCGA 1467 TCGAATTG T TTCCAGTG 1468 Lys Overproduction GCGGAAGCATCAAAGTCATTGGAAACACTGGAAGCAATTCGACTA 1469 DHPS GAGAAGCAATCCACG T GACTGAACAAGGATTCGCGGTTGGAATG Arabidopsis thaliana CATGCTGCTCTTCATATAAACCCTTACTATGG Ala151Val CCATAGTAAGGGTTTATATGAAGAGCAGCATGCATTCCAACCGCG 1470 GCG-GTG AATCCTTGTTCAGTC A CGTGGATTGCTTCTCTAGTCGAATTGCTTC CAGTGTTTCCAATGACTTTGATGCTTCCGC AATCCACG T GACTGAAC 1471 GTTCAGTC A CGTGGATT 1472 Lys Overproduction GGCGGAAGCATCAAAGTCATTGGAAACACTGGAAGCAATTCGACT 1473 DHPS AGAGAAGCAATCCAC A CGACTGAACAAGGATTCGCGGTTGGAAT Arabidopsis thaliana GCATGCTGCTCTTCATATAAACCCTTACTATG Ala151Thr CATAGTAAGGGTTTATATGAAGAGCAGCATGCATTCCAACCGCGA 1474 GCG-ACG ATCCTTGTTCAGTCG T GTGGATTGCTTCTCTAGTCGAATTGCTTCC AGTGTTTCCAATGACTTTGATGCTTCCGCC CAATCCAC A CGACTGAA 1475 TTCAGTCG T GTGGATTG 1476 Lys Overproduction TTATTGCTCATACAGTCAACTGTTTTGGTGGGAAAATTAAGGTTAT 1477 DHPS TGGAAATACTGGAA A CAACTCCACCAGGGAAGCAATTCATGCCAC Glycine max TGAGCAGGGTTTTGCTGTTGGAATGCATGC Ser103Asn GCATGCATTCCAACAGCAAAACCCTGCTCAGTGGCATGAATTGCT 1478 AGC-AAC TCCCTGGTGGAGTTGTTTCCAGTATTTCCAATAACCTTAATTTTCC CACCAAAACAGTTGACTGTATGAGCAATAA TACTGGAA A CAACTCCA 1479 TGGAGTTG T TTCCAGTA 1480 Lys Overproduction GTGGGAAAATTAAGGTTATTGGAAATACTGGAAGCAACTCCACCA 1481 DHPS GGGAAGCAATTCATG T CACTGAGCAGGGTTTTGCTGTTGGAATGC Glycine max ATGCTGCCCTTCACATAAACCCTTACTATGG Ala112Val CCATAGTAAGGGTTTATGTGAAGGGCAGCATGCATTCCAACAGCA 1482 GCC-GTC AAACCCTGCTCAGTG A CATGAATTGCTTCCCTGGTGGAGTTGCTT CCAGTATTTCCAATAACCTTAATTTTCCCAC AATTCATG T CACTGAGC 1483 GCTCAGTG A CATGAATT 1484 Lys Overproduction GGTGGGAAAATTAAGGTTATTGGAAATACTGGAAGCAACTCCACC 1485 DHPS AGGGAAGCAATTCAT A CCACTGAGCAGGGTTTTGCTGTTGGAATG Glycine max CATGCTGCCCTTCACATAAACCCTTACTATG Ala112Thr CATAGTAAGGGTTTATGTGAAGGGCAGCATGGATTCCAACAGCAA 1486 GCC-ACC AACCCTGCTCAGTGG T ATGAATTGCTTCCCTGGTGGAGTTGCTTC CAGTATTTCCAATAACCTTAATTTTCCCACC CAATTCAT A CCACTGAG 1487 CTCAGTGG T ATGAATTG 1488 Trp Overproduction CTTGCAGGAGACATATTTCAGATCGTGCTGAGTCAACGTTTTGAG 1489 AS CGGCGAACATTTGCA A ACCCCTTTGAAGTTTATAGAGCACTAAGA Arabidopsis thaliana GTTGTGAATCCAAGTCCGTATATGGGTTATT Asp341Asn AATAACCCATATACGGACTTGGATTCACAACTCTTAGTGCTCTATA 1490 GAG-AAC AACTTCAAAGGGGT T TGCAAATGTTCGCCGCTCAAAACGTTGACT CAGCACGATCTGAAATATGTCTCCTGCAAG CATTTGCA A ACCCCTTT 1491 AAAGGGGT T TGCAAATG 1492 Trp Overproduction GCTGCAGGAGACATATTTCAAATCGTTTTAAGTCAACGCTTTGAGA 1493 AS GAAGAACATTTGCT A ACCCATTTGAAGTGTACAGAGCATTAAGAAT Nicotiana tabacum TGTGAATCCAAGCCCATATATGACTTACA Asp326Asn TGTAAGTCATATATGGGCTTGGATTCACAATTCTTAATGCTCTGTA 1494 GAC-AAC CACTTCAAATGGGT T AGCAAATGTTCTTCTCTCAAAGCGTTGACTT AAAACGATTTGAAATATGTCTCCTGCAGC CATTTGCT A ACCCATTT 1495 AAATGGGT T AGCAAATG 1496 Trp Overproduction CTAGCTGGTGACATTTTTCAAGTAGTCTTAAGCCAGCGTTTTGAGA 1497 AS GGCGTACATTTGCT A ACCCCTTTGAGGTGTACCGTGCATTGCGTA Oryza sativa TTGTCAATCCTAGTCCTTATATGGCCTATC Asp323Asn GATAGGCCATATAAGGACTAGGATTGACAATACGCAATGCACGGT 1498 GAC-AAC ACACCTCAAAGGGGT T AGCAAATGTACGCCTCTCAAAACGCTGGC TTAAGACTACTTGAAAAATGTCACCAGCTAG CATTTGCT A ACCCCTTT 1499 AAAGGGGT T AGCAAATG 1500 Trp Overproduction CTTGCTGGTGACATATTCCAGATCGTACTAAGTCAGCGTTTTGAAA 1501 AS GGCGAACGTTCGCA A ACCCATTTGAAATCTATAGATCACTGAGGA Ruta graveolens TTGTTAATCCAAGCCCATATATGACTTATT Asp354Asn AATAAGTCATATATGGGCTTGGATTAACAATCCTCAGTGATCTATA 1502 GAC-AAC GATTTCAAATGGGT T TGCGAACGTTCGCCTTTCAAAACGCTGACTT AGTACGATCTGGAATATGTCACCAGCAAG CGTTCGCA A ACCCATTT 1503 AAATGGGT T TGCGAACG 1504 Trp Overproduction CTGGCTGGGGACATATTCCAGCTTGTCCTAAGTCAGCGTTTTGAA 1505 AS CGGCGAACATTTGCA A ATCCATTTGAAGTCTACCGAGCATTGAGA Catharanthus roseus ATTGTCAACCCAAGTCCATATATGACTTATT Asp354Asn AATAAGTCATATATGGACTTGGGTTGACAATTCTCAATGCTCGGTA 1506 GAT-AAT GACTTCAAATGGAT T TGCAAATGTTCGCCGTTCAAAACGCTGACTT AGGACAAGCTGGAATATGTCCCCAGCCAG CATTTGCA A ATCCATTT 1507 AAATGGAT T TGCAAATG 1508 - A principal aim of biotechnology is the improvement of crop plants for food value, agriculture, and to produce a range of plant-derived raw materials. Along with oils, fats and proteins, polysaccharides constitute the main raw materials derived from plants, and apart from cellulose, the storage polymer starch is the most important polysaccharide raw material. Starch is derived from a range of plants, but maize is the most important cultivated plant for the production of starch.
- The polysaccharide starch is a polymer made up of glucose molecules. However, starch is not a homogeneous raw material and is, in fact, a highly complex mixture of various types of molecules which differ from each other, for example, in their degree of polymerization and in the degree of branching of the glucose chains. For example, amylose-starch is a basically non-branched polymer made up of α-1,4-glycosidically branched glucose molecules, and amylopectin-starch is a complex mixture of variously branched glucose chains. The branching results from additional α-1,6-glycosidic linkages. In plants from which starch is typically isolated, for example maize or potato, the starch is approximately 25% amylose-starch and 75% amylopectin-starch.
- In maize, various mutants in starch metabolism are known, for example waxy, sugary, shrunken and opaque-2. In addition to producing a modified starch, these mutations greatly improve grain quality in maize, and thus expand the use of maize not only as the food but also for the important industrial materials in food chemistry. It would therefore be advantageous to be able readily to obtain mutants in these genes in particular maize genotypes as well as other plants. Such plants can be obtained, for example, using traditional breeding methods and through specific genetic modification by means of recombinant DNA techniques.
- The attached tables disclose exemplary oligonucleotide base sequences which can be used to generate site-specific mutations in genes involved in starch metabolism.
TABLE 20 Genome-Altering Oligos Conferring Increased Starch Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Increased Starch GAACTTGAGACTGAGAAAAGGGATCCAAGGACAGTTGCTTCCATT 1509 ADPGPP ATTCTTGGAGGTGGA AA AGGAACTCGACTCTTTCCTCTCACAAAA Arabidopsis thaliana CGCCGCGCCAAGCCTGCCGTTCCTATCGGGG Ala99Lys CCCCGATAGGAACGGCAGGCTTGGCGCGGCGTTTTGTGAGAGGA 1510 GCA-AAA AAGAGTCGAGTTCCT TT TCCACCTCCAAGAATAATGGAAGCAACT GTCCTTGGATCCCTTTTCTCAGTCTCAAGTTC GAGGTGGA AA AGGAACT 1511 AGTTCCT TT TCCACCTC 1512 Increased Starch CAAAACGCCGCGCCAAGCCTGCCGTTCCTATCGGGGGAGCCTAT 1513 ADPGPP AGGTTGATAGATGTAC T AATGAGCAATTGTATTAACAGCGGAATCA Arabidopsis thaliana ACAAAGTCTACATACTCACACAATATAACTC Pro127Leu GAGTTATATTGTGTGAGTATGTAGACTTTGTTGATTCCGCTGTTAA 1514 CCA-CTA TACAATTGCTCATT A GTACATCTATCAACCTATAGGCTCCCCCGAT AGGAACGGCAGGCTTGGCGCGGCGTTTTG AGATGTAC T AATGAGCA 1515 TGCTCATT A GTACATCT 1516 Increased Starch TCACACAATATAACTCAGCATCATTGAACAGGCATTTAGCCCGTGC 1517 ADPGPP TTACAACTCCAAT AAT CTTGGCTTTGGAGATGGCTATGTTGAGGTT Arabidopsis thaliana CTTGCGGCCACTCAAACGCCAGGAGAATC Gly162Asn GATTCTCCTGGCGTTTGAGTGGCCGCAAGAACCTCAACATAGCCA 1518 GGA-AAT TCTCCAAAGCCAAG ATT ATTGGAGTTGTAAGCACGGGGTAAATGC CTGTTCAATGATGCTGAGTTATATTGTGTGA CTCCAAT AAT CTTGGCT 1519 AGCCAAG ATT ATTGGAG 1520 Increased Starch TCACACAATATAACTCAGCATCATTGAACAGGCATTTAGCCCGTGC 1521 ADPGPP TTACAACTCCAAT AAC CTTGGCTTTGGAGATGGCTATGTTGAGGTT Arabidopsis thaliana CTTGCGGCCACTCAAACGCCAGGAGAATC Gly162Asn GATTCTCCTGGCGTTTGAGTGGCCGCAAGAACCTCAACATAGCCA 1522 GGA-AAC TCTCCAAAGCCAAG GTT ATTGGAGTTGTAAGCACGGGCTAAATGC CTGTTCAATGATGCTGAGTTATATTGTGTGA CTCCAAT AAC CTTGGCT 1523 AGCCAAG GTT ATTGGAG 1524 Increased Starch GTTTGAGAGAAGAAAGGTAGACCCGCAAAATGTGGCTGCAATCAT 1525 ADPGPP TCTAGGAGGAGGCAA A GGAGCTAAACTCTTCCCTCTTACAATGAG Arabidopsis thaliana AGCCGCAACACCAGCTGTAAATATTCATCTT Asn100Lys AAGATGAATATTTACAGCTGGTGTTGCGGCTCTCATTGTAAGAGG 1526 AAT-AAA GAAGAGTTTAGCTCC T TTGCCTCCTCCTAGAATGATTGCAGCCAC ATTTTGCGGGTCTACCTTTCTTCTCTCAAAC GGAGGCAA A GGAGCTAA 1527 TTAGCTCC T TTGCCTCC 1528 Increased Starch CTTGTGTCTTCAAATTATGTTAGGTTCCTGTTGGTGGATGCTACAG 1529 ADPGPP GCTGATCGATATCC T GATGAGTAACTGTATTAACAGCTGCATCAAC Arabidopsis thaliana AAGATATTTGTGCTGACACAGTTCAACTC Pro128Leu GAGTTGAACTGTGTCAGCACAAATATCTTGTTGATGCAGCTGTTAA 1530 CCG-CTG TACAGTTACTCATC A GGATATCGATCAGCCTGTAGCATCCACCAA CAGGAACCTAACATAATTTGAAGACACAAG CGATATCC T GATGAGTA 1531 TACTCATC A GGATATCG 1532 Increased Starch TGACACAGTTCAACTCAGCTTCCCTTAATCGACATTTAGCACGAAC 1533 ADPGPP TTATTTTGGGAAT AAT ATAAACTTTGGAGGTGGTTTCGTAGAGGTA Arabidopsis thaliana CAAACACTATGACAATAATAACTCTCAGC Gly163Asn GCTGAGAGTTATTATTGTCATAGTGTTTGTACCTCTACGAAACCAC 1534 GGC-AAT CTCCAAAGTTTAT ATT ATTCCCAAAATAAGTTCGTGCTAAATGTCG ATTAAGGGAAGCTGAGTTGAACTGTGTCA TGGGAAT AAT ATAAACT 1535 AGTTTAT ATT ATTCCCA 1536 Increased Starch TGACACAGTTCAACTCAGCTTCCCTTAATCGACATTTAGCACGAAC 1537 ADPGPP TTATTTTGGGAAT AAC ATAAACTTTGGAGGTGGTTTCGTAGAGGTA Arabidopsis thaliana CAAACACTATGACAATAATAACTCTCAGC Gly163Asn GCTGAGAGTTATTATTGTCATAGTGTTTGTACCTCTACGAAACCAC 1538 GGC-AAC CTCCAAAGTTTAT GTT ATTCCCAAAATAAGTTCGTGCTAAATGTCG ATTAAGGGAAGCTGAGTTGAACTGTGTCA TGGGAAT AAC ATAAACT 1539 AGTTTAT GTT ATTCCCA 1540 Increased Starch TTGAGGAACAACCAACGGCAGATCCAAAAGCTGTTGCCTCTGTCA 1541 ADPGPP TTCTAGGTGGTGGT AAA GGAACTCGTCTTTTTCCTCTTACAAGCA Lycopersicon GAAGAGCTAAACCAGCTGTTCCTATTGGTGG esculentum CCACCAATAGGAACAGCTGGTTTAGCTCTTCTGCTTGTAAGAGGA 1542 Val94Lys AAAAGACGAGTTCC TTT ACCACCACCTAGAATGACAGAGGCAACA GTT-AAA GCTTTTGGATCTGCCGTTGGTTGTTCCTCAA TGGTGGT AAA GGAACTC 1543 GAGTTCC TTT ACCACCA 1544 Increased Starch CAAGCAGAAGAGCTAAACCAGCTGTTCCTATTGGTGGTTGTTACC 1545 ADPGPP GGCTAATTGATGTAC A AATGAGTAACTGCATTAACAGTGGCATAC Lycopersicon GGAAAATTTTCATCTTAACACAGTTCAATTC esculentum GAATTGAACTGTGTTAAGATGAAAATTTTCCGTATGCCACTGTTAA 1546 Pro122Leu TGCAGTTACTCATT T GTACATCAATTAGCCGGTAACAACCACCAAT CCA-CAA AGGAACAGCTGGTTTAGCTCTTCTGGTTG TGATGTAC A AATGAGTA 1547 TACTCATT T GTACATCA 1548 Increased Starch CACAGTTCAATTCCTTTTCCCTCAATCGTCACCTTGCCCGCACGTA 1549 ADPGPP TAATTTTGGAAAT AAT GTGGGTTTTGGAGATGGATTTGTGGAGGTT Lycopersicon TTAGCTGCAACCCAGACTCCAGGGGATGC esculentum GCATCCCCTGGAGTCTGGGTTGCAGCTAAAACCTCCACAAATCCA 1550 Gly158Asn TCTCCAAAACCCAC ATT ATTTCCAAAATTATACGTGCGGGCAAGGT GGA-AAT GACGATTGAGGGAAAAGGAATTGAACTGTG TGGAAAT AAT GTGGGTT 1551 AACCCAC ATT ATTTCCA 1552 Increased Starch CACAGTTCAATTCCTTTTCCCTCAATCGTCACCTTGCCCGCACGTA 1553 ADPGPP TAATTTTGGAAAT AAC GTGGGTTTTGGAGATGGATTTGTGGAGGT Lycopersicon TTTAGCTGCAACCCAGACTCCAGGGGATGC esculentum GCATCCCCTGGAGTCTGGGTTGCAGCTAAAACCTCCACAAATCCA 1554 Gly158Asn TCTCCAAAACCCAC GTT ATTTCCAAAATTATACGTGCGGGCAAGGT GGA-AAC GACGATTGAGGGAAAAGGAATTGAACTGTG TGGAAAT AAC GTGGGTT 1555 AACCCAC GTT ATTTCCA 1556 Increased Starch ACGTAGATTTGGAAAAAAGAGACCCAAGTACAGTTGTAGCAATTAT 1557 ADPGPP ACTAGGTGGAGGT AAA GGAACTCGTCTCTTCCCTCTCACCAAGCG Cicer arietinum ACGAGCCAAGCCTGCTGTTCCAATTGGAGG Ala101Lys CCTCCAATTGGAACAGCAGGCTTGGCTCGTCGCTTGGTGAGAGG 1558 GCT-AAA GAAGAGACGAGTTCC TTT ACCTCCACCTAGTATAATTGCTACAACT GTACTTGGGTCTCTTTTTTCCAAATCTACGT TGGAGGT AAA GGAACTC 1559 GAGTTCC TTT ACCTCCA 1560 Increased Starch CCAAGCGACGAGCCAAGCCTGCTGTTCCAATTGGAGGTGCTTATA 1561 ADPGPP GGCTGATAGATGTAC T AATGAGTAACTGCATCAATAGTGGGATCA Cicer arietinum ACAAAGTATACATTCTCACTCAATTTAATTC Pro129Leu GAATTAAATTGAGTGAGAATGTATACTTTGTTGATCCCACTATTGA 1562 CCA-CTA TGCAGTTACTCATT A GTACATCTATCAGCCTATAAGCACCTCCAAT TGGAACAGCAGGCTTGGCTCGTCGCTTGG AGATGTAC T AATGAGTA 1563 TACTCATT A GTACATCT 1564 Increased Starch CTCAATTTAATTCAGCCTCACTCAACAGGCATATTGCACGTGCTTA 1565 ADPGPP TAACTCTGGTACT AAT GTCACTTTTGGAGATGGCTATGTTGAGGTT Cicer arietinum CTTGCAGCAACTCAAACTCCAGGGGAGCA Gly165Asn TGCTCCCGTGGAGTTTGAGTTGCTGCAAGAACCTCAACATAGCCA 1566 GGA-AAT TCTCCAAAAGTGAC ATT AGTACCAGAGTTATAAGCACGTGCAATAT GCCTGTTGAGTGAGGCTGAATTAAATTGAG TGGTACT AAT GTCACTT 1567 AAGTGAC ATT AGTACCA 1568 Increased Starch CTCAATTTAATTCAGCCTCACTCAACAGGCATATTGCACGTGCTTA 1569 ADPGPP TAACTCTGGTACT AAC GTCACTTTTGGAGATGGCTATGTTGAGGTT Cicer arietinum CTTGCAGCAACTCAAACTCCAGGGGAGCA Gly165Asn TGCTCCCCTGGAGTTTGAGTTGCTGCAAGAACCTCAACATAGCCA 1570 GGA-AAC TCTCCAAAAGTGAC GTT AGTACCAGAGTTATAAGCACGTGCAATAT GCCTGTTGAGTGAGGCTGAATTAAATTGAG TGGTACT AAC GTCACTT 1571 AAGTGAC GTT AGTACCA 1572 Increased Starch ATATTGGAGAGGCGTCGGGCAAACCCTAAGAATGTGGCTGCAATC 1573 ADPGPP ATACTGCCAGGCGGT AA AGGGACACACCTATTCCCTCTCACCAAT Ipomoea batatas CGAGCTGCAACCCCTGCTGTTCCACTTGGAG Ala94Lys CTCCAAGTGGAACAGCAGGGGTTGCAGCTCGATTGGTGAGAGGG 1574 GCA-AAA AATAGGTGTGTCCCT TT ACCGCCTGGCAGTATGATTGCAGCCACA TTCTTAGGGTTTGCCCGACGCCTCTCCAATAT CAGGCGGT AA AGGGACA 1575 TGTCCCT TT ACCGCCTG 1576 Increased Starch CCAATCGAGCTGCAACCCCTGCTGTTCCACTTGGAGGATGCTATA 1577 ADPGPP GGTTGATCGACATTC T AATGAGCAACTGCATCAACAGCGGGGTTA Ipomoea batatas ACAAGATCTTTGTGCTGACCCAGTTCAATTC Pro122Leu GAATTGAACTGGGTCAGCACAAAGATCTTGTTAACCCCGCTGTTG 1578 CCA-CTA ATGCAGTTGCTCATT A GAATGTCGATCAACCTATAGCATCCTCCAA GTGGAACAGCAGGGGTTGCAGCTCGATTGG CGACATTC T AATGAGCA 1579 TGCTCATT A GAATGTCG 1580 Increased Starch TGACCCAGTTCAATTCAGCTTCTCTTAACCGTCACATTTCCCGTAC 1581 ADPGPP CGTCTTTGGCAAT AAT GTGAGCTTCGGAGATGGATTTGTTGAGGT Ipomoea batatas GCTGGCTGCAACCCAAACACAAGGGGAAAC Gly157Asn GTTTCCCCTTGTGTTTGGGTTGCAGCCAGCACCTCAACAAATCCA 1582 GGT-AAT TCTCCGAAGCTCAC ATT ATTGCCAAAGACGGTACGGGAAATGTGA CGGTTAAGAGAAGCTGAATTGAACTGGGTCA TGGCAAT AAT GTGAGCT 1583 AGCTCAC ATT ATTGCCA 1584 Increased Starch TGACCCAGTTCAATTCAGCTTCTCTTAACCGTCACATTTCCCGTAC 1585 ADPGPP CGTCTTTGGCAAT AAC GTGAGCTTCGGAGATGGATTTGTTGAGGT Ipomoea batatas GCTGGCTGCAACCCAAACACAAGGGGAAAC Gly157Asn GTTTCCCCTTGTGTTTGGGTTGCAGCCAGCACCTCAACAAATCCA 1586 GGT-AAC TCTCCGAAGCTCAC GTT ATTGCCAAAGACGGTACGGGAAATGTGA CGGTTAAGAGAAGCTGAATTGAACTGGGTCA TGGCAAT AAC GTGAGCT 1587 AGCTCAC GTT ATTGCCA 1588 Increased Starch CATTCCGGAGGAACTTTGCGGATCCAAATGAGGTTGCTGCTGTTA 1589 ADPGPP TATTGGGTGGTGGCA AA GGGACTCAACTTTTTCCTCTCACAAGCA Oryza sativa CAAGGGCCACGCCTGCTGTTCCTATTGGAGG Thr96Lys CCTCCAATAGGAACAGCAGGCGTGGCCCTTGTGCTTGTGAGAGG 1590 ACC-AAA AAAAAGTTGAGTCCC TT TGCCACCACCCAATATAACAGCAGCAAC CTCATTTGGATCCGCAAAGTTCCTCCGGAATG TGGTGGCA AA GGGACTC 1591 GAGTCCC TT TGCCACCA 1592 Increased Starch CAAGCACAAGGGCCACGCCTGCTGTTCCTATTGGAGGATGCTATA 1593 ADPGPP GGCTTATCGATATCC T CATGAGCAACTGTTTCAACAGTGGCATAAA Oryza sativa CAAGATATTCATAATGACTCAATTCAACTC Pro124Leu GAGTTGAATTGAGTCATTATGAATATCTTGTTTATGCCACTGTTGA 1594 CCC-CTC AACAGTTGCTCATG A GGATATCGATAAGCCTATAGCATCCTCCAAT AGGAACAGCAGGCGTGGCCCTTGTGCTTG CGATATCC T CATGAGCA 1595 TGCTCATG A GGATATCG 1596 Increased Starch TGACTCAATTCAACTCAGCATCTCTTAATCGTCACATTCATCGTAC 1597 ADPGPP GTACCTTGGTGGT AAT ATCAACTTTACTGATGGTTCTGTTGAGGTA Oryza sativa TTAGCCGCTACACAAATGCCTGGGGAGGC Gly159Asn GCCTCCCCAGGCATTTGTGTAGCGGCTAATACCTCAACAGAACCA 1598 GGA-AAT TCAGTAAAGTTGAT ATT ACCACCAAGGTACGTACGATGAATGTGA CGATTAAGAGATGCTGAGTTGAATTGAGTCA TGGTGGT AAT ATCAACT 1599 AGTTGAT ATT ACCACCA 1600 Increased Starch TGACTCAATTCAACTCAGCATCTCTTAATCGTCACATTCATCGTAC 1601 ADPGPP GTACCTTGGTGGT AAC ATCAACTTTACTGATGGTTCTGTTGAGGTA Oryza sativa TTAGCCGCTACACAAATGCCTGGGGAGGC Gly159Asn GCCTCCCCAGGCATTTGTGTAGCGGCTAATACCTCAACAGAACCA 1602 GGA-AAC TCAGTAAAGTTGAT GTT ACCACCAAGGTACGTACGATGAATGTGA CGATTAAGAGATGCTGAGTTGAATTGAGTCA TGGTGGT AAC ATCAACT 1603 AGTTGAT GTT ACCACCA 1604 Increased Starch GTCCTTCAGGAGGATTAAGCGATCCGAACGAGGTTGCGGCCGTC 1605 ADPGPP ATACTCGGCGGCGGCA AA GGGACTCAGCTCTTCCCACTCACGAG Triticum aestivum CACAAGGGCCACACCTGCTGTTCCTATTGGAGG Thr80Lys CCTCCAATAGGAACAGCAGGTGTGGCCCTTGTGCTCGTGAGTGG 1606 ACC-AAA GAAGAGCTGAGTCCC TT TGCCGCCGCCGAGTATGACGGCCGCAA CCTCGTTCGGATCGCTTAATCCTCCTGAAGGAC CGGCGGCA AA GGGACTC 1607 GAGTCCC TT TGCCGCCG 1608 Increased Starch CGAGCACAAGGGCCACACCTGCTGTTCCTATTGGAGGATGTTACA 1609 ADPGPP GGCTCATCGACATTC T CATGAGCAACTGCTTCAACAGTGGCATCA Triticum aestivum ACAAGATATTCGTCATGACCCAGTTCAACTC Pro108Leu GAGTTGAACTGGGTCATGACGAATATCTTGTTGATGCCACTGTTG 1610 CCC-CTC AAGCAGTTGCTCATG A GAATGTCGATGAGCCTGTAACATCCTCCA ATAGGAACAGCAGGTGTGGCCCTTGTGCTCG CGACATTC T CATGAGCA 1611 TGCTCATG A GAATGTCG 1612 Increased Starch TGACCCAGTTCAACTCGGCCTCCCTTAATCGTCACATTCACCGCA 1613 ADPGPP CCTACCTCGGCGGG AAT ATCAATTTCACTGATGGATCCGTTGAGG Triticum aestivum TATTGGCCGCGACGCAAATGCCCGGGGAGGC Gly143Asn GCCTCCCCGGGCATTTGCGTCGCGGCCAATACCTCAACGGATCC 1614 GGA-AAT ATCAGTGAAATTGAT ATT CCCGCCGAGGTAGGTGCGGTGAATGTG ACGATTAAGGGAGGCCGAGTTGAACTGGGTCA CGGCGGG AAT ATCAATT 1615 AATTGAT ATT CCCGCCG 1616 Increased Starch TGACCCAGTTCAACTCGGCCTCCCTTAATCGTCACATTCACCGCA 1617 ADPGPP CCTACCTCGGCGGG AAC ATCAATTTCACTGATGGATCCGTTGAGG Triticum aestivum TATTGGCCGCGACGCAAATGCCCGGGGAGGC Gly143Asn GCCTCCCCGGGCATTTGCGTCGCGGCCAATACCTCAACGGATCC 1618 GGA-AAC ATCAGTGAAATTGAT GTT CCCGCCGAGGTAGGTGCGGTGAATGTG ACGATTAAGGGAGGCCGAGTTGAACTGGGTCA CGGCGGG AAC ATCAATT 1619 AATTGAT GTT CCCGCCG 1620 Increased Starch CCTCCCGAAAGAATTATGCTGATGCAAGCCACGTTTCTGCTGTCA 1621 ADPGPP TTTTGGGTGGAGGCA AA GGAGTTCAACTCTTTCCTCTGACAAGCA Oryza sativa CAAGGGCTACCCCCGCTGTTCCTGTTGGAGG Thr95Lys CCTCCAACAGGAACAGCGGGGGTAGCCCTTGTGCTTGTCAGAGG 1622 ACT-AAA AAAGAGTTGAACTCC TT TGCCTCCACCCAAAATGACAGCAGAAAC GTGGCTTGCATCAGCATAATTCTTTCGGGAGG TGGAGGCA AA GGAGTTC 1623 GAACTCC TT TGCCTCCA 1624 Increased Starch CAAGCACAAGGGCTACCCCCGCTGTTCCTGTTGGAGGATGTTACA 1625 ADPGPP GGCTTATTGACATCC T TATGAGCAATTGCTTCAATAGCGGAATAAA Oryza sativa TAAAATATTTGTGATGACTCAGTTCAATTC Pro123Leu GAATTGAACTGAGTCATCACAAATATTTTATTTATTCCGCTATTGAA 1626 CCT-CTT GCAATTGCTCATA A GGATGTCAATAAGCCTGTAACATCCTCCAACA GGAACAGCGGGGGTAGCCCTTGTGCTTG TGACATCC T TATGAGCA 1627 TGCTCATA A GGATGTCA 1628 Increased Starch TGACTCAGTTCAATTCTGCTTCTCTTAATCGCCATATCCATCATACA 1629 ADPGPP TACCTTGGTGGG AAT ATCAACTTTACTGATGGGTCTGTGCAGGTA Oryza sativa TTGGCTGCTACACAAATGCCTGACGAACC Gly158Asn GGTTCGTCAGGCATTTGTGTAGCAGCCAATACCTGCACAGACCCA 1630 GGG-AAT TCAGTAAAGTTGAT ATT CCCACCAAGGTATGTATGATGGATATGGC GATTAAGAGAAGCAGAATTGAACTGAGTCA TGGTGGG AAT ATCAACT 1631 AGTTGATATTCCCACCA 1632 Increased Starch TGACTCAGTTCAATTCTGCTTCTCTTAATCGCCATATCCATCATACA 1633 ADPGPP TACCTTGGTGGG AAC ATCAACTTTACTGATGGGTCTGTGCAGGTA Oryza sativa TTGGCTGCTACACAAATGCCTGACGAACC Gly158Asn GGTTCGTCAGGCATTTGTGTAGCAGCCAATACCTGCACAGACCCA 1634 GGG-AAC TCAGTAAAGTTGAT GTT CCCACCAAGGTATGTATGATGGATATGG CGATTAAGAGAAGCAGAATTGAACTGAGTCA TGGTGGG AAC ATCAACT 1635 AGTTGAT GTT CCCACCA 1636 Increased Starch CCTTCCGCAGGAATTACGCCGATCCGAACGAGGTCGCGGCCGTC 1637 ADPGPP ATACTCGGCGGTGGCAAAGGGACTCAGCTCTTCCCTCTCACAAG Triticum pestivum CACAAGGGCCACACCTGCTGTTCCTATTGGAGG Thr99Lys CCTCCAATAGGAACAGCAGGTGTGGCCCTTGTGCTTGTGAGAGG 1638 ACC-AAA GAAGAGCTGAGTCCC TT TGCCACCGCCGAGTATGACGGCCGCGA CCTCGTTCGGATCGGCGTAATTCCTGCGGAAGG CGGTGGCA AA GGGACTC 1639 GAGTCCC TT TGCCACCG 1640 Increased Starch CAAGCACAAGGGCCACACCTGCTGTTCCTATTGGAGGATGTTACA 1641 ADPGPP GGCTCATCGATATTC T CATGAGCAACTGCTTCAATAGTGGCATCAA Triticum aestivum CAAGATATTCGTCATGACGCAGTTCAACTC Pro127Leu GAGTTGAACTGCGTCATGACGAATATCTTGTTGATGCCACTATTGA 1642 CCC-CTC AGCAGTTGCTCATG A GAATATCGATGAGCCTGTAACATCCTCCAA TAGGAACAGCAGGTGTGGCCCTTGTGCTTG CGATATTC T CATGAGCA 1643 TGCTCATG A GAATATCG 1644 Increased Starch TGACGCAGTTCAACTCGGCCTCTCTTAATCGTCACATTCACCGCA 1645 ADPGPP CCTACCTCGGCGGG AAT ATCAATTTCACTGATGGATCTGTTGAGG Triticum aestivum TATTGGCCGCGACGCAAATGCCCGGGGAGGC Gly162Asn GCCTCCCCGGGCATTTGCGTCGCGGCCAATACCTCAACAGATCC 1646 GGA-AAT ATCAGTGAAATTGAT ATT CCCGCCGAGGTAGGTGCGGTGAATGTG ACGATTAAGAGAGGCCGAGTTGAACTGCGTCA CGGCGGG AAT ATCAATT 1647 AATTGAT ATT CCCGCCG 1648 Increased Starch TGACGCAGTTCAACTCGGCCTCTCTTAATCGTCACATTCACCGCA 1649 ADPGPP CCTACCTCGGCGGG AAC ATCAATTTCACTGATGGATCTGTTGAGG Triticum aestivum TATTGGCCGCGACGCAAATGCCCGGGGAGGC Gly162Asn GCCTCCCCGGGCATTTGCGTCGCGGCCAATACCTCAACAGATCC 1650 GGA-AAC ATCAGTGAAATTGAT GTT CCCGCCGAGGTAGGTGCGGTGAATGTG ACGATTAAGAGAGGCCGAGTTGAACTGCGTCA CGGCGGG AAC ATCAATT 1651 AATTGAT GTT CCCGCCG 1652 Increased Starch CTTTTCGGAGGAATTATGCTGATCCTAATGAAGTCGCTGCCGTCA 1653 ADPGPP TTTTGGGTGGTGGTA AA GGGACTCAGCTTTTCCCTCTCACAAGCA Zea mays CAAGGGCCACCCCTGCTGTTCCTATTGGAGG Thr96Lys CCTCCAATAGGAACAGCAGGGGTGGCCCTTGTGCTTGTGAGAGG 1654 ACC-AAA GAAAAGCTGAGTCCC TT TACCACCACCCAAAATGACGGCAGCGAG TTCATTAGGATCAGCATAATTCCTCCGAAAAG TGGTGGTA AA GGGACTC 1655 GAGTCCC TT TACCACCA 1656 Increased Starch CAAGCACAAGGGCCACCCCTGCTGTTCCTATTGGAGGATGTTACA 1657 ADPGPP GGCTTATTGATATCC T CATGAGCAACTGTTTCAACAGTGGCATAAA Zea mays CAAGATATTTGTTATGACTCAGTTCAACTC Pro124Leu GAGTTGAACTGAGTCATAACAAATATCTTGTTTATGCCACTGTTGA 1658 CCC-CTC AACAGTTGCTCATG A GGATATCAATAAGCCTGTAACATCCTCCAAT AGGAACAGCAGGGGTGGCCCTTGTGCTTG TGATATCC T CATGAGCA 1659 TGCTCATG A GGATATCA 1660 Increased Starch TGACTCAGTTCAACTCAGCTTCTCTTAACCGTCACATTCATCGTAC 1661 ADPGPP CTATCTTGGTGGG AAT ATCAACTTCACTGATGGATCTGTTGAGGT Zea mays GCTGGCTGCAACACAAATGCCTGGGGAGGC Gly159Asn GCCTCCCCAGGCATTTGTGTTGCAGCCAGCACCTCAACAGATCCA 1662 GGG-AAT TCAGTGAAGTTGAT ATT CCCACCAAGATAGGTACGATGAATGTGA CGGTTAAGAGAAGCTGAGTTGAACTGAGTCA TGGTGGG AAT ATCAACT 1663 AGTTGAT ATT CCCACCA 1664 Increased Starch TGACTCAGTTCAACTCAGCTTCTCTTAACCGTCACATTCATCGTAC 1665 ADPGPP CTATCTTGGTGGG AAC ATCAACTTCACTGATGGATCTGTTGAGGT Zea mays GCTGGCTGCAACACAAATGCCTGGGGAGGC Gly159Asn GCCTCCCCAGGCATTTGTGTTGCAGCCAGCACCTCAACAGATCCA 1666 GGG-AAC TCAGTGAAGTTGAT GTT CCCACCAAGATAGGTACGATGAATGTGA CGGTTAAGAGAAGCTGAGTTGAACTGAGTCA TGGTGGG AAC ATCAACT 1667 AGTTGAT GTT CCCACCA 1668 Increased Starch CTTGAGAGGCAAAAGAAGGGCGATGCAAGGACAGTAGTAGCAAT 1669 ADPGPP CATTCTAGGAGGGGGA AA GGGAACTCGTCTTTTCCCCCTCACCAA Solanum tuberosum ACGTCGTGCTAAGCCTGCCGTTCCAATGGGAG Ala58Lys CTCCCATTGGAACGGCAGGCTTAGCACGACGTTTGGTGAGGGGG 1670 GCG-AAG AAAAGACGAGTTCCC TT TCCCCCTCCTAGAATGATTGCTACTACTG TCCTTGCATCGCCCTTCTTTTGCCTCTCAAG GAGGGGGA AA GGGAACT 1671 AGTTCCC TT TCCCCCTC 1672 Increased Starch CCAAACGTCGTGCTAAGCCTGCCGTTCCAATGGGAGGAGCATATA 1673 ADPGPP GGCTAATTGATGTAC T AATGAGCAACTGTATTAACAGTGGCATCAA Solanum tuberosum CAAAGTATACATTCTCACTCAATTCAACTC Pro86Leu GAGTTGAATTGAGTGAGAATGTATACTTTGTTGATGCCACTGTTAA 1674 CCA-CTA TACAGTTGCTCATT A GTACATCAATTAGCCTATATGCTCCTCCCAT TGGAACGGCAGGCTTAGCACGACGTTTGG TGATGTAC T AATGAGCA 1675 TGCTCATT A GTACATCA 1676 Increased Starch CTCAATTCAACTCAGCCTCACTTAACAGGCATATAGCTCGTGCTTA 1677 ADPGPP CAACTTTGGCAAT AAT GTCACATTCGAGAGTGGCTATGTCGAGGT Solanum tuberosum CTTAGCAGCAACTCAAACACCAGGTGAATT Gly122Asn AATTCACCTGGTGTTTGAGTTGCTGCTAAGACCTCGACATAGCCA 1678 GGG-AAT CTCTCGAATGTGAC ATT ATTGCCAAAGTTGTAAGCACGAGCTATAT GCCTGTTAAGTGAGGCTGAGTTGAATTGAG TGGCAAT AAT GTCACAT 1679 ATGTGAC ATT ATTGCCA 1680 Increased Starch CTCAATTCAACTCAGCCTCACTTAACAGGCATATAGCTCGTGCTTA 1681 ADPGPP CAACTTTGGCAAT AAC GTCACATTCGAGAGTGGCTATGTCGAGGT Solanum tuberosum CTTAGCAGCAACTCAAACACCAGGTGAATT Gly122Asn AATTCACCTGGTGTTTGAGTTGCTGCTAAGACCTCGACATAGCCA 1682 GGG-AAC CTCTCGAATGTGAC GTT ATTGCCAAAGTTGTAAGCACGAGCTATAT GCCTGTTAAGTGAGGCTGAGTTGAATTGAG TGGCAAT AAC GTCACAT 1683 ATGTGACGTTATTGCCA 1684 Increased Starch TATTTGAATCTCCAAAAGCTGACCCAAAAAATGTGGCTGCAATTGT 1685 ADPGPP GCTGGGTGGTGGT AAA GGGACTCGCCTCTTTCCTCTTACTAGCAG Beta vulgaris GAGAGCTAAGCCAGCAGTGCCAATTGGAGG Ala98Lys CCTCCAATTGGCACTGCTGGCTTAGCTCTCCTGCTAGTAAGAGGA 1686 GCT-AAA AAGAGGCGAGTCCC TTT ACCACCACCCAGCACAATTGCAGCCACA TTTTTTGGGTCAGCTTTTGGAGATTCAAATA TGGTGGT AAA GGGACTC 1687 GAGTCCC TTT ACCACCA 1688 Increased Starch TATTTGAATCTCCAAAAGCTGACCCAAAAAATGTGGCTGCAATTGT 1689 ADPGPP GCTGGGTGGTGGT AAC GGGACTCGCCTCTTTCCTCTTACTAGCAG Beta vulgaris GAGAGCTAAGCCAGCAGTGCCAATTGGAGG Ala98Lys CCTCCAATTGGCACTGCTGGCTTAGCTCTCCTGCTAGTAAGAGGA 1690 GCT-AAC AAGAGGCGAGTCCC GTT ACCACCACCCAGCACAATTGCAGCCAC ATTTTTTGGGTCAGCTTTTGGAGATTCAAATA TGGTGGT AAC GGGACTC 1691 GAGTCCC GTT ACCACCA 1692 Increased Starch CTAGCAGGAGAGCTAAGCCAGCAGTGCCAATTGGAGGGTGTTAC 1693 ADPGPP AGGCTGATTGATGTGC T TATGAGCAACTGCATCAACAGTGGCATT Beta vulgaris AGAAAGATTTTCATTCTTACCCAGTTCAATTC Pro126Leu GAATTGAACTGGGTAAGAATGAAAATCTTTCTAATGCCACTGTTGA 1694 CCT-CTT TGCAGTTGCTCATA A GCACATCAATCAGCCTGTAACACCCTCCAA TTGGCACTGCTGGCTTAGCTCTCCTGCTAG TGATGTGC T TATGAGCA 1695 TGCTCATA A GCACATCA 1696 Increased Starch CCCAGTTCAATTCGTTTTCGCTTAATCGTCATCTTGCTCGAACCTA 1697 ADPGPP TAATTTTGGAGAT AAT GTGAATTTTGGGGATGGCTTTGTGGAGGTT Beta vulgaris TTTGCTGCTACACAAACACCTGGAGAATC Gly162Asn GATTCTCCAGGTGTTTGTGTAGCAGCAAAAACCTCCACAAAGCCA 1698 GGT-AAT TCCCCAAAATTCAC ATT ATCTCCAAAATTATAGGTTCGAGCAAGAT GACGATTAAGCGAAAACGAATTGAACTGGG TGGAGAT AAT GTGAATT 1699 AATTCAC ATT ATCTCCA 1700 Increased Starch CCCAGTTCAATTCGTTTTCGCTTAATCGTCATCTTGCTCGAACCTA 1701 ADPGPP TAATTTTGGAGAT AAC GTGAATTTTGGGGATGGCTTTGTGGAGGT Beta vulgaris TTTTGCTGCTACACAAACACCTGGAGAATC Gly162Asn GATTCTCCAGGTGTTTGTGTAGCAGCAAAAACCTCCACAAAGCCA 1702 GGT-AAC TCCCCAAAATTCAC GTT ATCTCCAAAATTATAGGTTCGAGCAAGAT GACGATTAAGCGAAAACGAATTGAACTGGG TGGAGAT AAC GTGAATT 1703 AATTCAC GTT ATCTCCA 1704 -
TABLE 21 Oligonucleotides to produce plants with waxy starch Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Waxy starch GAATCCAGGTAAACGGGTAGTTCATAATGGCAACTGTGACTGCTT 1705 GBSS CTTCTAACTTTGTGT G AAGAACTTCACTTTTCAACAATCATGGTGCT Arabidopsis thaliana TCTTCATGCTCTGATGTCGCTCAGATTAC Ser12Term GTAATCTGAGCGACATCAGAGCATGAAGAAGCACCATGATTGTTG 1706 TCA-TGA AAAAGTGAAGTTCTT C ACACAAAGTTAGAAGAAGCAGTCACAGTTG CCATTATGAACTACCCGTTTACCTGGATTC CTTTGTGT G AAGAACTT 1707 AAGTTCTT C ACACAAAG 1708 Waxy starch ATCCAGGTAAACGGGTAGTTCATAATGGCAACTGTGACTGCTTCTT 1709 GBSS CTAACTTTGTGTCA T GAACTTCACTTTTCAACAATCATGGTGCTTCT Arabidopsis thaliana TCATGCTCTGATGTCGCTCAGATTACCT Arg13Term AGGTAATCTGAGCGACATCAGAGCATGAAGAAGCACCATGATTGT 1710 AGA-TGA TGAAAAGTGAAGTTC A TGACACAAAGTTAGAAGAAGCAGTCACAGT TGCCATTATGAACTACCCGTTTACCTGGAT TTGTGTCA T GAACTTCA 1711 TGAAGTTC A TGACACAA 1712 Waxy starch TAAACGGGTAGTTCATAATGGCAACTGTGACTGCTTCTTCTAACTT 1713 GBSS TGTGTCAAGAACTTGACTTTTCAACAATCATGGTGCTTCTTCATGCT Arabidopsis thaliana CTGATGTCGCTCAGATTACCTTAAAAGG Ser15Term CCTTTTAAGGTAATCTGAGCGACATCAGAGCATGAAGAAGCACCAT 1714 TCA-TGA GATTGTTGAAAAGT C AAGTTCTTGACACAAAGTTAGAAGAAGCAGT CACAGTTGCCATTATGAACTACCCGTTTA AAGAACTT G ACTTTTCA 1715 TGAAAAGT C AAGTTCTT 1716 Waxy starch TGACTGCTTCTTCTAACTTTGTGTCAAGAACTTGACTTTTCAACAAT 1717 GBSS CATGGTGCTTCTT G ATGCTCTGATGTCGCTCAGATTACCTTAAAAG Arabidopsis thaliana GCCAATCCTTGACTCATTGTGGGTTAAG Ser24Term CTTAACCCACAATGAGTCAAGGATTGGCCTTTTAAGGTAATCTGAG 1718 TCA-TGA CGACATCAGAGCAT C AAGAAGCACCATGATTGTTGAAAAGTGAAG TTCTTGACACAAAGTTAGAAGAAGCAGTCA TGCTTCTT G ATGCTCTG 1719 CAGAGCAT C AAGAAGCA 1720 Waxy starch TGCTTCTTCTAACTTTGTGTCAAGAACTTCACTTTTCAACAATCATG 1721 GBSS GTGCTTCTTCATG A TCTGATGTCGCTCAGATTACCTTAAAAGGCCA Arabidopsis thaliana ATCCTTGACTCATTGTGGGTTAAGGTCA Cys25Term TGACCTTAACCCACAATGAGTCAAGGATTGGCCTTTTAAGGTAATC 1722 TGC-TGA TGAGCGACATCAGATCATGAAGAAGCACCATGATTGTTGAAAAGT GAAGTTCTTGACACAAAGTTAGAAGAAGCA TCTTCATG A TCTGATGT 1723 ACATCAGA T CATGAAGA 1724 Waxy starch GTAACAGCTTCACAGTTGGTGTCACATGTCCATGGTGGAGCAACG 1725 GBSS TCTTCACCGGATACT T AAACAAACTTGGCCCAGGTTGGCCTCAGG Antirrhinum majus AACCAGCAATTCACTCACAATGGGTTGAGAT Lys24Term ATCTCAAGCCATTGTGAGTGAATTGCTGGTTCGTGAGGCCAACCTG 1726 AAA-TAA GGCCAAGTTTGTTT A AGTATCGGGTGAAGACGTTGCTCCACCATG GACATGTGACACCAACTGTGAAGGTGTTAC CGGATACT T AAACAAAC 1727 GTTTGTTT A AGTATCCG 1728 Waxy starch CACAGTTGGTGTCACATGTCCATGGTGGAGCAAGGTCTTCACCGG 1729 GBSS ATAGTAAAACAAACT A GGGCGAGGTTGGCCTCAGGAACCAGCAAT Antirrhinum majus TCACTCACAATGGGTTGAGATCAATAAACAT Leu27Term ATGTTTATTGATCTCAACCCATTGTGAGTGAATTGCTGGTTCCTGA 1730 TTG-TAG GGCCAACCTGGGCC T AGTTTGTTTTAGTATCGGGTGAAGACGTTG CTCCACCATGGACATGTGACACCAACTGTG AACAAACT A GGCCCAGG 1731 CCTGGGCC T AGTTTGTT 1732 Waxy starch TTGGTGTCACATGTCCATGGTGGAGCAACGTCTTCACCGGATACT 1733 GBSS AAAACAAACTTGGCC T AGGTTGGCCTCAGGAACCAGCAATTCACT Antirrhinum majus CACAATGGGTTGAGATCAATAAACATGGTTG Gln29Term CAACCATGTTTATTGATCTCAACCCATTGTGAGTGAATTGCTGGTT 1734 GAG-TAG CCTGAGGCCAACCT A GGCCAAGTTTGTTTTAGTATCCGGTGAAGA CGTTGCTCCACCATGGACATGTGACACCAA ACTTGGCC T AGGTTGGC 1735 GCCAACCT A GGCCAAGT 1736 Waxy starch GGTGGAGCAACGTCTTCACCGGATACTAAAACAAACTTGGCCCAG 1737 GBSS GTTGGCCTCAGGAACTAGCAATTCACTCACAATGGGTTGAGATCA Antirrhinum majus ATAAACATGGTTGATAAGCTTCAAATGAGGA Gln35Term TCCTCATTTGAAGCTTATCAACCATGTTTATTGATGTCAACCCATTG 1738 GAG-TAG TGAGTGAATTGCT A GTTCCTGAGGCCAACCTGGGCCAAGTTTGTTT TAGTATCCGGTGAAGACGTTGCTCCACC TCAGGAAC T AGCAATTC 1739 GAATTGCT A GTTCCTGA 1740 Waxy starch GGAGCAACGTCTTCACCGGATACTAAAACAAACTTGGCCCAGGTT 1741 GBSS GGCCTCAGGAACCAG T AATTCACTCACAATGGGTTGAGATCAATAA Antirrhinum majus ACATGGTTGATAAGCTTCAAATGAGGAACA Gln36Term TGTTCCTCATTTGAAGCTTATCAACCATGTTTATTGATCTCAACCCA 1742 CAA-TAA TTGTGAGTGAATT A CTGGTTCCTGAGGCCAACCTGGGCCAAGTTT GTTTTAGTATCCGGTGAAGACGTTGCTCC GGAACCAG T AATTCACT 1743 AGTGAATT A CTGGTTCC 1744 Waxy starch GTGATGGCGACTATAACTGCCTCACACTTTGTTTCTCATGTCTGTG 1745 GBSS GGGGTGCCACTTCTTGAGAATCAAAAGTGGGGTTGGGTCAATTAG Ipomoea batatas CCCTGAGGAGCCAAGCTGTGACTCACAATG Gly20Term CATTGTGAGTCACAGCTTGGCTCCTCAGGGCTAATTGACCCAACC 1746 GGA-TGA CCACTTTTGATTCTC A AGAAGTGGCACCCCCACAGACATGAGAAA CAAAGTGTGAGGCAGTTATAGTCGCCATCAC CCACTTCT T GAGAATCA 1747 TGATTCTC A AGAAGTGG 1748 Waxy starch ATGGCGACTATAACTGCCTCACACTTTGTTTCTCATGTCTGTGGGG 1749 GBSS GTGCCACTTCTGGA T AATCAAAAGTGGGGTTGGGTCAATTAGCCC Ipomoea batatas TGAGGAGCCAAGCTGTGACTCACAATGGGT Glu21Term ACCCATTGTGAGTCACAGCTTGGCTCCTCAGGGCTAATTGACCCA 1750 GAA-TAA ACCCCACTTTTGATT A TCCAGAAGTGGCACCCCCACAGACATGAG AAACAAAGTGTGAGGCAGTTATAGTCGCCAT CTTCTGGA T AATCAAAA 1751 TTTTGATT A TCCAGAAG 1752 Waxy starch CGACTATAACTGCCTCACACTTTGTTTCTCATGTCTGTGGGGGTGC 1753 GBSS CACTTCTGGAGAAT G AAAAGTGGGGTTGGGTCAATTAGCCCTGAG Ipomoea batatas GAGCCAAGCTGTGACTCACAATGGGTTGAG Ser22Term CTCAACCCATTGTGAGTCACAGCTTGGCTCCTCAGGGCTAATTGA 1754 TCA-TGA CCCAACCCCACTTTT C ATTCTCCAGAAGTGGCACCCCCACAGACAT GAGAAACAAAGTGTGAGGCAGTTATAGTCG TGGAGAAT G AAAAGTGG 1755 CCACTTTT C ATTCTCCA 1756 Waxy starch ACTATAACTGCCTCACACTTTGTTTCTCATGTCTGTGGGGGTGCCA 1757 GBSS CTTCTGGAGAATCA T AAGTGGGGTTGGGTCAATTAGCCCTGAGGA Ipomoea batatas GCCAAGCTGTGACTCACAATGGGTTGAGAC Lys23Term GTCTCAACCCATTGTGAGTCACAGCTTGGCTCCTCAGGGCTAATT 1758 AAA-TAA GACCCAACCCCACTT A TGATTCTCCAGAAGTGGCACCCCCACAGA CATGAGAAACAAAGTGTGAGGCAGTTATAGT GAGAATCA T AAGTGGGG 1759 CCCCACTT A TGATTCTC 1760 Waxy starch CCTCACACTTTGTTTCTCATGTCTGTGGGGGTGCCACTTCTGGAGA 1761 G BSS ATCAAAAGTGGGGT A GGGTCAATTAGCCCTGAGGAGCCAAGCTGT Ipomoea batatas GACTCACAATGGGTTGAGACCTGTGAACAA Leu26Term TTGTTCACAGGTCTCAACCCATTGTGAGTCACAGCTTGGCTCCTCA 1762 TTG-TAG GGGCTAATTGACCC T ACCCCACTTTTGATTCTCCAGAAGTGGCACC CCCACAGACATGAGAAACAAAGTGTGAGG AGTGGGGT A GGGTCAAT 1763 ATTGACCC T ACCCCACT 1764 Waxy starch CATCGGCGATTGTTGCTCCTTACTGCTCTCTCACAGAATGGCAACG 1765 GBSS GTGACGGGGTCTTA G GTGGTGTCGAGAAGCGCGTGCTTCAATTCC Astragalus CAGGGAAGAACAGAAGCCAAAGTGAATTCA membranaeus TGAATTCACTTTGGCTTCTGTTCTTCCCTGGGAATTGAAGCACGCG 1766 Tyr8Term CTTCTCGACACCAC C TAAGACCCCGTCACCGTTGCCATTCTGTGA TAT-TAG GAGAGCAGTAAGGAGCAACAATCGCCGATG GGGTCTTA G GTGGTGTC 1767 GACACCAC C TAAGACCC 1768 Waxy starch ATTGTTGCTCCTTACTGCTCTCTCACAGAATGGCAACGGTGACGG 1769 GBSS GGTCTTATGTGGTGT A GAGAAGCGCGTGCTTCAATTCCCAGGGAA Astragalus GAACAGAAGCCAAAGTGAATTCACCTCAGAA membranaeus TTCTGAGGTGAATTCACTTTGGCTTCTGTTCTTCCCTGGGAATTGA 1770 Ser11Term AGCACGCGCTTCTCTACACCACATAAGACCCCGTCACCGTTGCCA TCG-TAG TTCTGTGAGAGAGCAGTAAGGAGCAACAAT TGTGGTGT A GAGAAGCG 1771 CGCTTCTC T ACACCACA 1772 Waxy starch TGTTGCTCCTTACTGCTCTCTCACAGAATGGCAACGGTGACGGGG 1773 GBSS TCTTATGTGGTGTCGTGAAGCGCGTGCTTCAATTCCCAGGGAAGA Astragalus ACAGAAGCCAAAGTGAATTCACCTCAGAAGA membranaeus TCTTCTGAGGTGAATTCACTTTGGCTTCTGTTCTTCCCTGGGAATT 1774 Arg12Term GAAGCACGCGCTTC A CGACACCACATAAGACCCCGTCACCGTTGC AGA-TGA CATTCTGTGAGAGAGCAGTCAGGAGCAACA TGGTGTCG T GAAGCGCG 1775 CGCGCTTC A CGACACCA 1776 Waxy starch ACTGCTCTCTCACAGAATGGCAACGGTGACGGGGTCTTATGTGGT 1777 GBSS GTCGAGAAGCGCGTG A TTCAATTCCCAGGGAAGAACAGAAGCCAA Astragalus AGTGAATTCACCTCAGAAGATAAATCTGAAT membranaeus ATTGAGATTTATCTTCTGAGGTGAATTCACTTTGGCTTCTGTTCTTC 1778 Cys15Term CCTGGGAATTGAATCACGCGCTTCTCGACACCACATAAGACCCCG TGC-TGA TCACCGTTGCCATTCTGTGAGAGAGCAGT AGCGCGTG A TTCAATTC 1779 GAATTGAA T CACGCGCT 1780 Waxy starch CACAGAATGGCAACGGTGACGGGGTCTTATGTGGTGTCGAGAAG 1781 GBSS CGCGTGGTTCAATTCCTAGGGAAGAACAGAAGCCAAAGTGAATTC Astragalus ACCTCAGAAGATAAATCTCAATAGCCAAGCAT membranaeus ATGCTTGGCTATTGAGATTTATCTTCTGAGGTGAATTCACTTTGGCT 1782 Gln19Term TCTGTTCTTCCCTAGGAATTGAAGCACGCGCTTCTCGACACCACAT CAG-TAG AAGACCCCGTCACCGTTGCCATTCTGTG TCAATTCC T AGGGAAGA 1783 TCTTCCCT A GGAATTGA 1784 Waxy starch TGTAGCTTGGTAGATTCCCCTTTTTGTCGACCACACATCACATGGC 1785 GBSS AAGCATCACAGCTT G ACACCACTTTGTGTCAAGAAGCCAAACTTCA Solanum tuberosum CTAGACACCAAATCAACCTTGTCACAGAT Ser7Term ATCTGTGACAAGGTTGATTTGGTGTCTAGTGAAGTTTGGCTTCTTG 1786 TCA-TGA ACACAAAGTGGTGT C AAGCTGTGATGCTTGCCATGTGATGTGTGG TCTACAAAAAGGGGAATCTACCAAGCTACA CACAGCTT G ACACCACT 1787 AGTGGTGT C AAGCTGTG 1788 Waxy starch TCCCCTTTTTGTAGACCACACATCACATGGCAAGCATCACAGCTTC 1789 GBSS ACACCACTTTGTGT G AAGAAGCCAAACTTCACTAGACACCAAATCA Solanum tuberosum ACCTTGTCACAGATAGGACTCAGGAACCA Ser12Term TGGTTCCTGAGTCCTATCTGTGACAAGGTTGATTTGGTGTCTAGTG 1790 TCA-TGA AAGTTTGGCTTCTT C ACACAAAGTGGTGTGAAGCTGTGATGCTTGC CATGTGATGTGTGGTCTACAAAAAGGGGA CTTTGTGT G AAGAAGCC 1791 GGCTTCTT C ACACAAAG 1792 Waxy starch CCCTTTTTGTAGACCACACATCACATGGCAAGCATCACAGCTTCAC 1793 GBSS ACCACTTTGTGTCATGAAGCCAAACTTCACTAGACACCAAATCAAC Solanum tuberosum CTTGTCACAGATAGGACTCAGGAACCATA Arg13Term TATGGTTCCTGAGTCCTATCTGTGACAAGGTTGATTTGGTGTCTAG 1794 AGA-TGA TGAAGTTTGGCTTC A TGACACAAAGTGGTGTGAAGCTGTGATGCTT GCCATGTGATGTGTGGTCTACAAAAAGGG TTGTGTCA T GAAGCCAA 1795 TTGGCTTC A TGACACAA 1796 Waxy starch TTGTAGACCACACATCACATGGCAAGCATCACAGCTTCACACCACT 1797 GBSS TTGTGTCAAGAAGCTAAACTTCACTAGACACCAAATCAACCTTGTC Solanum tuberosum ACAGATAGGACTCAGGAACCATACTCTGA Gln15Term TCAGAGTATGGTTCCTGAGTCCTATCTGTGACAAGGTTGATTTGGT 1798 CAA-TAA GTCTAGTGAAGTTT A GCTTCTTGACACAAAGTGGTGTGAAGCTGTG ATGCTTGCCATGTGATGTGTGGTCTACAA CAAGAAGC T AAACTTCA 1799 TGAAGTTT A GCTTCTTG 1800 Waxy starch CCACACATCACATGGCAAGCATCACAGCTTCACACCACTTTGTGTC 1801 GBSS AAGAAGCCAAACTT G ACTAGACACCAAATCAACCTTGTCACAGATA Solanum tuberosum GGACTCAGGAACCATACTCTGACTCACAA Sen17Term TTGTGAGTCAGAGTCTGGTTCCTGAGTCCTATCTGTGACAAGGTTG 1802 TCA-TGA ATTTGGTGTCTAGT C AAGTTTGGCTTGTTGACACAAAGTGGTGTGA AGCTGTGATGCTTGCCATGTGATGTGTGG CCAAACTT G ACTAGACA 1803 TGTCTAGT C AAGTTTGG 1804 Waxy starch GTCGATCACTCTTCTCTCACCGCCGAAACAGATTTTGACACAAAAA 1805 GBSS TGGCAACAATAACG T GATCTTCAATGCCGACGAGAACCGCGTGCT Pisum sativum TCAATTACCAAGGAAGATCAGCAGAGTCTA Gly6Term TAGACTCTGCTGATCTTCCTTGGTCATTGAAGCACGCGGTTCTCGT 1806 GGA-TGA CGGCATTGAAGATC A CGTTATTGTTGCCATTTTTGTGTCAAAATCT GTTTCGGCGGTGAGAGAAGAGTGATCGAC CAATAACG T GATCTTCA 1807 TGAAGATC A CGTTATTG 1808 Waxy starch ACTCTTCTCTCACCGCCGAAACAGATTTTGACACAAAAATGGCAAC 1809 GBSS AATAACGGGATCTT G AATGCCGACGAGAACCGCGTGCTTCAATTA Pisum sativum CCAAGGAAGATCAGCAGAGTCTAAACTGAA Ser8Term TTCAGTTTAGACTCTGCTGATCTTCCTTGGTCATTGAAGCACGCGG 1810 TCA-TGA TTCTCGTCGGCATT C AAGATCCCGTTATTGTTGCCATTTTTGTGTCA AAATCTGTTTCGGCGGTGAGAGAAGAGT GGGATCTT G AATGCCGA 1811 TCGGCATT C AAGATCCC 1812 Waxy starch ACCGCCGAAACAGATTTTGACACAAAAATGGCAACAATAACGGGA 1813 GBSS TCTTCAATGCCGACG T GAACCGCGTGCTTCAATTACCAAGGAAGA Pisum sativum TCAGCAGAGTCTAAACTGAATTTGCCTCAGA Arg12Term TCTGAGGCAAATTCAGTTTAGACTCTGCTGATCTTCCTTGGTCATT 1814 AGA-TGA GAAGCACGCGGTTC A CGTCGGCATTGAAGATCCCGTTATTGTTGC CATTTTTGTGTCAAAATCTGTTTCGGCGGT TGCCGACG T GAACCGCG 1815 CGCGGTTC A CGTCGGCA 1816 Waxy starch AGATTTTGACACAAAAATGGCAACAATAACGGGATCTTCAATGCCG 1817 GBSS ACGAGAACCGCGTG A TTCAATTACCAAGGAAGATCAGCAGAGTCT Pisum sativum AAACTGAATTTGCCTCAGATACACTTCAAT Cys15Term ATTGAAGTGTCTCTGAGGCAAATTCAGTTTAGACTCTGCTGATCTT 1818 TGC-TGA CCTTGGTCATTGAA T CACGCGGTTCTCGTCGGCATTGAAGATCCC GTTATTGTTGCCATTTTTGTGTCAAAATCT ACCGCGTG A TTCAATTA 1819 TAATTGAA T CACGCGGT 1820 Waxy starch CACAAAAATGGCAACAATAACGGGATCTTCAATGCCGACGAGAAC 1821 GBSS CGCGTGCTTCAATTA G CAAGGAAGATCAGCAGAGTCTAAACTGAA Pisum sativum TTTGCCTCAGATACACTTCAATAACAACCAA Tyr18Term TTGGTTGTTATTGAAGTGTATCTGAGGCAAATTCAGTTTAGACTCT 1822 TAC-TAG GCTGATCTTCCTTG C TAATTGAAGCACGCGGTTCTCGTCGGCATTG AAGATCCCGTTATTGTTGCCATTTTTGTG TTCAATTA G CAAGGAAG 1823 CTTCCTTG C TAATTGAA 1824 Waxy starch TCTACACCGGAGAGAGCACCATGGCAACTGTAATAGCTGCACATT 1825 GBSS TCGTTTCCAGGAGCT G ACACTTGAGCATCCATGCATTAGAGACTAA Manihot esculenta GGCTAATAATTTGTCTCACACTGGACCCTG Ser14Term CAGGGTCCAGTGTGAGACAAATTATTAGCCTTAGTCTCTAATGCAT 1826 TCA-TGA GGATGCTCAAGTGT C AGCTCCTGGAAACGAAATGTGCAGCTATTA CAGTTGCCATGGTGCTCTCTCCGGTGTAGA CAGGAGCT G ACACTTGA 1827 TCAAGTGT C AGCTCCTG 1828 Waxy starch CCGGAGAGAGCACCATGGCAACTGTAATAGCTGCACATTTCGTTT 1829 GBSS CCAGGAGCTCACACT A GAGCATCCATGCATTAGAGACTAAGGCTA Manihot esculenta ATAATTTGTCTCACACTGGACCCTGGACCCA Leu16Term TGGGTCCAGGGTCCAGTGTGAGACAAATTATTAGCCTTAGTCTCTA 1830 TTG-TAG ATGCATGGATGCTC T AGTGTGAGCTCCTGGAAACGAAATGTGCAG CTATTACAGTTGCCATGGTGCTCTCTCCGG CTCACACT A GAGCATCC 1831 GGATGCTC T AGTGTGAG 1832 Waxy starch TGGCAACTGTAATAGCTGCACATTTCGTTTCCAGGAGCTCACACTT 1833 GBSS GAGCATCCATGCAT G AGAGACTAAGGCTAATAATTTGTCTCACACT Manihot esculenta GGACCCTGGACCCAAACTATCACTCCCAA Leu21Term TTGGGAGTGATAGTTTGGGTCCAGGGTCCAGTGTGAGACAAATTA 1834 TTA-TGA TTAGCCTTAGTCTCT C ATGCATGGATGCTCAAGTGTGAGCTCCTGG AAACGAAATGTGCAGCTATTACAGTTGCCA CCATGCAT G AGAGACTA 1835 TAGTCTCT C ATGCATGG 1836 Waxy starch GCAACTGTAATAGCTGCACATTTCGTTTCCAGGAGCTCACACTTGA 1837 GBSS GCATCCATGCATTA T AGACTAAGGCTAATAATTTGTCTCACACTGG Manihot esculenta ACCCTGGACCCAAACTATCACTCCCAATG Glu22Term CATTGGGAGTGATAGTTTGGGTCCAGGGTCCAGTGTGAGACAAAT 1838 GAG-TAG TATTAGCCTTAGTCT A TAATGCATGGATGCTCAAGTGTGAGCTCCT GGAAACGAAATGTGCAGCTATTACAGTTGC ATGCATTA T AGACTAAG 1839 CTTAGTCT A TAATGCAT 1840 Waxy starch GTCATAGCTGCACATTTCGTTTCCAGGAGCTCACACTTGAGCATCC 1841 GBSS ATGCATTAGAGACT T AGGCTAATAATTTGTCTCACACTGGACCCTG Manihot esculenta GACCCAAACTATCACTCCCAATGGTTTAA Lys24Term TTAAACCATTGGGAGTGATAGTTTGGGTCCAGGGTCCAGTGTGAG 1842 AAG-TAG ACAAATTATTAGCCT A AGTCTCTAATGCATGGATGCTCAAGTGTGA GCTCCTGGAAACGAAATGTGCAGCTATTAC TAGAGACT T AGGCTAAT 1843 ATTAGCCT A AGTCTCTA 1844 Waxy starch ACAACTCCTCCGTCACCGGTATAAGCATGGCAACGGTATCGATGG 1845 GBSS CATCGTGCGTGGCGT G AAAAGGCGCGTGGAGTACAGAGACAAAA Phaseolus vulgaris GTGAAATCTTCGGGTCAGATGAGCCTGAACCG Ser12Term CGGTTCAGGCTCATCTGACCCGAAGATTTCACTTTTGTCTCTGTCC 1846 TCA-TGA TCCACGCGCCTTTT C ACGCCACGCACGATGCCATCGATACCGTTG CCATGCTTATACCGGTGACGGAGGAGTTGT CGTGGCGT G AAAAGGCG 1847 CGCCTTTT C ACGCCACG 1848 Waxy starch CACCGGTCTAAGCATGGCAACGGTATCGATGGCATCGTGCGTGGC 1849 GBSS GTCAAAAGGCGCGTG A AGTACAGAGACAAAAGTGAAATCTTCGGG Phaseolus vulgaris TCAGATGAGCCTGAACCGTCATGAATTGAAA Trp16Term TTTCAATTCATGACGGTTCAGGCTCATCTGACCCGAAGATTTCACT 1850 TGG-TGA TTTGTCTCTGTACT T CACGCGCCTTTTGACGCCACGCACGATGCCA TCGATACCGTTGGCATGCTTATACCGGTG GGCGCGTG A AGTACAGA 1851 TCTGTACT T CACGCGCC 1852 Waxy starch ATAAGCATGGCAACGGTCTCGATGGCATCGTGCGTGGCGTCAAAA 1853 GBSS GGCGCGTGGAGTACA T AGACAAAAGTGAAATCTTCGGGTCAGATG Phaseolus vulgaris AGCCTGAACCGTCATGAATTGAAATACGATG Glu19Term CATCGTATTTCAATTCATGACGGTTCAGGCTCATCTGACCCGAAGA 1854 GAG-TAG TTTCACTTTTGTCT A TGTACTCCACGCGCCTTTTGACGCCACGCAC GATGCCATCGATACCGTTGCCATGCTTAT GGAGTACA T AGACAAAA 1855 TTTTGTCT A TGTACTCC 1856 Waxy starch ATGGCAACGGTATCGATGGCATCGTGCGTGGGGTCAAAAGGCGC 1857 GBSS GTGGAGTACAGAGACA T AAGTGAAATCTTCGGGTCAGATGAGCCT Phaseolus vulgaris GAACCGTCATGAATTGAAATACGATGGGTTGA Lys21Term TCAACCCATCGTATTTCAATTCATGACGGTTCAGGCTCATCTGACC 1858 AAA-TAA CGAAGATTTCACTT A TGTCTCTGTACTCCACGCGCCTTTTGACGCC ACGCACGATGCCATCGATACCGTTGCCAT CAGAGACA T AAGTGAAA 1859 TTTCACTT A TGTCTCTG 1860 Waxy starch ACGGTATCGATGGCATCGTGCGTGGCGTCAAAAGGCGCGTGGAG 1861 GBSS TACAGAGACAAAAGTG T AATCTTCGGGTCAGATGAGCCTGAACCG Phaseolus vulgaris TCATGAATTGAAATACGATGGGTTGAGATCTC Lys23Term GAGATCTCAACCCATCGTATTTCAATTCATGACGGTTCAGGCTCAT 1862 AAA-TAA CTGACCCGAAGATT A CACTTTTGTCTCTGTACTCCACGCGCCTTTT GACGCCACGCACGATGCCATCGATACCGT CAAAAGTG T AATCTTCG 1863 CGAAGATT A CACTTTTG 1864 Waxy starch GCGCCTAGCTCGAAAAGGTCGTCATTGAGAGGCTGCACCAATGG 1865 GBSS GTTCCATTCCTAATTA G TGTTCTTATCAAACAAACAGTGTTGGTTCA Triticum aestivum CTGAAACTGTCGCCTCACATCCAATTCCAG Tyr7Term CTGGAATTGGATGTGAGGCGACAGTTTCAGTGAACCAACACTGTT 1866 TAT-TAG TGTTTGATAAGAACA C TAATTAGGAATGGAACCCATTGGTGCAGCC TCTCAATGACGACCTTTTCGAGCTAGGCGC CCTAATTA G TGTTCTTA 1867 TAAGAACA C TAATTAGG 1868 Waxy starch CCTAGCTCGAAAAGGTCGTCATTGAGAGGCTGCACCAATGGGTTC 1869 GBSS CATTCCTAATTATTG A TCTTATCAAACAAACAGTGTTGGTTCACTGA Triticum aestivum AACTGTCGCCTCACATCCAATTCCAGCAA Cys8Term TTGCTGGAATTGGATGTGAGGCGACAGTTTCAGTGAACCAACACT 1870 TGT-TGA GTTTGTTTGATAAGA T CAATAATTAGGAATGGAACCCATTGGTGCA GCCTCTCAATGACGACCTTTTCGAGCTAGG AATTATTG A TCTTATCA 1871 TGATAAGA T CAATAATT 1872 Waxy starch TCGAAAAGGTCGTCATTGAGAGGCTGCACCAATGGGTTCCATTCC 1873 GBSS TAATTATTGTTCTTA G CAAACAAACAGTGTTGGTTCACTGAAACTGT Triticum aestivum CGCCTCACATCCAATTCCAGCAATCTTGT Tyr10Term ACAAGATTGCTGGAATTGGATGTGAGGCGACAGTTTCAGTGAACC 1874 TAT-TAG AACACTGTTTGTTTG C TAAGAACAATAATTAGGAATGGAACCCATT GGTGCAGCCTCTCAATGACGACCTTTTCGA TGTTCTTA G CAAACAAA 1875 TTTGTTTG C TAAGAACA 1876 Waxy starch CGAAAAGGTCGTCATTGAGAGGCTGCACCAATGGGTTCCATTCCT 1877 GBSS AATTATTGTTCTTAT T AAACAAACAGTGTTGGTTCACTGAAACTGTC Triticum aestivum GCCTCACATCCAATTCCAGCAATCTTGTA Gln11Term TACAAGATTGCTGGAATTGGATGTGAGGCGACAGTTTCAGTGAAC 1878 CAA-TAA CAACACTGTTTGTTT A ATAAGAACAATAATTAGGAATGGAACCCATT GGTGCAGCCTCTCAATGACGACCTTTTCG GTTCTTAT T AAACAAAC 1879 GTTTGTTT A ATAAGAAC 1880 Waxy starch AGGCTGCACCAATGGGTTCCATTCCTAATTATTGTTCTTATCAAACA 1881 GBSS AACAGTGTTGGTT G ACTGAAACTGTCGCCTCACATCCAATTCCAGC Triticum aestivum AATCTTGTCACAATGAAGTTATGTTCCT Ser17Term AGGAACATAACTTCATTGTTACAAGATTGCTGGAATTGGATGTGAG 1882 TCA-TGA GCGACAGTTTCAGT C AACCAACACTGTTTGTTTGATAAGAACAATA ATTAGGAATGGAACCCATTGGTGCAGCCT TGTTGGTT G ACTGAAAC 1883 GTTTCAGT C AACCAACA 1884 Waxy starch CAGCTCGCCACCTCCGGCACCGTCCTCGGCATCACCGACAGGTT 1885 GBSS CCGGCGTGCAGGTTTC T AGGGCGTGAGGCCCCGGAGCCCGGCG Triticum aestivum GATGCGGCTCTCGGCATGAGGACCGTCGGAGCTA Gln28Term TAGCTCCGACGGTCCTCATGCCGAGAGCCGCATCCGCCGGGCTC 1886 CAG-TAG CGGGGCCTCACGCCCT A GAAACCTGCACGCCGGAACCTGTCGGT GATGCCGAGGACGGTGCCGGAGGTGGCGAGCTG CAGGTTTC T AGGGCGTG 1887 CACGCCCT A GAAACCTG 1888 Waxy starch GGTTTCCAGGGCGTGAGGCCCCGGAGCCCGGCGGATGCGGCTCT 1889 GBSS CGGCATGAGGACCGTC T GAGCTAGCGCCGCCCCAACGCAAAGCC Triticum aestivum GGAAAGCGCACCGCGGGACCCGGCGGTGCCTCT Gly46Term AGAGGCACCGCCGGGTCCCGCGGTGCGCTTTCCGGCTTTGCGTT 1890 GGA-TGA GGGGCGGCGCTAGCTC A GACGGTCCTCATGCCGAGAGCCGCATC CGCCGGGCTCCGGGGCCTCACGCCCTGGAAACC GGACCGTC T GAGCTAGC 1891 GCTAGCTC A GACGGTCC 1892 Waxy starch CGGAGCCCGGCGGATGCGGCTCTCGGCATGAGGACCGTCGGAG 1893 GBSS CTAGCGCCGCCCCAACG T AAAGCCGGAAAGCGCACCGCGGGACC Triticum aestivum CGGCGGTGCCTCTCCATGGTGGTGCGCGCCACCG Gln53Term CGGTGGCGCGCACCACCATGGAGAGGCACCGCCGGGTCCCGCG 1894 CAA-TAA GTGCGCTTTCCGGCTTT A CGTTGGGGCGGCGCTAGCTCCGACGG TCCTCATGCCGAGAGCCGCATCCGCCGGGCTCCG CCCCAACG T AAAGCCGG 1895 CCGGCTTT A CGTTGGGG 1896 Waxy starch GCGGATGCGGCTCTCGGCATGAGGACCGTCGGAGCTAGCGCCGC 1897 GBSS CCCAACGCAAAGCCGG T AAGCGCACCGCGGGACCCGGCGGTGC Triticum aestivum CTCTCCATGGTGGTGCGCGCCACCGGCAGCGGCG Lys56Term CGCCGCTGCCGGTGGCGCGCACCACCATGGAGAGGCACCGCCG 1898 AAA-TAA GGTCCCGCGGTGCGCTT A CCGGCTTTGCGTTGGGGCGGCGCTAG CTCCGACGGTCCTCATGCCGAGAGCCGCATCCGC AAAGCCGG T AAGCGCAC 1899 GTGCGCTT A CCGGCTTT 1900 Waxy starch CTCTCCATGGTGGTGCGCGCCACCGGCAGCGGCGGCATGAACCT 1901 GBSS CGTGTTCGTCGGCGCC T AGATGGCGCCCTGGACCAAGACCGGCG Triticum aestivum GCCTCGGCGACGTCCTCGGGGGCCTCCCCCCAG Glu85Term CTGGGGGGAGGCCCCCGAGGACGTCGCCGAGGCCGCCGGTCTT 1902 GAG-TAG GCTCCAGGGCGCCATCT A GGCGCCGACGAACACGAGGTTCATGC CGCCGCTGCCGGTGGCGCGCACCACCATGGAGAG TCGGCGCC T AGATGGCG 1903 CGCCATCT A GGCGCCGA 1904 Waxy starch GTGGTCTCTCGCTGCAGGTAGCCACACCCTGCGCGCGCGATGGC 1905 GBSS GGCTCTGGTCACGTCG T AGCTCGCCACCTCCGGCACCGTCCTCG Triticum aestivum GCATCACCGACAGGTTCCGGCGTGCAGGTTTTC Gln8Term GAAAACCTGCACGCCGGAACCTGTCGGTGATGCCGAGGACGGTG 1906 CAG-TAG CCGGAGGTGGCGAGCT A CGACGTGACCAGAGCCGCCATCGCGC GCGCAGGGTGTGGCTACCTGCAGCGAGAGACGAC TCACGTCG T AGCTCGCC 1907 GGCGAGCT A CGACGTGA 1908 Waxy starch CAGCTCGCCACCTCCGGCACCGTCCTCGGCATCACCGACAGGTT 1909 GBSS CCGGCGTGCAGGTTTT T AGGGTGTGAGGCCCCGGAGCCCGGCAG Triticum aestivum ATGCGCCGCTCGGCATGAGGACTACCGGAGCGA Gln28Term TCGCTCCGGTCGTCCTCATGCCGAGCGGCGCATCTGCCGGGCTC 1910 GAG-TAG CGGGGCCTCACACCCT A AAAACCTGCACGCCGGAACCTGTCGGT GATGCCGAGGACGGTGCCGGAGGTGGCGAGCTG CAGGTTTT T AGGGTGTG 1911 CACACCCT A AAAACCTG 1912 Waxy starch CCCCGGAGCCCGGCAGATGCGCCGCTCGGCATGAGGACTACCGG 1913 GBSS AGCGAGCGCCGCCCCG T AGCAACAAAGCCGGAAAGCGCACCGCG Triticum aestivum GGACCCGGCGGTGCCTCTCCATGGTGGTGCGCG Lys52Term CGCGCACCACCATGGAGAGGCACCGCCGGGTCCCGCGGTGCGC 1914 AAG-TAG TTTCCGGCTTTGTTGCT A CGGGGCGGCGCTCGCTCCGGTAGTCCT CATGCCGAGCGGCGCATCTGCCGGGCTCCGGGG CCGCCCCG T AGCAACAA 1915 TTGTTGCT A CGGGGCGG 1916 Waxy starch CGGAGCCCGGCAGATGCGCCGCTCGGCATGAGGACTACCGGAG 1917 GBSS CGAGCGCCGCCCCGAAG T AACAAAGCCGGAAAGCGCACCGCGG Triticum aestivum GACCCGGCGGTGCCTCTCCATGGTGGTGCGCGCCA Gln53Term TGGCGCGCACCACCATGGAGAGGCACCGCCGGGTCCCGCGGTG 1918 CAA-TAA CGCTTTCCGGCTTTGTT A CTTCGGGGCGGCGCTCGCTCCGGTAGT CCTCATGCCGAGCGGCGCATCTGCCGGGCTCCG CCCCGAAG T AACAAAGC 1919 GCTTTGTT A CTTCGGGG 1920 Waxy starch AGCCCGGCAGATGCGCCGCTCGGCATGAGGACTACCGGAGCGAG 1921 GBSS CGCCGCCCCGAAGCAA T AAAGCCGGAAAGCGCACCGCGGGACCC Triticum aestivum GGCGGTGCCTCTCCATGGTGGTGCGCGCCACGG Gln54Term CCGTGGCGCGCACCACCATGGAGAGGCACCGCCGGGTCCCGCG 1922 CAA-TAA GTGCGCTTTCCGGCTTT A TTGCTTCGGGGCGGCGCTCGCTCCGGT AGTCCTCATGCCGAGCGGCGCATCTGCCGGGCT CGAAGCAA T AAAGCCGG 1923 CCGGCTTT A TTGCTTCG 1924 Waxy starch CAGCTCGCCACCTCCGGCACCGTCCTCGGCATCACCGACAGGTT 1925 GBSS CCGGCGTGCAGGTTTC T AGGGCGTGAGGCCCCGGAACCCGGCG Triticum durum GATGCGGCCCTCGTCATGAGGACTATCGGAGCGA Gln28Term TCGCTCCGATAGTCCTCATGACGAGGGCCGCATCCGCCGGGTTC 1926 CAG-TAG CGGGGCCTCACGCCCT A GAAACCTGCACGCCGGAACCTGTCGGT GATGCCGAGGACGGTGCCGGAGGTGGCGAGCTG CAGGTTTC T AGGGCGTG 1927 CACGCCCT A GAAACCTG 1928 Waxy starch CCCCGGAACCCGGCGGATGCGGCCCTCGTCATGAGGACTATCGG 1929 GBSS AGCGAGCGCCGCCCCG T AGCAAAGCCGGAAAGCGCACCGCGGG Triticum durum AGCCGGCGGTGCCTCTCCATGGTGGTGCGCGCCA Lys52Term TGGCGCGCACCACCATGGAGAGGCACCGCCGGCTCCCGCGGTG 1930 AAG-TAG CGCTTTCCGGCTTTGCT A CGGGGCGGCGCTCGCTCCGATAGTCCT CATGACGAGGGCCGCATCCGCCGGGTTCCGGGG CCGCCCCG T AGCAAAGC 1931 GCTTTGCT A CGGGGCGG 1932 Waxy starch CGGAACCCGGCGGATGCGGCCCTCGTCATGAGGACTATCGGAGC 1933 GBSS GAGCGCCGCCCCGAAG T AAAGCCGGAAAGCGCACCGCGGGAGC Triticum durum CGGCGGTGCCTCTCCATGGTGGTGCGCGCCACGG Gln53Term CCGTGGCGCGCACCACCATGGAGAGGCACCGCCGGCTCCCGCG 1934 CAA-TAA GTGCGCTTTCCGGCTTT A CTTCGGGGCGGCGCTCGCTCCGATAGT CCTCATGACGAGGGCCGCATCCGCCGGGTTCCG CCCCGAAG T AAAGCCGG 1935 CCGGCTTT A CTTCGGGG 1936 Waxy starch GCGGATGCGGCCCTCGTCATGAGGACTATCGGAGCGAGCGCCGC 1937 GBSS CCCGAAGCAAAGCCGG T AAGCGCACCGCGGGAGCCGGCGGTGC Triticum durum CTCTCCATGGTGGTGCGCGCCACGGGCAGCGGCG Lys56Term CGCCGCTGCCCGTGGCGCGCACCACCATGGAGAGGCACCGCCG 1938 AAA-TAA GCTCCCGCGGTGCGCTT A CCGGCTTTGCTTCGGGGCGGGGCTCG CTCCGATAGTCCTCATGACGAGGGCCGCATCCGC AAAGCCGG T AAGCGCAC 1939 GTGCGCTT A CCGGCTTT 1940 Waxy starch TATCGGAGCGAGCGCCGCCCCGAAGCAAAGCCGGAAAGCGCACC 1941 GBSS GCGGGAGCCGGCGGTG A CTCTCCATGGTGGTGCGCGCCACGGG Triticum durum CAGCGGCGGCATGAACCTCGTGTTCGTCGGCGCC Cys64Term GGCGCCGACGAACACGAGGTTCATGCCGCCGCTGCCCGTGGCGC 1942 TGC-TGA GCACCACCATGGAGAG T CACCGCCGGCTCCCGCGGTGCGCTTTC CGGCTTTGCTTCGGGGCGGCGCTCGCTCCGATA CGGCGGTG A CTCTCCAT 1943 ATGGAGAG T CACCGCCG 1944 Waxy starch CAGCTCGCCACCTCCGGCACCGTCCTCGGCATCACCGACAGGTT 1945 GBSS CCGGCGTGCAGGTTTT T AGGGTGTGAGGCCCCGGAGCCCGGCAG Triticum turgidum ATGCGCCGCTCGGCATGAGGACTACCGGAGCGA Gln28Term TCGCTCCGGTAGTCCTCATGCCGAGCGGCGCATCTGCGGGGCTC 1946 CAG-TAG CGGGGCCTCACACCCT A AAAACGTGCACGCCGGAACCTGTCGGT GATGCCGAGGACGGTGCCGGAGGTGGCGAGCTG CAGGTTTT T AGGGTGTG 1947 CACACCCT A AAAACCTG 1948 Waxy starch CCCCGGAGCCCGGCAGATGCGCCGCTCGGCATGAGGACTACCGG 1949 GBSS AGCGAGCGCCGCCCCG T AGCAACAAAGCCGGAAAGCGCACCGCG Triticum turgidum GGACCCGGCGGTGCCTCTCCATGGTGGTGCGCG Lys52Term CGCGCACCACCATGGAGAGGCACCGCCGGGTCCCGCGGTGCGC 1950 AAG-TAG TTTCCGGCTTTGTTGCT A CGGGGCGGCGCTCGCTCCGGTAGTCCT CATGCCGAGCGGCGCATCTGCCGGGCTCCGGGG CCGCCCCG T AGCAACAA 1951 TTGTTGCT A CGGGGCGG 1952 Waxy starch CGGAGCCCGGCAGATGCGCCGCTCGGCATGAGGACTACCGGAG 1953 GBSS CGAGCGCCGCCCCGAAG T AACAAAGCCGGAAAGCGCACCGCGG Triticum turgidum GACCCGGCGGTGCCTCTCCATGGTGGTGCGCGCCA Gln53Term TGGCGCGCACCACCATGGAGAGGCACCGCCGGGTCCCGCGGTG 1954 CAA-TAA CGCTTTCCGGCTTTGTT A CTTCGGGGCGGCGCTCGCTCCGGTAGT CCTCATGCCGAGCGGCGCATCTGCCGGGCTCCG CCCCGAAG T AACAAAGC 1955 GCTTTGTT A CTTCGGGG 1956 Waxy starch AGCCCGGCAGATGCGCCGCTCGGCATGAGGACTACCGGAGCGAG 1957 GBSS CGCCGCCCCGAAGCAA T AAAGCCGGAAAGCGCACCGCGGGACCC Triticum turgidum GGCGGTGCCTCTCCATGGTGGTGCGCGCCACGG Gln54Term CCGTGGCGCGCACCACCATGGAGAGGCACCGCCGGGTCCCGCG 1958 CAA-TAA GTGCGCTTTCCGGCTTT A TTGCTTCGGGGCGGCGCTCGCTCCGGT AGTCCTCATGCCGAGCGGCGCATCTGCCGGGCT CGAAGCAA T AAAGCCGG 1959 CCGGCTTT A TTGCTTCG 1960 Waxy starch GATGCGCCGCTCGGCATGAGGACTACCGGAGCGAGCGCCGCCCC 1961 GBSS GAAGCAACAAAGCCGG T AAGCGCACCGCGGGACCCGGCGGTGC Triticum turgidum CTCTCCATGGTGGTGCGCGCCACGGGCAGCGCCG Lys57Term CGGCGCTGCCCGTGGCGCGCACCACCATGGAGAGGCACCGCCG 1962 AAA-TAA GGTCCCGCGGTGCGCTT A CCGGCTTTGTTGCTTCGGGGCGGCGC TCGCTCCGGTAGTCCTCATGCCGAGCGGCGCATC AAAGCCGG T AAGCGCAC 1963 GTGCGCTT A CCGGCTTT 1964 Waxy starch CAGCTCGCCACCTCCGCCACCGTCCTCGGCATCACCGACAGGTTC 1965 GBSS CGCCATGCAGGTTTC T AGGGCGTGAGGCCCCGGAGCCCGGCAGA Aegilops speltoides TGCGCCGCTCGGCATGAGGACTGTCGGAGCGA Gln28Term TCGCTCCGACAGTCCTCATGCCGAGCGGCGCATCTGCCGGGCTC 1966 CAG-TAG CGGGGCCTCACGCCCT A GAAACCTGCATGGCGGAACCTGTCGGT GATGCCGAGGACGGTGGCGGAGGTGGCGAGCTG CAGGTTTC T AGGGCGTG 1967 CACGCCCT A GAAACCTG 1968 Waxy starch GGTTTCCAGGGCGTGAGGCCCCGGAGCCCGGCAGATGCGCCGCT 1969 GBSS CGGCATGAGGACTGTC T GAGCGAGCGCCGCCCCGAAGCAACAAA Aegilops speltoides GCCGGAAAGCGCACCGCGGGACCCGGCGGTGCC Gly46Term GGCACCGCCGGGTCCCGCGGTGCGCTTTCCGGCTTTGTTGCTTC 1970 GGA-TGA GGGGCGGCGCTCGCTC A GACAGTCCTCATGCCGAGCGGCGCATC TGCCGGGCTCCGGGGCCTCACGCCCTGGAAACC GGACTGTC T GAGCGAGC 1971 GCTCGCTC A GACAGTCC 1972 Waxy starch CCCCGGAGCCCGGCAGATGCGCCGCTCGGCATGAGGACTGTCGG 1973 GBSS AGCGAGCGCCGCCCCG T AGCAACAAAGCCGGAAAGCGCACCGCG Aegilops speltoides GGACCCGGCGGTGCCTCTCGATGGTGGTGCGCG Lys52Term CGCGCACCACCATCGAGAGGCACCGCCGGGTCCCGCGGTGCGCT 1974 AAG-TAG TTCCGGCTTTGTTGCT A CGGGGCGGCGCTCGCTCCGACAGTCCTC ATGCCGAGCGGCGCATCTGCCGGGCTCCGGGG CCGCCCCG T AGCAACAA 1975 TTGTTGCT A CGGGGCGG 1976 Waxy starch CGGAGCCCGGCAGATGCGCCGCTCGGCATGAGGACTGTCGGAG 1977 GBSS CGAGCGCCGCCCCGAAG T AACAAAGCCGGAAAGCGCACCGCGG Aegilops speltoides GACCCGGCGGTGCCTCTCGATGGTGGTGCGCGCCA Gln53Term TGGCGCGCACCACCATCGAGAGGCACCGCCGGGTCCCGCGGTG 1978 CAA-TAA CGCTTTCCGGCTTTGTT A CTTCGGGGCGGCGCTCGCTCCGACAGT CCTCATGCCGAGCGGCGCATCTGCCGGGCTCCG CCCCGAAG T AACAAAGC 1979 GCTTTGTT A CTTCGGGG 1980 Waxy starch AGCCCGGCAGATGCGCCGCTCGGCATGAGGACTGTCGGAGCGAG 1981 GBSS CGCCGCCCCGAAGCAA T AAAGCCGGAAAGCGCACCGCGGGACCC Aegilops speltoides GGCGGTGCCTCTCGATGGTGGTGCGCGCCACCG Gln54Term CGGTGGCGCGCACCACCATCGAGAGGCACCGCCGGGTCCCGCG 1982 CAA-TAA GTGCGCTTTCCGGCTTT A TTGCTTCGGGGCGGCGCTCGCTCCGAC AGTCCTCATGCCGAGCGGCGCATCTGCCGGGCT CGAAGCAA T AAAGCCGG 1983 CCGGCTTT A TTGCTTCG 1984 Waxy starch AGTGCAGAGATCTTCCACAGCAACAGCTAGACAACCACCATGTCG 1985 GBSS GCTCTCACCACGTCC T AGCTCGCCACCTCGGCCACCGGCTTCGG Oryza glaberrima CATCGCTGACAGGTCGGCGCCGTCGTCGCTGC Gln8Term GCAGCGACGACGGCGCCGACCTGTCAGCGATGCCGAAGCCGGT 1986 GAG-TAG GGCCGAGGTGGCGAGCT A GGACGTGGTGAGAGCCGACATGGTG GTTGTCTAGCTGTTGCTGTGGAAGATCTCTGCACT CCACGTCC T AGCTCGCC 1987 GGCGAGCT A GGACGTGG 1988 Waxy starch TCCACAGCAACAGCTAGACAACCACCATGTCGGCTCTCACCACGT 1989 GBSS CCCAGCTCGCCACCT A GGCCACCGGCTTCGGCATCGCTGACAGG Oryza glaberrima TCGGCGCCGTCGTCGCTGCTCCGCCACGGGTT Ser12Term AACCCGTGGCGGAGCAGCGACGACGGCGCCGACCTGTCAGCGAT 1990 TCG-TAG GCCGAAGCCGGTGGCC T AGGTGGCGAGCTGGGACGTGGTGAGA GCCGACATGGTGGTTGTCTAGCTGTTGCTGTGGA CGCCACCT A GGCCACCG 1991 CGGTGGCC T AGGTGGCG 1992 Waxy starch CGGCTCTCACCACGTCCCAGCTCGCCACCTCGGCCACCGGCTTC 1993 GBSS GGCATCGCTGACAGGT A GGCGCCGTCGTCGCTGCTCCGCCACGG Oryza glaberrima GTTCCAGGGCCTCAAGCCCCGCAGCCCCGCCGG Ser22Term CCGGCGGGGCTGCGGGGCTTGAGGCCCTGGAACCCGTGGCGGA 1994 TCG-TAG GCAGCGACGACGGCGCC T ACCTGTCAGCGATGCCGAAGCCGGTG GCCGAGGTGGCGAGCTGGGACGTGGTGAGAGCCG TGACAGGT A GGCGCCGT 1995 ACGGCGCC T ACCTGTCA 1996 Waxy starch CCACGTCCCAGCTCGCCACCTCGGCCACCGGCTTCGGCATCGCT 1997 GBSS GACAGGTCGGCGCCGT A GTCGCTGCTCCGCCACGGGTTCCAGGG Oryza glaberrima CCTCAAGCCCCGCAGCCCCGCCGGCGGCGACGC Ser25Term GCGTCGCCGCCGGCGGGGCTGCGGGGCTTGAGGCCCTGGAACC 1998 TCG-TAG CGTGGCGGAGCAGCGAC T ACGGCGCCGACCTGTCAGCGATGCCG AAGCCGGTGGCCGAGGTGGCGAGCTGGGACGTGG GGCGCCGT A GTCGCTGC 1999 GCAGCGAC T ACGGCGCC 2000 Waxy starch CGTCCCAGCTCGCCACCTCGGCCACCGGCTTCGGCATCGCTGAC 2001 GBSS AGGTCGGCGCCGTCGT A GCTGCTCCGCCACGGGTTCCAGGGCCT Oryza glaberrima CAAGCCCCGCAGCCCCGCCGGCGGCGACGCGAC Ser26Term GTCGCGTCGCCGCCGGCGGGGCTGCGGGGCTTGAGGCCCTGGA 2002 TCG-TAG ACCCGTGGCGGAGCAGC T ACGACGGCGCCGACCTGTCAGCGATG CCGAAGCCGGTGGCCGAGGTGGCGAGCTGGGACG GCCGTCGT A GCTGCTCC 2003 GGAGCAGC T ACGACGGC 2004 Waxy starch TCCACAGCAAGAGCTAAACAGCCGACCGTGTGCACCACCATGTCG 2005 GBSS GCTGTCACCACGTCC T AGCTCGCCACCTCGGCCACCGGCTTCGG Oryza sativa CATCGCCGACAGGTCGGCGCCGTCGTCGCTGG Gln8Term GCAGCGACGACGGCGCCGACCTGTCGGCGATGCCGAAGCCGGT 2006 CAG-TAG GGCCGAGGTGGCGAGCT A GGACGTGGTGAGAGCCGACATGGTG GTGCACACGGTCGGCTGTTTAGCTCTTGCTGTGGA CCACGTCC T AGCTCGCC 2007 GGCGAGCT A GGACGTGG 2008 Waxy starch CTAAACAGCCGACCGTGTGCACCACCATGTCGGCTCTCACCACGT 2009 GBSS CCCAGCTCGCCACCT A GGCCACCGGCTTCGGCATCGCCGACAGG Oryza sativa TCGGCGCCGTCGTCGCTGCTTCGCCACGGGTT Ser12Term AACCCGTGGCGAAGCAGCGACGACGGCGCCGACCTGTCGGCGAT 2010 TCG-TAG GCCGAAGCCGGTGGCC T AGGTGGCGAGCTGGGACGTGGTGAGA GCCGACATGGTGGTGCACACGGTCGGCTGTTTAG CGCCACCT A GGCCACCG 2011 CGGTGGCC T AGGTGGCG 2012 Waxy starch CGGCTCTCACCACGTCCCAGCTCGCCACCTCGGCCACCGGCTTC 2013 GBSS GGCATCGCCGACAGGT A GGCGCCGTCGTCGCTGCTTCGCCACGG Oryza sativa GTTCCAGGGCCTCAAGCCCCGTAGCCCAGCCGG Ser22Term CCGGCTGGGCTACGGGGCTTGAGGCCCTGGAACCCGTGGCGAA 2014 TCG-TAG GGAGCGACGACGGCGCC T ACCTGTCGGCGATGCCGAAGCCGGTG GCCGAGGTGGCGAGCTGGGACGTGGTGAGAGCCG CGACAGGT A GGCGCCGT 2015 ACGGCGCC T ACCTGTCG 2016 Waxy starch CCACGTCCCAGCTCGCCACCTCGGCCACCGGCTTCGGCATCGCC 2017 GBSS GACAGGTCGGCGCCGT A GTCGCTGCTTCGCCACGGGTTCCAGGG Oryza sativa CCTCAAGCCCCGTAGCCCAGCCGGCGGGGACGC Ser25Term GCGTCCCCGCCGGCTGGGCTACGGGGCTTGAGGCCCTGGAACCC 2018 TCG-TAG GTGGCGAAGCAGCGAC T ACGGCGCCGACCTGTCGGCGATGCCGA AGCCGGTGGCCGAGGTGGCGAGCTGGGACGTGG GGCGCCGT A GTCGCTGC 2019 GCAGCGAC T ACGGCGCC 2020 Waxy starch CGTCCCAGCTCGCCACCTCGGCCACCGGCTTCGGCATCGCCGAC 2021 GBSS AGGTCGGCGCCGTCGT A GCTGCTTCGCCACGGGTTCCAGGGCCT Oryza sativa CAAGCCCCGTAGCCCAGCCGGCGGGGACGCATC Ser26Term GATGCGTCCCCGCCGGCTGGGCTACGGGGCTTGAGGCCCTGGAA 2022 TCG-TAG CCCGTGGCGAAGCAGC T ACGACGGCGCCGACCTGTCGGCGATGC CGAAGCCGGTGGCCGAGGTGGCGAGCTGGGACG GCCGTCGT A GCTGCTTC 2023 GAAGCAGC T ACGACGGC 2024 Waxy starch GTCTCTCACTGCAGGTAGCCACACCCTGTGCGCGGCGCCATGGC 2025 GBSS GGCTCTGGCCACGTCC T AGCTCGCCACCTCCGGCACCGTCCTCG Hordeum vulgare GCGTCACCGACAGATTCCGGCGTCCAGGTTTTC Gln8Term GAAAACCTGGACGCCGGAATCTGTCGGTGACGCCGAGGACGGTG 2026 GAG-TAG CCGGAGGTGGCGAGCT A GGACGTGGCCAGAGCCGGCATGGCGC CGCGCACAGGGTGTGGCTACCTGCAGTGAGAGAC CCACGTCC T AGCTCGCC 2027 GGCGAGCT A GGACGTGG 2028 Waxy starch ATGGCGGCTCTGGCCACGTCCCAGCTCGCCACGTCCGGCACCGT 2029 GBSS CCTCGGCGTCACCGAC T GATTCCGGCGTCCAGGTTTTGAGGGCCT Hordeum vulgare CAGGCCCCGGAACCCGGCGGATGCGGCGCTTG Arg21Term CAAGCGCGGCATCCGCCGGGTTCCGGGGCCTGAGGCCGTGAAAA 2030 AGA-TGA CCTGGACGCCGGAATC A GTCGGTGACGCCGAGGACGGTGCCGG AGGTGGCGAGCTGGGACGTGGCCAGAGCCGCCAT TCACCGAC T GATTCCGG 2031 CCGGAATC A GTCGGTGA 2032 Waxy starch CAGCTCGCCACCTCCGGCACCGTCCTCGGCGTCACCGACAGATT 2033 GBSS CCGGCGTCCAGGTTTT T AGGGCCTCAGGCCCCGGAACCCGGCGG Hordeum vulgare ATGCGGCGCTTGGTCTGAGGACTATCGGAGCAA Gln28Term TTGCTCCGATAGTCCTCATACCAAGCGCCGCATCCGCCGGGTTCC 2034 CAG-TAG GGGGCCTGAGGCCCT A AAAACCTGGACGCCGGAATCTGTCGGTG ACGCCGAGGACGGTGCCGGAGGTGGCGAGCTG CAGGTTTT T AGGGCCTC 2035 GAGGCCCT A AAAACCTG 2036 Waxy starch GGTTTTCAGGGCCTCAGGCCGCGGAACCCGGCGGATGCGGCGCT 2037 GBSS TGGTATGAGGACTATCTGAGCAAGCGCCGCCCCGAAGCAAAGGC Hordeum vulgare GGAAAGCGGACCGCGGGAGCCGGCGGTGCCTCT Gly46Term AGAGGCACCGCCGGCTCCCGCGGTGCGCTTTCCGGCTTTGCTTC 2038 GGA-TGA GGGGCGGCGCTTGCTC A GATAGTCCTCATACCAAGCGCCGCATC CGCCGGGTTCCGGGGCCTGAGGCCCTGAAAACC GGACTATC T GAGCAAGC 2039 GCTTGCTC A GATAGTCC 2040 Waxy starch CCCCGGAACCCGGCGGATGCGGCGCTTGGTATGAGGACTATCGG 2041 GBSS AGCAAGCGCCGCCCCG T AGCAAAGCCGGAAAGCGCACCGCGGG Hordeum vulgare AGCCGGCGGTGCCTCTCCGTGGTGGTGAGCGCCA Lys52Term TGGCGCTCACCACCACGGAGAGGCACCGCCGGCTCCCGCGGTGC 2042 AAG-TAG GCTTTGCGGCTTTGCT A CGGGGCGGCGCTTGCTCCGATAGTCCTC ATACCAAGCGCCGCATCCGCCGGGTTCCGGGG CCGCCCCG T AGCAAAGC 2043 GCTTTGCT A CGGGGCGG 2044 Waxy starch ACGTCTTTTCTCTCTCTCCTACGCAGTGGATTAATCGGCATGGCGG 2045 GBSS CTCTGGCCACGTCG T AGCTCGTCGCAACGCGGGCCGGCCTGGGC Zea mays GTCCCGGACGCGTCCACGTTCCGCCGCGGCG Gln8Term CGCCGCGGCGGAACGTGGACGCGTCCGGGACGCCCAGGCCGGC 2046 GAG-TAG GCGCGTTGCGACGAGCT A CGACGTGGCCAGAGCCGCCATGCCGA TTAATCCACTGCGTAGGAGAGAGAGAAAAGACGT CCACGTCG T AGCTCGTC 2047 GACGAGCT A CGACGTGG 2048 Waxy starch GTCGCAACGCGCGCCGGCCTGGGCGTCCCGGACGCGTCCACGTT 2049 GBSS CCGCCGCGGCGCCGCG T AGGGCCTGAGGGGGGCCCGGGCGTCG Zea mays GCGGGGGCGGACACGCTCAGCATGCGGACCAGCG Gln30Term CGCTGGTCCGCATGCTGAGCGTGTCCGCCGCCGCCGACGCCCGG 2050 CAG-TAG GCCCCCCTCAGGCCCT A CGCGGCGCCGCGGCGGAACGTGGACG CGTCCGGGACGCCCAGGCCGGCGCGCGTTGCGAC GCGCCGCG T AGGGCCTG 2051 CAGGCCCT A CGCGGCGC 2052 Waxy starch TCCCGGACGCGTCCACGTTCCGCCGCGGCGCCGCGCAGGGCCT 2053 GBSS GAGGGGGGCCCGGGCGT A GGCGGCGGCGGACACGCTCAGCATG Zea mays CGGACCAGCGCGCGCGCGGCGCCCAGGCACCAGCA Ser38Term TGCTGGTGCCTGGGCGCCGCGCGCGCGCTGGTCCGCATGCTGAG 2054 TCG-TAG CGTGTCCGCCGCCGCC T ACGCCCGGGCCCCCCTCAGGCCCTGCG CGGCGCCGCGGCGGAACGTGGACGCGTCCGGGA CCGGGCGT A GGCGGCGG 2055 CCGCCGCC T ACGCCCGG 2056 Waxy starch GCGTCGGCGGCGGCGGACACGCTCAGCATGCGGACCAGCGCGC 2057 GBSS GCGCGGCGCCCAGGCAC T AGCAGCAGGCGCGCCGCGGGGGCAG Zea mays GTTCCCGTCGCTCGTCGTGTGCGCCAGCGCCGGCA Ser57Term TGCCGGCGCTGGCGCACACGACGAGCGACGGGAACCTGCCCCC 2058 GAG-TAG GCGGCGCGCCTGCTGCT A GTGCCTGGGCGCCGCGCGCGCGCTG GTCCGCATGCTGAGCGTGTCCGCCGCCGCCGACGC CCAGGCAC T AGCAGCAG 2059 CTGCTGCT A GTGCCTGG 2060 Waxy starch TCGGCGGCGGCGGACACGCTCAGCATGCGGACCAGCGCGCGCG 2061 GBSS CGGCGCCCAGGCACCAG T AGCAGGCGCGCCGCGGGGGCAGGTT Zea mays CCCGTCGCTCGTCGTGTGCGCCAGCGCCGGCATGA Gln58Term TCATGCCGGGGCTGGCGCACACGACGAGCGACGGGAACCTGCCC 2062 CAG-TAG CCGCGGCGCGCCTGCT A CTGGTGCCTGGGCGCCGCGCGCGCGC TGGTCCGCATGCTGAGCGTGTCCGCCGCCGCCGA GGCACCAG T AGCAGGCG 2063 CGCCTGCT A CTGGTGCC 2064 - Improved means to manipulate fatty acid compositions, from biosynthetic or natural plant sources, are needed. For example, oils containing reduced saturated fatty acids are desired for dietary reasons and oils containing increased saturated fatty acids are also needed as alternatives to current sources of highly saturated oil products, such as tropical oils or chemically hydrogenated oils. It would therefore be advantageous to influence directly the production and composition of fatty acids in crop plants.
- Higher plants synthesize fatty acids, primarily palmitic, stearic and oleic acids, in the plastids (i.e., chloroplasts, proplastids, or other related organelles) as part of the Fatty Acid Synthase (FAS) complex. Fatty acid synthesis is the result of the three enzymatic activities: acyl-ACP elongase, acyl-ACP desaturase and acyl-ACP thioesterases specific for each of palmitoyl-, stearoyl- and oleoyl-ACP.
- A variety of enzymes have been identified that influence the relative levels of saturated vs. unsaturated fatty acids in plants. For example, the enzymes stearoyl-acyl carrier protein (stearoyl-ACP) desaturase, oleoyl desaturase and linoleate desaturase produce unsaturated fatty acids from saturated precursors. Similarly, relative enzymatic activities of the various acyl-ACP thioesterases influences the relative acyl-chain composition of the resultant fatty acids. Consequently a reduction or an increase of the activity of these enzymes can alter the properties of oils produced in a plant. In fact, specific targeting of particular enzymatic activities can results in altered levels of particular fatty acids.
- The attached tables disclose exemplary oligonucleotides base sequences which can be used to generate site-specific mutations in plant genes encoding proteins involved in fatty acid biosynthesis.
TABLE 22 Oligonucleotides to produce plants with reduced palmitate Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Reduced palmitate TTTGGTGGCAGTGTCTTTGAACGCTTCATCTCCTCGTCATGGTGGC 2065 Acyl-ACP-thioesterase CACCTCTGCTACGT A GTCATTCTTTCCTGTACCATCTTCTTCACTTG Arabidopsis thaliana ATCCTAATGGAAAAGGCAATAAGATTGG Ser8Term CCAATCTTATTGCCTTTTCCATTAGGATCAAGTGAAGAAGATGGTA 2066 TCG-TAG CAGGAAAGAATGAC T ACGTCGCAGAGGTGGCCACCATGACGAGG AGATGAAGCGTTCAAAGACACTGCCACCAAA TGCTACGT A GTCATTCT 2067 AGAATGAC T ACGTAGCA 2068 Reduced palmitate GGTGGCAGTGTCTTTGAACGCTTCATCTCCTCGTCATGGTGGCCA 2069 Acyl-ACP-thioesterase CCTCTGCTACGTCGT G ATTCTTTCCTGTACCATCTTCTTCACTTGAT Arabidopsis thaliana CCTAATGGAAAAGGCAATAAGATTGGGTC Ser9Term GACCCAATCTTATTGCCTTTTCCATTAGGATCAAGTGAAGAAGATG 2070 TCA-TGA GTACAGGAAAGAAT C ACGACGTAGCAGAGGTGGCCACCATGACG AGGAGATGAAGCGTTCAAAGACACTGCCACC TACGTCGT G ATTCTTTC 2071 GAAAGAAT C ACGACGTA 2072 Reduced palmitate ATCTCCTCGTCATGGTGGCCACCTCTGCTACGTCGTCATTCTTTCC 2073 Acyl-ACP-thioesterase TGTACCATCTTCTT G ACTTGATCCTAATGGAAAAGGCAATAAGATT Arabidopsis thaliana GGGTCTACGAATCTTGCTGGACTCAATTC Ser17Term GAATTGAGTCCAGCAAGATTCGTCGACCCAATCTTATTGCCTTTTC 2074 TCA-TGA CATTAGGATCAAGT C AAGAAGATGGTCCAGGAAAGAATGACGACG TAGCAGAGGTGGCCACCATGACGAGGAGAT ATCTTCTT G ACTTGATC 2075 GATCAAGT C AAGAAGAT 2076 Reduced palmitate GTGGCCACCTCTGCTACGTCGTCATTCTTTCCTGTACCATCTTCTT 2077 Acyl-AGP-thioesterase CACTTGATCCTAAT T GAAAAGGCAATAAGATTGGGTCTACGAATCT Arabidopsis thaliana TGCTGGACTCAATTCTGCACCTAACTCTG Gly22Term CAGAGTTAGGTGCAGAATTGAGTCCAGCAAGATTCGTCGACCCAA 2078 GGA-TGA TCTTATTGCCTTTTC A ATTAGGATCAAGTGAAGAAGATGGTCCAGG AAAGAATGACGACGTAGCAGAGGTGGCCAC ATCCTAAT T GAAAAGGC 2079 GCCTTTTC A ATTAGGAT 2080 Reduced palmitate GCTTGAATTTGTGATCTGATTGGTTAATTGTGGCCACAATGGTTGC 2081 Acyl-ACP-thioesterase TACTGCCGCCACGT G ATCATTCTTTCCGTTGACTTCCCCTTCTGGG Garcinia mangostana GATGCCAAATCGGGCAATCCCGGAAAAGG Ser8Term CCTTTTCCGGGATTGCCCGATTTGGCATCCCCAGAAGGGGAAGTC 2082 TCA-TGA AACGGAAAGAATGAT C ACGTGGCGGCAGTAGCAACCATTGTGGCC ACAATTAACCAATCAGATCACAAATTCAAGC CGCCACGT G ATCATTCT 2083 AGAATGAT C ACGTGGCG 2084 Reduced palmitate TGAATTTGTGATCTGATTGGTTAATTGTGGCCACAATGGTTGCTAC 2085 Acyl-ACP-thioesterase TGCCGCCACGTCAT G ATTCTTTCCGTTGACTTCCCCTTCTGGGGAT Garcinia mangostana GCCAAATCGGGCAATCCCGGAAAAGGGTC Ser9Term GACCCTTTTCCGGGATTGCCCGATTTGGCATCCCCAGAAGGGGAA 2086 TCA-TGA GTCAACGGAAAGAAT C ATGACGTGGCGGCAGTAGCAACCATTGTG GCCACAATTAACCAATCAGATCACAAATTCA CACGTCAT G ATTCTTTC 2087 GAAAGAAT C ATGACGTG 2088 Reduced palmitate CTGATTGGTTAATTGTGGCCACAATGGTTGCTACTGCCGCCACGT 2089 Acyl-ACP-thioesterase CATCATTCTTTCCGT A GACTTCCCCTTCTGGGGATGCCAAATCGGG Garcinia mangostana CAATCCCGGAAAAGGGTCGGTGAGTTTTGG Leu13Term CCAAAACTCACCGACCCTTTTCCGGGATTGCCCGATTTGGCATCC 2090 TTG-TAG CCAGAAGGGGAAGTC T ACGGAAAGAATGATGACGTGGCGGCAGT AGCAACCATTGTGGCCACAATTAACCAATCAG CTTTCCGT A GACTTCCC 2091 GGGAAGTC T ACGGAAAG 2092 Reduced palmitate ATGGTTGCTACTGCCGCCACGTCATCATTCTTTCCGTTGACTTCCC 2093 Acyl-ACP-thioesterase CTTCTGGGGATGCC T AATCGGGCAATCCCGGAAAAGGGTCGGTG Garcinia mangostana AGTTTTGGGTCAATGAAGTCGAAATCCGCGG Lys21Term CCGCGGATTTCGACTTCATTGACCCAAAACTCACCGACCCTTTTCC 2094 AAA-TAA GGGATTGCCCGATT A GGCATCCCCAGAAGGGGAAGTCAACGGAA AGAATGATGACGTGGCGGCAGTCGCAACCAT GGGATGCC T AATCGGGC 2095 GCCCGATT A GGCATCCC 2096 Reduced palmitate GGGATTTCAGCACGAAATTGAAGTTGTTTTTAAAAACCATGGTTGC 2097 Acyl-ACP-thioesterase TACTGCTGTGACAT A GGCGTTTTTCCCAGTCACTTCTTCACCTGAC Gossypium hirsutum TCCTCTGACTCGAAAAACAAGAAGCTCGG Ser8Term CCGAGCTTCTTGTTTTTCGAGTCAGAGGAGTCAGGTGAAGAAGTG 2098 TCG-TAG ACTGGGAAAAACGCC T ATGTCACAGCAGTAGCAACCATGGTTTTTA AAAACAACTTCAATTTCGTGCTGAAATCCC TGTGACAT A GGCGTTTT 2099 AAAACGCC T ATGTCACA 2100 Reduced palmitate TGTTTTTAAAAACCATGGTTGCTACTGCTGTGACATCGGCGTTTTT 2101 Acyl-ACP-thioesterase CCCAGTCACTTCTT G ACCTGACTCCTCTGACTCGAAAAACAAGAAG Gossypium hirsutum CTCGGAAGCATCAAGTCGAAGCCATCGGT Ser16Term ACCGATGGCTTCGACTTGATGCTTCCGAGCTTCTTGTTTTTCGAGT 2102 TCA-TGA CAGAGGAGTCAGGT C AAGAAGTGACTGGGAAAAACGCCGATGTCA CAGCAGTAGCAACCATGGTTTTTAAAAACA CACTTCTT G ACCTGACT 2103 AGTCAGGT C AAGAAGTG 2104 Reduced palmitate TTGCTACTGCTGTGACATCGGCGTTTTTCCCAGTCACTTCTTCACC 2105 Acyl-ACP-thioesterase TGACTCCTCTGACT A GAAAAACAAGAAGCTCGGAAGCATCAAGTC Gossypium hirsutum GAAGCCATCGGTTTCTTCTGGAAGTTTGCA Ser22Term TGCAAACTTCCAGAAGAAACCGATGGCTTCGACTTGATGCTTCCG 2106 TCG-TAG AGCTTCTTGTTTTTC T AGTCAGAGGAGTCAGGTGAAGAAGTGACTG GGAAAAACGCCGATGTCACAGCAGTCGCAA CTCTGACT A GAAAAACA 2107 TGTTTTTC T AGTCAGAG 2108 Reduced palmitate GCTACTGCTGTGACATCGGCGTTTTTCCCAGTCACTTCTTCACCTG 2109 Acyl-ACP-thioesterase ACTCCTCTGACTCG T AAAACAAGAAGCTCGGAAGCATCAAGTCGA Gossypium hirsutum AGCCATCGGTTTGTTCTGGAAGTTTGCAAG Lys23Term CTTGCAAACTTCCAGAAGAAACCGATGGCTTCGACTTGATGCTTCC 2110 AAA-TAA GAGCTTCTTGTTTT A CGAGTCAGAGGAGTCAGGTGAAGAAGTGAC TGGGAAAAACGCCGATGTCACAGCAGTAGC CTGACTCG T AAAACAAG 2111 CTTGTTTT A GGAGTCAG 2112 Reduced palmitate CTCCCGCTCGTTGAAAGACAATGGTGGCTACCGCTGCAAGCTCTG 2113 Acyl-ACP-thioesterase CATTCTTCCCCGTGT A GTCCCCGGTCACCTCCTCTAGACCAGGAA Cuphea hookeriana AGCCCGGAAATGGGTCATCGAGCTTCAGCCC Ser14Term GGGCTGAAGCTCGATGACCCATTTCCGGGCTTTCCTGGTCTAGAG 2114 TCG-TAG GAGGTGACCGGGGAC T ACACGGGGAAGAATGCAGAGCTTGCAGC GGTAGCCACCATTGTCTTTCAACGAGCGGGAG CCCCGTGT A GTCCCCGG 2115 CCGGGGAC T ACACGGGG 2116 Reduced palmitate ATGGTGGCTACCGCTGCAAGCTCTGCATTCTTCCCCGTGTCGTCC 2117 Acyl-ACP-thioesterase CCGGTCACCTCCTCT T GACCAGGAAAGCCCGGAAATGGGTCATCG Cuphea hookeriana AGCTTCAGCCCCATCAAGCCCAAATTTGTCG Arg21Term CGACAAATTTGGGCTTGATGGGGCTGAAGCTCGATGACCCATTTC 2118 AGA-TGA CGGGCTTTCCTGGTC A AGAGGAGGTGACCGGGGACGACACGGG GAAGAATGCAGAGCTTGCAGCGGTAGCCACCAT CCTCCTCT T GACCAGGA 2119 TCCTGGTC A AGAGGAGG 2120 Reduced palmitate GCTACCGCTGCAAGCTCTGCATTCTTCCCCGTGTCGTCCCCGGTC 2121 Acyl-ACP-thioesterase ACCTCCTCTAGACCA T GAAAGCCCGGAAATGGGTCATCGAGCTTC Cuphea hookeriana AGCCCCATCAAGCCCAAATTTGTCGCCAATG Gly23Term CATTGGCGACAAATTTGGGCTTGATGGGGCTGAAGCTCGATGACC 2122 GGA-TGA CATTTCCGGGCTTTC A TGGTCTAGAGGAGGTGACCGGGGACGAC ACGGGGAAGAATGCAGAGCTTGCAGCGGTAGC CTAGACCA T GAAAGCCC 2123 GGGCTTTC A TGGTCTAG 2124 Reduced palmitate ACCGCTGCAAGCTCTGCATTCTTCCCCGTGTCGTCCCCGGTCACC 2125 Acyl-ACP-thioesterase TCCTCTAGACCAGGA T AGCCCGGAAATGGGTCATGGAGCTTCAGC Cuphea hookeriana CCCATCAAGCCCAAATTTGTCGCCAATGGCG Lys24Term CGCCATTGGCGACAAATTTGGGCTTGATGGGGCTGAAGCTCGATG 2126 AAG-TAG ACCCATTTCCGGGCT A TCCTGGTCTAGAGGAGGTGACCGGGGAC GACACGGGGAAGAATGCAGAGCTTGCAGCGGT GACCAGGA T AGCCCGGA 2127 TCCGGGCT A TCCTGGTC 2128 Reduced palmitate GCCACCGCTGCAAGTTCTGCATTCTTCCCCCTGCCGTCCCCGGAC 2129 Acyl-ACP-thioesterase ACCTCCTCTAGGCCG T GAAAGCTGGGAAATGGGTCATCGAGCTTG Cuphea lanceolata AGCCCCCTCAAGCCCAAATTTGTCGCCAATG Gly23Term CATTGGCGACAAATTTGGGCTTGAGGGGGCTCAAGCTCGATGACC 2130 GGA-TGA CATTTCCGAGCTTTC A CGGCCTAGAGGAGGTGTCCGGGGACGGC AGGGGGAAGAATGCAGAACTTGCAGCGGTGGC CTAGGCCG T GAAAGCTC 2131 GAGCTTTC A CGGCCTAG 2132 Reduced palmitate ACCGCTGCAAGTTCTGCATTCTTCCCCCTGCCGTCCCCGGACACC 2133 Acyl-ACP-thioesterase TCCTCTAGGCCGGGA T AGCTCGGAAATGGGTCATCGAGCTTGAGC Cuphea lanceolata CCCCTCAAGCCCAAATTTGTCGCCAATGCCG Lys24Term CGGCATTGGCGACAAATTTGGGCTTGAGGGGGCTCAAGCTCGAT 2134 AAG-TAG GACCCATTTCCGAGCT A TCCCGGCCTAGAGGAGGTGTCCGGGGA CGGCAGGGGGAAGAATGCAGAACTTGCAGCGGT GGCCGGGA T AGCTCGGA 2135 TCCGAGCT A TCCCGGCC 2136 Reduced palmitate GCAAGTTCTGCATTCTTCCCCCTGCCGTCCCCGGACACCTCCTCT 2137 Acyl-ACP-thioesterase AGGCCGGGAAAGCTC T GAAATGGGTCATCGAGCTTGAGCCCCCT Cuphea lanceolata CAAGCCCAAATTTGTCGCCAATGCCGGGTTGA Gly26Term TCAACCCGGCATTGGCGACAAATTTGGGGTTGAGGGGGCTCAAGC 2138 GGA-TGA TCGATGACCCATTTC A GAGCTTTCCCGGCCTAGAGGAGGTGTCCG GGGACGGCAGGGGGAAGAATGCAGAACTTGC GAAAGCTC T GAAATGGG 2139 CCCATTTC A GAGCTTTC 2140 Reduced palmitate CATTCTTCCCCCTGCCGTCCCCGGACACCTCCTCTAGGCCGGGAA 2141 Acyl-ACP-thioesterase AGCTCGGAAATGGGT G ATCGAGCTTGAGCCCCCTCAAGCCCAAAT Cuphea lanceolata TTGTCGCCAATGCCGGGTTGAAGGTTAAGGC Ser29Term GCCTTAACCTTCAACCCGGCATTGGCGACAAATTTGGGCTTGAGG 2142 TCA-TGA GGGCTCAAGCTCGAT C ACCCATTTCCGAGCTTTCCCGGCCTAGAG GAGGTGTCCGGGGACGGCAGGGGGAAGAATG AAATGGGT G ATCGAGCT 2143 AGCTCGAT C ACCCATTT 2144 Reduced palmitate CGTTTAAGTGGATCGGACATTTAAGTGTTTTAATCATGGTAGCTAT 2145 Acyl-ACP-thioesterase GAGTGCTACTGCGT A GCTGTTTCCGGTTTCTTCCCCAAAACCTCAC Helianthus annuus TCTGGAGCCAAGACATCTGATAAGCTTGG Ser9Term CCAAGCTTATCAGATGTCTTGGCTCCAGAGTGAGGTTTTGGGGAA 2146 TCG-TAG GAAACCGGAAACAGC T ACGCAGTCGCACTCATAGCTACCATGATT AAAACACTTAAATGTCCGATCCACTTAAACG TACTGCGT A GCTGTTTC 2147 GAAACAGC T ACGCAGTA 2148 Reduced palmitate AGTGTTTTAATCATGGTCGCTATGAGTGCTACTGCGTCGCTGTTTC 2149 Acyl-ACP-thioesterase CGGTTTCTTCCCCA T AACCTCACTCTGGAGCCAAGACATCTGATAA Helianthus annuus GCTTGGAGGTGAACCAGGTAGTGTTGCTG Lys17Term CAGCAACACTACCTGGTTCACCTCCAAGCTTATCAGATGTCTTGGC 2150 AAA-TAA TCCAGAGTGAGGTT A TGGGGAAGAAACCGGAAACAGCGACGCAG TAGCACTCATAGCTACCATGATTAAAACACT CTTCCCCA T AACCTCAC 2151 GTGAGGTT A TGGGGAAG 2152 Reduced palmitate ATGGTAGCTATGAGTGCTACTGCGTCGCTGTTTCCGGTTTCTTCCC 2153 Acyl-ACP-thioesterase CAAAACCTCACTCT T GAGCCAAGACATCTGATAAGCTTGGAGGTG Helianthus annuus AACCAGGTAGTGTTGCTGTGCGCGGAATCA Gly21Term TGATTCCGCGCACAGCAACACTACCTGGTTCACCTCCAAGCTTATC 2154 GGA-TGA AGATGTCTTGGCTC A AGAGTGAGGTTTTGGGGAAGAAACCGGAAA CAGCGACGCAGTAGCACTCATAGCTACCAT CTCACTCT T GAGCCAAG 2155 CTTGGCTC A AGAGTGAG 2156 Reduced palmitate GCTATGAGTGCTACTGCGTCGCTGTTTCCGGTTTCTTCCCCAAAAC 2157 Acyl-ACP-thioesterase CTCACTCTGGAGCCT A GACATCTGATAAGCTTGGAGGTGAACCAG Helianthus annuus GTAGTGTTGCTGTGCGCGGAATCAAGACAA Lys23Term TTGTCTTGATTCCGCGCACAGCAACACTACCTGGTTCACCTCCAAG 2158 AAG-TAG CTTATCAGATGTCT A GGCTCCAGAGTGAGGTTTTGGGGAAGAAAC CGGAAACAGCGACGCAGTCGCACTCATAGC CTGGAGCC T AGACATCT 2159 AGATGTCT A GGCTCCAG 2160 Reduced palmitate ATGGTGGCTGCTGCAGCAAGTTCTGCATGCTTCCCTGTTCCATCC 2161 Acyl-ACP-thioesterase CCAGGAGCCTCCCCT T AACCTGGGAAGTTAGGCAACTGGTCATCG Cuphea palustris AGTTTGAGCCCTTCCTTGAAGCCCAAGTCAA Lys21Term TTGACTTGGGCTTCAAGGAAGGGCTCAAACTCGATGACCAGTTGC 2162 AAA-TAA CTAACTTCCCAGGTT A AGGGGAGGCTCCTGGGGATGGAACAGGG AAGCATGCAGAACTTGCTGCAGCAGCCACCAT CCTCCCCT T AACCTGGG 2163 CCCAGGTT A AGGGGAGG 2164 Reduced palmitate GCTGCAGCAAGTTCTGCATGCTTCCCTGTTCCATCCCCAGGAGCC 2165 Acyl-ACP-thioesterase TCCCCTAAACCTGGG T AGTTAGGCAACTGGTCATCGAGTTTGAGC Cuphea palustris CCTTCCTTGAAGCCCAAGTCAATCCCCAATG Lys24Term CATTGGGGATTGACTTGGGCTTCAAGGAAGGGCTCAAACTCGATG 2166 AAG-TAG ACCAGTTGCCTAACT A CCCAGGTTTAGGGGAGGCTCCTGGGGATG GAACAGGGAAGCATGCAGAACTTGCTGCAGC AACCTGGG T AGTTAGGC 2167 GCCTAACT A CCCAGGTT 2168 Reduced palmitate TGCATGCTTCCCTGTTCCATCCCCAGGAGCCTCCCCTAAACCTGG 2169 Acyl-ACP-thioesterase GAAGTTAGGCAACTG A TCATCGAGTTTGAGCCCTTCCTTGAAGCC Cuphea palustris CAAGTCAATCCCCAATGGCGGATTTCAGGTT Trp28Term AACCTGAAATCCGCCATTGGGGATTGACTTGGGCTTCAAGGAAGG 2170 TGG-TGA GCTCAAACTCGATGA T CAGTTGCCTAACTTCCCAGGTTTAGGGGA GGCTCCTGGGGATGGAACAGGGAAGCATGCA GGCAACTG A TCATCGAG 2171 CTCGATGA T CAGTTGCC 2172 Reduced palmitate CATGCTTCCCTGTTCCATCCCCAGGAGCCTCCCCTAAACCTGGGA 2173 Acyl-ACP-thioesterase AGTTAGGCAACTGGT G ATCGAGTTTGAGCCCTTCCTTGAAGCCCA Cuphea palustris AGTCAATCCCCAATGGCGGATTTCAGGTTAA Ser29Term TTAACCTGAAATCCGCCATTGGGGATTGACTTGGGCTTCAAGGAA 2174 TCA-TGA GGGCTCAAACTCGAT C ACCAGTTGCCTAACTTCCCAGGTTTAGGG GAGGCTCCTGGGGATGGAACAGGGAAGCATG CAACTGGT G ATCGAGTT 2175 AACTCGAT C ACCAGTTG 2176 Reduced paimitate ATGGTGGCTGCCGCAGCAAGTTCTGCATTCTTCTCCGTTCCAACC 2175 Acyl-ACP-thioesterase CCGGGAATCTCCCCT T AACCCGGGAAGTTCGGTAATGGTGGCTTT Cuphea hookeriana CAGGTTAAGGCAAACGCCAATGCCCATCCTA Lys21Term TAGGATGGGCATTGGCGTTTGCCTTAACCTGAAAGCCACCATTAC 2178 AAA-TAA CGAACTTCCCGGGTT A AGGGGAGATTCCCGGGGTTGGAACGGAG AAGAATGCAGAACTTGCTGCGGCAGCCACCAT TCTCCCCT T AACCCGGG 2179 CCCGGGTT A AGGGGAGA 2180 Reduced palmitate GCCGCAGCAAGTTCTGCATTCTTCTCCGTTCCAACCCCGGGAATC 2181 Acyl-ACP-thioesterase TCCCCTAAACCCGGG T AGTTCGGTAATGGTGGCTTTCAGGTTAAG Cuphea hookeriana GCAAACGCCAATGCCCATCCTAGTCTAAAGT Lys24Term ACTTTAGACTAGGATGGGCATTGGCGTTTGCCTTAACCTGAAAGC 2182 AAG-TAG CACCATTACCGAACT A CCCGGGTTTAGGGGAGATTCCCGGGGTTG GAACGGAGAAGAATGCAGAACTTGCTGCGGC AACCCGGG T AGTTCGGT 2183 ACCGAACT A CCCGGGTT 2184 Reduced palmitate TTCTCCGTTCCAACCCCGGGAATCTCCCCTAAACCCGGGAAGTTC 2185 Acyl-ACP-thioesterase GGTAATGGTGGCTTT T AGGTTAAGGCAAACGCCAATGCCCATCCT Cuphea hookeriana AGTCTAAAGTCTGGCAGCCTCGAGACTGAAG Gln31Term CTTCAGTCTCGAGGCTGCCAGACTTTAGACTAGGATGGGCATTGG 2186 CAG-TAG CGTTTGCCTTAACCT A AAAGCCACCATTACCGAACTTCCCGGGTTT AGGGGAGATTCCCGGGGTTGGAACGGAGAA GTGGCTTT T AGGTTAAG 2187 CTTAACCT A AAAGCCAC 2188 Reduced palmitate GTTCCAACCCCGGGAATCTCCCCTAAACCCGGGAAGTTCGGTAAT 2189 Acyl-ACP-thioesterase GGTGGCTTTCAGGTT T AGGCAAACGCCAATGCCCATCCTAGTCTA Cuphea hookeriana AAGTCTGGCAGCCTCGAGACTGAAGATGACA Lys33Term TGTCATCTTCAGTCTCGAGGCTGCCAGACTTTAGACTAGGATGGG 2190 AAG-TAG CATTGGCGTTTGCCT A AACCTGAAAGCCACCATTACCGAACTTCCC GGGTTTAGGGGAGATTCCCGGGGTTGGAAC TTCAGGTT T AGGCAAAC 2191 GTTTGCCT A AACCTGAA 2192 Reduced palmitate ATGTTGAAGCTCTCGTGTAATGCGACTGATAAGTTACAGACCCTCT 2193 Acyl-ACP-thioesterase TCTCGCATTCTCAT T AACCGGATCCGGCACACCGGAGAACCGTCT Brassica rapa CCTCCGTGTCGTGCTCTCATCTGAGGAAAC Gln21Term GTTTCCTCAGATGAGAGCACGACACGGAGGAGACGGTTCTCCGGT 2194 CAA-TAA GTGCCGGATCCGGTT A ATGAGAATGCGAGAAGAGGGTCTGTAACT TATCAGTCGCATTACACGAGAGCTTCAACAT ATTCTCAT T AACCGGAT 2195 ATCCGGTT A ATGAGAAT 2196 Reduced palmitate GCGACTGATAAGTTACAGACCCTCTTCTCGCATTCTCATCAACCGG 2197 Acyl-ACP-thioesterase ATCCGGCACACCGG T GAACCGTCTCCTCCGTGTCGTGCTCTCATC Brassica rapa TGAGGAAACCGGTTCTCGATCCTTTGCGAG Arg28Term CTCGCAAAGGATCGAGAACCGGTTTCCTCAGATGAGAGCACGACA 2198 AGA-TGA CGGAGGAGACGGTTC A CCGGTGTGCCGGATCCGGTTGATGAGAA TGCGAGAAGAGGGTCTGTAACTTATCAGTCGC CACACCGG T GAACCGTC 2199 GACGGTTC A CCGGTGTG 2200 Reduced palmitate CCCTCTTCTCGCATTCTCATCAACCGGATCCGGCACACCGGAGAA 2201 Acyl-ACP-thioesterase CCGTCTCCTCCGTGT A GTGCTCTCATCTGAGGAAACCGGTTCTCG Brassica rapa ATCCTTTGCGAGCGATCGTATCTGCTGATCA Ser24Term TGATCAGCAGATACGATCGCTCGCAAAGGATCGAGAACCGGTTTC 2202 TCG-TAG CTCAGATGAGAGCAC T ACACGGAGGAGACGGTTCTCCGGTGTGC CGGATCCGGTTGATGAGAATGCGAGAAGAGGG CTCCGTGT A GTGCTCTC 2203 GAGAGCAC T ACACGGAG 2204 Reduced palmitate CTTCTCGCATTCTCATCAACCGGATCCGGCACACCGGAGAACCGT 2205 Acyl-ACP-thioesterase CTCCTCCGTGTCGTG A TCTCATCTGAGGAAACCGGTTCTCGATCC Brassica rapa TTTGCGAGCGATCGTATCTGCTGATCAAGGA Cys25Term TCCTTGATCAGCAGATACGATCGCTCGCAAAGGATCGAGAACCGG 2206 TGC-TGA TTTCCTCAGATGAGA T CACGACACGGAGGAGACGGTTCTCCGGTG TGCCGGATCCGGTTGATGAGAATGCGAGAAG GTGTCGTG A TCTCATCT 2207 AGATGAGA T CACGACAC 2208 Reduced palmitate ATTCTTCTTCTATAAACCAAAACCTCAGGAACCATAAAAAAAAAAGG 2209 Acyl-ACP-thioesterase GCATCAAAAATGT A GAAGCTTTCGTGTAATGTGACTAACAACTTAC Brassica napus ACACCTTCTCCTTCTTCTCCGATTCCTC Leu2Term GAGGAATCGGAGAAGAAGGAGAAGGTGTGTAAGTTGTTAGTCACA 2210 TTG-TAG TTACACGAAAGCTTC T ACATTTTTGATGCCCTTTTTTTTTTATGGTTC CTGAGGTTTTGGTTTATAGAAGAAGAAT AAAAATGT A GAAGCTTT 2211 AAAGCTTC T ACATTTTT 2212 Reduced palmitate TCTTCTTCTATAAACCAAAACCTCAGGAACCATAAAAAAAAAAGGG 2213 Acyl-ACP-thioesterase CATCAAAAATGTTG T AGCTTTCGTGTAATGTGACTAACAACTTACAC Brassica napus ACCTTCTCCTTCTTCTCCGATTCCTCCC Lys3Term GGGAGGAATCGGAGAAGAAGGAGAAGGTGTGTAAGTTGTTAGTCA 2214 AAG-TAG CATTACACGAAAGCT A CAACATTTTTGATGCCCTTTTTTTTTTATGG TTCCTGAGGTTTTGGTTTATAGAAGAAGA AAATGTTG T AGCTTTCG 2215 CGAAAGCT A CAACATTT 2216 Reduced palmitate CTATAAACCAAAACCTCAGGAACCATAAAAAAAAAAGGGCATCAAA 2217 Acyl-ACP-thioesterase AATGTTGAAGCTTT A GTGTAATGTGACTAACAACTTACACACCTTCT Brassica napus CCTTCTTCTCCGATTCCTCCCTTTTCAT Ser5Term ATGAAAAGGGAGGAATCGGAGAAGAAGGAGAAGGTGTGTAAGTT 2218 TCG-TAG GTTAGTCACATTACAC T AAAGCTTCAACATTTTTGATGCCCTTTTTT TTTTATGGTTCCTGAGGTTTTGGTTTATAG GAAGCTTT A GTGTAATG 2219 CATTACAC T AAAGCTTC 2220 Reduced palmitate AAACCAAAACCTCAGGAACCATAAAAAAAAAAGGGCATCAAAAATG 2221 Acyl-ACP-thioesterase TTGAAGCTTTCGTG A AATGTGACTAACAACTTACACACCTTCTCCTT Brassica napus CTTCTCCGATTCCTCCCTTTTCATCCCG Cys6Term CGGGATGAAAAGGGAGGAATCGGAGAAGAAGGAGAAGGTGTGTA 2222 TGT-TGA AGTTGTTAGTCACATT T CACGAAAGCTTCAACATTTTTGATGCCCTT TTTTTTTTATGGTTCCTGAGGTTTTGGTTT CTTTCGTG A AATGTGAC 2223 GTCACATT T CACGAAAG 2224 -
TABLE 23 Oligonucleotides to produce plants with increased stearate Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Increased stearate GGGAGAGCTCTAGCTCTGTAGAAAAGAAGGATTCATTCATCATATC 2225 stearoyl-ACP CAGAAATGGCTCTA T AGTTTAACCCTTTGGTGGCATCTCAGCCTTA desaturase CAAATTCCCTTCCTCGACTCGTCCGCCAA Arabidopsis thaliana TTGGCGGACGAGTCGAGGAAGGGAATTTGTAAGGCTGAGATGCC 2226 Lys4 Term ACCAAAGGGTTAAACT A TAGAGCCATTTCTGGATATGATGAATGAA AAG-TAG TCCTTCTTTTCTACAGAGCTAGAGCTCTCCC TGGCTCTA T AGTTTAAC 2227 GTTAAACT A TAGAGCCA 2228 Increased stearate CTCTGTAGAAAAGAAGGATTCATTCATCATATCCAGAAATGGCTCT 2229 stearoyl-ACP AAAGTTTAACCCTT A GGTGGCATCTCAGCCTTACAAATTCCCTTCC desaturase TCGACTCGTCCGCCAACTCCTCTTTCAG Arabidopsis thaliana CTGAAAGAAGGAGTTGGCGGACGAGTCGAGGAAGGGAATTTGTA 2230 Leu8 Term AGGCTGAGATGCCACC T AAGGGTTAAACTTTAGAGCCATTTCTGG TTG-TAG ATATGATGAATGAATCCTTCTTTTCTACAGAG TAACCCTT A GGTGGCAT 2231 ATGCCACC T AAGGGTTA 2232 Increased stearate AGAAGGATTCATTCATCATATCCAGAAATGGCTCTAAAGTTTAACC 2233 stearoyl-ACP CTTTGGTGGCATCT T AGCCTTACAAATTCCCTTCCTCGACTCGTCC desaturase GCCAACTCCTTCTTTCAGATCTCCCAAGT Arabidopsis thaliana ACTTGGGAGATCTGAAAGAAGGAGTTGGCGGACGAGTCGAGGAA 2234 Gln12 Term GGGAATTTGTAAGGCT A AGATGCCACCAAAGGGTTAAACTTTAGA CAG-TAG GCCATTTCTGGATATGATGAATGAATCCTTCT TGGCATCT T AGCCTTAC 2235 GTAAGGCT A AGATGCCA 2236 Increased stearate TCATTCATCATATCCAGAAATGGCTCTAAAGTTTAACCCTTTGGTG 2237 stearoyl-ACP GCATCTCAGCCTTA G AAATTCCCTTCCTCGACTCGTCCGCCAACTC desaturase CTTCTTTCAGATCTCCCAAGTTCCTCTGC Arabidopsis thaliana GCAGAGGAACTTGGGAGATCTGAAAGAAGGAGTTGGCGGACGAG 2238 Phe14 Term TCGAGGAAGGGAATTT C TAAGGCTGAGATGCCACCAAAGGGTTAA TAC-TAG ACTTTAGAGCCATTTCTGGATATGATGAATGA CAGCCTTA G AAATTCCC 2239 GGGAATTT C TAAGGCTG 2240 Increased stearate GAGAGCTCGCTCGTGTCTGAAAGAACATCAAACCTCGTATCAAAAA 2241 stearoyl-ACP AAAGAAAATGGCAT A GAAGCTTAACCCTTTGGCATCTCAGCCTTAC desaturase AAACTCCCTTCCTCGGCTCGTCCGCCAAT Brassica napus ATTGGCGGACGAGCCGAGGAAGGGAGTTTGTAAGGCTGAGATGC 2242 Leu3 Term CAAAGGGTTAAGCTTC T ATGCCATTTTCTTTTTTTTGATACGAGGTT TTG-TAG TGATGTTCTTTCAGACACGAGCGAGCTCTC AATGGCAT A GAAGCTTA 2243 TAAGCTTC T ATGCCATT 2244 Increased stearate GAGCTCGCTCGTGTCTGAAAGAACATCAAACCTCGTATCAAAAAAA 2245 stearoyl-ACP AGAAAATGGCATTG T AGCTTAACCCTTTGGCATCTCAGCCTTACAA desaturase ACTCCCTTCCTCGGCTCGTCCGCCAATCT Brassica napus AGATTGGCGGACGAGCCGAGGAAGGGAGTTTGTAAGGCTGAGAT 2246 Lys4 Term GCCAAAGGGTTAAGCT A CAATGCCATTTTCTTTTTTTTGATACGAG AAG-TAG GTTTGATGTTCTTTCAGACACGAGCGAGCTC TGGCATTG T AGCTTAAC 2247 GTTAAGCT A CAATGCCA 2248 Increased stearate TCTGAAAGAACATCAAACCTCGTATCAAAAAAAAGAAAATGGCATT 2249 stearoyl-ACP GAAGCTTAACCCTT A GGCATCTCAGCCTTACAAACTCCCTTCCTCG desaturase GCTCGTCCGCCAATCTCTACTCTCAGATC Brassica napus GATCTGAGAGTAGAGATTGGCGGACGAGCCGAGGAAGGGAGTTT 2250 Leu8 Term GTAAGGCTGAGATGCC T AAGGGTTAAGCTTCAATGCCATTTTCTTT TTG-TAG TTTTTGATACGAGGTTTGATGTTCTTTCAGA TAACCCTT A GGCATCTC 2251 GAGATGCC T AAGGGTTA 2252 Increased stearate AACATCAAACCTCGTATCAAAAAAAAGAAAATGGCATTGAAGCTTA 2253 stearoyl-ACP ACCCTTTGGCATCT T AGCCTTACAAACTCCCTTCCTCGGCTCGTCC desaturase GCCAATCTCTACTCTCAGATCTCCCAAGT Brassica napus ACTTGGGAGATCTGAGAGTAGAGATTGGCGGACGAGCCGAGGAA 2254 Gln11 Term GGGAGTTTGTAAGGCT A AGATGCCAAAGGGTTAAGCTTCAATGCC CAG-TAG ATTTTCTTTTTTTTGATACGAGGTTTGATGTT TGGCATCT T AGCCTTAC 2255 GTAAGGCT A AGATGCCA 2256 Increased stearate AACCAAAAGAAAAGGTAAGAAAAAAAACAATGGCTCTCAAGCTCA 2257 stearoyl-ACP ATCCTTTCCTTTCT T AAACCCAAAAGTTACCTTCTTTCGCTCTTCCA desaturase CCAATGGCCAGTACCAGATCTCCTAAGT Ricinus communis ACTTAGGAGATCTGGTACTGGCCATTGGTGGAAGAGCGAAAGAAG 2258 Gln27 Term GTAACTTTTGGGTTT A AGAAAGGATTGAGCTTGAGAGCCAT CAA-TAA TGTTTTTTTTCTTACCTTTTTCTTTTGGTT TCCTTTCT T AAACCCAA 2259 TTGGGTTT A AGAAAGGA 2260 Increased stearate AAGAAAAAGGTAAGAAAAAAAACAATGGCTCTCAAGCTCAATCCTT 2261 stearoyl-ACP TCCTTTCTCAAACC T AAAAGTTACCTTCTTTCGCTCTTCCACCAATG desaturase GCCAGTACCAGATCTCCTAAGTTCTACA Ricinus communis TGTAGAACTTAGGAGATCTGGTACTGGCCATTGGTGGAAGAGCGA 2262 Gln29 Term AAGAAGGTAACTTTT A GGTTTGAGAAAGGAAAGGATTGAGCTTGA CAA-TAA GAGCCATTGTTTTTTTTCTTACCTTTTTCTT CTCAAACC T AAAAGTTA 2263 TAACTTTT A GGTTTGAG 2264 Increased stearate AAAAAGGTAAGAAAAAAAACAATGGCTCTCAAGCTCAATCCTTTCC 2265 stearoyl-ACP TTTCTCAAACCCAA T AGTTACCTTCTTTCGCTCTTCCACCAATGGCC desaturase AGTACCAGATCTCCTAAGTTCTACATGG Ricinus communis CCATGTAGAACTTAGGAGATCTGGTACTGGCCATTGGTGGAAGAG 2266 Lys30 TermCGAAAGAAGGTAACT A TTGGGTTTGAGAAAGGAAAGGATTGAGCT AAG-TAG TGAGAGCCATTGTTTTTTTTCTTACCTTTTT AAACCCAA T AGTTACCT 2267 AGGTAACT A TTGGGTTT 2268 Increased stearate TCTCAAACCCAAAAGTTACCTTCTTTCGCTCTTCCACCAATGGCCA 2269 stearoyl-ACP GTACCAGATCTCCT T AGTTCTACATGGCCTCTACCCTCAAGTCTGG desaturase TTCTAAGGAAGTTGAGAATCTCAAGAAGC Ricinus communis GCTTCTTGAGATTCTCAACTTCCTTAGAACCAGACTTGAGGGTAGA 2270 Lys46 Term GGCCATGTAGAACT A AGGAGATCTGGTACTGGCCATTGGTGGAG AAG-TAG AGCGAAAGAAGGTAACTTTTGGGTTTGAGA GATCTCCT T AGTTCTAC 2271 GTAGAACT A AGGAGATC 2272 Increased stearate TCTTCTGATTCATTTAATCTTTACTCATCAATGGCTCTGAGACTGAA 2273 stearoyl-ACP CCCTATCCCCACC T AAACCTTCTCCCTCCCCCAAATGGCCAGTCTC desaturase AGATCTCCCAGGTTCCGCATGGCCTCTA Glycine max TAGAGGCCATGCGGAACCTGGGAGATCTGAGACTGGCCATTTGG 2274 Gln11 Term GGGAGGGAGAAGGTTT A GGTGGGGATAGGGTTCAGTCTCAGAGC CAA-TAA CATTGATGAGTAAAGATTAAATGAATCAGAAGA TCCCCACC T AAACCTTC 2275 GAAGGTTT A GGTGGGGA 2276 Increased stearate CTTTACTCATCAATGGCTCTGAGACTGAACCCTATCCCCACCCAAA 2277 stearoyl-ACP CCTTCTCCCTCCCC T AAATGGCCAGTCTCAGATCTCCCAGGTTCC desaturase GCATGGCCTCTACCCTCCGCTCCGGTTCCA Glycine max TGGAACCGGAGCGGAGGGTAGAGGCCATGCGGAACCTGGGAGAT 2278 Gln17 Term CTGAGACTGGCCATTT A GGGGAGGGAGAAGGTTTGGGTGGGGAT CAA-TAA AGGGTTCAGTCTCAGAGCCATTGATGAGTAAAG CCCTCCCC T AAATGGCC 2279 GGCCATTT A GGGGAGGG 2280 Increased stearate GCTCTGAGACTGAACCCTATCCCCACCCAAACCTTCTCCCTCCCC 2281 stearoyl-ACP CAAATGGCCAGTCTC T GATCTCCCAGGTTCCGCATGGCCTCTACC desaturase CTCCGCTCCGGTTCCAAAGAGGTTGAAAATA Glycine max TATTTTCAACCTCTTTGGAACCGGAGCGGAGGGTAGAGGCCATGC 2282 Arg22 Term GGAACCTGGGAGATC A GAGACTGGCCATTTGGGGGAGGGAGAAG AGA-TGA GTTTGGGTGGGGATAGGGTTCAGTCTCAGAGC CCAGTCTC T GATCTCCC 2283 GGGAGATC A GAGACTGG 2284 Increased stearate CAAATGGCCAGTCTCAGATCTCCCAGGTTCCGCATGGCCTCTACC 2285 stearoyl-ACP CTCCGCTCCGGTTCC T AAGAGGTTGAAAATATTAAGAAGCCATTCA desaturase CTCCTCCCAGAGAAGTGCATGTTCAAGTAA Glycine max TTACTTGAACATGCACTTCTCTGGGAGGAGTGAATGGCTTCTTAAT 2286 Lys37 Term ATTTTCAACCTCTT A GGAACCGGAGCGGAGGGTAGAGGCCATGCG AAA-TAA GAACCTGGGAGATCTGAGACTGGCCATTTG CCGGTTCC T AAGAGGTT 2287 AACCTCTT A GGAACCGG 2288 Increased stearate CAACAAGCACACACAAGAACAACATCAACAATGGCGATTCGCATC 2289 stearoyl-ACP AATACGGCGACGTTT T AATCAGACCTGTACCGTTCATTCGCGTTTC desaturase CTCAACCGAAACCTCTCAGATCTCCCAAAT Helianthus annuus ATTTGGGAGATCTGAGAGGTTTCGGTTGAGGAAACGCGAATGAAC 2290 Gln11 Term GGTACAGGTCTGATT A AAACGTCGCCGTATTGATGCGAATCGCCA CAA-TAA TTGTTGATGTTGTTCTTGTGTGTGCTTGTTG CGACGTTT T AATCAGAC 2291 GTCTGATT A AAACGTCG 2292 Increased stearate AAGCACACACAAGAAGCAACATCAACAATGGCGATTCGCATCAATAC 2293 stearoyl-ACP GGCGACGTTTCAAT G AGACCTGTACCGTTCATTCGCGTTTCCTCAA desaturase CCGAAACCTCTCAGATCTCCCAAATTCGC Helianthus annuus GCGAATTTGGGAGATCTGAGAGGTTTCGGTTGAGGAAACGCGAAT 2294 Ser12 Term GAACGGTACAGGTCT C ATTGAAACGTCGCCGTATTGATGCGAATC TCA-TGA GCCATTGTTGATGTTGTTCTTGTGTGTGCTT GTTTCAAT G AGACCTGT 2295 ACAGGTCT C ATTGAAAC 2296 Increased stearate AAGAACAACATCAACAATGGCGATTCGCATCAATACGGCGACGTTT 2297 stearoyl-ACP CAATCAGACCTGTA G CGTTCATTCGCGTTTCCTCAACCGAAACCTC desaturase TCAGATCTCCCAAATTCGCCATGGCTTCC Helianthus annuus GGAAGCCATGGCGAATTTGGGAGATCTGAGAGGTTTCGGTTGAGG 2298 Tyr15 Term AAACGCGAATGAACG C TACAGGTCTGATTGAAACGTCGCCGTATT TAC-TAG GATGCGAATCGCCATTGTTGATGTTGTTCTT GACCTGTA G CGTTCATT 2299 AATGAACG C TACAGGTC 2300 Increased stearate CAACATCAACAATGGCGATTCGCATCAATACGGCGACGTTTCAATC 2301 stearoyl-ACP AGACCTGTACCGTT G ATTCGCGTTTCCTCAACCGAAACCTCTCAGA desaturase TCTCCCAAATTCGCCATGGCTTCCACCAT Helianthus annuus ATGGTGGAAGCCATGGCGAATTTGGGAGATCTGAGAGGTTTCGGT 2302 Ser17 Term TGAGGAAACGCGAAT C AACGGTACAGGTCTGATTGAAACGTCGCC TCA-TGA GTATTGATGCGAATCGCCATTGTTGATGTTG GTACCGTT G ATTCGCGT 2303 ACGCGAAT C AACGGTAC 2304 Increased stearate ACACACAACACACACTCAATCACACACACATCATCATCTTCTTCATC 2305 stearoyl-ACP AACGATGGCGCTT T GAATGAGTCCGGTGACGCTTCAACGGGAGAT desaturase ATATCCTTCATACACTTTTCATCAATCGA Helianthus annuus TCGATTGATGAAAAGTGTATGAAGGATATATCTCCCGTTGAAGCGT 2306 Arg4 Term CACCGGACTCATTC A AAGCGCCATCGTTGATGAAGAAGATGATGA CGA-TGA TGTGTGTGTGATTGAGTGTGTGTTGTGTGT TGGCGCTT T GAATGAGT 2307 ACTCATTC A AAGCGCCA 2308 Increased stearate ACACACACATCATCATCTTCTTCATCAACGATGGCGCTTCGAATGA 2309 stearoyl-ACP GTCCGGTGACGCTT T AACGGGAGATATATCCTTCATACACTTTTCA desaturase TCAATCGAAAAATCTCAGATCTCCTAAAT Helianthus annuus ATTTAGGAGATCTGAGATTTTTCGATTGATGAAAAGTGTATGAAGG 2310 Gln11 Term ATATATCTCCCGTT A AAGCGTCACCGGACTCATTCGAAGCGCCATC CAA-TAA GTTGATGAAGAAGATGATGATGTGTGTGT TGACGCTT T AACGGGAG 2311 CTCCCGTT A AAGCGTCA 2312 Increased stearate ACATCATCATCTTCTTCATCAACGATGGCGCTTCGAATGAGTCCGG 2313 stearoyl-ACP TGACGCTTCAACGG T AGATATATCCTTCATACACTTTTCATCAATCG desaturase AAAAATCTCAGATCTCCTAAATTCGCGA Helianthus annuus TCGCGAATTTAGGAGATCTGAGATTTTTCGATTGATGAAAAGTGTA 2314 Glu13 Term TGAAGGATATATCT A CCGTTGAAGCGTCACCGGACTCATTCGAAG GAG-TAG CGCCATCGTTGATGAAGAAGATGATGATGT TTCAACGG T AGATATAT 2315 ATATATCT A CCGTTGAA 2316 Increased stearate ATCTTCTTCATCAACGATGGCGCTTCGAATGAGTCCGGTGACGCTT 2317 stearoyl-ACP CAACGGGAGATATA G CCTTCATACACTTTTCATCAATCGAAAAATC desaturase TCAGATCTCCTAAATTCGCGATGGCTTCC Helianthus annuus GGAAGCCATCGCGAATTTAGGAGATCTGAGATTTTTCGATTGATGA 2318 Tyr15 Term AAAGTGTATGAAGG C TATATCTCCCGTTGAAGCGTCACCGGACTC TAT-TAG ATTCGAAGCGCCATCGTTGATGAAGAAGAT GAGATATA G CCTTCATA 2319 TATGAAGG C TATATCTC 2320 Increased stearate AACTCAGCCAGCTTGCCCCCAAACAACAGCGCAGAAAAACCTTCA 2321 stearoyl-ACP ACAACAATGGCTCTC T AGCTCAACCCAGTCACCACCTTCCCTTCAA desaturase CACGCTCCCTCAACAACTTCTCCTCCAGAT Linum usitatissimum ATCTGGAGGAGAAGTTGTTGAGGGAGCGTGTTGAAGGGAAGGTG 2322 Lys4 Term GTGACTGGGTTGAGCT A GAGAGCCATTGTTGTTGAAGGTTTTTCT AAG-TAG GCGCTGTTGTTTGGGGGCAAGCTGGCTGAGTT TGGCTCTC T AGCTCAAC 2323 GTTGAGCT A GAGAGCCA 2324 Increased stearate GCGCAGAAAAACCTTCAACAACAATGGCTCTCAAGCTCAACCCAG 2325 stearoyl-ACP TCACCACCTTCCCTT G AACACGCTCCCTCAACAACTTCTCCTCCAG desaturase ATCTCCTCGCACCTTTCTCATGGCTGCTTC Linum usitatissimum GAAGCAGCCATGAGAAAGGTGCGAGGAGATCTGGAGGAGAAGTT 2326 Ser13 Term GTTGAGGGAGCGTGTT C AAGGGAAGGTGGTGACTGGGTTGAGCT TCA-TGA TGAGAGCCATTGTTGTTGAAGGTTTTTCTGCGC CTTCCCTT G AACACGCT 2327 AGCGTGTT C AAGGGAAG 2328 Increased stearate CTCAAGCTCAACCCAGTCACCACCTTCCCTTCAACACGCTCCCTCA 2329 stearoyl-ACP ACAACTTCTCCTCC T GATCTCCTCGCACCTTTCTCATGGCTGCTTC desaturase CACTTTCAATTCCACCTCCACCAAGTAAG Linum usitatissimum CTTACTTGGTGGAGGTGGAATTGAAAGTGGAAGCAGCCATGAGAA 2330 Arg23 Term AGGTGCGAGGAGATC A GGAGGAGAAGTTGTTGAGGGAGCGTGTT AGA-TGA GAAGGGAAGGTGGTGACTGGGTTGAGCTTGAG TCTCCTCC T GATCTCCT 2331 AGGAGATC A GGAGGAGA 2332 Increased stearate TCCTCCAGATCTCCTCGCACCTTTCTCATGGCTGCTTCCACTTTCA 2333 stearoyl-ACP ATTCCACCTCCACC T AGTAAGCATCTCCTCCTCCTCGGAATCTCCG desaturase CCGATTTCTTTTAAGCGATTGATCGTAGA Linum usitatissimum TCTACGATCAATCGCTTAAAAGAAATCGGCGGAGATTCCGAGGAG 2334 Lys411 Term GAGGAGATGCTTACT A GGTGGAGGTGGAATTGAAAGTGGAAGCA AAG-TAG GCCATGAGAAAGGTGCGAGGAGATCTGGAGGA CCTCCACC T AGTAAGCA 2335 TGCTTACT A GGTGGAGG 2336 Increased stearate ATGGCACTGAAACTTTGCTTTCCACCCCACAAGATGCCTTCCTTCC 2337 stearoyl-ACP CCGATGCTCGTATC T GATCTCACAGGGTTTTCATGGCTTCAACTAT desaturase TCATTCTCCTTCTATGGAGGTCGGAAAAG Olea europaeap CTTTCCGACCTCCATAGAAGGAGAATGAATAGTTGAAGCCATGAA 2338 Arg21 Term AACCCTGTGAGATC A GATACGAGCATCGGGGAAGGAAGGCATCTT AGA-TGA GTGGGGTGGAAAGCAAAGTTTCAGTGCCAT CTCGTATC T GATCTCAC 2339 GTGAGATC A GATACGAG 2340 Increased stearate CCCACAAGATGCCTTCCTTCCCCGATGCTCGTATCAGATCTCACAG 2341 stearoyl-ACP GGTTTTCATGGCTT G AACTATTCATTCTCCTTCTATGGAGGTCGGA desaturase AAAGTTAAAAAGCCTTTCACGCCTCCACG Olea europaeap CGTGGAGGCGTGAAAGGCTTTTTAACTTTTCCGACCTCCATAGAA 2342 Ser29 Term GGAGAATGAATAGTT C AAGCCATGAAAACCCTGTGAGATCTGATAC TCA-TGA GAGCATCGGGGAAGGAAGGCATCTTGTGGG CATGGCTT G AACTATTC 2343 GAATAGTT C AAGCCATG 2344 Increased stearate GATGCTCGTATCAGATCTCACAGGGTTTTCATGGCTTCAACTATTC 2345 stearoyl-ACP ATTCTCCTTCTATG T AGGTCGGAAAAGTTAAAAAGCCTTTCACGCC desaturase TCCACGAGAGGTACATGTTCAAGTAACCC Olea europaeap GGGTTACTTGAACATGTACCTCTCGTGGAGGCGTGAAAGGCTTTT 2346 Glu37 Term TAACTTTTCCGACCT A CATGAAGGAGAATGAATAGTTGAAGCCAT GAG-TAG GAAAACCCTGTGAGATCTGATACGAGCATC CTTCTATG T AGGTCGGA 2347 TCCGACCT A CATAGAAG 2348 Increased stearate CGTATCAGATCTCACAGGGTTTTCATGGCTTCAACTATTCATTCTC 2349 stearoyl-ACP CTTCTATGGAGGTC T GAAAAGTTAAAAAGCCTTTCACGCCTCCACG desaturase AGAGGTACATGTTCAAGTAACCCATTCCT Olea europaeap AGGAATGGGTTACTTGAACATGTACCTCTCGTGGAGGCGTGAAAG 2350 Gly39 Term GCTTTTTAACTTTTC A GACCTCCATAGAAGGAGAATGAATAGTTGA GGA-TGA AGCCATGAAAACCCTGTGAGATCTGATACG TGGAGGTC T GAAAAGTT 2351 AACTTTTC A GACCTCCA 2352 Increased stearate TTCTCGTTTTTGTCGTCCCCTCTGCTCTCTCTCTCTATCAGGCACG 2353 stearoyl-ACP GAGAAATGGCACTG T AACTCAGTCCAGTCATGTTTCAATCTCAGAA desaturase GCTTCCATTTCTTGCCTCCTATCCGCCTT Persea americana AAGGCGGATAGGAGGCAAGAAATGGAAGCTTCTGAGATTGAAACA 2354 Lys4 Term TGACTGGACTGAGTT A CAGTGCCATTTCTCCGTGCCTGATAGAGA AAA-TAA GAGAGAGCAGAGGGGACGACAAAAACGAGAA TGGCACTG T AACTCAGT 2355 ACTGAGTT A CAGTGCCA 2356 Increased stearate CTGCTCTCTCTCTCTATCAGGCACGGAGAAATGGCACTGAAACTCA 2357 stearoyl-ACP GTCCAGTCATGTTT T AATCTCAGAAGCTTCCATTTCTTGCCTCCTAT desaturase CCGCCTTCCAATCTCAGATCTCCGAGGG Persea americana CCCTCGGAGATCTGAGATTGGAAGGCGGATAGGAGGCAAGAAAT 2358 Gln11 Term GGAAGCTTCTGAGATT A AAACATGACTGGACTGAGTTTCAGTGCC CAA-TAA ATTTCTCCGTGCCTGATAGAGAGAGAGAGCAG TCATGTTT T AATCTCAG 2359 CTGAGATT A AAACATGA 2360 Increased stearate TCTCTCTCTATCAGGCACGGAGAAATGGCACTGAAACTCAGTCCA 2361 stearoyl-ACP GTCATGTTTCAATCT T AGAAGCTTCCATTTCTTGCCTCCTATCCGCC desaturase TTCCAATCTCAGATCTCCGAGGGTTTTCA Persea americana TGAAAACCCTCGGAGATCTGAGATTGGAAGGCGGATAGGAGGCAA 2362 Gln13 Term GAAATGGAAGCTTCT A AGATTGAAACATGACTGGACTGAGTTTCAG CAG-TAG TGCCATTTCTCCGTGCCTGATAGAGAGAGA TTCAATCT T AGAAGCTT 2363 AAGCTTCT A AGATTGAA 2364 Increased stearate CTCTCTATCAGGCACGGAGAAATGGCACTGAAACTCAGTCCAGTC 2365 stearoyl-ACP ATGTTTCAATCTCAG T AGCTTCCATTTCTTGCCTCCTATCCGCCTTC desaturase CAATCTCAGATCTCCGAGGGTTTTCATGG Persea americana CCATGAAAACCCTCGGAGATCTGAGATTGGAAGGCGGATAGGAG 2366 Lys14 Term GCAAGAAATGGAAGCT A CTGAGATTGAAACATGACTGGACTGAGT AAG-TAG TTCAGTGCCATTTCTCCGTGCCTGATAGAGAG AATCTCAG T AGCTTCCA 2367 TGGAAGCT A CTGAGATT 2368 Increased stearate CCCCGAGATCTCGCTGCCGCTGCTCATGGCGTTCGCGGCGTCCC 2369 stearoyl-ACP ACACCGCATCGCCGTA G TCCTGCGGCGGCGTGGCGCAGAGGAG desaturase GAGCAATGGGATGTCGAAGATGGTGGCCATGGCC Oryza sativa GGCCATGGCCACCATCTTCGACATCCCATTGCTCCTCCTCTGCGC 2370 Tyr12 Term CACGCCGCCGCAGGA C TACGGCGATGCGGTGTGGGACGCCGCG TAC-TAG AACGCCATGAGCAGCGGCAGCGAGATCTCGGGG TCGCCGTA G TCCTGCGG 2371 CCGCAGGA C TACGGCGA 2372 Increased stearate CTGCTCATGGCGTTCGCGGCGTCCCACACCGCATCGCCGTACTCC 2373 stearoyl-ACP TGCGGCGGCGTGGCG T AGAGGAGGAGCAATGGGATGTCGAAGAT desaturase GGTGGCCATGGCCTCCACCATCAACAGGGTCA Oryza sativa TGACCCTGTTGATGGTGGAGGCCATGGCCACCATCTTCGACATCC 2374 Gln19 Term CATTGCTCCTCCTCT A CGCCACGCCGCCGCAGGAGTACGGCGAT CAG-TAG GCGGTGTGGGACGCCGCGAACGCCATGAGCAG GCGTGGCG T AGAGGAGG 2375 CCTCCTCT A CGCCACGC 2376 Increased stearate CCCACACCGCATCGCCGTACTCCTGCGGCGGCGTGGCGCAGAGG 2377 stearoyl-ACP AGGAGCAATGGGATGT A GAAGATGGTGGCCATGGCCTCCACCAT desaturase CAACAGGGTCAAGACTGCTAAGAAGCCCTACAC Oryza sativa GTGTAGGGCTTCTTAGCAGTCTTGACCCTGTTGATGGTGGAGGCC 2378 Ser26 Term ATGGCCACCATCTTC T ACATCCCATTGCTCCTCCTCTGCGCCACGC TCG-TAG CGCCGCAGGAGTACGGCGATGCGGTGTGGG TGGGATGT A GAAGATGG 2379 CCATCTTC T ACATCCCA 2380 Increased stearate CACACCGCATCGCCGTACTCCTGCGGCGGCGTGGCGCAGAGGAG 2381 stearoyl-ACP GAGCAATGGGATGTCG T AGATGGTGGCCATGGCCTCCACCATCAA desaturase CAGGGTCAAGACTGCTAAGAAGCCCTACACTC Oryza sativa GAGTGTAGGGCTTCTTAGCAGTCTTGACCCTGTTGATGGTGGAGG 2382 Lys27 Term CCATGGCCACCATCT A CGACATCCCATTGCTCCTCCTCTGCGCCA AAG-TAG CGCCGCCGCAGGAGTACGGCGATGCGGTGTG GGATGTCG T AGATGGTG 2383 CACCATCT A CGACATCC 2384 Increased stearate TTCTCTCTCTAGGTTGAGCGGTTACCAACAGAAGCACTTAGGAGA 2385 stearoyl-ACP GAGAAGCAATGGCGT A GAAGCTTCACCACACGGCCTTCAATCCTT desaturase CCATGGCGGTTACCTCTTCGGGACTTCCTCG Simmondsia chinensis CGAGGAAGTCCCGAAGAGGTAACCGCCATGGAAGGATTGAAGGC 2386 Leu3 Term CGTGTGGTGAAGCTTC T ACGCCATTGCTTCTCTCTCCTAAGTGCTT TTG-TAG CTGTTGGTAACCGCTCAACCTAGAGAGAGAA AATGGCGT A GAAGCTTC 2387 GAAGCTTC T ACGCCATT 2388 Increased stearate CTCTCTCTAGGTTGAGCGGTTACCAACAGAAGCACTTAGGAGAGA 2389 stearoyl-ACP GAGCAATGGCGTTG T AGCTTCACCACACGGCCTTCAATCCTTCC desaturase ATGGCGGTTACCTCTTCGGGACTTCCTCGAT Simmondsia chinensis ATCGAGGAAGTCCCGAAGAGGTAACCGCCATGGAAGGATTGAAG 2390 Lys4 Term GCCGTGTGGTGAAGCT A CAACGCCATTGCTTCTCTCTCCTAAGTG AAG-TAG CTTCTGTTGGTAACCGCTCAACCTAGAGAGAG TGGCGTTG T AGCTTCAC 2391 GTGAAGCT A CAACGCCA 2392 Increased stearate AAGCAATGGCGTTGAAGCTTCACCACACGGCCTTCAATCCTTCCAT 2393 stearoyl-ACP GGCGGTTACCTCTT A GGGACTTCCTCGATCGTATCACCTCAGATCT desaturase CACCGCGTTTTCATGGCTTCTTCTACAAT Simmondsia chinensis ATTGTAGAAGAAGCCATGAAAACGCGGTGAGATCTGAGGTGATAC 2394 Ser19 Term GATCGAGGAAGTCCC T AAGAGGTAACCGCCATGGAAGGATTGAAG TCG-TAG GCCGTGTGGTGAAGCTTCAACGCCATTGCTT TACCTCTT A GGGACTTC 2395 GAAGTCCC T AAGAGGTA 2396 Increased stearate GCAATGGCGTTGAAGCTTCACCACACGGCCTTCAATCCTTCCATG 2397 stearoyl-ACP GCGGTTACCTCTTCG T GACTTCCTCGATCGTATCACCTCAGATCTC desaturase ACCGCGTTTTCATGGCTTCTTCTACAATTG Simmondsia chinensis CAATTGTAGAAGAAGCCATGAAAACGCGGTGAGATCTGAGGTGAT 2398 Gly20 Term ACGATCGAGGAAGTC A CGAAGAGGTAACCGCCATGGAAGGATTG GGA-TGA AAGGCCGTGTGGTGAAGCTTCAACGCCATTGC CCTCTTCG T GACTTCCT 2399 AGGAAGTC A CGAAGAGG 2400 Increased stearate TGGCTCTGAATCTCAACCCCGTTTCCACACCATTTCAGTGTCGTCG 2401 stearoyl-ACP ATTGCCGTCTTTCT G ACCTCGTCAAACGCCTTCTCGCAGATCTCCC desaturase AAATTCTTCATGGCTTCCACTCTCAGCAG Spinacia oleracea CTGCTGAGAGTGGAAGCCATGAAGAATTTGGGAGATCTGCGAGAA 2402 Ser21 Term GGCGTTTGACGAGGT C AGAAAGACGGCAATCGACGACACTGAAAT TCA-TGA GGTGTGGAAACGGGGTTGAGATTCAGAGCCA GTCTTTCT G ACCTCGTC 2403 GACGAGGT C AGAAAGAC 2404 Increased stearate AATCTCAACCCCGTTTCCACACCATTTCAGTGTCGTCGATTGCCGT 2405 stearoyl-ACP CTTTCTCACCTCGT T AAACGCCTTCTCGCAGATCTCCCAAATTCTT desaturase CATGGCTTCCACTCTCAGCAGCTCTTCTC Spinacia oleracea GAGAAGAGCTGCTGAGAGTGGAAGCCATGAAGAATTTGGGAGATC 2406 Gln24 Term TGCGAGAAGGCGTTT A ACGAGGTGAGAAAGACGGCAATCGACGA CAA-TAA CACTGAAATGGTGTGGAAACGGGGTTGAGATT CACCTCGT T AAACGCCT 2407 AGGCGTTT A ACGAGGTG 2408 Increased stearate TCCACACCATTTCAGTGTCGTCGATTGCCGTCTTTCTCACCTCGTC 2409 stearoyl-ACP AAACGCCTTCTCGC T GATCTCCCAAATTCTTCATGGCTTCCACTCT desaturase CAGCAGCTCTTCTCCTAAGGAAGCGGAAA Spinacia oleracea TTTCCGCTTCCTTAGGAGAAGAGCTGCTGAGAGTGGAAGCCATGA 2410 Arg29 Term AGAATTTGGGAGATC A GCGAGAAGGCGTTTGACGAGGTGAGAAA AGA-TGA GACGGCAATCGACGACACTGAAATGGTGTGGA CTTCTCGC T GATCTCCC 2411 GGGAGATC A GCGAGAAG 2412 Increased stearate TTTCAGTGTCGTCGATTGCCGTCTTTCTCACCTCGTCAAACGCCTT 2413 stearoyl-ACP CTCGCAGATCTCCC T AATTCTTCATGGCTTCCACTCTCAGCAGCTC desaturase TTCTCCTAAGGAAGCGGAAAGCCTGAAGA Spinacia oleracea TCTTCAGGCTTTCCGCTTCCTTAGGAGAAGAGCTGCTGAGAGTGG 2414 Lys32 Term AAGCCATGAAGAATT A GGGAGATCTGCGAGAAGGCGTTTGACGAG AAA-TAA GTGAGAAAGACGGCAATCGACGACACTGAAA GATCTCCC T AATTCTTC 2415 GAAGAATT A GGGAGATC 2416 Increased stearate AAATAGTCGAGGTGAAAAACAGAGCATCAACAATGGCACTGAATAT 2417 stearoyl-ACP CAATGGGGTGTCGT G AAAATCTCACAAAATGTTACCATTTCCTTGT desaturase TCTTCAGCCAGATCTGAGCGAGTTTTCAT Solanum tuberosum ATGAAAACTCGCTCAGATCTGGCTGAAGAACAAGGAAATGGTAAC 2418 Leu10 Term ATTTTGTGAGATTTT C ACGACACCCCATTGATATTCAGTGCCATTGT TTA-TGA TGATGCTCTGTTTTTCACCTCGACTATTT GGTGTCGT G AAAATCTC 2419 GAGATTTT C ACGACACC 2420 Increased stearate ATAGTCGAGGTGAAAACAGAGCATCAACAATGGCACTGAATATCA 2421 stearoyl-ACP ATGGGGTGTCGTTA T AATCTCACAAAATGTTACCATTTCCTTGTTCT desaturase TCAGCCAGATCTGAGCGAGTTTTCATGG Solanum tuberosum CCATGAAAACTCGCTCAGATCTGGCTGAAGAACAAGGAAATGGTA 2422 Lys11 Term ACATTTTGTGAGATT A TAACGACACCCCATTGATATTCAGTGCCATT AAA-TAA GTTGATGCTCTGTTTTTCACCTCGACTAT TGTCGTTA T AATCTCAC 2423 GTGAGATT A TAACGACA 2424 Increased stearate GTGAAAAACAGAGCATCAACAATGGCACTGAATATCAATGGGGTG 2425 stearoyl-ACP TCGTTAAAATCTCAC T AAATGTTACCATTTCCTTGTTCTTCAGCCAG desaturase ATCTGAGCGAGTTTTCATGGCTTCAACCA Solanum tuberosum TGGTTGAAGCCATGAAAACTCGCTCAGATCTGGCTGAAGAACAAG 2426 Lys14 Term GAAATGGTAACATTT A GTGAGATTTTAACGACACCCCATTGATATT AAA-TAA CAGTGCCATTGTTGATGCTCTGTTTTTCAC AATCTCAC T AAATGTTA 2427 TAACATTT A GTGAGATT 2428 Increased stearate ACAGAGCATCAACAATGGCACTGAATATCAATGGGGTGTCGTTAAA 2429 stearoyl-ACP ATCTCACAAAATGT G ACCATTTCCTTGTTCTTCAGCCAGATCTGAG desaturase CGAGTTTTCATGGCTTCAACCATTCATCG Solanum tuberosum CGATGAATGGTTGAAGCCATGAAAACTCGCTCAGATCTGGCTGAA 2430 Leu16 Term GAACAAGGAAATGGT C ACATTTTGTGAGATTTTAACGACACCCCAT TTA-TGA TGATATTCAGTGCCATTGTTGATGCTCTGT CAAAATGT G ACCATTTC 2431 GAAATGGT C ACATTTTG 2432 Increased stearate TGGCTCTGAGGCTGAACCCTAACCCTTCACAGAAGCTCTTTCTCTC 2433 stearoyl-ACP TCCTTCTTCATCAT G ATCTTCTTCTTCTTCATCGTTCTCGCTTCCTC desaturase AAATGGCTAGCCTCAGATCTCCAAGGTT Arachis hypogaea AACCTTGGAGATCTGAGGCTAGCCATTTGAGGAAGCGAGAACGAT 2434 Ser21 Term GAAGAAGAAGAAGAT C ATGATGAAGAAGGAGAGAGAAAGAGCTTC TCA-TGA TGTGAAGGGTTAGGGTTCAGCCTCAGAGCCA TTCATCAT G ATCTTCTT 2435 AAGAAGAT C ATGATGAA 2436 Increased stearate ACCCTAACCCTTCACAGAAGCTCTTTCTCTCTCCTTCTTCATCATCA 2437 stearoyl-ACP TCTTCTTCTTCTT G ATCGTTCTCGCTTCCTCAAATGGCTAGCCTCA desaturase GTCTCCAAGGTTCCGCATGGCCTCCAC Arachis hypogaea GTGGAGGCCATGCGGAACCTTGGAGATCTGAGGCTAGCCATTTGA 2438 Ser26 Term GGAAGCGAGAACGAT C AAGAAGAAGAAGATGATGATGAAGAAGGA TCA-TGA GAGAGAAAGAGCTTCTGTGAAGGGTTAGGGT TTCTTCTT G ATCGTTCT 2439 AGAACGAT C AAGAAGAA 2440 Increased stearate CTAACCCTTCACAGAAGCTCTTTCTCTCTCCTTCTTCATCATCATCT 2441 stearoyl-ACP TCTTCTTCTTCAT A GTTCTCGCTTCCTCAAATGGCTAGCCTCAGAT desaturase CTCCAAGGTTCCGCATGGCCTCCACCCT Arachis hypogaea AGGGTGGAGGCCATGCGGAACCTTGGAGATCTGAGGCTAGCCAT 2442 Ser27 Term TTGAGGAAGCGAGAAC T ATGAAGAAGAAGAAGATGATGATGAAGA TCG-TAG AGGAGAGAGAAAGAGCTTCTGTGAAGGGTTAG TTCTTCAT A GTTCTCGC 2443 GCGAGAAC T ATGAAGAA 2444 Increased stearate CTTCACAGAAGCTCTTTCTCTCTCCTTCTTCATCATCATCTTCTTCT 2445 stearoyl-ACP TCTTCATCGTTCT A GCTTCCTCAAATGGCTAGCCTCAGATCTCCAA desaturase GGTTCCGCATGGCCTCCACCCTCCGCAC Arachis hypogaea GTGCGGAGGGTGGAGGCCATGCGGAACCTTGGAGATCTGAGGCT 2446 Ser29 Term AGCCATTTGAGGAAGC T AGAACGATGAAGAAGAAGAAGATGATGA TCG-TAG TGAAGAAGGAGAGAGAAAGAGCTTCTGTGAAG ATCGTTCT A GCTTCCTC 2447 GAGGAAGC T AGAACGAT 2448 Increased stearate AAAGTTAAAAGCCGTCCAAAACCCAAACCAGGAAAGGCAAACGAA 2449 stearoyl-ACP AAGAAAAAATGGCTT A GAATTTTAATGCCATCGCCTCGAAATCTCA desaturase GAAGCTCCCTTGCTTTGCTCTTCCACCAAA Gossypium hirsutum TTTGGTGGAAGAGCAAAGCAAGGGAGCTTCTGAGATTTCGAGGCG 2450 Leu3 Term ATGGCATTAAAATTC T AAGCCATTTTTTCTTTTCGTTTGCCTTTCCT TTG-TAG GGTTTGGGTTTTGGACGGCTTTTAACTTT AATGGCTT A GAATTTTA 2451 TAAAATTC T AAGCCATT 2452 Increased stearate CCCAAACCAGGAAAGGCAAACGAAAAGAAAAAATGGCTTTGAATTT 2453 stearoyl-ACP TAATGCCATCGCCT A GAAATCTCAGAAGCTCCCTTGCTTTGCTCTT desaturase CCACCAAAGGCCACCCTTAGATCTCCCAA Gossypium hirsutum TTGGGAGATCTAAGGGTGGCCTTTGGTGGAAGAGCAAAGCAAGG 2454 Ser1-Term GAGCTTCTGAGATTTC T AGGCGATGGCATTAAAATTCAAAGCCATT TCG-TAG TTTTCTTTTCGTTTGCCTTTCCTGGTTTGGG CATCGCCT A GAAATCTC 2455 GAGATTTC T AGGCGATG 2456 Increased stearate CAAACCAGGAAAGGCAAACGAAAAGAAAAAATGGCTTTGAATTTTA 2457 stearoyl-ACP ATGCCATCGCCTCG T AATCTCAGAAGCTCCCTTGCTTTGCTCTTCC desaturase ACCAAAGGCCACCCTTAGATCTCCCAAGT Gossypium hirsutum ACTTGGGAGATCTAAGGGTGGCCTTTGGTGGAAGAGCAAAGCAAG 2458 Lys11 Term GGAGCTTCTGAGATT A CGAGGCGATGGCATTAAAATTCAAAGCCAA AAA-TAA TTTTTTCTTTTCGTTTGCCTTTCCTGGTTTG TCGCCTCG T AATCTCAG 2459 CTGAGATT A CGAGGCGA 2460 Increased stearate AGGAAAGGCAAACGAAAAGAAAAAATGGCTTTGAATTTTAATGCCA 2461 stearoyl-ACP TCGCCTCGAAATCT T AGAAGCTCCCTTGCTTTGCTCTTCCACCAAA desaturase GGCCACCCTTAGATCTCCCAAGTTTTCCA Gossypium hirsutum TGGAAAACTTGGGAGATCTAAGGGTGGCCTTTGGTGGAAGAGCAA 2462 Gln13 Term AGCAAGGGAGCTTCT A AGATTTCGAGGCGATGGCATTAAAATTCA CAG-TAG AAGCCATTTTTTCTTTTCGTTTGCCTTTCCT CGAAATCT T AGAAGCTC 2463 GAGCTTCT A AGATTTCG 2464 -
TABLE 24 Oligonucleotides to produce plants with reduced linolenic acid Phenotype, Gene, Plant & Targeted SEQ ID Alteration Altering Oligos NO: Reducing linolenic acid AATAGAACGACAGAGACTTTTTCCTCTTTTCTTCTTGGGAAGAGGC 2465 omega-3 fatty acid TCCAATGGCGAGCT A GGTTTTATCAGAATGTGGTTTTAGACCTCTC desaturase CCCAGATTCTACCCTAAACACACAACCTC Arabidopsis thaliana GAGGTTGTGTGTTTAGGGTAGAATCTGGGGAGAGGTCTAAAACCA 2466 Ser4 Term CATTCTGATAAAACC T AGCTCGCCATTGGAGCCTCTTCCCAAGAAG TCG-TAG AAAAGAGGAAAAAGTCTCTGTCGTTCTATT GGCGAGCT T GGTTTTAT 2467 ATAAAACC A AGCTCGCC 2468 Reducing linolenic acid ACGACAGAGACTTTTTCCTCTTTTCTTCTTGGGAAGAGGCTCCAAT 2469 omega-3 fatty acid GGCGAGCTCGGTTT G ATCAGAATGTGGTTTTAGACCTCTCCCCAG desaturase ATTCTACCCTAAACACACAACCTCTTTTGC Arabidopsis thaliana GCAAAAGAGGTTGTGTGTTTAGGGTAGAATCTGGGGAGAGGTCTA 2470 Leu6 Term AAACCACATTCTGAT C AAACCGAGCTCGCCATTGGAGCCTCTTCCC TTA-TGA AAGAAGAAAAGAGGAAAAAGTCTCTGTCGT CTCGGTTT G ATCAGAAT 2471 ATTCTGAT C AAACCGAG 2472 Reducing linolenic acid ACAGAGACTTTTTCCTCTTTTCTTCTTGGGAAGAGGCTCCAATGGC 2473 omega-3 fatty acid GAGCTCGGTTTTAT G AGAATGTGGTTTTAGACCTCTCCCCAGATTC desaturase TACCCTAAACACACAACCTCTTTTGCCTC Arabidopsis thaliana GAGGCAAAAGAGGTTGTGTGTTTAGGGTAGAATCTGGGGAGAGGT 2474 Ser7 Term CTAAAACCACATTCT C ATAAAACCGAGCTCGCCATTGGAGCCTCTT TCA-TGA CCAAGAAGAAAAGAGGAAAAAGTCTCTGT GGTTTTAT G AGAATGTG 2475 CACATTCT C ATAAAACC 2476 Reducing linolenic acid AGAGACTTTTTCCTCTTTTCTTCTTGGGAAGAGGCTCCAATGGCGA 2477 omega-3 fatty acid GCTCGGTTTTATCA T AATGTGGTTTTAGACCTCTCCCCAGATTCTA desaturase CCCTAAACACACAACCTCTTTTGCCTCTA Arabidopsis thaliana TAGAGGCAAAAGAGGTTGTGTGTTTAGGGTAGAATCTGGGGAGAG 2478 Glu8 Term GTCTAAAACCACATT A TGATAAAACCGAGCTCGCCATTGGAGCCTC GAA-TAA TTCCCAAGAAGAAAAGAGGAAAAAGTCTCT TTTTATCA T AATGTGGT 2479 ACCACATT A TGATAAAA 2480 Reducing linolenic acid TCATCATCTTCTTCTTCTGGGGAGAGAGAGAGAGCAAAAGAGCTC 2481 omega-3 fatty acid TAGCAATGGCGAACT A GGTCTTATCCGAATGTGGCATAAGACCTC desaturase TCCCCAGAATCTACACCACACCCAGATCCAC Brassica juncea GTGGATCTGGGTGTGGTGTAGATTCTGGGGAGAGGTCTTATGCCA 2482 Leu4 Term CATTCGGATAAGACC T AGTTCGCCATTGCTAGAGCTCTTTTGCTCT TTG-TAG CTCTCTCTCCCCAGAAGAAGAAGATGATGA GGCGAACT A GGTCTTAT 2483 ATAAGACC T AGTTCGCC 2484 Reducing linolenic acid TCTTCTTCTTCTGGGGAGAGAGAGAGAGCAAAAGAGCTCTAGCAA 2485 omega-3 fatty acid TGGCGAACTTGGTCT G ATCCGAATGTGGCATAAGACCTCTCCCCA desaturase GAATCTACACCACACCCAGATCCACTTTCCT Brassica juncea AGGAAAGTGGATCTGGGTGTGGTGTAGATTCTGGGGAGAGGTCTT 2486 Leu6 Term ATGCCACATTCGGAT C AGACCAAGTTCGCCATTGCTAGAGCTCTTT TTA-TGA TGCTCTCTCTCTCTCCCCAGAAGAAGAAGA CTTGGTCT G ATCCGAAT 2487 ATTCGGAT C AGACCAAG 2488 Reducing linolenic acid TTCTTCTGGGGAGAGAGAGAGAGCAAAAGAGCTCTAGCAATGGCG 2489 omega-3 fatty acid AACTTGGTCTTATCC T AATGTGGCATAAGACCTCTCCCCAGAATCT desaturase ACACCACACCCAGATCCACTTTCCTCTCCA Brassica juncea TGGAGAGGAAAGTGGATCTGGGTGTGGTGTAGATTCTGGGGAGA 2490 Glu8 Term GGTCTTATGCCACATT A GGATAAGACCAAGTTCGCCATTGCTAGA GAA-TAA GCTCTTTTGCTCTCTCTCTCTCCCCAGAAGAA TCTTATCC T AATGTGGC 2491 GCCACATT A GGATAAGA 2492 Reducing linolenic acid CTGGGGAGAGAGAGAGAGCAAAAGAGCTCTAGCAATGGCGAACT 2493 omega-3 fatty acid TGGTCTTATCCGAATG A GGCATAAGACCTCTCCCCAGAATCTACAC desaturase CACACCCAGATCCACTTTCCTCTCCAACACC Brassica juncea GGTGTTGGAGAGGAAAGTGGATCTGGGTGTGGTGTAGATTCTGG 2494 Cys9 Term GGAGAGGTCTTATGCC T CATTCGGATAAGACCAAGTTCGCCATTG TGT-TGA CTAGAGCTCTTTTGCTCTCTCTCTCTCCCCAG TCCGAATG A GGCATAAG 2495 CTTATGCC T CATTCGGA 2496 Reducing linolenic acid ATAACAGAATTGCTGAATTCTTGCATTTTTAGCTTCTGGGTTTTCAA 2497 omega-3 fatty acid TGGCTGCTGGTTG A GTATTATCAGAATGTGGTTTAAGGCCTCTCCC desaturase AAGAATCTACTCACGACCCAGAATTGGT Ricinus communis ACCAATTCTGGGTCGTGAGTAGATTCTTGGGAGAGGCCTTAAACC 2498 Trp5 Term ACATTCTGATAATAC T CAACCAGCAGCCATTGAAAACCCAGAAGCT TGG-TGA AAAAATGCAAGAATTCAGCAATTCTGTTAT GCTGGTTG A GTATTATC 2499 GATAATAC T CAACCAGC 2500 Reducing linolenic acid AGAATTGCTGAATTCTTGCATTTTTAGCTTCTGGGTTTTCAATGGCT 2501 omega-3 fatty acid GCTGGTTGGGTAT G ATCAGAATGTGGTTTAAGGCCTCTCCCAAGA desaturase ATCTACTCACGACCCAGAATTGGTTTTAC Ricinus communis GTAAAACCAATTCTGGGTCGTGAGTAGATTCTTGGGAGAGGCCTT 2502 Leu7 Term AAACCACATTCTGAT C ATACCCAACCAGCAGCCATTGAAAACCCAG TTA-TGA AAGCTAAAAATGCAAGAATTCAGCAATTCT TTGGGTAT GATCAGAAT 2503 ATTCTGAT C ATACCCAA 2504 Reducing linolenic acid ATTGCTGAATTCTTGCATTTTTAGCTTCTGGGTTTTCAATGGCTGCT 2505 omega-3 fatty acid GGTTGGGTATTAT G AGAATGTGGTTTAAGGCCTCTCCCAAGAATCT desaturase ACTCACGACCCAGAATTGGTTTTACATC Ricinus communis GATGTAAAACCAATTCTGGGTCGTGAGTAGATTCTTGGGAGAGGC 2506 Ser8 Term CTTAAACCACATTCT C ATAATACCCAACCAGCAGCCATTGAAAACC TCA-TGA CAGAAGCTAAAAATGCAAGAATTCAGCAAT GGTATTAT G AGAATGTG 2507 CACATTCT C ATAATACC 2508 Reducing linolenic acid TGCTGAATTCTTGCATTTTTAGCTTCTGGGTTTTCAATGGCTGCTG 2509 omega-3 fatty acid GTTGGGTATTATCA T AATGTGGTTTAAGGCCTCTCCCAAGAATCTA desaturase CTCACGACCCAGAATTGGTTTTACATCGA Ricinus communis TCGATGTAAAACCAATTCTGGGTCGTGAGTAGATTCTTGFGGAGAG 2510 Glu9 Term CGCCTTAAACCACATT A TGATAATACCCAACCAGCAGCCATTGAAAA GAA-TAA CCCAGAAGCTAAAAATGCAAGAATTCAGCA TATTATCA T AATGTGGT 2511 ACCACATT A TGATAATA 2512 Reducing linolenic acid GCAAGTTGGTTTTATCAGAATGTGGTCTTAGACCACTCCCAAGAA 2513 omega-3 fatty acid TCTACCCTAAGCCC T GAACTGGGGCAGCCACTTCTGCCTCCTCTC desaturase ACATTAAGTTGAGAATTTCACGTACAGATC Nicotiana tabacum GATCTGTACGTGAAATTCTCAACTTAATGTGAGAGGAGGCAGAAGT 2514 Arg22 Term GGCTGCCCCAGTTC A GGGCTTAGGGTAGFATTCTTGGGAGTGGTCT AGA-TGA AAGACCACATTCTGATAAAACCCAACTTGC CTAAGCCC T GAACTGGG 2515 CCCAGTTC A GGGCTTAG 2516 Reducing linolenic acid CTCCCAAGAATCTACCCTAAGCCCAGAACTGGGGCAGCCACTTCT 2517 omega-3 fatty acid GCCTCCTCTCACATT T AGTTGAGAATTTCACGTACAGATCTGAGTG desaturase GTTCTGCAATTTCTTTGTCTAATACTAAT Nicotiana tabacum TATTAGTATTAGACAAAGAAATTGCAGAACCACTCAGATCTGTACG 2518 Lys34 Term TGAAATTCTCAACT A AATGTGAGAGGAGGCAGAAGTGGCTGCCCC AAG-TAG AGTTCTGGGCTTAGGGTAGATTCTTGGGAG CTCACATT T AGTTGAGA 2519 TCTCAACT A AATGTGAG 2520 Reducing linolenic acid CAAGAATCTACCCTAAGCCCAGAACTGGGGCAGCCACTTCTGCCT 2521 omega-3 fatty acid CCTCTCACATTAAGT A GAGAATTTCACGTACAGATCTGAGTGGTTC desaturase TGCAATTTCTTTGTCTAATACTAATAAAGA Nicotiana tabacum TCTTTATTAGTATTAGACAAAGAAATTGCAGAACCACTCAGATCTGT 2522 Leu35 Term ACGTGAAATTCTC T ACTTAATGTGAGAGGAGGCAGAAGTGGCTGC TTG-TAG CCCAGTTCTGGGCTTAGGGTAGATTCTTG CATTAAGT A GAGAATTT 2523 AAATTCTC T ACTTAATG 2524 Reducing linolenic acid AGAATCTACCCTAAGCCCAGAACTGGGGCAGCCACTTCTGCCTCC 2525 omega-3 fatty acid TCTCACATTAAGTTG T GAATTTCACGTACAGATCTGAGTGGTTCTG desaturase CAATTTCTTTGTCTAATACTAATAAAGAGA Nicotiana tabacum TCTCTTTATTAGTATTAGACAAAGAAATTGCAGAACCACTCAGATCT 2526 Arg36 Term GTACGTGAAATTC A CAACTTAATGTGAGAGGAGGCAGAAGTGGCT AGA-TGA GCCCCAGTTCTGGGCTTAGGGTAGATTCT TTAAGTTG T GAATTTCA 2527 TGAAATTC A CAACTTAA 2528 Reducing linolenic acid GCGAGTTGGGTTTTATCAGAATGTGGTCTGAGGCCACTCCCGAGG 2529 omega-3 fatty acid GTCTATCCTAAGCCA T GAACTGGCCACCCTTTGTTGAATTCCAATC desaturase CCACAAAGCTGAGATTTTCAAGAACAGATC Sesamum indicum GATCTGTTCTTGAAAATCTCAGCTTTGTGGGATTGGAATTCAACAA 2530 Arg22 Term AGGGTGGCCAGTTC A TGGCTTAGGATAGACCCTCGGGAGTGGCC AGA-TGA TCAGACCACATTCTGATAAAACCCAACTCGC CTAAGCCA T GAACTGGC 2531 GCCAGTTC A TGGCTTAG 2532 Reducing linolenic acid CAGAATGTGGTCTGAGGCCACTCCCGAGGGTCTATCCTAAGCCAA 2533 omega-3 fatty acid GAACTGGCCACCCTT A GTTGAATTCCAATCCCACAAAGCTGAGATT desaturase TTCAAGAACAGATCTTGGAAATGGTTCTTC Sesamum indicum GAAGAACCATTTCCAAGATCTGTTCTTGAAAATCTCAGCTTTGTGG 2534 Leu27 Term GATTGGAATTCAAC T AAGGGTGGCCAGTTCTTGGCTTAGGATAGA TTG-TAG CCCTCGGGAGTGGCCTCAGACCACATTCTG CCACCCTT A GTTGAATT 2535 AATTCAAC T AAGGGTGG 2536 Reducing linolenic acid AATGTGGTCTGAGGCCACTCCCGAGGGTCTATCCTAAGCCAAGAA 2537 omega-3 fatty acid CTGGCCACCCTTTGT A GAATTCCAATCCCACAAAGCTGAGATTTTC desaturase AAGAACAGATCTTGGAAATGGTTCTTCATT Sesamum indicum AATGAAGAACCATTTCCAAGATCTGTTCTTGAAAATCTCAGCTTTGT 2538 Leu28 Term GGGATTGGAATTC T ACAAAGGGTGGCCAGTTCTTGGCTTAGGATA TTG-TAG GACCCTCGGGAGTGGCCTCAGACCACATT CCCTTTGT A GAATTCCA 2539 TGGAATTC T ACAAAGGG 2540 Reducing linolenic acid CTCCCGAGGGTCTATCCTAAGCCAAGAACTGGCCACCCTTTGTTG 2541 omega-3 fatty acid AATTCCAATCCCACA T AGCTGAGATTTTCAAGAACAGATCTTGGAA desaturase ATGGTTCTTCATTCTGTTTGTCGAGTGGGA Sesamum indicum TCCCACTCGACAAACAGAATGAAGAACCATTTCCAAGATCTGTTCT 2542 Lys34 Term TGAAAATCTCAGCT A TGTGGGATTGGAATTCAACAAAGGGTGGCC AAG-TAG AGTTCTTGGCTTAGGATAGACCCTCGGGAG ATCCCACA T AGCTGAGA 2543 TCTCAGCT A TGTGGGAT 2544 Reducing linolenic acid CATCAGAGCGGCGATACCTAAGCATTGCTGGGTTAAGAATCCATG 2545 omega-3 fatty acid GAAGTCTATGAGTTA G GTCGTCAGAGAGCTAGCCATCGTGTTCGC desaturase ACTAGCTGCTGGAGCTGCTTACCTCAACAAT Brassica napus ATTGTTGAGGTAAGCAGCTCCAGCAGCTAGTGCGAACACGATGGC 2546 Tyr3 Term TAGCTCTCTGACGAC C TAACTCATAGACTTCCATGGATTCTTAACC TAC-TAG CAGCAATGCTTAGGTATCGCCGCTCTGATG ATGAGTTA G GTCGTCAG 2547 CTGACGAC C TAACTCAT 2548 Reducing linolenic acid GCGGCGATACCTAAGCATTGCTGGGTTAAGAATCCATGGAAGTCT 2549 omega-3 fatty acid ATGAGTTACGTCGTC T GAGAGCTAGCCATCGTGTTCGCACTAGCT desaturase GCTGGAGCTGCTTACCTCAACAATTGGCTTG Brassica napus CAAGCCAATTGTTGAGGTAAGCAGCTCCAGCAGCTAGTGCGAACA 2550 Arg6 Term CGATGGCTAGCTCTC A GACGACGTAACTCATAGACTTCCATGGAT AGA-TGA CTTAACCCAGCAATGCTTAGGTATCGCCGC ACGTCGTC T GAGAGCTA 2551 TAGCTCTC A GACGACGT 2552 Reducing linolenic acid GCGATACCTAAGCATTGCTGGGTTAAGAATCCATGGAAGTCTATGA 2553 omega-3 fatty acid GTTACGTCGTCAGA T AGCTAGCCATCGTGTTCGCACTAGCTGCTG desaturase GAGCTGCTTACCTCAACAATTGGCTTGTTT Brassica napus AAACAAGCCAATTGTTGAGGTAAGCAGCTCCAGCAGCTAGTGCGA 2554 Glu7 Term ACACGATGGCTAGCT A TCTGACGACGTAACTCATAGACTTCCATG GAG-TAG GATTCTTAACCCAGCAATGCTTAGGTATCGC TCGTCAGA T AGCTAGCC 2555 GGCTAGCT A TCTGACGA 2556 Reducing linolenic acid CCATGGAAGTCTATGAGTTACGTCGTCAGAGAGCTAGCCATCGTG 2557 omega-3 fatty acid TTCGCACTAGCTGCT T GAGCTGCTTACCTCAACAATTGGCTTGTTT desaturase GGCCTCTCTATTGGATTGCTCAAGGAACCA Brassica napus TGGTTCCTTGAGCAATCCAATAGAGAGGCCAAACAAGCCAATTGTT 2558 Gly17 Term GAGGTAAGCAGCTC A AGCAGCTAGTGCGAACACGATGGCTAGCT GGA-TGA CTCTGACGACGTAACTCATAGACTTCCATGG TAGCTGCT T GAGCTGCT 2559 AGCAGCTC A AGCAGCTA 2560 Reducing linolenic acid GCAAGTTGGGTTCTATCAGAATGTGGTCTTAGACCACTACCAAGAA 2561 omega-3 fatty acid TATACCCAAAGCCC T GAATAGGGTCTTCTTCCGTTTGCGCCACCAA desaturase TTTAAATCTGAGAAGAATTTCACCTTCAC Solanum tuberosum GTGAAGGTGAAATTCTTCTCAGATTTAAATTGGTGGCGCAAACGGA 2562 Arg22 Term AGAAGACCCTATTC A GGGCTTTGGGTATATTCTTGGTAGTGGTCTA AGA-TGA AGACCACATTCTGATAGAACCCAACTTGC CAAAGCCC T GAATAGGG 2563 CCCTATTC A GGGCTTTG 2564 Reducing linolenic acid TGGTCTTAGACCACTACCAAGAATATACCCAAAGCCCAGAATAGG 2565 omega-3 fatty acid GTCTTCTTCCGTTTG A GCCACCAATTTAAATCTGAGAAGAATTTCA desaturase CCTTCACCTATACGAACAGATCGGAATTGT Solanum tuberosum ACAATTCCGATCTGTTCGTATAGGTGAAGGTGAAATTCTTCTCAGA 2566 Cys29 Term TTTAAATTGGTGGC T CAAACGGAAGAAGACCCTATTCTGGGCTTTG TGC-TGA GGTATATTCTTGGTAGTGGTCTAAGACCA TCCGTTTG A GCCACCAA 2567 TTGGTGGC T CAAACGGA 2568 Reducing linolenic acid CACTACCAAGAATATACCCAAAGCCCAGAATAGGGTCTTCTTCCGT 2569 omega-3 fatty acid TTGCGCCACCAATT G AAATCTGAGAAGAATTTCACCTTCACCTATA desaturase CGAACAGATCGGAATTGTTGGGCATTGAG Solanum tuberosum CTCAATGCCCAACAATTCCGATCTGTTCGTATAGGTGAAGGTGAAA 2570 Leu33 Term TTCTTCTCAGATTT C AATTGGTGGCGCAAACGGAAGAAGACCCTAT TTA-TGA TCTGGGTTTGGGTATATTCTTGGTAGTG CACCAATT G AAATCTGA 2571 TCAGATTT C AATTGGTG 2572 Reducing linolenic acid AGAATATACCCAAAGCCCAGAATAGGGTCTTCTTCCGTTTGCGCCA 2573 omega-3 fatty acid CCAATTTAAATCTG T GAAGAATTTCACCTTCACCTATACGAACAGAT desaturase CGGAATTGTTGGGCATTGAGGGTAAGTG Solanum tuberosum CACTTACCCTCAATGCCCAACAATTCCGATCTGTTCGTATAGGTGA 2574 Arg36 Term AGGTGAAATTCTTC A CAGATTTAAATTGGTGGCGCAAACGGAAGAA AGA-TGA GACCCTATTCTGGGCTTTGGGTATATTCT TAAATCTG T GAAGAATT 2575 AATTCTTC A CAGATTTA 2576 Reducing linolenic acid CTCTTTATTATCCTCCTCTTCTTTGTTTTTTTTGAGTTCTGAGTCACC 2577 omega-3 fatty acid TATGGCAAGTTG A GTGATTTCAGAATGTGGGCTAAGGCCACTTCC desaturase AAGAATCTATGCCAGGCCCAGAAGTGGA Petroselinum crispum TCCACTTCTGGGCCTGGCATAGATTCTTGGAAGTGGCCTTAGCCC 2578 Trp4 Term ACATTCTGAAATCAC T CAACTTGCCATAGGTGACTCAGAACTCAAA TGG-TGA AAAAACAAAGAAGAGGAGGATAATAAAGAG GCAAGTTG A GTGATTTC 2579 GAAATCAC T CAACTTGC 2580 Reducing linolenic acid TATCCTCCTCTTCTTTGTTTTTTTTGAGTTCTGAGTCACCTATGGCA 2581 omega-3 fatty acid AGTTGGGTGATTT G AGAATGTGGGCTAAGGCCACTTCCAAGAATC desaturase TATGCCAGGCCCAGAAGTGGAGCTTCATG Petroselinum crispum CATGAAGCTCCACTTCTGGGCCTGGCATAGATTCTTGGAAGTGGC 2582 Ser7 Term CTTAGCCCACATTCT C AAATCACCCAACTTGCCATAGGTGACTCAG TCA-TGA AACTCAAAAAAAACAAAGAAGAGGAGGATA GGTGATTT G AGAATGTG 2583 CACATTCT C AAATCACC 2584 Reducing linolenic acid TCCTCCTCTTCTTTGTTTTTTTTGAGTTCTGAGTCACCTATGGCAAG 2585 omega-3 fatty acid TTGGGTGATTTCA T AATGTGGGCTAAGGCCACTTCCAAGAATCTAT desaturase GCCAGGCCCAGAAGTGGAGCTTCATGTT Petroselinum crispum AACATGAAGCTCCACTTCTGGGCCTGGCATAGATTCTTGGAAGTG 2586 Glu8 Term GCCTTAGCCCACATT A TGAAATCACCCAACTTGCCATAGGTGACTC GAA-TAA AGAACTCAAAAAAAACAAAGAAGAGGAGGA TGATTTCA T AATGTGGG 2587 CCCACATT A TGAAATCA 2588 Reducing linolenic acid CTCTTCTTTGTTTTTTTTGAGTTCTGAGTCACCTATGGCAAGTTGGG 2589 omega-3 fatty acid TGATTTCAGAAT G AGGGCTAAGGCCACTTCCAAGAATCTATGCCA desaturase GGCCCAGAAGTGGAGCTTCATGTTTCAAC Petroselinum crispum GTTGAAACATGAAGCTCCACTTCTGGGCCTGGCATAGATTCTTGG 2590 Cys9 Term AAGTGGCCTTAGCCC T CATTCTGAAATCACCCAACTTGCCATAGGT TGT-TGA GACTCAGAACTCAAAAAAAACAAAGAAGAG TCAGAATG A GGGCTAAG 2591 CTTAGCCC T CATTCTGA 2592 Reducing linolenic acid ATGAAGCAGCAACAGTACAAAGACACCCCAATTCTAAATGGCGTTA 2593 omega-3 fatty acid ATGGTTTTCATGCT T AAGAAGAAGAAGAAGAAGAGGATTTCGACTT desaturase AAGCAATCCTCCTCCATTCAATATTGGTC Vernicia fordii GACCAATATTGAATGGAGGAGGATTGCTTAAGTCGAAATCCTCTTC 2594 Lys21 Term TTCTTCTTCTTCTT A AGCATGAAAACCATTAACGCCATTTAGAATTG AAA-TAA GGGTGTCTTTGTACTGTTGCTGCTTCAT TTCATGCT T AAGAAGAA 2595 TTCTTCTT A AGCATGAA 2596 Reducing linolenic acid AAGCAGCAACAGTACAAAGACACCCCAATTCTAAATGGCGTTAATG 2597 omega-3 fatty acid GTTTTCATGCTAAA T AAGAAGAAGAAGAAGAGGATTTCGACTTAAG desaturase CAATCCTCCTCCATTCAATATTGGTCAGA Vernicia fordii TCTGACCAATATTGAATGGAGGAGGATTGCTTAAGTCGAAATCCTC 2598 Glu22 Term TTCTTCTTCTTCTT A TTTAGCATGAAAACCATTAACGCCATTTAGAA GAA-TAA TTGGGGTGTCTTTGTACTGTTGCTGCTT ATGCTAAA T AAGAAGAA 2599 TTCTTCTT A TTTAGCAT 2600 Reducing linolenic acid CAGCAACAGTACAAAGACACCCCAATTCTAAATGGCGTTAATGGTT 2601 omega-3 fatty acid TTCATGCTAAAGAA T AAGAAGAAGAAGAGGATTTCGACTTAAGCAA desaturase TCCTCCTCCATTCAATATTGGTCAGATCC Vernicia fordii GGATCTGACCAATATTGAATGGAGGAGGATTGCTTAAGTCGAAATC 2602 Glu23 Term CTCTTCTTCTTCTT A TTCTTTAGCATGAAAACCATTAACGCCATTTA GAA-TAA GAATTGGGGTGTCTTTGTACTGTTGCTG CTAAAGAA T AAGAAGAA 2603 TTCTTCTT A TTCTTTAG 2604 Reducing linolenic acid CAGCAACAGTACAAAGACACCCCAATTCTAAATGGCGTTAATGGTT 2605 omega-3 fatty acid TTCATGCTAAAGAA T AAGAAGAAGAAGAGGATTTCGACTTAAGCAA desaturase TCCTCCTCCATTCAATATTGGTCAGATCC Vernicia fordii GGATCTGACCAATATTGAATGGAGGAGGATTGCTTAAGTCGAAATC 2606 Glu24 Term CTCTTCTTCTTCTT A TTCTTTAGCATGAAAACCATTAACGCCATTTA GAA-TAA GAATTGGGGTGTCTTTGTACTGTTGCTG CTAAAGAA T AAGAAGAA 2607 TTCTTCTT A TTCTTTAG 2608 Reducing linolenic acid GGTCCAAGCACAGCCTCTACAACATGTTGGTAATGGTGCAGGGAA 2609 omega-3 fatty acid AGAAGATCAAGCTTA G TTTGATCCAAGTGCTCCACCACCCTTCAAG desaturase ATTGCAAATATCAGAGCAGCAATTCCAAAA Glycine max TTTTGGAATTGCTGCTCTGATATTTGCAATCTTGAAGGGTGGTGGA 2610 Tyr21 Term GCACTTGGATCAAA C TAAGCTTGATCTTCTTTCCCTGCACCATTAC TAT-TAG CAACATGTTGTAGAGGCTGTGCTTGGACC CAAGCTTA G TTTGATCC 2611 GGATCAAA C TAAGCCTG 2612 Reducing linolenic acid GGTAATGGTGCAGGGAAAGAAGATCAAGCTTATTTTGATCCAAGT 2613 omega-3 fatty acid GCTCCACCACCCTTC T AGATTGCAAATATCAGAGCAGCAATTCCAA desaturase AACATTGCTGGGAGAAGAACACATTGAGAT Glycine max ATCTCAATGTGTTCTTCTCCCAGCAATGTTTTGGAATTGCTGCTCT 2614 Lys31 Term GATATTTGCAATCT A GAAGGGTGGTGGAGCACTTGGATCAAAATAA AAG-TAG GCTTGATCTTCTTTCCCTGCACCATTACC CACCCTTC T AGATTGCA 2615 TGCAATCT A GAAGGGTG 2616 Reducing linolenic acid AAAGAAGATCAAGCTTATTTTGATCCAAGTGCTCCACCACCCTTCA 2617 omega-3 fatty acid AGATTGCAAATATC T GAGCAGCAATTCCAAAACATTGCTGGGAGAA desaturase GAACACATTGAGATCTCTGAGTTATGTTC Glycine max GAACATAACTCAGAGATCTCAATGTGTTCTTCTCCCAGCAATGTTTT 2618 Arg36 Term GGAATTGCTGCTC A GATATTTGCAATCTTGAAGGGTGGTGGAGCA AGA-TGA CTTGGATCAAAATAAGCTTGATCTTCTTT CAAATATC T GAGCAGCA 2619 TGCTGCTC A GATATTTG 2620 Reducing linolenic acid TATTTTGATCCAAGTGCTCCACCACCCTTCAAGATTGCAAATATCA 2621 omega-3 fatty acid GAGCAGCAATTCCA T AACATTGCTGGGAGAAGAACACATTGAGAT desaturase CTCTGAGTTATGTTCTGAGGGATGTGTTGG Glycine max CCAACACATCCCTCAGAACATAACTCAGAGATCTCAATGTGTTCTT 2622 Leu41 Term CTCCCAGCAATGTT A TGGAATTGCTGCTCTGATATTTGCAATCTTG AAA-TAA AAGGGTGGTGGAGCACTTGGATCAAAATA CAATTCCA T AACATTGC 2623 GCAATGTT A TGGAATTG 2624 Reducing linolenic acid CATCCACCCGCACCCGCACCCGCCCCGCTGACGGCGGCAATGGC 2625 omega-3 fatty acid CCGGCTCGTGCTCTCC T AGTGCTCGGGCCTCGCGCCCGTCCGCC desaturase GCCTGCGCGCCGGCCGGGGCGCCATTGCGGCGC Zea mays GCGCCGCAATGGCGCCCCGGCCGGCGCGCAGGCGGCGGACGG 2626 Glu8 Term GCGCGAGGCCCGAGCACT A GGAGAGCACGAGCCGGGCCATTGC GAG-TAG CGCCGTCAGCGGGGCGGGTGCGGGTGCGGGTGGATG TGCTCTCC T AGTGCTCG 2627 CGAGCACT A GGAGAGCA 2628 Reducing linolenic acid ACCCGCACCCGCACCCGCCCCGCTGACGGCGGCAATGGCCCGG 2629 omega-3 fatty acid CTCGTGCTCTCCGAGTG A TCGGGCCTCGCGCCCGTCCGCCGCCT desaturase GCGCGCCGGCCGGGGCGCCATTGCGGCGCGGTCA Zea mays TGACCGCGCCGCAATGGCGCCCCGGCCGGCGCGCAGGCGGCGG 2630 Cys9 Term ACGGGCGCGAGGCCCGA T CACTCGGAGAGCACGAGCCGGGCCA TGC-TGA TTGCCGCCGTCAGCGGGGCGGGTGCGGGTGCGGGT TCCGAGTG A TCGGGCCT 2631 AGGCCCGA T CACTCGGA 2632 Reducing linolenic acid CCGCACCCGCACCCGCCCCGCTGACGGCGGCAATGGCCCGGCT 2633 omega-3 fatty acid CGTGCTCTCCGAGTGCT A GGGCCTCGCGCCCGTCCGCCGCCTGC desaturase GCGCCGGCCGGGGCGCCATTGCGGCGCGGTCACC Zea mays GGTGACCGCGCCGCAATGGCGCCCCGGCCGGCGCGCAGGCGGC 2634 Ser10 Term GGACGGGCGCGAGGCCC T AGCACTCGGAGAGCACGAGCCGGGC TCG-TAG CATTGCCGCCGTCAGCGGGGCGGGTGCGGGTGCGG CGAGTGCT A GGGCCTCG 2635 CGAGGCCC T AGCACTCG 2636 Reducing linolenic acid GCTCGGGCCTCGCGCCCGTCCGCCGCCTGCGCGCCGGCCGGGG 2637 omega-3 fatty acid CGCCATTGCGGCGCGGT G ACCCCCCGCGCTCTCCGCGGCGCCG desaturase CGCCGTCGTCCCGCGTCCGCGTCCATCCACCGCGA Zea mays TCGCGGTGGATGGACGCGGACGCGGGACGACGGCGCGGCGCCG 2638 Ser29 Term CGGAGAGCGCGGGGGGT C ACCGCGCCGCAATGGCGCCCCGGCC TCA-TGA GGCGCGCAGGCGGCGGACGGGCGCGAGGCCCGAGC GGCGCGGT G ACCCCCCG 2639 CGGGGGGT C ACCGCGCC 2640 Reducing linolenic acid CCCCCTCCCCCACGCACACGCACAGATCCATCCGCGGCCATGGC 2641 omega-3 fatty acid CCCCGCAATGAGGCCG T AGCAGGAGGCGAGCTGCAAGGCCACCG desaturase AGGACCACCGCTCCGAGTTCGACGCCGCCAAGC Triticum aestivum GCTTGGCGGCGTCGAACTCGGAGCGGTGGTCCTCGGTGGCCTTG 2642 Glu8 Term CAGCTCGCCTCCTGCT A CGGCCTCATTGCGGGGGCCATGGCCGC GAG-TAG GGATGGATCTGTGCGTGTGCGTGGGGGAGGGGG TGAGGCCG T AGCAGGAG 2643 CTCCTGCT A CGGCCTCA 2644 Reducing linolenic acid CCTCCCCCACGCACACGCACAGATCCATCCGCGGCCATGGCCCC 2645 omega-3 fatty acid CGCAATGAGGCCGGAG T AGGAGGCGAGCTGCAAGGCCACCGAG desaturase GACCACCGCTCCGAGTTCGACGCCGCCAAGCCGC Triticum aestivum GCGGCTTGGCGGCGTCGAACTCGGAGCGGTGGTCCTCGGTGGCC 2646 Gln9 Term TTGCAGCTCGCCTCCT A CTCCGGCCTCATTGCGGGGGCCATGGC CAG-TAG CGCGGATGGATCTGTGCGTGTGCGTGGGGGAGG GGCCGGAG T AGGAGGCG 2647 CGCCTCCT A CTCCGGCC 2648 Reducing linolenic acid CCCCCACGCACACGCACAGATCCATCCGCGGCCATGGCCCCCGC 2649 omega-3 fatty acid AATGAGGCCGGAGCAG T AGGCGAGCTGCAAGGCCACCGAGGACC desaturase ACCGCTCCGAGTTCGACGCCGCCAAGCCGCCGC Triticum aestivum GCGGCGGCTTGGCGGCGTCGAACTCGGAGCGGTGGTCCTCGGT 2650 Glu10 Term GGCCTTGCAGCTCGCCT A CTGCTCCGGCCTCATTGCGGGGGCCA GAG-TAG TGGCCGCGGATGGATCTGTGCGTGTGCGTGGGGG CGGAGCAG T AGGCGAGC 2651 GCTCGCCT A CTGCTCCG 2652 Reducing linolenic acid ACGCACAGATCCATCCGCGGCCATGGCCCCCGCAATGAGGCCGG 2653 omega-3 fatty acid AGCAGGAGGCGAGCTG A AAGGCCACCGAGGACCACCGCTCCGA desaturase GTTCGACGCCGCCAAGCCGCCGCCCTTCCGCATC Triticum aestivum GATGCGGAAGGGCGGCGGCTTGGCGGCGTCGAACTCGGAGCGG 2654 Cys13 TermTGGTCCTCGGTGGCCTT T CAGCTCGCCTCCTGCTCCGGCCTCATT TGC-TGA GCGGGGGCCATGGCCGCGGATGGATCTGTGCGT GCGAGCTG A AAGGCCAC 2655 GTGGCCTT T CAGCTCGC 2656 Reducing linolenic acid CTTCACAAATCACAAATCGGAATCAGATCCACCACGACACCCCGG 2657 omega-3 fatty acid CGGCAATGGCGGCGT A GGCGACCCAGGAGGCCGACTGCAAGGC desaturase TTCCGAGGACGCCCGTCTCTTCTTCGACGCCGC Oryza sativa GCGGCGTCGAAGAAGAGACGGGCGTCCTCGGAAGCCTTGCAGTC 2658 Ser4 Term GGCCTCCTGGGTCGCC T ACGCCGCCATTGCCGCCGGGGTGTCGT TCG-TAG GGTGGATCTGATTCCGATTTGTGATTTGTGAAG GGCGGCGT A GGCGACCC 2659 GGGTCGCC T ACGCCGCC 2660 Reducing linolenic acid ATCACAAATCGGAATCAGATCCACCACGACACCCCGGCGGCAATG 2661 omega-3 fatty acid GCGGCGTCGGCGACC T AGGAGGCCGACTGCAAGGCTTCCGAGGA desaturase CGCCCGTCTCTTCTTCGACGCCGCCAAGCCCC Oryza sativa GGGGCTTGGCGGCGTCGAAGAAGAGACGGGCGTCCTCGGAAGC 2662 Gln7 Term CTTGCAGTCGGCCTCCT A GGTCGCCGACGCCGCCATTGCCGCCG CAG-TAG GGGTGTCGTGGTGGATCTGATTCCGATTTGTGAT CGGCGACC T AGGAGGCC 2663 GGCCTCCT A GGTCGCCG 2664 Reducing linolenic acid ACAAATCGGAATCAGATCCACCACGACACCCCGGCGGCAATGGC 2665 omega-3 fatty acid GGCGTCGGCGACCCAG T AGGCCGACTGCAAGGCTTCCGAGGACG desaturase CCCGTCTCTTCTTCGACGCCGCCAAGCCCCCGC Oryza sativa GCGGGGGCTTGGCGGCGTCGAAGAAGAGACGGGCGTCCTCGGA 2666 Glu8 Term AGCCTTGCAGTCGGCCT A CTGGGTCGCCGACGCCGCCATTGCCG GAG-TAG CCGGGGTGTCGTGGTGGATCTGATTCCGATTTGT CGACCCAG T AGGCCGAC 2667 GTCGGCCT A CTGGGTCG 2668 Reducing linolenic acid TCAGATCCACCACGACACCCCGGCGGCAATGGCGGCGTCGGCGA 2669 omega-3 fatty acid CCCAGGAGGCCGACTG A AAGGCTTCCGAGGACGCCCGTCTCTTC desaturase TTCGACGCCGCCAAGCCCCCGCCCTTCCGCATC Oryza sativa GATGCGGAAGGGCGGGGGCTTGGCGGCGTCGAAGAAGAGACGG 2670 Cys10 Term GCGTCCTCGGAAGCCTT T CAGTCGGCCTCCTGGGTCGCCGACGC TGC-TGA CGCCATTGCCGCCGGGGTGTCGTGGTGGATCTGA GCCGACTG A AAGGCTTC 2671
Claims (20)
1. An oligonucleotide for targeted alteration of genetic sequence, comprising a single-stranded oligonucleotide having a DNA domain, said DNA domain having at least one mismatch with respect to the genetic sequence to be altered, and further comprising chemical modifications of the oligonucleotide, said chemical modifications selected from the group consisting of an o-methyl modification, an LNA modification including LNA derivatives and analogs, two or more phosphorothioate linkages on a terminus, and a combination of any two or more of these modifications.
2. The oligonucleotide according to claim one that comprises two or more phosphorothioate linkages on at least the 3′ terminus.
3. The oligonucleotide according to claim one that comprises a 2′-O-methyl analog.
4. The oligonucleotide according to claim one that comprises an LNA nucleotide, including an LNA derivative or analog.
5. The oligonucleotide according to claim one that comprises a combination of at least two modifications selected from the group of a phosphorothioate linkage, a 2′-O-methyl analog, a locked nucleotide analog and a ribonucleotide.
6. The oligonucleotide according to any one of claims 1 to 5 that comprises at least one unmodified ribonucleotide.
7. The oligonucleotide according to any one of claims 1 to 6 , wherein the sequence of said oligonucleotide is selected from the group consisting of SEQ ID NOS: 1-2672.
8. A method of targeted alteration of genetic material, comprising combining the target genetic material with an oligonucleotide according to any one of claims 1 to 7 in the presence of purified proteins.
9. A method of targeted alteration of genetic material, comprising administering to a cell extract an oligonucleotide of any one of claims 1 to 7 .
10. A method of targeted alteration of genetic material, comprising administering to a cell an oligonucleotide of any one of claims 1 to 7 .
11. A method of targeted alteration of genetic sequence in callus, comprising administering to the callus an oligonucleotide of any one of claims 1 to 7 .
12. A method of targeted alteration of genetic sequence, comprising combining target genetic material with an oligonucleotide according to any one of claims 1 to 7 , said target genetic material being a non-transcribed DNA strand of a duplex DNA.
13. The genetic material obtained by any one of the methods of claim 8 , 9 or claim 10 .
14. A cell comprising the genetic material of claim 13 .
15. A plant organism comprising the cell according to claim 14 .
16. A plant or plant part produced by the method of claim 11 .
17. A method of determining whether an oligonucleotide is optimized for targeted alteration of a genetic sequence, which comprises:
(a) comparing the efficiency of alteration of a targeted genetic sequence by an oligonucleotide of any one of claims 1 to 7 with the efficiency of alteration of the same targeted genetic sequence by a second oligonucleotide, said second oligonucleotide selected from the group of an oligonucleotide that lacks the mismatch, a fully modified phosphorothiolated oligonucleotide, a fully modified 2′-O-methylated oligonucleotide and a chimeric double-stranded double hairpin containing RNA and DNA nucleotides.
18. The method of claim 17 in which the alteration is produced in a plant cell extract.
19. The method of claim 17 in which the alteration is produced in a cell.
20. A kit comprising the oligonucleotide according to any one of claims 1 to 7 and a second oligonucleotide selected from the group of an oligonucleotide that lacks the mismatch, a fully modified phosphorothiolated oligonucleotide, a fully modified 2-O-methylated oligonucleotide and a chimeric double stranded double hairpin containing RNA and DNA nucleotides.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/307,005 US20030236208A1 (en) | 2000-06-01 | 2002-11-26 | Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20853800P | 2000-06-01 | 2000-06-01 | |
US24498900P | 2000-10-30 | 2000-10-30 | |
US09/818,875 US6936467B2 (en) | 2000-03-27 | 2001-03-27 | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
PCT/US2001/017672 WO2001092512A2 (en) | 2000-06-01 | 2001-06-01 | Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
US10/307,005 US20030236208A1 (en) | 2000-06-01 | 2002-11-26 | Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/017672 Continuation WO2001092512A2 (en) | 2000-06-01 | 2001-06-01 | Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030236208A1 true US20030236208A1 (en) | 2003-12-25 |
Family
ID=27395218
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/818,875 Expired - Fee Related US6936467B2 (en) | 2000-03-27 | 2001-03-27 | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
US10/209,787 Expired - Lifetime US7258854B2 (en) | 2000-03-27 | 2002-07-30 | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
US10/307,005 Abandoned US20030236208A1 (en) | 2000-06-01 | 2002-11-26 | Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/818,875 Expired - Fee Related US6936467B2 (en) | 2000-03-27 | 2001-03-27 | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
US10/209,787 Expired - Lifetime US7258854B2 (en) | 2000-03-27 | 2002-07-30 | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
Country Status (6)
Country | Link |
---|---|
US (3) | US6936467B2 (en) |
EP (1) | EP1297122A2 (en) |
AU (2) | AU6527701A (en) |
CA (1) | CA2410523A1 (en) |
IL (1) | IL153122A0 (en) |
WO (1) | WO2001092512A2 (en) |
Cited By (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006094084A2 (en) | 2005-03-02 | 2006-09-08 | Instituto Nacional De Tecnologia Agropecuaria | Herbicide-resistant rice plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
WO2007037676A1 (en) * | 2005-09-29 | 2007-04-05 | Keygene N.V. | Method and means for targeted nucleotide exchange |
US20070118920A1 (en) * | 2005-11-09 | 2007-05-24 | Basf Agrochemical Products B.V. | Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
US20080216187A1 (en) * | 2006-12-07 | 2008-09-04 | Kansas State University Research Foundation | Acetolactate Synthase Herbicide Resistant Sorghum |
US20090205064A1 (en) * | 2007-10-05 | 2009-08-13 | Christian Schopke | Mutated Acetohydroxyacid Synthase Genes in Brassica |
US20100115650A1 (en) * | 2007-04-04 | 2010-05-06 | Kening Yao | Herbicide-Resistant Brassica Plants and Methods of Use |
US20100287641A1 (en) * | 2007-04-04 | 2010-11-11 | Basf Plant Science Gmbh | Ahas mutants |
US20110126327A1 (en) * | 2008-05-06 | 2011-05-26 | Christopher Pittock | Herbicide resistant barley |
US20110209232A1 (en) * | 2005-07-01 | 2011-08-25 | Nidera Semillas S.A. | Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
US20110214196A1 (en) * | 2008-06-20 | 2011-09-01 | University Of Georgia Research Foundation | Development of herbicide-resistant grass species |
US20120060243A1 (en) * | 2008-09-26 | 2012-03-08 | Peter Beetham | Herbicide-Resistant AHAS-Mutants and Methods of Use |
WO2012074386A1 (en) | 2010-12-02 | 2012-06-07 | Keygene N.V. | Targeted alteration of dna with oligonucleotides |
WO2012074385A1 (en) | 2010-12-02 | 2012-06-07 | Keygene N.V. | Targeted alteration of dna |
US20120322102A1 (en) * | 2008-12-31 | 2012-12-20 | Sapphire Energy, Inc. | Genetically engineered herbicide resistant algae |
US20130074214A1 (en) * | 2008-09-25 | 2013-03-21 | University Of Guelph | Nitrogen Responsive Early Nodulin Gene |
US20130145498A1 (en) * | 2011-11-02 | 2013-06-06 | University Of North Texas | MtNIP REGULATED PLANTS WITH SIGNIFICANTLY INCREASED SIZE AND BIOMASS |
US20130167265A1 (en) * | 2010-08-30 | 2013-06-27 | David Panik | Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance |
US20130190170A1 (en) * | 2001-08-09 | 2013-07-25 | Northwest Plant Breeding Company | Wheat plants having increased resistance to imidazolinone herbicides |
US20130198896A1 (en) * | 2011-10-03 | 2013-08-01 | University Of Kentucky Research Foundation | Systems and methods for the production of linear and branched-chain hydrocarbons |
US20130205445A1 (en) * | 2010-03-27 | 2013-08-08 | Technische Universitat Kaiserslautern | Method of Enhancing the Seed Yield and Promoting the Growth of Plants |
US20130219560A1 (en) * | 2010-09-02 | 2013-08-22 | Richard T. Sayre | Reduction of post-harvest physiological deterioration |
US20130219563A1 (en) * | 2008-03-18 | 2013-08-22 | Mendel Biotechnology, Inc. | Enhancement of plant yield vigor and stress tolerance |
US20130326728A1 (en) * | 2010-12-08 | 2013-12-05 | Katholieke Universiteit Leuven | Agents for increased resistance against oxidative stress conditions |
US20140123342A1 (en) * | 2011-06-02 | 2014-05-01 | Board Of Regents, The University Of Texas System | Regulation of Stomatal Apertures by Apyrases and Extracellular Nucleotides |
US20140157457A1 (en) * | 2011-02-25 | 2014-06-05 | Plant Bioscience Limited | Plant protease |
US20140165229A1 (en) * | 2011-06-23 | 2014-06-12 | Basf Plant Science Company Gmbh | Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
US20140165228A1 (en) * | 2010-01-06 | 2014-06-12 | E.I. Dupont De Nemours | Identification of diurnal rhythms in photosynthetic and non-photosynthetic tissues from zea mays and use in improving crop plants |
US20140189906A1 (en) * | 2010-08-03 | 2014-07-03 | Cibus Europe B.V. | Mutated protoporphyrinogen ix oxidase (ppx) genes |
US20140199760A1 (en) * | 2011-05-20 | 2014-07-17 | University Of Toronto | Plants having enhanced abiotic stress resistance |
US20140223604A1 (en) * | 2011-05-13 | 2014-08-07 | Andy Pereira | Crop plants with improved water use efficiency and grain yield and methods of making them |
US20140234904A1 (en) * | 2011-10-06 | 2014-08-21 | University Of Wyoming | Method for harvesting photosynthetic unicells using genetically induced flotation |
US20140237684A1 (en) * | 2013-02-05 | 2014-08-21 | Clemson University | Methods and compositions for transgenic plants with enhanced resistance to biotic and abiotic stress |
US20140325699A1 (en) * | 2013-03-15 | 2014-10-30 | United States Of America, As Represented By The Secretary Of Agriculture | Engineering rubber production in plants |
US20140331347A1 (en) * | 2011-11-16 | 2014-11-06 | The State Of Queensland Acting Through The Department Of Agriculture, Fisheries And Forestry | Drought tolerant plants produced by modification of the stay-green stgx locus |
US20140359899A1 (en) * | 2011-12-08 | 2014-12-04 | Carnegie Institution Of Washington | Sucrose Transporters and Methods of Generating Pathogen-Resistant Plants |
US20150121570A1 (en) * | 2013-10-24 | 2015-04-30 | Industry-Academic Cooperation Foundation, Yonsei University | Gene implicated in drought stress tolerance and transformed plants with the same |
US20150128305A1 (en) * | 2012-05-07 | 2015-05-07 | National Institute Of Plant Genome Research | POLYNUCLEOTIDE ENCODING CaTLP1 PROTEIN AND USES THEREOF |
US20150135361A1 (en) * | 2011-05-10 | 2015-05-14 | China Agricultural University | Drought Tolerance Associated Protein DT1 and Coding Sequence and Application Thereof |
US20150135373A1 (en) * | 2012-06-21 | 2015-05-14 | Toyota Jidosha Kabushiki Kaisha | Technique for regulating flower bud formation in sugarcane |
US20150184193A1 (en) * | 2013-12-30 | 2015-07-02 | Dow Agrosciences Llc | Trait stacking strategy for corn introgression |
US20150203863A1 (en) * | 2011-03-31 | 2015-07-23 | Shanghai Institutes For Biological Sciences, Cas | Genetic engineering method and material for increasing plant yield |
US20150240251A1 (en) * | 2012-09-13 | 2015-08-27 | Postech Academy-Industry Foundation | Composition for regulating flowering of a plant containing the gene coding for abi3 protein |
US20150247161A1 (en) * | 2013-12-24 | 2015-09-03 | National Institute Of Plant Genome Research | METHOD OF PRODUCING STRESS TOLERANT PLANTS OVER-EXPRESSING OsAlba1 |
US20150252379A1 (en) * | 2010-12-16 | 2015-09-10 | Basf Se | Plants Having Increased Tolerance to Herbicides |
US20150315250A1 (en) * | 2014-05-02 | 2015-11-05 | Academia Sinica | Transgenic plants with increased trace element contents and methods for producing the same |
US9399772B2 (en) * | 2008-07-01 | 2016-07-26 | Arcadia Biosciences, Inc. | Tomatoes that soften more slowly post-harvest due to non-transgenic alterations in an expansin gene |
US20160222405A1 (en) * | 2007-04-04 | 2016-08-04 | Basf Agrochemical Products, B.V. | Herbicide-resistant sunflower plants with multiple herbicide resistant alleles of ahasl1 and methods of use |
US20160244774A1 (en) * | 2015-02-23 | 2016-08-25 | Sumitomo Rubber Industries, Ltd. | Vector comprising specific promoter and gene encoding specific protein, transgenic plant into which the vector has been introduced, and method for improving polyisoprenoid production by introducing the vector into plant |
US20160244776A1 (en) * | 2015-02-23 | 2016-08-25 | Sumitomo Rubber Industries, Ltd. | Vector comprising specific promoter and gene encoding specific protein, transgenic plant into which the vector has been introduced, and method for improving polyisoprenoid production by introducing the vector into plant |
US20160244773A1 (en) * | 2015-02-23 | 2016-08-25 | Sumitomo Rubber Industries, Ltd. | Vector comprising specific promoter and gene encoding specific protein, transgenic plant into which the vector has been introduced, and method for improving polyisoprenoid production by introducing the vector into plant |
US20160244775A1 (en) * | 2015-02-23 | 2016-08-25 | Sumitomo Rubber Industries, Ltd. | Vector comprising specific promoter and gene encoding specific protein, transgenic plant into which the vector has been introduced, and method for improving polyisoprenoid production by introducing the vector into plant |
US20160264987A1 (en) * | 2011-05-27 | 2016-09-15 | Industry-Academic Cooperation Foundation, Yonsei University | Gene associated with non-biological stress resistance, and transformed plant |
JP2016220685A (en) * | 2010-08-03 | 2016-12-28 | キブス ユーエス エルエルシー | Mutated protoporphyrinogen ix oxidase (ppx) genes |
US20170088854A1 (en) * | 2009-12-06 | 2017-03-30 | A.B. Seeds Ltd. | MicroRNA Compositions and Methods for Enhancing Plant Resistance to Abiotic Stress |
EP3178312A1 (en) | 2009-09-01 | 2017-06-14 | BASF Agrochemical Products, B.V. | Herbicide-tolerant plants |
KR101806342B1 (en) * | 2009-12-24 | 2017-12-07 | 고쿠리츠겐큐가이하츠호징 노우교 · 쇼쿠힝 산교기쥬츠 소고겐큐기코 | Gene Dro1 controlling deep-rooted characteristics of plant and utilization of same |
US20180080037A1 (en) * | 2014-04-11 | 2018-03-22 | Kws Saat Se | Tonoplast proton/sugar antiporter proteins and the use thereof to increase the saccharose concentration in a saccharose storage organ of plants |
US20180112228A1 (en) * | 2016-10-26 | 2018-04-26 | Salk Institute For Biological Studies | Environmental stress response transcriptional regulatory network |
US9957520B2 (en) | 2013-03-13 | 2018-05-01 | The Board Of Trustees Of The University Of Arkansas | Methods of increasing resistance of crop plants to heat stress and selecting crop plants with increased resistance to heat stress |
US10041087B2 (en) | 2012-06-19 | 2018-08-07 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US20180223304A1 (en) * | 2011-11-02 | 2018-08-09 | Ceres, Inc. | Transgenic plants having increased tolerance to aluminum |
US10087460B2 (en) | 2013-08-12 | 2018-10-02 | BASF Agro B.V. | Transgenic or non-transgenic plants with mutated protoporphyrinogen oxidase having increased tolerance to herbicides |
US10100329B2 (en) | 2012-06-19 | 2018-10-16 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US10106815B2 (en) * | 2016-01-22 | 2018-10-23 | Nanjing Agricultural University | Fusarium head blight resistant gene Tafhb1 of wheat and use thereof |
US10392630B2 (en) | 2013-08-12 | 2019-08-27 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US10494641B2 (en) * | 2013-12-27 | 2019-12-03 | Toyota Jidosha Kabushiki Kaisha | Transformed plant and method for producing exudate containing sugar using transformed plant |
CN110545659A (en) * | 2017-01-31 | 2019-12-06 | 赖斯泰克有限公司 | Effect of multiple mutations on increasing herbicide resistance/tolerance in Rice |
US11096346B2 (en) | 2009-09-01 | 2021-08-24 | Basf Se | Method for treating post-emergent rice |
US11111499B2 (en) | 2011-05-03 | 2021-09-07 | Evogene Ltd. | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
US11193140B2 (en) * | 2008-09-09 | 2021-12-07 | Stora Enso Oyj | Method for the alteration of plants using CLE polypeptides/peptides |
US11236365B2 (en) * | 2015-06-30 | 2022-02-01 | Sumitomo Rubber Industries, Ltd. | Method for producing polyisoprenoid, transformed plant, method for producing pneumatic tire and method for producing rubber product |
US20220073941A1 (en) * | 2019-01-02 | 2022-03-10 | Smart Earth Camelina Corp. | Herbicide-resistant camelina sativa plants, and variant camelina acetohydroxyacid synthase polypeptides |
US11312972B2 (en) * | 2016-11-16 | 2022-04-26 | Cellectis | Methods for altering amino acid content in plants through frameshift mutations |
Families Citing this family (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
OA12240A (en) * | 2000-03-27 | 2006-05-10 | Univ Delaware | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides. |
US6936467B2 (en) | 2000-03-27 | 2005-08-30 | University Of Delaware | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
WO2002026967A2 (en) * | 2000-09-25 | 2002-04-04 | Thomas Jefferson University | Targeted gene correction by single-stranded oligodeoxynucleotides |
WO2002079495A2 (en) | 2001-03-27 | 2002-10-10 | University Of Delaware | Genomics applications for modified oligonucleotides |
US7053195B1 (en) * | 2001-06-12 | 2006-05-30 | Syngenta Participatious Ag | Locked nucleic acid containing heteropolymers and related methods |
US20030109476A1 (en) * | 2001-08-07 | 2003-06-12 | Kmiec Eric B. | Compositions and methods for the prevention and treatment of Huntington's disease |
AU2002322212B8 (en) | 2001-08-09 | 2008-08-21 | University Of Saskatchewan | Wheat plants having increased resistance to imidazolinone herbicides |
US7897845B2 (en) | 2001-08-09 | 2011-03-01 | University Of Saskatchewan | Wheat plants having increased resistance to imidazolinone herbicides |
EP1448766A2 (en) * | 2001-09-27 | 2004-08-25 | University Of Delaware | Coisogenic eukaryotic cell collections |
US7468244B2 (en) | 2001-09-27 | 2008-12-23 | University Of Delaware | Polymorphism detection and separation |
EP1446503A2 (en) * | 2001-09-27 | 2004-08-18 | University Of Delaware | Composition and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration |
EP1466973A4 (en) * | 2001-12-20 | 2006-08-09 | Univ Okayama Nat Univ Corp | Characteristic base sequences occurring in plant genes and method of utilizing the same |
ATE458047T1 (en) * | 2002-03-07 | 2010-03-15 | Univ Delaware | METHOD FOR ENHANCING OLIGONUCLEOTIDE-MEDIATED NUCLEIC ACID SEQUENCE CHANGE USING COMPOSITIONS CONTAINING A HYDROXYUREA |
DE10221224A1 (en) * | 2002-05-13 | 2003-12-04 | Frommer Wolf Bernd | Process for the production of a transgenic plant with an altered mass transport |
WO2004016073A2 (en) | 2002-07-10 | 2004-02-26 | The Department Of Agriculture, Western Australia | Wheat plants having increased resistance to imidazolinone herbicides |
WO2004033708A2 (en) * | 2002-10-07 | 2004-04-22 | University Of Delaware | Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration |
CA2498511A1 (en) * | 2002-10-29 | 2004-05-13 | Basf Plant Science Gmbh | Compositions and methods for identifying plants having increased tolerance to imidazolinone herbicides |
WO2004040011A1 (en) * | 2002-10-29 | 2004-05-13 | Advanta Canada Inc. | Assay for imidazolinone resistance mutations in brassica species |
US20040198640A1 (en) * | 2003-04-02 | 2004-10-07 | Dharmacon, Inc. | Stabilized polynucleotides for use in RNA interference |
US20040205840A1 (en) * | 2003-04-11 | 2004-10-14 | Pioneer Hi-Bred International, Inc. | Method for reducing gene expression |
RS20050889A (en) | 2003-05-28 | 2008-04-04 | Basf Aktiengesellschaft, | Wheat plants having increased tolerance to imidaz olinone herbicides |
US20060281092A1 (en) * | 2003-07-24 | 2006-12-14 | Tanja Wille | Method for the reverse transcription and/or amplification of nucleic acids |
AU2004276226B2 (en) * | 2003-08-05 | 2009-07-30 | Avi Biopharma, Inc. | Oligonucleotide analog and method for treating flavivirus infections |
US7825235B2 (en) | 2003-08-18 | 2010-11-02 | Isis Pharmaceuticals, Inc. | Modulation of diacylglycerol acyltransferase 2 expression |
FR2866349B1 (en) * | 2004-02-12 | 2008-05-16 | Biomerieux Sa | METHOD FOR DIAGNOSING / PROGNOSING THROMBOSIS |
US7432082B2 (en) | 2004-03-22 | 2008-10-07 | Basf Ag | Methods and compositions for analyzing AHASL genes |
US8314226B2 (en) | 2004-03-29 | 2012-11-20 | The General Hospital Corporation | Oligonucleotide complex compositions and methods of use as gene alteration tools |
KR101147147B1 (en) * | 2004-04-01 | 2012-05-25 | 머크 샤프 앤드 돔 코포레이션 | Modified polynucleotides for reducing off-target effects in rna interference |
US7355098B2 (en) | 2004-06-22 | 2008-04-08 | Saskatchewan Wheat Poo1 | Brassica AHAS genes and gene alleles that provide resistance to imidazolinone herbicides |
US7759479B1 (en) * | 2004-09-13 | 2010-07-20 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to Gemin Genes |
US7923207B2 (en) | 2004-11-22 | 2011-04-12 | Dharmacon, Inc. | Apparatus and system having dry gene silencing pools |
US20060166234A1 (en) | 2004-11-22 | 2006-07-27 | Barbara Robertson | Apparatus and system having dry control gene silencing compositions |
US7935811B2 (en) | 2004-11-22 | 2011-05-03 | Dharmacon, Inc. | Apparatus and system having dry gene silencing compositions |
AR051690A1 (en) | 2004-12-01 | 2007-01-31 | Basf Agrochemical Products Bv | MUTATION INVOLVED IN THE INCREASE OF TOLERANCE TO IMIDAZOLINONE HERBICIDES IN PLANTS |
WO2007073149A1 (en) * | 2005-12-22 | 2007-06-28 | Keygene N.V. | Alternative nucleotides for improved targeted nucleotide exchange |
JP5713377B2 (en) | 2005-12-28 | 2015-05-07 | ザ スクリプス リサーチ インスティテュート | Natural antisense and non-coding RNA transcripts as drug targets |
JP5635772B2 (en) * | 2006-08-01 | 2014-12-03 | ジェン−プロウブ インコーポレイテッド | Method for capturing non-specific target of nucleic acid |
CA2663601C (en) | 2006-09-22 | 2014-11-25 | Dharmacon, Inc. | Duplex oligonucleotide complexes and methods for gene silencing by rna interference |
US20080124712A1 (en) * | 2006-10-26 | 2008-05-29 | Hantash Feras M | Alpha globin gene dosage assay |
UA108733C2 (en) | 2006-12-12 | 2015-06-10 | Sunflower herbicide tolerant to herbicide | |
US10017827B2 (en) | 2007-04-04 | 2018-07-10 | Nidera S.A. | Herbicide-resistant sunflower plants with multiple herbicide resistant alleles of AHASL1 and methods of use |
EP2152915A2 (en) * | 2007-05-14 | 2010-02-17 | Insight Genetics, Inc. | Methods of screening nucleic acids for single nucleotide variations |
KR20100051795A (en) * | 2007-06-22 | 2010-05-18 | 키진 엔.브이. | Targeted nucleotide exchange with improved modified oligonucleotides |
US7845686B2 (en) * | 2007-12-17 | 2010-12-07 | S & B Technical Products, Inc. | Restrained pipe joining system for plastic pipe |
US8188060B2 (en) | 2008-02-11 | 2012-05-29 | Dharmacon, Inc. | Duplex oligonucleotides with enhanced functionality in gene regulation |
AU2014262183B2 (en) * | 2008-05-06 | 2017-02-02 | Agriculture Victoria Services Pty Ltd | Herbicide resistant barley (2) |
EP2998397B1 (en) | 2008-09-11 | 2017-11-01 | Keygene N.V. | Method for diagnostic marker development |
CA2739464C (en) | 2008-10-03 | 2020-03-31 | Opko Curna, Llc | Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1 |
CN102317458B (en) | 2008-12-04 | 2018-01-02 | 库尔纳公司 | Pass through treatment of the suppression of erythropoietin(EPO) (EPO) natural antisense transcript to EPO relevant diseases |
US8927511B2 (en) | 2008-12-04 | 2015-01-06 | Curna, Inc. | Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGF |
WO2010065787A2 (en) | 2008-12-04 | 2010-06-10 | Curna, Inc. | Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene |
JP5766126B2 (en) | 2009-02-12 | 2015-08-19 | クルナ・インコーポレーテッド | Treatment of brain-derived neurotrophic factor (BDNF) -related diseases by suppression of natural antisense transcripts against BDNF |
EA021797B1 (en) | 2009-02-13 | 2015-09-30 | Икс-Чем, Инк. | Methods of creating and screening dna-encoded libraries |
CN102482677B (en) | 2009-03-16 | 2017-10-17 | 库尔纳公司 | Nuclear factor (red blood cell derives 2) sample 2 (NRF2) relevant disease is treated by suppressing NRF2 natural antisense transcript |
CN102549159B (en) | 2009-03-17 | 2016-08-10 | 库尔纳公司 | By suppressing to treat the disease that DLK1 is correlated with for the natural antisense transcript of δ sample 1 congener (DLK1) |
ES2609655T3 (en) | 2009-05-06 | 2017-04-21 | Curna, Inc. | Treatment of diseases related to tristetraproline (TTP) by inhibition of natural antisense transcript for TTP |
WO2010129799A2 (en) | 2009-05-06 | 2010-11-11 | Curna, Inc. | Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
WO2010129861A2 (en) | 2009-05-08 | 2010-11-11 | Curna, Inc. | Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family |
EP2432881B1 (en) | 2009-05-18 | 2017-11-15 | CuRNA, Inc. | Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor |
WO2010135695A2 (en) | 2009-05-22 | 2010-11-25 | Curna, Inc. | TREATMENT OF TRANSCRIPTION FACTOR E3 (TFE3) and INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TFE3 |
ES2618576T3 (en) | 2009-05-28 | 2017-06-21 | Curna, Inc. | Treatment of diseases related to an antiviral gene by inhibiting a natural antisense transcript to an antiviral gene |
JP6128846B2 (en) | 2009-06-16 | 2017-05-17 | クルナ・インコーポレーテッド | Treatment of PON1 gene-related diseases by suppression of natural antisense transcripts against paraoxonase (PON1) |
WO2010148050A2 (en) | 2009-06-16 | 2010-12-23 | Curna, Inc. | Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene |
WO2010151671A2 (en) | 2009-06-24 | 2010-12-29 | Curna, Inc. | Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2 |
CA2765815A1 (en) | 2009-06-26 | 2010-12-29 | Opko Curna, Llc | Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene |
CA2768947C (en) | 2009-07-24 | 2018-06-19 | Opko Curna, Llc | Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
CA2769665A1 (en) | 2009-08-05 | 2011-02-10 | Opko Curna, Llc | Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
ES2599986T3 (en) | 2009-08-11 | 2017-02-06 | Curna, Inc. | Treatment of adiponectin-related diseases (ADIPOQ) by inhibiting a natural antisense transcript of an adiponectin (ADIPOQ) |
EP2982755B1 (en) | 2009-08-21 | 2020-10-07 | CuRNA, Inc. | Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
KR101892760B1 (en) | 2009-08-25 | 2018-08-28 | 큐알엔에이, 인크. | Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap |
CA2775111C (en) | 2009-09-25 | 2019-12-31 | Opko Curna, Llc | Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity |
NO2513310T3 (en) | 2009-12-16 | 2018-03-31 | ||
CN102869776B (en) | 2009-12-23 | 2017-06-23 | 库尔纳公司 | HGF relevant diseases are treated by suppressing the natural antisense transcript of HGF (HGF) |
US9068183B2 (en) | 2009-12-23 | 2015-06-30 | Curna, Inc. | Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2 |
KR101853508B1 (en) | 2009-12-29 | 2018-06-20 | 큐알엔에이, 인크. | TREATMENT OF TUMOR PROTEIN 63 (p63) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO p63 |
CA2785173A1 (en) | 2009-12-29 | 2011-07-28 | Curna, Inc. | Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1 |
ES2677044T3 (en) | 2009-12-31 | 2018-07-27 | Curna, Inc. | Treatment of diseases related to insulin receptor substrate 2 (IRS2) by inhibition of natural antisense transcript for IRS2 and transcription factor E3 (TFE3) |
US8946181B2 (en) | 2010-01-04 | 2015-02-03 | Curna, Inc. | Treatment of interferon regulatory factor 8 (IRF8) related diseases by inhibition of natural antisense transcript to IRF8 |
RU2612161C2 (en) | 2010-01-06 | 2017-03-02 | Курна, Инк. | Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to pancreatic developmental gene |
WO2011085347A2 (en) | 2010-01-11 | 2011-07-14 | Opko Curna, Llc | Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg |
CN102782135A (en) | 2010-01-25 | 2012-11-14 | 库尔纳公司 | Treatment of RNase H1 related diseases by inhibition of natural antisense transcript to RNase H1 |
CA2790506A1 (en) | 2010-02-22 | 2011-08-25 | Curna, Inc. | Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1 |
CN102869777B (en) | 2010-04-02 | 2018-11-02 | 库尔纳公司 | CSF3 relevant diseases are treated by inhibiting the natural antisense transcript of colony stimulating factor 3 (CSF3) |
TWI644675B (en) | 2010-04-09 | 2018-12-21 | 可娜公司 | Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21 |
CN107988228B (en) | 2010-05-03 | 2022-01-25 | 库尔纳公司 | Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to Sirtuin (SIRT) |
TWI531370B (en) | 2010-05-14 | 2016-05-01 | 可娜公司 | Treatment of par4 related diseases by inhibition of natural antisense transcript to par4 |
DK2576783T3 (en) | 2010-05-26 | 2018-03-12 | Curna Inc | TREATMENT OF ATONAL HOMOLOGY 1- (ATOH1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPTS AT ATOH1 |
DK2576784T3 (en) | 2010-05-26 | 2018-02-26 | Curna Inc | TREATMENT OF METHIONIN SULPHOXIDE REDUCTASE A (MSRA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENCE TRANSCRIPTION TO MSRA |
CA2803882C (en) | 2010-06-23 | 2022-10-18 | Opko Curna, Llc | Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna |
NO2593547T3 (en) | 2010-07-14 | 2018-04-14 | ||
RU2624048C2 (en) | 2010-10-06 | 2017-06-30 | Курна, Инк. | Treatment of diseases associated with the sialidase 4 (neu4) gene, by gene neu4 natural antisense transcript inhibition |
JP6049623B2 (en) | 2010-10-22 | 2016-12-21 | カッパーアールエヌエー,インコーポレイテッド | Treatment of IDUA-related diseases by inhibition of natural antisense transcripts to α-L-iduronidase (IDUA) |
US10000752B2 (en) | 2010-11-18 | 2018-06-19 | Curna, Inc. | Antagonat compositions and methods of use |
JP6071893B2 (en) | 2010-11-23 | 2017-02-01 | カッパーアールエヌエー,インコーポレイテッド | Treatment of NANOG-related diseases by inhibition of natural antisense transcripts to NANOG |
CN103620036B (en) | 2011-06-09 | 2016-12-21 | 库尔纳公司 | FXN relevant disease is treated by the natural antisense transcript of suppression Frataxin (FXN) |
KR101991980B1 (en) | 2011-09-06 | 2019-06-21 | 큐알엔에이, 인크. | TREATMENT OF DISEASES RELATED TO ALPHA SUBUNITS OF SODIUM CHANNELS, VOLTAGE-GATED (SCNxA) WITH SMALL MOLECULES |
CA2848023C (en) | 2011-09-07 | 2022-03-15 | X-Chem, Inc. | Methods for tagging dna-encoded libraries |
US20140322717A1 (en) * | 2011-11-18 | 2014-10-30 | The Trustees Of Columbia University In The City Of New York | Selective amplification and detection of mutant gene alleles |
BR112014014664B1 (en) | 2011-12-16 | 2023-02-28 | Basf Agrochemical Products, B.V | METHOD FOR ANALYZING A PLANT AHASL GENE AND KIT FOR ANALYZING A PLANT AHASL GENE |
ES2694592T3 (en) | 2012-03-15 | 2018-12-21 | Curna, Inc. | Treatment of diseases related to brain-derived neurotrophic factor (BDNF) by inhibition of the natural antisense transcript of BDNF |
NZ703766A (en) | 2012-07-13 | 2018-03-23 | X Chem Inc | Dna-encoded libraries having encoding oligonucleotide linkages not readable by polymerases |
EP2966980A4 (en) | 2013-03-15 | 2016-12-28 | Cibus Us Llc | Methods and compositions for increasing efficiency of increased efficiency of targeted gene modification using oligonucleotide-mediated gene repair |
SI3102673T1 (en) | 2014-02-03 | 2020-11-30 | Sangamo Therapeutics, Inc. | Methods and compositions for treatment of a beta thalessemia |
PE20180800A1 (en) | 2015-07-10 | 2018-05-09 | Ionis Pharmaceuticals Inc | DIACIGLYCEROL ACILTRANSFERASE 2 (DGAT2) MODULATORS |
US20190300872A1 (en) | 2016-05-06 | 2019-10-03 | Tod M. Woolf | Improved Methods of Genome Editing with and without Programmable Nucleases |
AU2017340511B2 (en) * | 2016-10-04 | 2022-06-02 | Membrane Protective Technologies, Inc. | Systems and methods for natural cryoprotectants for preservation of cells |
EP3568470B1 (en) * | 2017-01-10 | 2022-07-06 | Christiana Care Health Services, Inc. | Methods for in vitro site-directed mutagenesis using gene editing technologies |
CN108396072B (en) * | 2018-03-21 | 2021-04-30 | 新疆维吾尔自治区药物研究所 | Method for rapidly identifying cichorium hirsutum and cichorium intybus |
CN110100732A (en) * | 2019-05-27 | 2019-08-09 | 东北林业大学 | A kind of black nightshade method for in-vitro rapid propagation |
Citations (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US51270A (en) * | 1865-11-28 | Improvement in children s bedclothes-retainers | ||
US119570A (en) * | 1871-10-03 | Improvement in coopers crozes and howels | ||
US163849A (en) * | 1875-06-01 | Improvement in grading apparatus | ||
US193334A (en) * | 1877-07-24 | Improvement in show-cases | ||
US217377A (en) * | 1879-07-08 | hislop | ||
US4459355A (en) * | 1982-07-12 | 1984-07-10 | International Paper Company | Method for transforming plant cells |
US5188642A (en) * | 1985-08-07 | 1993-02-23 | Monsanto Company | Glyphosate-resistant plants |
US5312910A (en) * | 1987-05-26 | 1994-05-17 | Monsanto Company | Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase |
US5422251A (en) * | 1986-11-26 | 1995-06-06 | Princeton University | Triple-stranded nucleic acids |
US5565350A (en) * | 1993-12-09 | 1996-10-15 | Thomas Jefferson University | Compounds and methods for site directed mutations in eukaryotic cells |
US5731181A (en) * | 1996-06-17 | 1998-03-24 | Thomas Jefferson University | Chimeric mutational vectors having non-natural nucleotides |
US5792903A (en) * | 1993-10-25 | 1998-08-11 | Yissum Research Development Company Of Hebrew University Of Jerusalem | Lycopene cyclase gene |
US5801154A (en) * | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
US5810222A (en) * | 1996-09-27 | 1998-09-22 | Shoemaker; Randy R. | Holster with handgun detent means |
US5880277A (en) * | 1994-07-15 | 1999-03-09 | City Of Hope | Ribozyme cleavage of 5α-reductase mRNA |
US5882941A (en) * | 1994-05-04 | 1999-03-16 | Massachusette Institute Of Technology | Programmable genotoxic agents and uses therefor |
US5905185A (en) * | 1995-11-30 | 1999-05-18 | Ppl Therapeutics | Protein C production in non-human transgenic mammals |
US5912340A (en) * | 1995-10-04 | 1999-06-15 | Epoch Pharmaceuticals, Inc. | Selective binding complementary oligonucleotides |
US5955363A (en) * | 1990-01-03 | 1999-09-21 | Promega Corporation | Vector for in vitro mutagenesis and use thereof |
US6004804A (en) * | 1998-05-12 | 1999-12-21 | Kimeragen, Inc. | Non-chimeric mutational vectors |
US6010907A (en) * | 1998-05-12 | 2000-01-04 | Kimeragen, Inc. | Eukaryotic use of non-chimeric mutational vectors |
US6046380A (en) * | 1994-05-03 | 2000-04-04 | Ppl Therapeutics (Scotland) Limited | Factor IX production in transgenic non-human mammals and factor IX DNA sequences with modified splice sites |
US6136601A (en) * | 1991-08-21 | 2000-10-24 | Epoch Pharmaceuticals, Inc. | Targeted mutagenesis in living cells using modified oligonucleotides |
US6271360B1 (en) * | 1999-08-27 | 2001-08-07 | Valigen (Us), Inc. | Single-stranded oligodeoxynucleotide mutational vectors |
US6387699B1 (en) * | 2000-09-08 | 2002-05-14 | Isis Pharmaceuticals, Inc. | Antisense inhibition of A20 expression |
US6528700B1 (en) * | 1997-11-18 | 2003-03-04 | Pioneer Hi-Bred International, Inc. | Targeted manipulation of genes in plants |
US6982169B2 (en) * | 2001-01-15 | 2006-01-03 | Morphotek, Inc. | Chemical inhibitors of mismatch repair |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ502929A (en) * | 1997-08-05 | 2001-09-28 | Kimeragen Inc | The use of mixed duplex oligonucleotides to effect localized genetic changes in plants |
EP1557424A1 (en) | 1997-09-12 | 2005-07-27 | Exiqon A/S | Bi-cyclic nucleoside, nucleotide and oligonucleoide analogues |
ATE465168T1 (en) | 1999-03-18 | 2010-05-15 | Exiqon As | XYLO-LNA ANALOGUE |
CN102180924A (en) | 1999-05-04 | 2011-09-14 | 桑塔里斯制药公司 | L-ribo-LNA analogues |
AR025996A1 (en) * | 1999-10-07 | 2002-12-26 | Valigen Us Inc | NON-TRANSGENIC PLANTS RESISTANT TO HERBICIDES. |
OA12240A (en) * | 2000-03-27 | 2006-05-10 | Univ Delaware | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides. |
US6936467B2 (en) | 2000-03-27 | 2005-08-30 | University Of Delaware | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
WO2002026967A2 (en) | 2000-09-25 | 2002-04-04 | Thomas Jefferson University | Targeted gene correction by single-stranded oligodeoxynucleotides |
-
2001
- 2001-03-27 US US09/818,875 patent/US6936467B2/en not_active Expired - Fee Related
- 2001-06-01 IL IL15312201A patent/IL153122A0/en unknown
- 2001-06-01 CA CA002410523A patent/CA2410523A1/en not_active Abandoned
- 2001-06-01 AU AU6527701A patent/AU6527701A/en active Pending
- 2001-06-01 AU AU2001265277A patent/AU2001265277B2/en not_active Ceased
- 2001-06-01 EP EP01939797A patent/EP1297122A2/en not_active Withdrawn
- 2001-06-01 WO PCT/US2001/017672 patent/WO2001092512A2/en not_active Application Discontinuation
-
2002
- 2002-07-30 US US10/209,787 patent/US7258854B2/en not_active Expired - Lifetime
- 2002-11-26 US US10/307,005 patent/US20030236208A1/en not_active Abandoned
Patent Citations (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US51270A (en) * | 1865-11-28 | Improvement in children s bedclothes-retainers | ||
US119570A (en) * | 1871-10-03 | Improvement in coopers crozes and howels | ||
US163849A (en) * | 1875-06-01 | Improvement in grading apparatus | ||
US193334A (en) * | 1877-07-24 | Improvement in show-cases | ||
US217377A (en) * | 1879-07-08 | hislop | ||
US4459355A (en) * | 1982-07-12 | 1984-07-10 | International Paper Company | Method for transforming plant cells |
US5188642A (en) * | 1985-08-07 | 1993-02-23 | Monsanto Company | Glyphosate-resistant plants |
US5422251A (en) * | 1986-11-26 | 1995-06-06 | Princeton University | Triple-stranded nucleic acids |
US5312910A (en) * | 1987-05-26 | 1994-05-17 | Monsanto Company | Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase |
US5955363A (en) * | 1990-01-03 | 1999-09-21 | Promega Corporation | Vector for in vitro mutagenesis and use thereof |
US6136601A (en) * | 1991-08-21 | 2000-10-24 | Epoch Pharmaceuticals, Inc. | Targeted mutagenesis in living cells using modified oligonucleotides |
US5801154A (en) * | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
US5792903A (en) * | 1993-10-25 | 1998-08-11 | Yissum Research Development Company Of Hebrew University Of Jerusalem | Lycopene cyclase gene |
US5565350A (en) * | 1993-12-09 | 1996-10-15 | Thomas Jefferson University | Compounds and methods for site directed mutations in eukaryotic cells |
US6046380A (en) * | 1994-05-03 | 2000-04-04 | Ppl Therapeutics (Scotland) Limited | Factor IX production in transgenic non-human mammals and factor IX DNA sequences with modified splice sites |
US5882941A (en) * | 1994-05-04 | 1999-03-16 | Massachusette Institute Of Technology | Programmable genotoxic agents and uses therefor |
US5880277A (en) * | 1994-07-15 | 1999-03-09 | City Of Hope | Ribozyme cleavage of 5α-reductase mRNA |
US5912340A (en) * | 1995-10-04 | 1999-06-15 | Epoch Pharmaceuticals, Inc. | Selective binding complementary oligonucleotides |
US5905185A (en) * | 1995-11-30 | 1999-05-18 | Ppl Therapeutics | Protein C production in non-human transgenic mammals |
US5731181A (en) * | 1996-06-17 | 1998-03-24 | Thomas Jefferson University | Chimeric mutational vectors having non-natural nucleotides |
US5810222A (en) * | 1996-09-27 | 1998-09-22 | Shoemaker; Randy R. | Holster with handgun detent means |
US6528700B1 (en) * | 1997-11-18 | 2003-03-04 | Pioneer Hi-Bred International, Inc. | Targeted manipulation of genes in plants |
US6010907A (en) * | 1998-05-12 | 2000-01-04 | Kimeragen, Inc. | Eukaryotic use of non-chimeric mutational vectors |
US6004804A (en) * | 1998-05-12 | 1999-12-21 | Kimeragen, Inc. | Non-chimeric mutational vectors |
US6271360B1 (en) * | 1999-08-27 | 2001-08-07 | Valigen (Us), Inc. | Single-stranded oligodeoxynucleotide mutational vectors |
US6479292B1 (en) * | 1999-08-27 | 2002-11-12 | Valigen (Us), Inc. | Genetic alteration in plants using single-stranded oligodeoxynucleotide vectors |
US6387699B1 (en) * | 2000-09-08 | 2002-05-14 | Isis Pharmaceuticals, Inc. | Antisense inhibition of A20 expression |
US6982169B2 (en) * | 2001-01-15 | 2006-01-03 | Morphotek, Inc. | Chemical inhibitors of mismatch repair |
Cited By (114)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11746343B2 (en) | 2001-08-09 | 2023-09-05 | Northwest Plant Breeding Company | Wheat plants having increased resistance to imidazolinone herbicides |
US20130190170A1 (en) * | 2001-08-09 | 2013-07-25 | Northwest Plant Breeding Company | Wheat plants having increased resistance to imidazolinone herbicides |
US20120233723A1 (en) * | 2005-03-02 | 2012-09-13 | Instituto Nacional De Tecnologia Agropecuaria | Herbicide-resistant rice plants, polynucleotides encoding herbicide resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
WO2006094084A2 (en) | 2005-03-02 | 2006-09-08 | Instituto Nacional De Tecnologia Agropecuaria | Herbicide-resistant rice plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
US20100029485A1 (en) * | 2005-03-02 | 2010-02-04 | Instituto Nacional De Tecnologia Agropecuaria | Herbicide-resistant rice plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
US20160230184A1 (en) * | 2005-07-01 | 2016-08-11 | Basf Aktiengesellschaft | Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
US20160222403A1 (en) * | 2005-07-01 | 2016-08-04 | Basf Aktiengesellschaft | Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
US20110209232A1 (en) * | 2005-07-01 | 2011-08-25 | Nidera Semillas S.A. | Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
WO2007037676A1 (en) * | 2005-09-29 | 2007-04-05 | Keygene N.V. | Method and means for targeted nucleotide exchange |
US20070118920A1 (en) * | 2005-11-09 | 2007-05-24 | Basf Agrochemical Products B.V. | Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use |
US10647991B2 (en) * | 2006-12-07 | 2020-05-12 | Kansas State University Research Foundation | Acetolactate synthase herbicide resistant sorghum |
US10519461B2 (en) * | 2006-12-07 | 2019-12-31 | Kansas State University Research Foundation | Acetolactate synthase herbicide resistant sorghum |
US10674690B2 (en) | 2006-12-07 | 2020-06-09 | Kansas State University Research Foundation | Acetolactate synthase herbicide resistant sorghum |
US20080216187A1 (en) * | 2006-12-07 | 2008-09-04 | Kansas State University Research Foundation | Acetolactate Synthase Herbicide Resistant Sorghum |
US20160222404A1 (en) * | 2007-04-04 | 2016-08-04 | Basf Agrochemical Products, B.V. | Herbicide-resistant sunflower plants with multiple herbicide resistant alleles of ahasl1 and methods of use |
US20160222405A1 (en) * | 2007-04-04 | 2016-08-04 | Basf Agrochemical Products, B.V. | Herbicide-resistant sunflower plants with multiple herbicide resistant alleles of ahasl1 and methods of use |
US20100287641A1 (en) * | 2007-04-04 | 2010-11-11 | Basf Plant Science Gmbh | Ahas mutants |
US20100115650A1 (en) * | 2007-04-04 | 2010-05-06 | Kening Yao | Herbicide-Resistant Brassica Plants and Methods of Use |
US20120178628A1 (en) * | 2007-10-05 | 2012-07-12 | Incima Us Llc | Mutated acetohydroxyacid synthase genes in brassica |
US20090205064A1 (en) * | 2007-10-05 | 2009-08-13 | Christian Schopke | Mutated Acetohydroxyacid Synthase Genes in Brassica |
US20130219563A1 (en) * | 2008-03-18 | 2013-08-22 | Mendel Biotechnology, Inc. | Enhancement of plant yield vigor and stress tolerance |
US8889951B2 (en) * | 2008-05-06 | 2014-11-18 | Agriculture Victoria Services Pty Ltd | Herbicide resistant barley expressing mutant acetohydroxy acid synthase |
US20110126327A1 (en) * | 2008-05-06 | 2011-05-26 | Christopher Pittock | Herbicide resistant barley |
US20110214196A1 (en) * | 2008-06-20 | 2011-09-01 | University Of Georgia Research Foundation | Development of herbicide-resistant grass species |
US9399772B2 (en) * | 2008-07-01 | 2016-07-26 | Arcadia Biosciences, Inc. | Tomatoes that soften more slowly post-harvest due to non-transgenic alterations in an expansin gene |
US11193140B2 (en) * | 2008-09-09 | 2021-12-07 | Stora Enso Oyj | Method for the alteration of plants using CLE polypeptides/peptides |
US20130074214A1 (en) * | 2008-09-25 | 2013-03-21 | University Of Guelph | Nitrogen Responsive Early Nodulin Gene |
US20120060243A1 (en) * | 2008-09-26 | 2012-03-08 | Peter Beetham | Herbicide-Resistant AHAS-Mutants and Methods of Use |
US20140335562A1 (en) * | 2008-12-31 | 2014-11-13 | Sapphire Energy, Inc. | Genetically Engineered Herbicide Resistant Algae |
US20120322102A1 (en) * | 2008-12-31 | 2012-12-20 | Sapphire Energy, Inc. | Genetically engineered herbicide resistant algae |
EP3178312A1 (en) | 2009-09-01 | 2017-06-14 | BASF Agrochemical Products, B.V. | Herbicide-tolerant plants |
US11096345B2 (en) | 2009-09-01 | 2021-08-24 | Basf Se | Method for treating post-emergent rice |
US11096346B2 (en) | 2009-09-01 | 2021-08-24 | Basf Se | Method for treating post-emergent rice |
US20170088854A1 (en) * | 2009-12-06 | 2017-03-30 | A.B. Seeds Ltd. | MicroRNA Compositions and Methods for Enhancing Plant Resistance to Abiotic Stress |
KR101806342B1 (en) * | 2009-12-24 | 2017-12-07 | 고쿠리츠겐큐가이하츠호징 노우교 · 쇼쿠힝 산교기쥬츠 소고겐큐기코 | Gene Dro1 controlling deep-rooted characteristics of plant and utilization of same |
US20140165228A1 (en) * | 2010-01-06 | 2014-06-12 | E.I. Dupont De Nemours | Identification of diurnal rhythms in photosynthetic and non-photosynthetic tissues from zea mays and use in improving crop plants |
US20130205445A1 (en) * | 2010-03-27 | 2013-08-08 | Technische Universitat Kaiserslautern | Method of Enhancing the Seed Yield and Promoting the Growth of Plants |
US11111500B2 (en) * | 2010-08-03 | 2021-09-07 | Cibus Us Llc | Mutated protoporphyrinogen IX oxidase (PPX) genes |
US20140189906A1 (en) * | 2010-08-03 | 2014-07-03 | Cibus Europe B.V. | Mutated protoporphyrinogen ix oxidase (ppx) genes |
JP2016220685A (en) * | 2010-08-03 | 2016-12-28 | キブス ユーエス エルエルシー | Mutated protoporphyrinogen ix oxidase (ppx) genes |
JP2019004899A (en) * | 2010-08-03 | 2019-01-17 | キブス ユーエス エルエルシー | Mutated protoporphyrinogen ix oxidase (ppx) genes |
US10457954B2 (en) * | 2010-08-30 | 2019-10-29 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance |
US11130957B2 (en) | 2010-08-30 | 2021-09-28 | Evogene Ltd. | Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance |
US20130167265A1 (en) * | 2010-08-30 | 2013-06-27 | David Panik | Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance |
US20130219560A1 (en) * | 2010-09-02 | 2013-08-22 | Richard T. Sayre | Reduction of post-harvest physiological deterioration |
EP2857512A1 (en) | 2010-12-02 | 2015-04-08 | Keygene N.V. | Targeted alteration of DNA |
US9518258B2 (en) | 2010-12-02 | 2016-12-13 | Keygene N.V. | Targeted alteration of DNA with oligonucleotides |
US9150854B2 (en) | 2010-12-02 | 2015-10-06 | Keygene N.V. | Targeted alteration of DNA |
WO2012074385A1 (en) | 2010-12-02 | 2012-06-07 | Keygene N.V. | Targeted alteration of dna |
WO2012074386A1 (en) | 2010-12-02 | 2012-06-07 | Keygene N.V. | Targeted alteration of dna with oligonucleotides |
US20130326728A1 (en) * | 2010-12-08 | 2013-12-05 | Katholieke Universiteit Leuven | Agents for increased resistance against oxidative stress conditions |
US11274313B2 (en) * | 2010-12-16 | 2022-03-15 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US20150252379A1 (en) * | 2010-12-16 | 2015-09-10 | Basf Se | Plants Having Increased Tolerance to Herbicides |
US20140157457A1 (en) * | 2011-02-25 | 2014-06-05 | Plant Bioscience Limited | Plant protease |
US20150203863A1 (en) * | 2011-03-31 | 2015-07-23 | Shanghai Institutes For Biological Sciences, Cas | Genetic engineering method and material for increasing plant yield |
US11111499B2 (en) | 2011-05-03 | 2021-09-07 | Evogene Ltd. | Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency |
US9879276B2 (en) * | 2011-05-10 | 2018-01-30 | China Agricultural University | Drought tolerance associated protein DT1 and coding sequence and application thereof |
US20150135361A1 (en) * | 2011-05-10 | 2015-05-14 | China Agricultural University | Drought Tolerance Associated Protein DT1 and Coding Sequence and Application Thereof |
US20140223604A1 (en) * | 2011-05-13 | 2014-08-07 | Andy Pereira | Crop plants with improved water use efficiency and grain yield and methods of making them |
US20140199760A1 (en) * | 2011-05-20 | 2014-07-17 | University Of Toronto | Plants having enhanced abiotic stress resistance |
US20160264987A1 (en) * | 2011-05-27 | 2016-09-15 | Industry-Academic Cooperation Foundation, Yonsei University | Gene associated with non-biological stress resistance, and transformed plant |
US20140123342A1 (en) * | 2011-06-02 | 2014-05-01 | Board Of Regents, The University Of Texas System | Regulation of Stomatal Apertures by Apyrases and Extracellular Nucleotides |
US20140165229A1 (en) * | 2011-06-23 | 2014-06-12 | Basf Plant Science Company Gmbh | Plants Having Enhanced Yield-Related Traits and a Method for Making the Same |
US20130198896A1 (en) * | 2011-10-03 | 2013-08-01 | University Of Kentucky Research Foundation | Systems and methods for the production of linear and branched-chain hydrocarbons |
US11149282B2 (en) * | 2011-10-03 | 2021-10-19 | University Of Kentucky Research Foundation | Systems and methods for the production of linear and branched-chain hydrocarbons |
US20140234904A1 (en) * | 2011-10-06 | 2014-08-21 | University Of Wyoming | Method for harvesting photosynthetic unicells using genetically induced flotation |
US20180223304A1 (en) * | 2011-11-02 | 2018-08-09 | Ceres, Inc. | Transgenic plants having increased tolerance to aluminum |
US10557143B2 (en) * | 2011-11-02 | 2020-02-11 | Ceres, Inc. | Transgenic plants having increased tolerance to aluminum |
US20130145498A1 (en) * | 2011-11-02 | 2013-06-06 | University Of North Texas | MtNIP REGULATED PLANTS WITH SIGNIFICANTLY INCREASED SIZE AND BIOMASS |
US10472646B2 (en) | 2011-11-02 | 2019-11-12 | Ceres, Inc. | Transgenic plants having increased tolerance to aluminum |
US9297021B2 (en) * | 2011-11-02 | 2016-03-29 | University Of North Texas | MtNIP regulated plants with significantly increased size and biomass |
US10590431B2 (en) * | 2011-11-16 | 2020-03-17 | The State Of Queensland | Drought tolerant plants produced by modification of the stay-green STGX locus |
US20140331347A1 (en) * | 2011-11-16 | 2014-11-06 | The State Of Queensland Acting Through The Department Of Agriculture, Fisheries And Forestry | Drought tolerant plants produced by modification of the stay-green stgx locus |
US20140359899A1 (en) * | 2011-12-08 | 2014-12-04 | Carnegie Institution Of Washington | Sucrose Transporters and Methods of Generating Pathogen-Resistant Plants |
US20150128305A1 (en) * | 2012-05-07 | 2015-05-07 | National Institute Of Plant Genome Research | POLYNUCLEOTIDE ENCODING CaTLP1 PROTEIN AND USES THEREOF |
US10041087B2 (en) | 2012-06-19 | 2018-08-07 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US10100329B2 (en) | 2012-06-19 | 2018-10-16 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US11441154B2 (en) | 2012-06-19 | 2022-09-13 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US11572571B2 (en) * | 2012-06-19 | 2023-02-07 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US9512441B2 (en) * | 2012-06-21 | 2016-12-06 | Toyota Jidosha Kabushiki Kaisha | Technique for regulating flower bud formation in sugarcane |
US20150135373A1 (en) * | 2012-06-21 | 2015-05-14 | Toyota Jidosha Kabushiki Kaisha | Technique for regulating flower bud formation in sugarcane |
US20150240251A1 (en) * | 2012-09-13 | 2015-08-27 | Postech Academy-Industry Foundation | Composition for regulating flowering of a plant containing the gene coding for abi3 protein |
US9441241B2 (en) * | 2013-02-05 | 2016-09-13 | Clemson University | Methods and compositions for transgenic plants with enhanced resistance to biotic and abiotic stress |
US20140237684A1 (en) * | 2013-02-05 | 2014-08-21 | Clemson University | Methods and compositions for transgenic plants with enhanced resistance to biotic and abiotic stress |
US10801034B2 (en) | 2013-03-13 | 2020-10-13 | The Board Of Trustees Of The University Of Arkansas | Methods of increasing resistance of crop plants to heat stress and selecting crop plants with increased resistance to heat stress |
US9957520B2 (en) | 2013-03-13 | 2018-05-01 | The Board Of Trustees Of The University Of Arkansas | Methods of increasing resistance of crop plants to heat stress and selecting crop plants with increased resistance to heat stress |
US9523097B2 (en) * | 2013-03-15 | 2016-12-20 | The United States Of America, As Represented By The Secretary Of Agriculture | Engineering rubber production in plants |
US20140325699A1 (en) * | 2013-03-15 | 2014-10-30 | United States Of America, As Represented By The Secretary Of Agriculture | Engineering rubber production in plants |
US11866720B2 (en) | 2013-08-12 | 2024-01-09 | BASF Agro B.V. | Transgenic or non-transgenic plants with mutated protoporphyrinogen oxidase having increased tolerance to herbicides |
US11827896B2 (en) | 2013-08-12 | 2023-11-28 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US10087460B2 (en) | 2013-08-12 | 2018-10-02 | BASF Agro B.V. | Transgenic or non-transgenic plants with mutated protoporphyrinogen oxidase having increased tolerance to herbicides |
US10968462B2 (en) | 2013-08-12 | 2021-04-06 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US10982227B2 (en) | 2013-08-12 | 2021-04-20 | BASF Agro B.V. | Transgenic or non-transgenic plants with mutated protoporphyrinogen oxidase having increased tolerance to herbicides |
US10392630B2 (en) | 2013-08-12 | 2019-08-27 | BASF Agro B.V. | Plants having increased tolerance to herbicides |
US20150121570A1 (en) * | 2013-10-24 | 2015-04-30 | Industry-Academic Cooperation Foundation, Yonsei University | Gene implicated in drought stress tolerance and transformed plants with the same |
US20150247161A1 (en) * | 2013-12-24 | 2015-09-03 | National Institute Of Plant Genome Research | METHOD OF PRODUCING STRESS TOLERANT PLANTS OVER-EXPRESSING OsAlba1 |
US10494641B2 (en) * | 2013-12-27 | 2019-12-03 | Toyota Jidosha Kabushiki Kaisha | Transformed plant and method for producing exudate containing sugar using transformed plant |
US20150184193A1 (en) * | 2013-12-30 | 2015-07-02 | Dow Agrosciences Llc | Trait stacking strategy for corn introgression |
US10961543B2 (en) * | 2014-04-11 | 2021-03-30 | KWS SAAT SE & Co. KGaA | Tonoplast proton/sugar antiporter proteins and the use thereof to increase the saccharose concentration in a saccharose storage organ of plants |
US20180080037A1 (en) * | 2014-04-11 | 2018-03-22 | Kws Saat Se | Tonoplast proton/sugar antiporter proteins and the use thereof to increase the saccharose concentration in a saccharose storage organ of plants |
CN105441475A (en) * | 2014-05-02 | 2016-03-30 | 中央研究院 | Transgenic plants with increased trace element contents and methods for producing the same |
US20150315250A1 (en) * | 2014-05-02 | 2015-11-05 | Academia Sinica | Transgenic plants with increased trace element contents and methods for producing the same |
US20160244773A1 (en) * | 2015-02-23 | 2016-08-25 | Sumitomo Rubber Industries, Ltd. | Vector comprising specific promoter and gene encoding specific protein, transgenic plant into which the vector has been introduced, and method for improving polyisoprenoid production by introducing the vector into plant |
US20160244776A1 (en) * | 2015-02-23 | 2016-08-25 | Sumitomo Rubber Industries, Ltd. | Vector comprising specific promoter and gene encoding specific protein, transgenic plant into which the vector has been introduced, and method for improving polyisoprenoid production by introducing the vector into plant |
US20160244774A1 (en) * | 2015-02-23 | 2016-08-25 | Sumitomo Rubber Industries, Ltd. | Vector comprising specific promoter and gene encoding specific protein, transgenic plant into which the vector has been introduced, and method for improving polyisoprenoid production by introducing the vector into plant |
US20160244775A1 (en) * | 2015-02-23 | 2016-08-25 | Sumitomo Rubber Industries, Ltd. | Vector comprising specific promoter and gene encoding specific protein, transgenic plant into which the vector has been introduced, and method for improving polyisoprenoid production by introducing the vector into plant |
US11236365B2 (en) * | 2015-06-30 | 2022-02-01 | Sumitomo Rubber Industries, Ltd. | Method for producing polyisoprenoid, transformed plant, method for producing pneumatic tire and method for producing rubber product |
US10106815B2 (en) * | 2016-01-22 | 2018-10-23 | Nanjing Agricultural University | Fusarium head blight resistant gene Tafhb1 of wheat and use thereof |
US20180112228A1 (en) * | 2016-10-26 | 2018-04-26 | Salk Institute For Biological Studies | Environmental stress response transcriptional regulatory network |
US10913952B2 (en) * | 2016-10-26 | 2021-02-09 | Salk Institute For Biological Studies | Environmental stress response transcriptional regulatory network |
US11312972B2 (en) * | 2016-11-16 | 2022-04-26 | Cellectis | Methods for altering amino acid content in plants through frameshift mutations |
CN110545659A (en) * | 2017-01-31 | 2019-12-06 | 赖斯泰克有限公司 | Effect of multiple mutations on increasing herbicide resistance/tolerance in Rice |
US11877553B2 (en) * | 2017-01-31 | 2024-01-23 | Ricetec, Inc. | Effects of a plurality of mutations to improve herbicide resistance/tolerance in rice |
US20220073941A1 (en) * | 2019-01-02 | 2022-03-10 | Smart Earth Camelina Corp. | Herbicide-resistant camelina sativa plants, and variant camelina acetohydroxyacid synthase polypeptides |
Also Published As
Publication number | Publication date |
---|---|
WO2001092512A2 (en) | 2001-12-06 |
AU2001265277B2 (en) | 2006-09-07 |
WO2001092512A3 (en) | 2003-01-09 |
EP1297122A2 (en) | 2003-04-02 |
US7258854B2 (en) | 2007-08-21 |
US20030217377A1 (en) | 2003-11-20 |
AU6527701A (en) | 2001-12-11 |
US6936467B2 (en) | 2005-08-30 |
IL153122A0 (en) | 2003-06-24 |
US20030051270A1 (en) | 2003-03-13 |
CA2410523A1 (en) | 2001-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001265277B2 (en) | Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides | |
AU2001265277A1 (en) | Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides | |
AU2013203454B2 (en) | Improved techniques for transfecting protoplasts | |
US20070122822A1 (en) | Compositions and methods for enhancing oligonucleotide-directed nucleic acid sequence alteration | |
NZ582721A (en) | Targeted nucleotide exchange with improved modified oligonucleotides | |
CA2404780A1 (en) | Targeted chromosomal genomic alterations with modified single stranded oligonucleotides | |
WO2003104451A2 (en) | Modifying dna recombination and repair | |
DK2857512T3 (en) | Targeted DNA change | |
EP1490013B1 (en) | Methods for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising hydroxyurea | |
US20110312094A1 (en) | Use of double stranded rna to increase the efficiency of targeted gene alteration in plant protoplasts | |
CN111954462A (en) | FAD2 gene and mutations | |
NZ524366A (en) | Methods for enhancing targeted gene alteration using oligonucleotides | |
CA3080234A1 (en) | Lodging resistance in plants | |
US10676755B2 (en) | Mutated acetohydroxyacid synthase genes in euphorbiaceae and plant material comprising such genes | |
ZA200209833B (en) | Targeted chromosomal genomic alterations in plants using modified single stranded oligonucleotides. | |
US20040175722A1 (en) | Methods and compositions for reducing screening in oligonucleotide-directed nucleic acid sequence alteration | |
CN114787364A (en) | TAL effector nucleases for gene editing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: UNIVERSITY OF DELAWARE, DELAWARE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KMIEC, ERIC B.;GAMPER, HOWARD B.;RICE, MICHAEL C.;AND OTHERS;REEL/FRAME:014341/0378 Effective date: 20010525 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |